{"updated":"2026-10-30","grades":[["A","Consistent results from several randomized trials or a systematic review of them"],["B","Some positive randomized trials, but small, short, few or inconsistent"],["C","Limited human evidence: single small trials, observational data or mixed results"],["D","Laboratory or animal evidence only; not shown in people"],["X","Well-designed human trials found no meaningful effect"]],"cats":["Botanical","Mushroom","Marine and algae","Vitamin","Mineral","Amino acid and protein","Fatty acid","Probiotic","Other"],"classes":[[1,"Well studied in people"],[2,"Moderately studied in people"],[3,"Limited studies in people"],[4,"Animal studies only"],[5,"Laboratory studies only"]],"outcomes":[["headache-migraine","Headache and migraine","/atlas/supplements/effects/headache-migraine/"],["menstrual-pms","Menstrual pain and PMS","/atlas/supplements/effects/menstrual-pms/"],["menopause","Menopause","/atlas/supplements/effects/menopause/"],["fertility-pregnancy","Fertility and pregnancy","/atlas/supplements/effects/fertility-pregnancy/"],["sleep","Sleep","/atlas/supplements/effects/sleep/"],["anxiety-stress","Anxiety, stress and cortisol","/atlas/supplements/effects/anxiety-stress/"],["mood","Mood and depression","/atlas/supplements/effects/mood/"],["cognition","Memory and cognition","/atlas/supplements/effects/cognition/"],["energy-exercise","Energy, exercise and muscle","/atlas/supplements/effects/energy-exercise/"],["hydration-electrolytes","Hydration and electrolytes","/atlas/supplements/effects/hydration-electrolytes/"],["inflammation-joints","Inflammation, joints and pain","/atlas/supplements/effects/inflammation-joints/"],["aging-skin","Skin, hair and healthy aging","/atlas/supplements/effects/aging-skin/"],["heart-blood-pressure","Heart, lipids and blood pressure","/atlas/supplements/effects/heart-blood-pressure/"],["blood-sugar","Blood sugar and weight","/atlas/supplements/effects/blood-sugar/"],["digestion","Digestion and gut","/atlas/supplements/effects/digestion/"],["immune-infection","Colds and immune function","/atlas/supplements/effects/immune-infection/"],["liver-kidney","Liver and kidney","/atlas/supplements/effects/liver-kidney/"],["bone","Bone health","/atlas/supplements/effects/bone/"],["cancer","Cancer research","/atlas/supplements/effects/cancer/"],["urinary-prostate","Urinary tract and prostate","/atlas/supplements/effects/urinary-prostate/"],["eyes","Eyes and vision","/atlas/supplements/effects/eyes/"]],"ingredients":[["butterbur","Butterbur",0,2,"Petasites hybridus","Root and leaf (extracts)","Asteraceae","Europe to N. Iran, Algeria",["Petasins (sesquiterpenes), considered the active constituents","Pyrrolizidine alkaloids (PAs), which can damage the liver and lungs and may cause cancer"]],["magnesium","Magnesium",4,1,"","Magnesium aspartate, citrate, lactate, chloride, oxide, sulfate and other salts (labels state elemental magnesium)","","",["Magnesium aspartate, citrate, lactate and chloride (appear more bioavailable than oxide and sulfate in small studies)"]],["riboflavin","Riboflavin (vitamin B2)",3,1,"","Free riboflavin (most supplements); riboflavin 5'-phosphate","","",[]],["5-htp","5-HTP (5-hydroxytryptophan)",5,2,"","5-Hydroxy-L-tryptophan from Griffonia simplicifolia seed, synthetic L-5-HTP, or whole-cell biosynthesis (E. coli, S. cerevisiae)","","",["5-Hydroxy-L-tryptophan, the immediate precursor of serotonin (5-hydroxytryptamine) in its biosynthesis from L-tryptophan"]],["feverfew","Feverfew",0,2,"Tanacetum parthenium (L.) Schultz Bip.","Herb (Tanaceti parthenii herba in the EU monograph); leaves","Asteraceae","SE. Europe to W. Himalaya",["Sesquiterpene lactones, particularly parthenolide, are considered the active constituents"]],["peppermint-oil","Peppermint oil",0,1,"Mentha x piperita","Essential oil from flowering parts and leaves","","",["Menthol"]],["resveratrol","Resveratrol",8,1,"","Purified resveratrol (sources include grapes and Japanese knotweed)","","",[]],["vitex-chasteberry","Chasteberry (vitex)",0,1,"Vitex agnus-castus L.","Fruit (other products: leaves, stems, flowers, seeds)","Lamiaceae","Medit. to C. Asia and India (NW. Rajasthan)",["Flavonoids including casticin and apigenin; diterpenes such as clerodadienols and rotundifuran with dopaminergic activity in vitro"]],["fennel","Fennel",0,1,"Foeniculum vulgare Mill.","Dried fruit (\"seed\"); fennel oil","Apiaceae","Medit. to Ethiopia and W. Nepal",["Volatile oil composed largely of anethole, with fenchone, estragole, 1,8-cineole (eucalyptol) and other constituents"]],["saffron","Saffron",0,1,"Crocus sativus L.","Stigma (dried)","Iridaceae","as a cultigen from Greece",["Crocin, crocetin and safranal, with phenolic compounds"]],["vitamin-b6","Vitamin B6",3,2,"","Pyridoxine hydrochloride (most common); pyridoxal 5'-phosphate (PLP)","","",[]],["costus","Costus root",0,3,"Dolomiaea costus (Falc.) Kasana & A.K.Pandey","Dried root (the popular medicinal material comes from cultivated plants)","Asteraceae","N. Pakistan to China and N. Vietnam",["Sesquiterpene lactones costunolide and dehydrocostus lactone, described as its core active metabolites","335 compounds reported, including sesquiterpenes, sesquiterpene dimers and flavonoids"]],["dong-quai","Dong quai",0,3,"Angelica sinensis (Oliv.) Diels","Root (the European Pharmacopoeia describes smoke-dried root)","Apiaceae","N. & C. China",["Alkyl phthalides such as (Z)-ligustilide (main essential-oil components) and ferulic acid","Coumarins, including phototoxic furocoumarins (bergapten, psoralen, imperatorin), plus safrole and isosafrole in the essential oil, with no quantitative data"]],["fenugreek","Fenugreek",0,1,"Trigonella foenum-graecum","Seed","Fabaceae","Iraq to N. Pakistan",[]],["ginger","Ginger",0,1,"Zingiber officinale Roscoe","Rhizome","Zingiberaceae","E. Himalaya to SC. China",["Volatile oil (2% to 3%) and pungent phenolic compounds, including gingerols, shogaols, gingerdiols and diarylheptanoids; about 50% starch by weight"]],["lemon-balm","Lemon balm",0,1,"Melissa officinalis L.","Leaf","Lamiaceae","Medit. to C. Asia",["Phenolic acids (mainly rosmarinic acid and caffeic acid); essential-oil components citral, citronellal, geraniol and linalool; triterpenes ursolic and oleanolic acid"]],["pau-darco","Pau d'arco",0,3,"Handroanthus impetiginosus (Mart. ex DC.) Mattos","Inner bark","Bignoniaceae","C. Mexico to S. Trop. America",["Lapachol and beta-lapachone (naphthoquinones), thought to be the active constituents"]],["phosphatidylserine","Phosphatidylserine",8,2,"","Soy-derived phosphatidylserine; phosphatidylserine–phosphatidic acid complex (PAS)","","",[]],["royal-jelly","Royal jelly",8,1,"","Fresh royal jelly, dried or powdered royal jelly and non-standardized extracts, per Health Canada's monograph; lyophilized royal jelly powder is also sold","","",["Major royal jelly proteins; MSK reports major royal jelly protein 3 was identified as the main allergen that can induce anaphylaxis","Fatty acids and a sterol with weak estrogenic activity in laboratory studies, per MSK"]],["red-clover","Red clover",0,1,"Trifolium pratense L.","Flower, herb top and leaf, as standardized isoflavone extracts","Fabaceae","Macaronesia, NW. Africa, Europe to Mongolia and Himalaya",["Isoflavones, structurally similar to estrogen","Isoflavones biochanin A, genistein, formononetin and daidzein (potencies may be declared for each, in mg aglycone isoflavone equivalents)"]],["soy-isoflavones","Soy isoflavones",8,1,"","Isolated soy isoflavones (extracts), as aglycones or beta-glycosides; some studied isoflavones were chemically synthesized","","",["Isoflavones genistein, daidzein and glycitein","Aglycones (genistein, daidzein) and their beta-glycosides; glycitin is hydrolyzed to glycitein in the body"]],["bee-pollen","Bee pollen",8,3,"","Bee pollen granules, sold as a food and as dietary supplements (including capsules)","","",["Proteins, amino acids, lipids, carbohydrates, minerals, vitamins and polyphenols, per a 2021 review"]],["black-cohosh","Black cohosh",0,1,"Actaea racemosa (Cimicifuga racemosa)","Root and rhizome","Ranunculaceae","SE. Canada to NC. & E. U.S.A.",["Triterpene glycosides (actein, 23-epi-26-deoxyactein, cimicifugoside), resins (cimicifugin) and aromatic acid derivatives (caffeic, isoferulic, fukinolic acids); the active compounds are unknown"]],["hops","Hops",0,1,"Humulus lupulus L.","Female inflorescences (strobiles)","Cannabaceae","Europe to Siberia and N. Iran, Morocco",["Prenyl flavonoids xanthohumol, isoxanthohumol and 8-prenylnaringenin (a potent phytoestrogen); isohumulones (isohumulone, isocohumulone, isoadhumulone)"]],["lavender","Lavender",0,1,"Lavandula angustifolia Mill.","Flowering tops; essential oil","Lamiaceae","NE. Spain to Italy",["Linalool and linalyl acetate (major constituents); 1,8-cineole"]],["maca","Maca",0,2,"Lepidium meyenii Walp.","Hypocotyl and root (dried, raw or gelatinized powder; extracts)","Brassicaceae","S. Peru to NW. Argentina",["Principal components are carbohydrates and protein; secondary components include macaridine, macaenes, macamides, maca alkaloids, sterols and glucosinolates","Glucosinolates, mostly benzylglucosinolate; macamides are normally not present in fresh plants but are introduced during traditional drying; composition differences among red, yellow, purple and black phenotypes may be associated with different biological effects"]],["sage","Sage",0,2,"Salvia officinalis L.","Leaf (as tea, extracts, tinctures); sage oil","Lamiaceae","SW. Germany to S. Europe",["Tannins (salviatannin); essential oil with alpha- and beta-thujone, 1,8-cineole and camphor; flavones, phenolic acids, phenylpropanoid glycosides, triterpenoids and diterpenes"]],["schisandra","Schisandra",0,2,"Schisandra chinensis (Turcz.) Baill.","Fruit","Schisandraceae","Russian Far East to N. China and C. Japan",["Lignans, notably schisandrin A and schisantherins","Polysaccharides; an anthocyanin identified as responsible for its antioxidant activity"]],["sea-buckthorn","Sea buckthorn",0,2,"Hippophae rhamnoides L.","Berries (fruit pulp oil, seed oil, juice, powder); leaves","Elaeagnaceae","Europe to S. Siberia and SC. China",["Sea buckthorn oil containing linoleic and alpha-linolenic acids; carotenoids and tocopherols in the oil are discussed as possible contributors to its effects","Carotenoids (total 53-97 mg/100 g dry weight in berries of six varieties), mainly as di-esters, with zeaxanthin di-palmitate the major compound"]],["shatavari","Shatavari",0,1,"Asparagus racemosus Willd.","Root","Asparagaceae","Trop. Africa to N. Australia",["Steroidal saponins (shatavarins), asparagamine, racemosol, polysaccharides, mucilage, flavonoids and polyphenols"]],["valerian","Valerian",0,1,"Valeriana officinalis L.","Roots and rhizomes","Caprifoliaceae","Europe to NW. Iran",["Valepotriates (iridoid esters) and volatile oils, including monoterpenes and sesquiterpenes, to which sedative effects are attributed"]],["folate","Folate (folic acid)",3,1,"","Folic acid; 5-methyltetrahydrofolate (5-MTHF, methylfolate)","","",[]],["iron","Iron",4,1,"","Ferrous sulfate, fumarate, gluconate; ferric citrate and sulfate; heme iron polypeptides; carbonyl iron; amino acid chelates; polysaccharide-iron complexes","","",["Ferrous fumarate (33% elemental iron), ferrous sulfate (20%), ferrous gluconate (12%)"]],["multivitamin-mineral","Multivitamin/mineral supplements",8,1,"","Basic, high-potency and specialized (for example prenatal) formulations; nutrients and amounts set by each manufacturer","","",["Varies by product; no standard composition"]],["calcium","Calcium",4,1,"","Calcium carbonate; calcium citrate (labels state elemental calcium)","","",["Calcium carbonate (about 40% elemental calcium by weight)","Calcium citrate (about 21% elemental calcium)"]],["l-carnitine","L-carnitine",5,1,"","L-carnitine and acetyl-L-carnitine (main supplement forms); propionyl-L-carnitine","","",["L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine"]],["lactoferrin","Lactoferrin",5,1,"","Bovine (cow's milk-derived) lactoferrin, oral or added to enteral feeds and formulas","","",["Lactoferrin, a milk glycoprotein with antimicrobial and immune-modulating properties"]],["moringa","Moringa",0,1,"Moringa oleifera Lam.","Leaf (also seed, flower, root and bark in traditional use)","Moringaceae","NE. Pakistan to NW. India",["Polyphenols, phenolic acids, flavonoids, glycolates and alkaloids; candidate active compounds named include kaempferol, myricetin, niazirin and moringin, but none has been definitely shown to be responsible","Leaves contain vitamins, minerals and essential amino acids as well as several glycosides"]],["myo-inositol","Myo-inositol",8,1,"","Myo-inositol powder or capsules; sometimes combined with D-chiro-inositol","","",[]],["omega-3-fatty-acids","Omega-3 fatty acids",6,1,"","Fish, krill, cod liver and algal oils; supplied as natural triglycerides, free fatty acids, ethyl esters, re-esterified triglycerides or phospholipids (krill oil mainly phospholipids)","","",["Alpha-linolenic acid (ALA), from plant oils","Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), long-chain marine omega-3s"]],["ashwagandha","Ashwagandha",0,1,"Withania somnifera (L.) Dunal","Root (some products use root and leaf)","Solanaceae","S. Europe to C. China, Africa to Myanmar",["Withanolides (steroidal lactones) and alkaloids; root and leaf differ in chemical composition"]],["choline","Choline",8,1,"","Choline bitartrate, phosphatidylcholine and lecithin","","",["Choline (as choline bitartrate, phosphatidylcholine or lecithin)"]],["cumin","Cumin",0,1,"Cuminum cyminum L.","Seed (also seed oil and extracts)","Apiaceae","Iraq to Afghanistan",["Volatile oil containing cuminaldehyde and other aldehydes; flavonoids and terpenes in the seed","Cuminaldehyde described as the major bioactive"]],["evening-primrose-oil","Evening primrose oil",6,1,"Oenothera biennis L.","Seed oil","Onagraceae","Canada to C. Mexico",["Omega-6 fatty acids, including gamma-linolenic acid (GLA)","GLA makes up about 10% of the oil"]],["iodine","Iodine",4,1,"","Potassium iodide; sodium iodide; kelp","","",["Potassium iodide, sodium iodide"]],["milk-thistle","Milk thistle",0,1,"Silybum marianum (L.) Gaertn.","Seeds (fruit)","Asteraceae","Macaronesia, Medit. to C. Asia and India, Ethiopia",["Silymarin, a group of flavanolignans, mainly silybinin, silychristin and silydianin"]],["damask-rose","Damask rose",0,1,"Rosa × damascena Herrm.","Fresh flowers; products are essential oil (by water distillation), rose water (hydrosol), concrete and absolute","","",["Rose essential oil: acyclic monoterpene alcohols β-citronellol (ca. 20–49%), geraniol (up to 22% per ISO 9842:2003, or up to 34%), nerol and linalool; also rose oxide, 2-phenylethanol and long-chain hydrocarbons (stearoptenes)","Rose absolute: 2-phenylethanol (78.4%), citronellol (9.9%), nonadecane (4.4%) and geraniol (3.7%) reported as main compounds"]],["l-theanine","L-theanine",5,1,"","Purified L-theanine (oral)","","",["L-theanine, a non-protein amino acid that crosses the blood-brain barrier"]],["melatonin","Melatonin",8,1,"","Synthetic melatonin (most products); tablets, capsules, liquids and gummies","","",["Melatonin"]],["california-poppy","California poppy",0,3,"Eschscholzia californica Cham.","Above-ground parts (herb), dried and powdered","Papaveraceae","W. & SC. U.S.A. to N. Mexico",["Alkaloids californidine, escholtzine and protopine (main alkaloids)","Allocryptopine is also among the major alkaloids isolated"]],["chamomile","Chamomile",0,1,"Matricaria recutita (Matricaria chamomilla, Chamomilla recutita)","Flower","","",[]],["holy-basil","Holy basil",0,1,"Ocimum tenuiflorum L.","Leaf (dried leaf or leaf extracts)","Lamiaceae","Trop. & Subtrop. Asia to W. Pacific",["Eugenol, rosmarinic acid, apigenin, myrtenal, luteolin, beta-sitosterol and carnosic acid; flavonoids orientin and vicenin","Purple tulsi contains more methyl eugenol than green tulsi"]],["jatamansi","Jatamansi (spikenard)",0,3,"Nardostachys jatamansi (D.Don) DC.","Rhizome","Caprifoliaceae","Himalaya to W. & C. China and N. Myanmar",["Terpenoids and phenolic compounds are the main constituents reported in the genus Nardostachys; sesquiterpenoids are the major bioactive components","Jatamansone is among the named constituents"]],["l-tryptophan","L-tryptophan",5,2,"","L-tryptophan (oral supplements)","","",["L-tryptophan; ingesting it raises brain tryptophan and stimulates its conversion to serotonin in neurons"]],["lactobacillus-casei-shirota","Lacticaseibacillus paracasei strain Shirota (LcS)",7,1,"","Live bacteria, mostly studied in fermented milk drinks; amounts stated as CFU or viable cells","","",["Lacticaseibacillus paracasei strain Shirota YIT 9029 (LcS; formerly Lactobacillus casei strain Shirota YIT 9029)","Cell-wall neutral polysaccharides LCPS-1 and LCPS-2; LCPS-1 is associated with the strain's immunomodulatory functions","Genus Lacticaseibacillus: one of 23 novel genera proposed in the 2020 reclassification of Lactobacillus"]],["passionflower","Passionflower",0,2,"Passiflora incarnata L.","Above-ground parts (aerial parts)","Passifloraceae","C. & E. U.S.A., Bermuda",["Flavonoids, mainly C-glycosides of apigenin and luteolin such as isovitexin","Maltol and gamma-pyrone derivatives","Beta-carboline alkaloids (harman and related compounds) are reported, but the EMA assessment states they may be present only in traces and are undetectable in most commercial material"]],["tart-cherry","Tart cherry",0,1,"Prunus cerasus L.","Fruit (juice, concentrate, freeze-dried skin powder)","Rosaceae","Caucasus",["Melatonin and anthocyanins"]],["kava","Kava",0,1,"Piper methysticum","Root and rhizome (rootstock)","Piperaceae","Santa Cruz Is. to Vanuatu",["Kavalactones (kavapyrones)"]],["eleuthero","Eleuthero (Siberian ginseng)",0,1,"Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.","Root","Araliaceae","Russian Far East to C. China and Japan.",["Eleutherosides (including eleutherosides B and E) and polysaccharides, named as active components","Isofraxidin, named with eleutherosides B and E as an active constituent"]],["galactooligosaccharides","Galactooligosaccharides (GOS)",8,1,"","Transgalactooligosaccharides (GOS) preparations, DP 2–9 with the majority DP 3–5 (Health Canada specification)","","",["Galactooligosaccharides (transgalactooligosaccharides), DP 2–9, majority DP 3–5"]],["hawthorn","Hawthorn",0,1,"Crataegus monogyna Jacq. and Crataegus laevigata (Poir.) DC.","Leaf and flower; fruit","Rosaceae","Europe to Caucasus, N. Africa to Iraq",["Flavonoids and oligomeric procyanidins are credited with the pharmacologic activity"]],["kanna","Kanna",0,2,"Mesembryanthemum tortuosum L.","Whole plant material; trials used a standardized 2:1 dry extract","Aizoaceae","Cape Prov.",["Mesembrine-type alkaloids: 25 alkaloids in four structural classes identified, the mesembrine class predominant","The standardized extract studied is reported to act as a dual serotonin (5-HT) reuptake and PDE4 inhibitor"]],["st-johns-wort","St. John's wort",0,1,"Hypericum perforatum L.","Flowers and leaves","Hypericaceae","Europe to China, NW. Africa",["Hypericin, pseudohypericin and hyperforin are the most likely active candidates; the active principle is not known"]],["methylfolate","Methylfolate (L-5-MTHF)",3,2,"","L-5-methyltetrahydrofolate as calcium, glucosamine or dicholine salt; 6(S) and 6(R,S) forms appear on FDA's NDI list","","",["5-Methyltetrahydrofolate (5-methyl-THF), a reduced form of folate"]],["same","SAMe (S-adenosyl-L-methionine)",5,1,"","S-adenosylmethionine, including forms stabilized as salts (e.g. 1,4-butanedisulfonate, disulfate tosylate) named in FDA's NDI list","","",["S-adenosyl-L-methionine, made in the body from methionine"]],["gotu-kola","Gotu kola",0,1,"Centella asiatica (L.) Urb.","Leaves and aerial parts (herb)","Apiaceae","Caucasus, Trop. & Subtrop. Old World to E. Australia and W. Pacific",["Pentacyclic triterpenoid glycosides (asiaticoside, centelloside, madecassoside) and their aglycones asiatic acid and madecassic acid; extracts contain more than 100 constituents"]],["lions-mane","Lion's mane",1,2,"Hericium erinaceus (Bull.) Pers.","Fruiting body; mycelium (one trial used mycelium enriched in erinacine A)","","",["Hericenones and erinacines (terpenoids), phenolic acids, polysaccharides, sterols and lactones"]],["mangosteen","Mangosteen",0,2,"Garcinia mangostana L.","Pericarp (fruit hull) extracts in supplements and trials; juice products are a different preparation","Clusiaceae","Pen. Malaysia, Borneo",["Xanthones, including alpha-, beta- and gamma-mangostin, garcinone B and E, gartanin and isogarcinol; studied mainly in laboratory settings"]],["n-acetylcysteine","N-acetylcysteine (NAC)",5,1,"","N-acetyl-L-cysteine (synthetic), oral","","",["N-acetylcysteine, derived from the amino acid L-cysteine"]],["rosemary","Rosemary",0,2,"Salvia rosmarinus Spenn.","Leaf (dried, whole or fragmented); rosemary oil used on the scalp in one trial","Lamiaceae","Medit.",["Carnosic acid, carnosol, rosmarinic acid and the essential oil are the most studied constituents","Rosmarinic acid measured at 21.13 ± 0.56 mg/g of dried plant in one trial's material"]],["vitamin-d","Vitamin D",3,1,"","Vitamin D3 (cholecalciferol); vitamin D2 (ergocalciferol)","","",[]],["bacopa","Bacopa",0,1,"Bacopa monnieri (L.) Wettst.","Aerial parts (stems and leaves)","Plantaginaceae","Tropics & Subtropics",["Dammarane-type triterpenoid saponins (bacosides, bacopasides, bacopasaponins), plus alkaloids, cucurbitacins, sterols and flavonoids","The active ingredients are thought to be the saponin glycosides called bacosides"]],["citicoline","Citicoline (CDP-choline)",8,1,"","Citicoline (CDP-choline); trials gave it orally, intravenously or both","","",["CDP-choline (cytidine 5'-diphosphocholine), a precursor essential for the synthesis of phosphatidylcholine"]],["algal-oil","Algal oil (DHA and EPA)",6,1,"","Algal oil, DHA-rich or DHA plus EPA; forms on FDA's NDI list include ethyl ester, re-esterified triglyceride (r-TG) and monoacylglycerol (MAG) oils","","",["Docosahexaenoic acid (DHA); some algal oils also contain eicosapentaenoic acid (EPA)"]],["arachidonic-acid","Arachidonic acid",6,1,"","Arachidonic acid as ARA-enriched triglyceride oil (capsules); added with DHA to infant formula","","",["Arachidonic acid (C20:4n-6), one of the major omega-6 fatty acids"]],["asian-ginseng","Asian ginseng",0,1,"Panax ginseng C.A.Mey.","Root","Araliaceae","Russian Far East to Korea",["Ginsenosides (panaxosides), thought to be the most important constituents","30 different triterpene saponins (ginsenosides and panaxosides); content varies widely between products, and some contain none"]],["benfotiamine","Benfotiamine",3,1,"","Benfotiamine (S-benzoylthiamine O-monophosphate)","","",["Benfotiamine, a synthetic thiamin derivative converted to thiamin in the body"]],["carnosine","Carnosine (L-carnosine)",5,2,"","L-carnosine (oral); zinc-L-carnosine is another form; some trials combine L-carnosine with anserine","","",["L-carnosine (β-alanyl-L-histidine), a histidine-containing dipeptide"]],["copper","Copper",4,2,"","Cupric oxide, cupric sulfate, copper amino acid chelates, copper gluconate","","",["Cupric oxide, cupric sulfate, copper amino acid chelates, copper gluconate"]],["ginkgo","Ginkgo",0,1,"Ginkgo biloba L.","Leaf (usually as an extract)","Ginkgoaceae","China (Zhejiang)",["Multiple compounds; ginkgolides and bilobalide are unique to this herb"]],["guarana","Guarana",0,1,"Paullinia cupana Kunth","Seed (shelled, dried or roasted, and powdered)","Sapindaceae","S. Trop. America",["Caffeine (2% to 8% of the seed, versus 1% to 3% in coffee beans), plus theophylline and theobromine, catechins, epicatechins and procyanidins"]],["guayusa","Guayusa",0,2,"Ilex guayusa Loes.","Leaf","Aquifoliaceae","W. South America to Venezuela",["Methylxanthines caffeine and theobromine, chlorogenic acids, flavonoids and sugars"]],["haritaki","Haritaki",0,1,"Terminalia chebula Retz.","Fruit (aqueous or ethanol extracts; mouth rinses and a cream in some trials)","Combretaceae","Indian Subcontinent to China (W. Yunnan) and Indo-China",["Chebulic acid, chebulinic acid and chebulagic acid named as major bioactive compounds; chebulagic acid and chebulanin linked to antioxidant activity"]],["lutein-and-zeaxanthin","Lutein and zeaxanthin",8,2,"","Lutein and zeaxanthin (AREDS2 used lutein 10 mg plus zeaxanthin 2 mg); EFSA's food-additive evaluation covers lutein from Tagetes erecta","","",["Lutein and zeaxanthin, non-provitamin A carotenoids that accumulate in the retina","Tagetes erecta lutein preparation: at least 80% carotenoids, of which about 79% lutein and about 5% zeaxanthin"]],["maitake","Maitake",1,2,"Grifola frondosa (Dicks.) Gray","Mushroom (food); polysaccharide extracts such as D-fraction","","",["Beta-1,6-glucan, a protein-bound polysaccharide identified as the active constituent; alpha-glucan"]],["mct-oil","MCT oil (medium-chain triglycerides)",6,1,"","MCT oil (triglycerides of C8:0 and C10:0 fatty acids); medium-long-chain triglycerides (MLCTs) are a different product","","",["Medium-chain fatty acids (6:0–10:0) bound as triglycerides"]],["perilla","Perilla",0,2,"Perilla frutescens (L.) Britton","Leaf (extract or powder); seed (oil)","Lamiaceae","S. Russian Far East to Pakistan",["Extracts: rosmarinic acid, a polyphenol (an extract enriched for it was studied)","Water extract of dried leaves: about 10 flavonoids, notably vicenin-2 (apigenin-6,8-di-C-glycoside), with caffeic acid and rosmarinic acid","Seed oil: alpha-linolenic acid, a plant omega-3 fatty acid"]],["pqq","PQQ (pyrroloquinoline quinone)",8,2,"","Pyrroloquinoline quinone disodium salt","","",["Pyrroloquinoline quinone (PQQ), a water-soluble quinone compound"]],["spearmint","Spearmint",0,2,"Mentha spicata L.","Spearmint tea; dried aqueous spearmint extract (forms studied)","Lamiaceae","Europe to China",["Polyphenols, notably rosmarinic acid; one studied extract contains at least 14.5% rosmarinic acid and 24% total phenolics"]],["spermidine","Spermidine",8,2,"","Spermidine-rich wheat germ extract; spermidine (oral)","","",[]],["taurine","Taurine",5,1,"","Taurine (oral)","","",["Taurine (proper name 2-aminoethanesulfonic acid)"]],["thiamin","Thiamin (vitamin B1)",3,2,"","Thiamin mononitrate, thiamin hydrochloride; benfotiamine (synthetic derivative)","","",[]],["vitamin-e","Vitamin E",3,1,"","Natural RRR-alpha-tocopherol (d-); synthetic all-rac-alpha-tocopherol (dl-); esters such as tocopheryl acetate and succinate","","",[]],["selenium","Selenium",4,1,"","Selenomethionine, selenium-enriched yeast, sodium selenite, sodium selenate","","",["Selenomethionine, selenium-enriched yeast, sodium selenite, sodium selenate (up to about 90% absorbed)"]],["vitamin-b12","Vitamin B12",3,1,"","Cyanocobalamin (most common); methylcobalamin, adenosylcobalamin, hydroxocobalamin","","",[]],["caffeine","Caffeine",8,1,"","Caffeine anhydrous and caffeine from plant sources (for example guarana, kola nut, yerba mate)","","",["Caffeine (a methylated xanthine)"]],["creatine","Creatine",5,1,"","Creatine monohydrate (most studied form); also ethyl ester, alpha-ketoglutarate and buffered forms","","",["Creatine (stored in muscle as phosphocreatine)"]],["american-ginseng","American ginseng",0,1,"Panax quinquefolius L.","Root (dried)","Araliaceae","SE. Canada to NC. & E. U.S.A.",["Ginsenosides (eight major ginsenosides identified by HPLC-UV in Panax samples, including P. quinquefolius)"]],["beetroot-nitrate","Beetroot juice (dietary nitrate)",8,1,"","Beetroot juice or juice concentrate; beetroot powder","","",[]],["beta-alanine","Beta-alanine",5,1,"","Beta-alanine (standard and sustained-release forms)","","",["Beta-alanine (raises muscle carnosine)"]],["betaine","Betaine (trimethylglycine)",8,1,"","Betaine (betaine anhydrous), from Beta vulgaris root isolate or synthetic; Health Canada lists betaine hydrochloride as a separate medicinal ingredient","","",["Betaine (trimethylglycine)"]],["bcaa","Branched-chain amino acids (BCAAs)",5,1,"","Leucine, isoleucine and valine (BCAA supplements, oral; intravenous BCAAs are used in some clinical trials)","","",["Leucine, isoleucine and valine; together they make up about 14%–18% of the amino acids in human skeletal muscle proteins"]],["collagen-peptides","Collagen peptides",5,1,"","Hydrolyzed collagen (collagen peptides) and gelatin from bovine, porcine, marine and poultry sources","","",["Collagen peptides high in glycine, proline and hydroxyproline"]],["hmb","HMB (beta-hydroxy-beta-methylbutyrate)",8,1,"","HMB monohydrated calcium salt (HMB-Ca) or calcium-free HMB free acid (HMB-FA)","","",["Beta-hydroxy-beta-methylbutyrate (HMB), a leucine metabolite"]],["l-citrulline","L-citrulline",5,1,"","L-citrulline; citrulline malate (citrulline combined with malic acid), the form used in most exercise studies","","",["L-citrulline, which may raise arginine and nitric oxide levels"]],["quercetin","Quercetin",8,1,"","Quercetin (aglycone) supplements; quercetin glycosides such as quercetin glucosides and rutin occur in foods","","",["Quercetin, the most abundant dietary flavonol","Food forms include quercetin glucosides (onions) and quercetin rutinoside (rutin, the major quercetin compound in tea)"]],["sodium-electrolytes","Sodium (electrolytes)",4,1,"","Sodium chloride, sodium citrate (in ORS), sodium bicarbonate","","",[]],["whey-protein","Whey protein",5,1,"","Whey protein concentrate, isolate or hydrolysate (protein powders and drinks)","","",["Whey proteins, a complete milk protein; whey has more leucine than either casein or soy"]],["akkermansia-muciniphila","Akkermansia muciniphila (pasteurized)",7,3,"","Pasteurized bacterial cells (EFSA condition: fewer than 10 viable CFU/g); amounts stated in cells per day","","",["Akkermansia muciniphila MucT (ATCC BAA-835T = CIP 107961T); whole genome sequenced (NCBI NC_010655.1)"]],["astaxanthin","Astaxanthin",2,1,"Haematococcus pluvialis Flotow (source alga; accepted name in WoRMS: Haematococcus lacustris)","Astaxanthin-rich oleoresin extracted from Haematococcus pluvialis algae","","",["Astaxanthin (3,3′-dihydroxy-β,β-carotene-4,4′-dione)"]],["bitter-orange","Bitter orange",0,1,"Citrus aurantium L.","Fruit and peel (extracts); essential oil","Rutaceae","",["p-Synephrine (often called synephrine) and other protoalkaloids; synephrine is structurally similar to ephedrine but has different pharmacological properties"]],["black-ginger","Black ginger",0,1,"Kaempferia parviflora Wall. ex Baker","Rhizome (extracts)","","",["Polymethoxyflavones; 5,7-dimethoxyflavone and 3,5,7,3',4'-pentamethoxyflavone are named as main ingredients of the extract","Nine flavones detected by UPLC-QTOF-MS in rhizome extracts"]],["buchu","Buchu",0,3,"Agathosma betulina (P.J.Bergius) Pillans","Dried leaves; leaf essential oil","Rutaceae","SW. Cape Prov.",["More than 120 compounds, including volatile oils such as pulegone (a suspected liver toxin), at higher levels in A. crenulata than in A. betulina","Diosphenol (unique to the genus; blackcurrant flavor), menthone, isomenthone and 8-mercapto-p-menthan-3-one in the essential oil"]],["cordyceps","Cordyceps",1,1,"Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones & Spatafora; Cordyceps militaris (L.) Fr.","Wild fungus–larva complex (O. sinensis); laboratory-grown mycelium (Cs-4); C. militaris preparations","Ophiocordycipitaceae","",["Cordycepin"]],["d-ribose","D-ribose",8,2,"","D-ribose (taken as powder or capsules in trials)","","",["D-ribose, a pentose carbohydrate"]],["ecklonia-cava","Ecklonia cava",2,2,"Ecklonia cava Kjellman, 1885 (marine brown alga; accepted name in WoRMS)","Alcohol extract of the dried seaweed (phlorotannin-rich)","","",["Phlorotannins (polyphenols): 90 ± 5% of the EU novel-food extract by Folin-Ciocalteu, including dieckol (6.6-9.9% by HPLC), 8,8'-bieckol, 6,6'-bieckol, eckol and phlorofucofuroeckol-A"]],["ephedra","Ephedra",0,3,"Ephedra sinica Stapf","Stems and branches","Ephedraceae","S. Siberia to N. & NE. China",["Ephedrine alkaloids (stimulant compounds)"]],["l-arginine","L-arginine",5,1,"","L-arginine; Health Canada also lists L-arginine monohydrochloride, L-arginine alpha-ketoglutarate, L-arginine ketoisocaproic acid and DL-arginine as source ingredients (oral, synthetic)","","",["L-arginine, which can be converted to nitric oxide (a blood-vessel dilator) and is a precursor for creatine"]],["l-glutamine","L-glutamine",5,1,"","L-glutamine (oral; pill or powder)","","",["L-glutamine, which the body makes to build protein"]],["msm","MSM (methylsulfonylmethane)",8,1,"","Methylsulfonylmethane (dimethyl sulfone), synthetic, in oral capsules, tablets and powders","","",["Dimethyl sulfone (methylsulfonylmethane), an organosulfur compound"]],["nicotinamide-riboside","Nicotinamide riboside",3,1,"","Nicotinamide riboside chloride (oral)","","",[]],["nmn","NMN (nicotinamide mononucleotide)",8,1,"","Beta-nicotinamide mononucleotide (oral)","","",[]],["tongkat-ali","Tongkat ali",0,2,"Eurycoma longifolia Jack","Root (root extracts)","Simaroubaceae","Indo-China to W. Malesia",["Quassinoids (the major portion of root phytochemicals), canthin-6-one and beta-carboline alkaloids, tirucallane-type triterpenes, squalene derivatives and a biphenyl neolignan","More than 65 compounds identified; it is not clear which have the claimed activities"]],["tribulus","Tribulus",0,1,"Tribulus terrestris L.","Fruit, leaves and roots (Health Canada's monograph covers dried fruit and root)","Zygophyllaceae","Old World",["Steroidal saponins, including dioscine, diosgenin and protodioscin, believed to be the active constituents"]],["ubiquinol","Ubiquinol",8,2,"","Ubiquinol (reduced coenzyme Q10), capsules or liquid","","",["Ubiquinol-10, the reduced form of coenzyme Q10"]],["rooibos","Rooibos",0,2,"Aspalathus linearis (Burm.f.) R.Dahlgren","Leaves and fine stems, as tea (fermented or unfermented) or extract","Fabaceae","Cape Prov.",["Polyphenols, especially the dihydrochalcones aspalathin and nothofagin; no catechins (the main flavonoids of green and black tea)"]],["boswellia","Boswellia",0,2,"Boswellia serrata Roxb.","Gum resin (oleo-gum resin)","Burseraceae","Indian Subcontinent",["Boswellic acids, including 11-keto-beta-boswellic acid (KBA) and 3-acetyl-11-keto-beta-boswellic acid (AKBA); boswellic acid inhibits 5-lipoxygenase in preclinical studies"]],["bromelain","Bromelain",8,1,"","Bromelain enzyme concentrate from pineapple stem and fruit","","",["Bromelain, a sulfhydryl proteolytic enzyme (cysteine proteinase)"]],["devils-claw","Devil's claw",0,1,"Harpagophytum procumbens (Burch.) DC.","Dried tuberous roots","Pedaliaceae","S. Africa",["Iridoid glycoside harpagoside in root extracts","Harpagide (an iridoid glycoside) and beta-sitosterol"]],["gla-oils","GLA oils (borage and blackcurrant seed oil)",6,2,"","Seed oil (borage seed oil; blackcurrant seed oil)","","",["Borage seed oil: gamma-linolenic acid (approximately 25% of the oil) and linoleic acid, plus oleic, palmitic, stearic, eicosenoic and erucic acids","Borage: unsaturated pyrrolizidine alkaloids (amabiline, supinine, lycopsamine, intermedine, acetyllycopsamine, acetylintermedine)","Blackcurrant seed oil: alpha- and gamma-linolenic acid, anthocyanins, proanthocyanidin, flavonoids, vitamin C and 2 nitrile-containing compounds"]],["hesperidin","Hesperidin",8,1,"","Citrus hesperidin extracts or purified hesperidin; modified forms such as glucosyl hesperidin and micronized hesperidin","","",["Hesperidin (the flavonoid hesperetin with a rutinoside moiety attached)"]],["palmitoylethanolamide","Palmitoylethanolamide (PEA)",8,1,"","Palmitoylethanolamide (PEA), including micronized, ultramicronized and cold-water dispersible formulations","","",["Palmitoylethanolamide, an endogenous fatty acid amide"]],["rose-hip","Rose hip",0,2,"Rosa canina L.","Fruit (hip), as powder or extract","Rosaceae","Madeira, NW. Africa, Europe to C. Asia and Pakistan",["Phenolics, terpenoids, galactolipids, carotenoids, fruit acids and fatty oils, besides vitamin C; the review considers their combination responsible for observed effects"]],["turmeric","Turmeric (and curcumin)",0,1,"Curcuma longa L.","Rhizome","Zingiberaceae","as a cultigen from SW. India",["Curcuminoids, including curcumin, to which turmeric's health activities are commonly attributed","Curcumin makes up between 1% and 6% by dry weight of whole turmeric extracts"]],["undenatured-type-ii-collagen","Undenatured type II collagen",5,1,"","Undenatured type II collagen from chicken sternum cartilage, in capsules (40 mg/day in most trials)","","",["Undenatured type II collagen protein, characterized in trials by an ELISA using a monoclonal antibody specific for epitopes expressed only by undenatured type II collagen","Proposed to act through oral tolerance, an immune-mediated mechanism, per a 2025 review"]],["andrographis","Andrographis",0,1,"Andrographis paniculata (Burm.f.) Wall. ex Nees","Plant extracts; trials mostly used commercial products, alone or in herbal mixtures","Acanthaceae","Indian Subcontinent",["Diterpenoid lactones known as andrographolides, described as the active constituents"]],["argan-oil","Argan oil",6,1,"Sideroxylon spinosum L.","Seed (kernel) oil, culinary or cosmetic grade","","",["Fatty acids: oleic acid most abundant, then linoleic and palmitic acids","Tocopherols and phytosterols"]],["arnica","Arnica",0,2,"Arnica montana L.","Flower heads (tinctures, gels, ointments for the skin)","Asteraceae","Europe",["Sesquiterpene lactones, mainly helenalin and 11,13-dihydrohelenalin and their esters (0.3-1.0% of the flowers); Ph. Eur. sets a minimum of 0.4%","Flavonoids (0.4-0.6%), essential oil (0.2-0.35%), hydroxycoumarins and phenyl acrylic acids"]],["aronia","Aronia (black chokeberry)",0,1,"Aronia melanocarpa (Michx.) Elliott","Fruit (berry): whole, dried or freeze-dried, juice, powder or extract","Rosaceae","E. Canada to NC. & E. U.S.A.",["Anthocyanins dominated by cyanidin glycosides (cyanidin-3-O-galactoside, cyanidin-3-O-arabinoside); procyanidins; chlorogenic and neochlorogenic acids; quercetin derivatives"]],["acai","Açaí",0,2,"Euterpe oleracea Mart.","Fruit pulp (dried fruit flesh in supplements)","","",["Polyphenols, predominantly anthocyanins","Anthocyanins measured as cyanidin-3-O-glucoside appear in human plasma after açaí pulp or juice"]],["bacillus-coagulans","Bacillus coagulans (Heyndrickxia coagulans)",7,2,"","Bacterial spore preparations; amounts stated in CFU or spores","","",["Heyndrickxia coagulans (formerly Bacillus coagulans): spore-forming, lactic acid-producing bacterium","Weizmannia coagulans is a synonym of Bacillus coagulans","A 2023 genome-based study proposed transferring the genus Weizmannia to Heyndrickxia"]],["baikal-skullcap","Baikal skullcap",0,3,"Scutellaria baicalensis Georgi","Root","Lamiaceae","Siberia to Russian Far East and Vietnam",["Flavonoids baicalin (the main flavonoid), baicalein and wogonin"]],["boron","Boron",4,2,"","Sodium borate, sodium tetraborate, calcium fructoborate, boron amino acid chelate, ascorbate, aspartate, citrate, gluconate, glycinate, picolinate","","",["Sodium borate, sodium tetraborate, calcium fructoborate, boron citrate, boron glycinate and other chelates"]],["bpc-157","BPC-157",5,3,"","BPC-157 (free base) and BPC-157 acetate; products proposed to FDA included oral capsules, subcutaneous injection, nasal spray, rectal suppository and transdermal cream","","",["BPC-157, a pentadecapeptide (15 amino acids)"]],["cats-claw","Cat's claw",0,2,"Uncaria tomentosa (Willd. ex Schult.) DC.","Bark (stem bark or root bark; many studies do not state which)","Rubiaceae","C. & S. Trop. America to Trinidad",["Oxindole alkaloids, in two chemotypes: one mainly pentacyclic (e.g., pteropodine, mitraphylline), one mainly tetracyclic (e.g., rhynchophylline)","Pyroquinovic acid glycosides, described as markers of the species"]],["glucosamine-and-chondroitin","Glucosamine and chondroitin",8,1,"","Glucosamine sulfate or glucosamine hydrochloride; chondroitin sulfate","","",["Glucosamine (sulfate or hydrochloride)","Chondroitin sulfate"]],["hyaluronic-acid-oral","Hyaluronic acid (oral)",8,2,"","Hyaluronic acid or sodium hyaluronate taken by mouth as capsules or drinks","","",["Hyaluronic acid, a polymer of alternating N-acetyl-D-glucosamine and D-glucuronic acid units"]],["krill-oil","Krill oil",6,1,"","Krill oil (omega-3s mainly as phospholipids); lysophosphatidylcholine-rich oil extracts of Antarctic krill also appear on FDA's NDI list","","",["Long-chain omega-3s (EPA and DHA), present primarily as phospholipids"]],["propolis","Propolis",8,1,"","Dried propolis, powdered propolis and non-standardized extracts (dry extract, tincture, fluid extract, decoction, infusion), per Health Canada's oral propolis monograph; dry extracts made with ethanol and/or water only","","",["Phenolic compounds; MSK names caffeic acid phenethyl ester (CAPE), artepillin C and the flavonoid chrysin as well-known constituents, whose amounts vary with geographic origin"]],["serrapeptase","Serrapeptase",8,2,"","Serratiopeptidase enzyme (from Serratia bacteria)","","",["Serratiopeptidase, a proteolytic enzyme"]],["artemisia-annua","Sweet wormwood",0,2,"Artemisia annua L.","Leaves and upper shoots (aerial parts); teas, powders and extracts","Asteraceae","N. Africa to Eurasia",["Artemisinin, described as the active constituent; its antimalarial effect involves free radicals formed by cleavage of its endoperoxide bond","Artemisinins used as drugs (artesunate, artemether, artemisinin, dihydroartemisinin) are derivatives of this plant"]],["tocotrienols","Tocotrienols",3,1,"","Tocotrienol-rich fraction (TRF) from palm oil; tocotrienols from annatto seed oil (Bixa orellana); delta-tocotrienol","","",["Alpha-, beta-, gamma- and delta-tocotrienol"]],["chaga","Chaga",1,4,"Inonotus obliquus (Fr.) Pilát","Conk (mycelium mixed with host-tree wood), as tea, powder or extract","Hymenochaetaceae","",["Oxalic, gallic, protocatechuic and p-hydroxybenzoic acids; inotodiol and other triterpenoids; ergosterol; polysaccharides"]],["glutathione","Glutathione",5,2,"","Reduced glutathione (oral tablets, capsules, orally dissolving film); topical and intravenous glutathione are also studied","","",["Glutathione (GSH), a tripeptide antioxidant"]],["biotin","Biotin",3,2,"","Biotin (alone, in B-complex products, or in multivitamin/mineral products)","","",[]],["calendula","Calendula",0,1,"Calendula officinalis L.","Flower (infusions, tinctures, liquid extracts, oil extracts, ointments and creams)","Asteraceae","W. Medit.",["Triterpenoids (named by MSK in connection with anti-inflammatory and antiviral activity); lutein and beta-carotene are found in leaves and stems"]],["dunaliella","Dunaliella",2,2,"Dunaliella salina (Dunal) Teodoresco, 1905 (green microalga; accepted name in WoRMS)","Dried algal biomass (powder) or cell extract","","",["Beta-carotene made up of about equal amounts of the all-trans and 9-cis isomers (Dunaliella bardawil)","Commercial beta-carotene production is driven by stress factors such as high light, high salinity, temperature and nutrient availability"]],["honeybush","Honeybush",0,3,"Cyclopia intermedia E.Mey.","Leaves and stems, as tea (fermented or green) or extract","","",["Principal polyphenols: the xanthone mangiferin and the flavanones hesperetin and isokuranetin","C. subternata extract contains xanthones, benzophenones, flavanones, flavones and dihydrochalcones"]],["manuka-honey","Manuka honey",8,1,"","Honey, eaten or used in trials as liquid honey, lozenges, eye preparations, sinus rinses and wound dressings","","",["Methylglyoxal, which MSK names as the major bactericidal factor","Flavonoids, which showed anti-inflammatory and antimicrobial properties in preclinical studies"]],["pumpkin-seed","Pumpkin seed",0,3,"Cucurbita pepo L.","Whole, ripe, dried seed; soft and dry extracts; fatty oil","Cucurbitaceae","as a cultigen from Mexico",["About 50% fatty oil (mostly linoleic and oleic acids, with tocopherol); putative active constituents are Δ7-sterols (avenasterol, spinasterol) and Δ5-sterols (sitosterol, stigmasterol)"]],["purslane","Purslane",0,1,"Portulaca oleracea L.","Leaves and other aerial parts, eaten as food or used as extracts; several trials used the seeds","Portulacaceae","Macaronesia, Africa, EC. & S. Europe to Pakistan and Arabian Pen.",["Flavonoids, homoisoflavonoids, alkaloids, organic acids, esters, lignans, terpenoids, catecholamines, sterols and cerebrosides, plus omega-3 fatty acids, amino acids, minerals and vitamins","Alpha-linolenic acid (omega-3), alpha-tocopherol and ascorbic acid; potassium 494 mg/100 g; leaf oxalate reported at 671–869 mg/100 g fresh weight"]],["sangre-de-grado","Sangre de grado",0,2,"Croton lechleri Müll.Arg.","Red latex (sap)","Euphorbiaceae","W. South America",["Proanthocyanidins, the predominant group; alkaloids, diterpenoids, phytosteroids, saponins and other phenolics are also reported","SP-303: a large proanthocyanidin oligomer isolated from the latex (the material tested in the travelers' diarrhea trial)","Crofelemer: an oligomeric proanthocyanidin mixture of catechin, epicatechin, gallocatechin and epigallocatechin units (average degree of polymerization 5 to 7.5)"]],["saw-palmetto","Saw palmetto",0,1,"Serenoa repens (W.Bartram) Small","Berries (fruit)","Arecaceae","SE. U.S.A.",["Volatile oils and free fatty acids are believed to be the active components"]],["lactobacillus-rhamnosus-gg","Lacticaseibacillus rhamnosus GG (LGG)",7,1,"","Live bacteria (L. rhamnosus GG); amounts stated in colony-forming units (CFU)","","",["Lacticaseibacillus rhamnosus GG, formerly Lactobacillus rhamnosus GG (nickname LGG)","Genus Lacticaseibacillus: one of 23 novel genera proposed in the 2020 reclassification of Lactobacillus"]],["beta-glucan","Beta-glucan (oat and barley)",8,1,"","Oat and barley sources named in 21 CFR 101.81 (oat bran, rolled oats, whole oat flour, oatrim, whole grain and dry milled barley, barley betafiber); Health Canada lists oat and barley seed bran","","",["Beta (β) glucan soluble fiber, determined by AOAC method 992.28 for the US health claim"]],["glucomannan","Glucomannan",8,1,"","Glucomannan from Amorphophallus tuber, as oral capsules and powders (Health Canada's monograph excludes other forms); tablets have been linked to esophageal obstruction","","",["Glucomannan, described in 21 CFR 201.319 as (B-1,4 linked) polymannose acetate, a water-soluble gum"]],["linoleic-acid","Linoleic acid",6,1,"","Linoleic acid, studied mainly as linoleic-acid-rich vegetable oils (corn oil, safflower oil) and polyunsaturated margarines made from them","","",["Linoleic acid (C18:2n-6), one of the major omega-6 fatty acids"]],["niacin","Niacin (vitamin B3)",3,1,"","Nicotinic acid, nicotinamide; inositol hexanicotinate","","",[]],["plant-sterols-and-stanols","Plant sterols and stanols",8,1,"","Plant sterol esters, plant stanol esters and free plant sterols (Health Canada monographs); the US health claim covers sterol and stanol esters","","",["Plant sterols: beta-sitosterol, campesterol and stigmasterol (at least 80% of the sterol mixture combined, for the US claim)","Plant stanols: sitostanol and campestanol (at least 80% of the stanol mixture combined, for the US claim)"]],["psyllium","Psyllium",0,1,"Plantago ovata Forssk.","Seed husk (dried seed coat, epidermis)","Plantaginaceae","SE. Spain, N. Africa to India and Somalia, SW. & SC. U.S.A. to N. Mexico",["Soluble fiber (psyllium seed husk)"]],["red-yeast-rice","Red yeast rice",8,1,"","Fermented rice and red yeast rice extracts; monacolin K content is usually not stated on labels","","",["Monacolins, including monacolin K (structurally identical to lovastatin)","Citrinin, a contaminant toxic to the kidneys, found in some products"]],["amla","Amla",0,1,"Phyllanthus emblica L.","Fruit (dried)","Phyllanthaceae","Trop. & Subtrop. Asia",["Tannins, flavonoids, saponins, terpenoids, alkaloids and ascorbic acid; the fruit is a rich source of vitamin C, minerals and amino acids"]],["berberine","Berberine",8,1,"","Isolated alkaloid, sold alone or in multi-ingredient supplements","","",["Berberine (isoquinoline alkaloid)"]],["bitter-melon","Bitter melon",0,1,"Momordica charantia L.","Fruit (extracts, powders); some preparations use leaf","Cucurbitaceae","Trop. & Subtrop. Old World to S. Pacific",["Alkaloids, glycosides, saponins, triterpenes, oils, steroids/sterols, polysaccharides, resins and proteins; the hypoglycemic component has not been identified","Momordicosides and momordicines (linked to bitterness), ribosome-inactivating proteins; seeds contain vicine"]],["black-seed","Black seed",0,1,"Nigella sativa L.","Seed; cold-pressed (fixed) seed oil; essential oil","Ranunculaceae","Romania to W. & SW. Iran",["Fatty oils (linoleic, oleic and palmitic acids) and volatile oils including thymoquinone, the suspected major bioactive component","Seed oil also contains phytosterols, thymol and dithymoquinone; seeds contain isoquinoline alkaloids"]],["chlorella","Chlorella",2,1,"Chlorella vulgaris Beijerinck","Algal biomass in supplements (e.g., tablets)","","",["Carotenes, protein, fiber, vitamins (including vitamin K), minerals and chlorophyll"]],["cocoa-flavanols","Cocoa flavanols",8,1,"","High-flavanol cocoa extract (capsules or tablets); flavanol-rich cocoa powder, beverages and dark chocolate in trials","","",["Cocoa flavanols, including (-)-epicatechin and (+)-catechin"]],["garcinia-cambogia","Garcinia cambogia",0,1,"Garcinia gummi-gutta (L.) N.Robson","Fruit rind (peel); extracts standardized to hydroxycitric acid","","",["Hydroxycitric acid (HCA), the suspected active component: Garcinia fruit is 10% to 30% HCA by weight and extracts contain 20% to 60%; HCA inhibits ATP citrate lyase, an enzyme of fatty acid synthesis"]],["garlic","Garlic",0,1,"Allium sativum L.","Bulb","Amaryllidaceae","C. Asia to NE. Iran",["Allicin (the one trial in the Cochrane common-cold review specified its supplement by allicin content)"]],["grape-seed-extract","Grape seed extract",0,1,"Vitis vinifera L.","Seed extract","Vitaceae","SC. & SE. Europe to C. Asia and N. Iran",["Proanthocyanidins (monomers and oligomers), the major bioactive compounds"]],["green-tea","Green tea",0,1,"Camellia sinensis","Leaf (beverage or concentrated extract)","Theaceae","E. Himalaya to S. China and N. Indo-China, Hainan",["Catechins, about 10% of extracts; epigallocatechin-3-gallate (EGCG) is the most concentrated","Caffeine"]],["gymnema","Gymnema",0,2,"Gymnema sylvestre (Retz.) R.Br. ex Sm.","Leaf","Apocynaceae","Trop. & Subtrop. Old World",["Gymnemic acids (triterpene saponins), the most distinctive of more than 50 components; also flavones, anthraquinones, alkaloids, resins and tannins","Gymnemic acids bind to and inhibit human sweet-taste receptors in vitro, and human and animal studies show suppressed taste response to sweet substances"]],["hibiscus","Hibiscus (roselle)",0,1,"Sabdariffa gossypiifolia (Mill.) M.M.Hanes & R.L.Barrett","Dried calyces, as tea, beverage or extract","Malvaceae","W. Trop. Africa to Sudan",["Anthocyanins (delphinidin-3-sambubioside and cyanidin-3-sambubioside), organic acids (hydroxycitric acid and hibiscus acid) and phenolic acids (especially protocatechuic acid)"]],["inulin-and-fos","Inulin and FOS",8,1,"","Inulin (degree of polymerization, DP, 2–60), FOS/oligofructose (DP 2–10) and short-chain FOS (DP 2–5), as defined in Health Canada's Prebiotics monograph","","",["Inulin-type fructans (β-fructans): short-chain forms (DP below 10, such as oligofructose) and long-chain forms (DP 10 or more)"]],["lactotripeptides","Lactotripeptides (IPP and VPP)",5,1,"","IPP and VPP in tablets or capsules, or added to milk drinks, yogurt drinks or fruit and vegetable juices; made with Lactobacillus helveticus or Saccharomyces cerevisiae fermentation or Aspergillus oryzae enzyme hydrolysis of casein","","",["Isoleucine-proline-proline (IPP) and valine-proline-proline (VPP)"]],["nattokinase","Nattokinase",8,1,"","Nattokinase enzyme; trial doses stated in fibrinolytic units (FU)","","",["Nattokinase, an extracellular enzyme of Bacillus subtilis"]],["notoginseng","Notoginseng (san qi)",0,1,"Panax notoginseng (Burkill) F.H.Chen","Root; trials used oral root preparations or Panax notoginseng saponin (PNS) extracts, given orally or (in most stroke trials) by intravenous injection","Araliaceae","China (SE. Yunnan) to N. Vietnam",["Saponins, including ginsenoside Rb1, ginsenoside Rg1 and notoginsenoside R1, named as its main active ingredients"]],["pantothenic-acid","Pantothenic acid (vitamin B5)",3,2,"","Calcium pantothenate (most common); pantethine","","",[]],["pomegranate","Pomegranate",0,1,"Punica granatum L.","Fruit juice (from the arils), fruit extracts and seed oil","Lythraceae","NE. Türkiye to W. & N. Pakistan",["Hydrolyzable tannins (punicalagins and punicalin) and tannin-based complex oligomers; ellagic acid","Punicalagin, an ellagitannin, is the most abundant polyphenol; others include flavonols, anthocyanins and ellagic acid"]],["potassium","Potassium",4,1,"","Potassium chloride, citrate, phosphate, aspartate, bicarbonate, gluconate","","",["Potassium chloride (most common), citrate, phosphate, aspartate, bicarbonate, gluconate"]],["prickly-pear","Prickly pear",0,1,"Opuntia ficus-indica (L.) Mill.","Fruit (prickly pear or cactus pear) and cladode (stem pad, nopal), including cladode fiber and extracts","Cactaceae","Mexico (Oaxaca)",["High levels of bioactive phytochemicals, in particular betalains","Dietary fiber: the fruit is rich in fiber, and fiber composition is cited as a difference between fruit and cladode","Nopal (cladode) fiber contains both insoluble and soluble fibers"]],["resistant-starch","Resistant starch",8,1,"","High-amylose maize starch (type 2 resistant starch, RS2); cross-linked phosphorylated RS4","","",["Type 2 resistant starch (RS2) in high-amylose maize (HAM) starch; FDA's qualified claim covers HAM starch with 50 percent or more RS2 that is unmodified and only conventionally milled"]],["safflower","Safflower",0,1,"Carthamus tinctorius L.","Seed oil (food-oil studies) and flower (traditional medicine; source of safflower yellow)","Asteraceae","C. & E. Türkiye to Iran",["Flower: carthamin and safflower yellow are the main constituents; hydroxysafflor yellow A, safflor yellow A and luteolin are also reported","Flavonoids and alkaloids, especially the quinochalcone C-glycoside hydroxysafflor yellow A, N-(p-coumaroyl)serotonin and N-feruloylserotonin, are responsible for most pharmacological activities","Seed oil: omega-6 linoleic acid (the safflower oil used in the Sydney Diet Heart Study)","High-oleic safflower oil: a type containing at least 70% oleic acid, named in FDA's qualified health claim"]],["spirulina","Spirulina",2,1,"Arthrospira platensis Gomont","Whole dried biomass (powder, tablets); aqueous extract (phycocyanin color)","","",["Protein (about 65% to 70%), vitamins, minerals and phycocyanin","Gamma-linolenic acid; calcium spirulan (a polysaccharide)"]],["sumac","Sumac",0,1,"Rhus coriaria L.","Ground spice (sumac powder); some trials used extracts","Anacardiaceae","Macaronesia, Medit. to Afghanistan",["Polyphenols as the main bioactive ingredients: tannins, flavonoids and phenolic acids","Hydroxyphenyl pyranoanthocyanins and other anthocyanins, responsible for the red pigment"]],["arjuna","Arjuna",0,1,"Terminalia arjuna (Roxb. ex DC.) Wight & Arn.","Stem bark (powder or extract)","Combretaceae","Indian Subcontinent to Myanmar",["Bark extract described as containing acids (arjunic acid, terminic acid), glycosides (arjunetin, arjunosides I-IV), flavones, tannins and oligomeric proanthocyanidins, plus minerals","Saponins and flavonoids"]],["chromium","Chromium",4,1,"","Chromium picolinate, nicotinate, polynicotinate, chloride, histidinate","","",["Chromium picolinate (about 1.2% absorbed); chromium chloride (about 0.4%)"]],["coenzyme-q10","Coenzyme Q10",8,1,"","Coenzyme Q10 (ubiquinone)","","",["Coenzyme Q10 (ubiquinone)"]],["cla","Conjugated linoleic acid (CLA)",6,1,"","CLA-rich oil (triacylglycerol or free fatty acid forms); Health Canada specification: total CLA at least 78%, c9,t11 and t10,c12 isomers each at least 36%","","",["CLA isomers c9,t11 and t10,c12 (each at least 36% of CLA-rich oil in Health Canada's specification)"]],["danshen","Danshen",0,1,"Salvia miltiorrhiza Bunge","Root and rhizome","Lamiaceae","C. & S. China to Vietnam",["More than 200 compounds: lipophilic diterpenoid quinones of the tanshinone type (tanshinone I, IIA, IIB, cryptotanshinone) and hydrophilic phenolic acids (salvianolic acids, danshensu)"]],["fucoidan","Fucoidan",2,2,"","Extracts of brown seaweeds (e.g., Fucus vesiculosus, Undaria pinnatifida); high- and low-molecular-weight forms","","",["Sulfated alpha-L-fucan (sulfated polysaccharide)"]],["goji","Goji",0,1,"Lycium barbarum L.","Fruit (berry); the root bark (di gu pi) is a separate traditional ingredient","Solanaceae","N. & C. China",["Carotenoids and polysaccharides (Lycium barbarum polysaccharides, LBP); beta-sitosterol in bark and berries","Zeaxanthin, a macular xanthophyll pigment (goji is described as zeaxanthin-rich)"]],["guggul","Guggul",0,1,"Commiphora wightii (Arn.) Bhandari","Gum resin and resin extracts (e.g., guggulipid)","Burseraceae","Oman, S. Pakistan to NW. & W. India",["Guggulsterones, the purported bioactive compounds, antagonists of two nuclear hormone receptors involved in cholesterol metabolism"]],["jujube","Jujube",0,2,"Ziziphus jujuba Mill.","Fruit (fresh or dried; also syrups and extracts in trials)","Rhamnaceae","N. & E. China to S. Korea",["Vitamin C, phenolics, flavonoids, triterpenic acids and polysaccharides"]],["picrorhiza","Kutki (Picrorhiza)",0,3,"Picrorhiza kurrooa Royle","Root and rhizome","Plantaginaceae","NE. Pakistan to W. Himalaya",["Kutkoside and the iridoid glycosides picroside I and II, found mainly in the rhizome and roots","Picroliv: a standardized iridoid glycoside fraction of the root and rhizome","Other reported classes: alkaloids, cucurbitacins, phenolics (including apocynin) and terpenes"]],["lycopene","Lycopene",8,2,"","Lycopene from tomato extracts or synthetic lycopene (both studied in supplements)","","",["Lycopene, a carotenoid pigment","Lycopene is a non-provitamin A carotenoid (not converted into vitamin A)"]],["noni","Noni",0,2,"Morinda citrifolia L.","Fruit, mostly as juice (fresh or fermented); fruit extracts, capsules and powders","Rubiaceae","Trop. & Subtrop. Asia to N. Australia",["Iridoids (deacetylasperulosidic acid named as the main iridoid), scopoletin, rutin and polysaccharides","Low levels of anthraquinones in the fruit extract","A substantial amount of potassium"]],["olive-leaf","Olive leaf extract",0,1,"Olea europaea L.","Leaf (fresh or dried leaf, powdered leaf, extracts)","Oleaceae","Africa, Medit. to SC. China",["Oleuropein, a major component of olive leaf","Hydroxytyrosol; conjugated hydroxytyrosol metabolites are the main compounds found in blood and urine after olive leaf extract"]],["stevia","Stevia",0,1,"Stevia rebaudiana (Bertoni) Bertoni","Leaf; sweeteners use purified steviol glycosides (at least 95% purity)","Asteraceae","Brazil (Minas Gerais, Mato Grosso do Sul) to Paraguay",["Steviol glycosides (rebaudiosides and stevioside), reported to be 200 to 400 times sweeter than table sugar"]],["vitamin-k","Vitamin K",3,1,"","Phylloquinone or phytonadione (K1); menaquinone-4 (MK-4) and menaquinone-7 (MK-7)","","",[]],["vitamin-k2-mk7","Vitamin K2 (menaquinone-7)",3,2,"","Menaquinone-7 (MK-7); menaquinone-7 dipropionate also appears on FDA's NDI list","","",["Menaquinone-7 (MK-7), a menaquinone with an unsaturated isoprenyl side chain"]],["white-mulberry","White mulberry leaf",0,1,"Morus alba L.","Leaf (powder or extract)","Moraceae","C. China",["1-Deoxynojirimycin (DNJ), a potent alpha-glucosidase inhibitor; DNJ content of commercial mulberry products was as low as about 0.1% (100 mg/100 g of dry product)","Phytochemicals mainly 1-deoxynojirimycin, flavonoids, phenolics and polysaccharides"]],["vitamin-c","Vitamin C",3,1,"","Ascorbic acid (most common); sodium, calcium and other mineral ascorbates","","",[]],["alpha-lipoic-acid","Alpha-lipoic acid",8,1,"","DL-alpha-lipoic acid (racemic) or R-alpha-lipoic acid, both synthetic; tablets and capsules (oral). Some trials used intravenous ALA.","","",["Alpha-lipoic acid (1,2-dithiolane-3-pentanoic acid), an endogenous cofactor found in cells"]],["kelp-and-seaweed","Kelp and seaweed",2,1,"","Dried, ground seaweed (kelp powder and tablets); whole or sheet seaweed foods","","",["Iodine","Minerals absorbed from seawater, including calcium and iron (and contaminants such as mercury, lead, cadmium and arsenic)"]],["stinging-nettle","Stinging nettle",0,1,"Urtica dioica L.","Root (prostate studies); leaf, herb or herb top (other uses)","Urticaceae","Europe to Siberia and W. China, NW. Africa",["Root: lectins (about 0.05-0.6%, e.g. Urtica dioica agglutinin, UDA), lignans, sterols, phenylpropanes, ceramides, triterpenes, tannins and coumarins","Fresh leaf: stinging hairs that inject histamine, acetylcholine and other irritants; processing destroys the hairs"]],["aloe-vera","Aloe vera",0,1,"Aloe vera (also listed as Aloe barbadensis)","Leaf: inner-leaf gel, outer-leaf latex, or whole crushed leaf","Asphodelaceae","N. Oman (Hajar Mts.)",["Acemannan (a carbohydrate fraction), emodin and aloeride are named as constituents","Anthraquinones are present in aloe juice and latex, not in the clear gel","Aloin is the marker used to set limits for drinkable products (see Quality)"]],["astragalus","Astragalus",0,1,"Astragalus mongholicus Bunge","Root","Fabaceae","Siberia to Russian Far East and W. & N. China",["Saponins (astragalosides), sterols, fatty acids, isoflavonoids and polysaccharides; no specific active ingredient has been identified"]],["bladderwrack","Bladderwrack",2,2,"Fucus vesiculosus Linnaeus, 1753 (marine brown alga; accepted name in WoRMS)","Thallus (whole dried seaweed), powdered","Fucaceae","",["Iodine; soluble fiber (alginic acid); vitamin B12 and iron; may also contain heavy metals such as arsenic, cadmium and lead","European Pharmacopoeia limits for the powder: 0.03% to 0.2% iodine"]],["carrageenan-and-agar","Carrageenan and agar",2,2,"","Carrageenan: refined hydrocolloid from Chondrus, Eucheuma and Gigartina species; agar: dried colloidal polysaccharide from red algae","","",["Carrageenan: sulfated polysaccharide of galactose and anhydrogalactose units, 20% to 40% sulfate (dry weight)","Agar-agar: dried, hydrophilic, colloidal polysaccharide"]],["cinnamon","Cinnamon",0,1,"Cinnamomum verum (Ceylon); Cinnamomum cassia (cassia; synonym C. aromaticum)","Bark (products may not specify the part)","Lauraceae","Sri Lanka",["Coumarin (in cassia cinnamon; trace amounts may occur in Ceylon cinnamon)"]],["cissus","Cissus",0,1,"Cissus quadrangularis L.","Stem and leaf (aqueous extract in weight trials)","Vitaceae","Trop. & S. Africa, Madagascar, Arabian Pen., Indian Subcontinent to Myanmar",["Alkaloids, flavonoids and triterpenoids, which the 2025 review says are thought to influence bone formation and resorption"]],["flaxseed","Flaxseed and flaxseed oil",0,1,"Linum usitatissimum L.","Seed; seed oil; mucilage powder and lignan extracts made from the seed","Linaceae","Türkiye to Iran",["Alpha-linolenic acid (ALA), an omega-3 fatty acid","Lignans: flaxseed is the most concentrated food source of secoisolariciresinol (studied as secoisolariciresinol diglucoside)"]],["manganese","Manganese",4,3,"","Manganese bisglycinate, glycinate, aspartate, gluconate, picolinate, sulfate, citrate, chloride","","",["Manganese amino acid chelates, gluconate, picolinate, sulfate, citrate, chloride"]],["neem","Neem",0,2,"Azadirachta indica A.Juss.","Leaves, bark, flowers and seeds; neem (margosa) oil","Meliaceae","Assam to Indo-China",["More than 140 compounds, including limonoids (e.g., azadirachtin, nimbolide, gedunin), flavonoids and phenolic acids, across all plant parts","Nimbidin, from the seeds"]],["reishi","Reishi",1,1,"Ganoderma lucidum (Curtis) P. Karst.","Fruiting body, mycelium or spore powder","Polyporaceae","",["Beta-glucan polysaccharides and triterpenes","Oxidized lanostane triterpenes, a complex mixture unique to the genus Ganoderma"]],["zinc","Zinc",4,1,"","Zinc sulfate, acetate, gluconate, citrate, oxide (labels state elemental zinc)","","",["Zinc citrate and gluconate (about 61% absorbed in young adults); zinc oxide (about 50%)"]],["saccharomyces-boulardii","Saccharomyces boulardii",7,1,"","Live yeast cells (lyophilized products are listed in FDA's NDI list); amounts stated in CFU","","",["S. cerevisiae var. boulardii: a S. cerevisiae strain distinguished by tetrasomy of chromosome XII, absence of intact Ty transposon elements and gene copy-number variations"]],["bifidobacterium-lactis-bb12","Bifidobacterium animalis subsp. lactis BB-12",7,1,"","Live bacteria, used in foods and as freeze-dried powders; amounts stated in colony-forming units (CFU)","","",["Bifidobacterium lactis was reclassified as Bifidobacterium animalis subsp. lactis (type strain DSM 10140), a subspecies of B. animalis","BB-12: complete genome sequence determined and published; the strain originates from a collection of dairy cultures"]],["e-coli-nissle-1917","Escherichia coli Nissle 1917 (EcN)",7,2,"","Live bacteria, studied as an oral preparation (adults), an oral suspension (young children) and rectal enemas; amounts stated as viable cells","","",["E. coli strain Nissle (serotype O6:K5:H1)","pks pathogenicity island coding for biosynthesis of the genotoxin colibactin, a DNA alkylator"]],["lactobacillus-plantarum-299v","Lactiplantibacillus plantarum 299v",7,1,"","Live bacteria, freeze-dried in capsules, tablets or powder sachets and used in foods; amounts stated in CFU","","",["L. plantarum 299v (formerly Lactobacillus plantarum 299v); genome sequence in GenBank (NZ_LEAV01000004)","Genus Lactiplantibacillus: one of 23 novel genera proposed in the 2020 reclassification of Lactobacillus"]],["lactobacillus-reuteri-dsm17938","Limosilactobacillus reuteri DSM 17938",7,1,"","Live bacteria given orally in trials (also notified to FDA for foods and infant formula); amounts stated in colony-forming units (CFU)","","",["L. reuteri DSM 17938: daughter strain of ATCC 55730 without the two plasmids carrying the tet(W) and lnu(A) resistance genes; it lost the associated resistances","Genus Limosilactobacillus: one of 23 novel genera proposed in the 2020 reclassification of Lactobacillus"]],["probiotics","Probiotics",7,1,"","Live bacteria (commonly Lactobacillus-family and Bifidobacterium species) and yeasts such as Saccharomyces boulardii; amounts stated as colony-forming units (CFU)","","",["Common genera: Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Escherichia, Bacillus and the family Lactobacillaceae"]],["asafoetida","Asafoetida",0,3,"Ferula assa-foetida L.","Oleo-gum-resin from the root","Apiaceae","S. Iran",["Sugars, sesquiterpene coumarins and polysulfides isolated from the oleo-gum-resin","Essential oil of bitter asafoetida from southwest Iran: α-pinene (27.8–38.2%) and (Z)-propenyl sec-butyl disulfide (12.4–24.2%) as main components"]],["bilberry","Bilberry",0,2,"Vaccinium myrtillus L.","Fruit (fresh-fruit extracts, dried fruit); leaves also used traditionally","Ericaceae","Greenland, Temp. Eurasia, W. Canada to NW. & WC. U.S.A.",["Anthocyanins and anthocyanosides, tannins and flavonoids","The EU-assessed fresh-fruit dry extract contains 36% anthocyanosides, corresponding to 25% anthocyanidins"]],["gentian","Gentian root",0,3,"Gentiana lutea L.","Root (dried)","Gentianaceae","European Mts. to W. Türkiye",["Bitter constituents (2-8%), mostly secoiridoid glycosides: mainly gentiopicroside, with a lower amount of amarogentin (0.025-0.4%), described as the most bitter substance known","Xanthones (some gave positive Ames test results)"]],["java-turmeric","Java turmeric",0,3,"Curcuma zanthorrhiza Roxb.","Rhizome (dried, sliced)","","",["Curcuminoids (1-2%): curcumin and monodemethoxycurcumin, plus other diarylheptanoids","Volatile oil (3-12%), mainly sesquiterpenes (e.g., beta-curcumene, ar-curcumene) and xanthorrhizol (44.5% of the oil), with a little camphor"]],["licorice-root","Licorice root",0,1,"Glycyrrhiza glabra; Glycyrrhiza uralensis; Glycyrrhiza inflata","Root","","",["Glycyrrhizin (glycyrrhizic or glycyrrhizinic acid)"]],["mastic-gum","Mastic gum",0,2,"Pistacia lentiscus L.","Resin (powdered, for oral or skin use)","Anacardiaceae","Canary Is., Medit.",["More than 120 compounds identified; the major components are a natural polymer, acidic and neutral triterpenes, and volatile secondary metabolites"]],["senna","Senna",0,2,"Senna alexandrina Mill.","Leaves and pods (fruits)","Fabaceae","Sahara & Sahel to Indian Subcontinent",["Anthraquinone derivatives and their glucosides; colonic bacteria release the active forms rhein and rhein-anthrone","Hydroxyanthracene derivatives, standardized and expressed as sennoside B"]],["vitamin-a","Vitamin A",3,1,"","Retinyl acetate, retinyl palmitate, provitamin A beta-carotene, or a combination","","",["Retinol and retinyl esters (preformed vitamin A); beta-carotene, alpha-carotene and beta-cryptoxanthin (provitamin A carotenoids)"]],["elderberry","Elderberry",0,2,"Sambucus nigra","Berry (cooked preparations)","Viburnaceae","Azores, Europe to W. Iran",[]],["pelargonium-sidoides","Pelargonium sidoides",0,1,"Pelargonium sidoides DC.","Root, as ethanolic liquid or dry extracts","","",["Polyphenols (e.g. catechin) and hydroxycoumarins (e.g. umckalin) as main constituents; also proanthocyanidins, flavan-3-ols, phenolic acids and gallic acid","Highly substituted benzopyranones, prodelphinidins and coumarin sulfates"]],["echinacea","Echinacea",0,1,"Echinacea purpurea (L.) Moench","Above-ground parts and roots","Asteraceae","C. & E. U.S.A.",["Active ingredients not well defined; extracts contain polysaccharides, volatile oils, caffeic and ferulic acid derivatives, flavonoids, alkamides and polyenes"]],["shiitake","Shiitake",1,1,"Lentinula edodes (Berk.) Pegler","Fruiting body (fresh or dried); mycelial extracts; lentinan (purified polysaccharide)","Omphalotaceae","",["Lentinan (1,3 beta-D-glucan)","Eritadenine"]],["streptococcus-salivarius-k12","Streptococcus salivarius K12",7,1,"","Live bacteria in lozenges, chewable tablets or oral powder sachets; amounts stated in CFU","","",["Salivaricin A2 (2,368 Da) and salivaricin B (2,740 Da), lantibiotic bacteriocins encoded on the 190-kb megaplasmid pSsal-K12","S. salivarius is naturally a predominant member of the human oropharynx"]],["sutherlandia","Sutherlandia (cancer bush)",0,3,"Lessertia frutescens (L.) Goldblatt & J.C.Manning","Leaves; tea, or dried leaf powder in capsules","Fabaceae","S. Africa",["Pinitol and GABA (gamma-aminobutyric acid) in the leaves","Canavanine, used as a Sutherlandia biomarker"]],["thyme","Thyme",0,2,"Thymus vulgaris L.","Herb (aerial parts); the EU monograph also covers Thymus zygis","Lamiaceae","SW. Europe, SE. Italy",["Essential-oil constituents thymol and carvacrol; flavonoids","Chemotypes cultivated in southern France: thymol (41.0% thymol), geraniol (26.4% geraniol), linalool (72.5% linalool) and 4-thujanol/terpinen-4-ol"]],["european-mistletoe","European mistletoe",0,1,"Viscum album L.","Plant extracts, mostly given by subcutaneous injection in studies; oral supplement products","Santalaceae","Europe to Lebanon and Nepal, NE. Algeria",["Mistletoe lectins (ML-1, ML-2, ML-3), viscotoxins and polysaccharides, thought to contribute to its effects; most research focuses on the lectins"]],["turkey-tail","Turkey tail",1,1,"Trametes versicolor (L.) Lloyd","Cultivated mycelium (hot-water extracts such as PSK and PSP)","","",["PSK: a protein-bound beta-glucan mixture averaging 9.4 kDa (range 5–300 kDa); 25% to 38% of its mass is covalently linked protein"]],["sulforaphane","Sulforaphane",8,1,"","Broccoli sprout or seed extracts rich in glucoraphanin (with or without active myrosinase); sulforaphane capsules or tablets","","",["Sulforaphane (1-isothiocyanato-4-(methylsulfinyl)butane)","Glucoraphanin, a water-soluble, relatively inert glucosinolate precursor of sulforaphane"]],["cranberry","Cranberry",0,1,"Vaccinium macrocarpon","Fruit (juice, tablets, capsules)","Ericaceae","E. Canada to NC. & E. U.S.A.",[]],["butchers-broom","Butcher's broom",0,2,"Ruscus aculeatus L.","Rhizome (dried underground parts)","Asparagaceae","Macaronesia to Medit., W. & SC. Europe to Caucasus",["Spirostanol saponins based on the aglycones ruscogenin and neoruscogenin (including ruscin, neoruscin and deglucoruscin), plus minor sterols, triterpenes, flavonoids and coumarins such as esculin"]],["tea-tree-oil","Tea tree oil",0,1,"Melaleuca alternifolia (Maiden & Betche) Cheel","Leaves (essential oil by steam distillation); topical use only","Myrtaceae","Queensland to NE. New South Wales",["Terpinen-4-ol (a major constituent), alpha-terpineol and alpha-pinene"]]],"rows":[[0,0,"B","Migraine frequency in adults and children (root extract)","NCCIH reports oral butterbur root extract may reduce migraine frequency. The American Academy of Neurology recommended it in 2012 but stopped in 2015 because of serious safety concerns.",{"st":"none","pl":false}],[0,1,"B","Migraine frequency","Three of four small, short-term, placebo-controlled trials (up to 600 mg/day) reported modest reductions in migraine frequency; the AAN/AHS guideline rates magnesium as probably effective.",{"st":"none","pl":false}],[0,2,"B","Migraine frequency in adults","A randomized trial in 55 adults found 400 mg/day reduced attacks by two per month versus placebo. Neurology societies rate riboflavin probably effective for migraine prevention.",{"st":"no-estimate","mt":"exact","om":"migraine attack frequency","n":55,"dur":"3 months","c":"Schoenen J et al. Neurology 1998","p":"9484373","url":"https://pubmed.ncbi.nlm.nih.gov/9484373/","pl":false}],[0,3,"C","Chronic tension-type headache","In a double-blind RCT (78 patients; 300 mg/day for 8 weeks), 5-HTP did not change headache days or intensity versus placebo, though analgesic use fell.",{"st":"no-estimate","mt":"exact","om":"headache days and intensity","c":"Ribeiro CA et al. Headache 2000","p":"10849040","url":"https://pubmed.ncbi.nlm.nih.gov/10849040/","pl":false}],[0,4,"C","Migraine frequency (Cochrane review)","Six trials (561 participants), mixed and inconclusive. In the largest (218 people), attacks fell from 4.8 to 2.9 per month versus 4.8 to 3.5 with placebo; two rigorous trials found no difference. Low-quality evidence.",{"st":"no-ci","mt":"exact","m":"MD","v":0.6,"u":"attacks per month","om":"migraine frequency","n":218,"c":"Wider B et al. Cochrane Database Syst Rev 2015","p":"25892430","url":"https://pubmed.ncbi.nlm.nih.gov/25892430/","pl":false}],[0,4,"C","Migraine (later review)","A 2020 review of 7 studies (634 participants) found inconsistent results; studies were small and used different sources and doses.",{"st":"no-estimate","mt":"partial","om":"migraine","c":"Lopresti AL et al. Phytother Res 2020","p":"32310327","url":"https://pubmed.ncbi.nlm.nih.gov/32310327/","pl":false}],[0,4,"C","Migraine pain severity and attack duration","The Cochrane review found no difference from placebo in pain severity or attack duration; the evidence was rated low quality.",{"st":"no-estimate","mt":"exact","om":"migraine attack intensity and duration","c":"Wider B et al. Cochrane Database Syst Rev 2015","p":"25892430","url":"https://pubmed.ncbi.nlm.nih.gov/25892430/","pl":false}],[0,5,"C","Tension-type headache (applied to skin)","Limited evidence suggests topical peppermint oil may relieve tension headaches.",{"st":"none","pl":false}],[0,6,"C","Hormonal migraine in premenopausal women","Resveratrol was ineffective in reducing hormonal migraine burden.",{"st":"no-estimate","mt":"exact","om":"hormonal migraine burden index (days with menstrual migraine per month)","n":62,"dur":"three months per treatment (crossover)","c":"Dzator JSA et al. Nutrients 2022","p":"35565731","url":"https://pubmed.ncbi.nlm.nih.gov/35565731/","pl":false}],[0,2,"C","Migraine in children and adolescents","A retrospective study of 41 children (200 or 400 mg/day, 3–6 months) reported fewer attacks, but two small randomized trials (50–200 mg/day) found no reduction versus placebo.",{"st":"no-estimate","mt":"partial","om":"migraine attack frequency and intensity","n":41,"dur":"3, 4 or 6 months","c":"Condò M et al. J Headache Pain 2009","p":"19649688","url":"https://pubmed.ncbi.nlm.nih.gov/19649688/","pl":false}],[1,7,"B","Premenstrual syndrome (PMS), including breast pain","Several studies of low-to-moderate quality suggest chasteberry might reduce PMS symptoms such as breast pain or tenderness; higher-quality evidence is needed.",{"st":"none","pl":false}],[1,7,"B","Premenstrual syndrome: one specific dry extract","In a placebo-controlled study of 178 women, a specific dry extract improved irritability, mood changes, anger, headache and breast fullness; the EU accepts it as well-established use for PMS.",{"st":"no-estimate","mt":"exact","om":"self-assessed PMS symptoms (irritability, mood, anger, headache, breast fullness, bloating)","n":178,"dur":"three menstrual cycles","c":"Schellenberg R. BMJ 2001","p":"11159568","url":"https://pubmed.ncbi.nlm.nih.gov/11159568/","pl":false}],[1,8,"B","Period pain (primary dysmenorrhea)","A review of 12 RCTs found fennel similar to conventional drugs for period pain (7 trials, 502 women) and better than placebo (468 women); many small favorable studies suggest possible publication bias.",{"st":"pooled","mt":"exact","m":"SMD","v":-3.27,"lo":-5.28,"hi":-1.26,"om":"pain in primary dysmenorrhea (fennel vs placebo)","n":468,"i2":98,"c":"Lee HW et al. Nutrients 2020","p":"33182553","url":"https://pubmed.ncbi.nlm.nih.gov/33182553/","pl":true}],[1,9,"B","Premenstrual syndrome and period pain","A meta-analysis of randomized trials reported reduced PMS symptoms (SMD −0.64, 95% CI −0.84 to −0.44) and reduced dysmenorrhea (SMD −0.51, 95% CI −1.01 to −0.01).",{"st":"pooled","mt":"exact","m":"SMD","v":-0.64,"lo":-0.84,"hi":-0.44,"om":"PMS symptoms","c":"Mohammadi MM et al. Korean J Fam Med 2026","p":"41151539","url":"https://pubmed.ncbi.nlm.nih.gov/41151539/","pl":true}],[1,10,"B","Premenstrual syndrome (PMS) symptoms","A meta-analysis of nine trials (almost 1,000 women) found B6 more effective than placebo; a 94-woman RCT (80 mg/day, three cycles) reported significant reductions. ODS states more research is needed.",{"st":"pooled","mt":"exact","m":"OR","v":2.32,"lo":1.95,"hi":2.54,"om":"improvement in overall premenstrual symptoms","k":9,"n":940,"c":"Wyatt KM et al. BMJ 1999","p":"10334745","url":"https://pubmed.ncbi.nlm.nih.gov/10334745/","pl":true}],[1,7,"C","Heavy menstrual bleeding with an IUD","One study suggested a reduction, but the evidence is of low quality.",{"st":"no-estimate","mt":"partial","om":"IUD-induced menstrual bleeding score","n":84,"dur":"four months","c":"Yavarikia P et al. J Caring Sci 2013","p":"25276733","url":"https://pubmed.ncbi.nlm.nih.gov/25276733/","pl":false}],[1,11,"C","Period pain (primary dysmenorrhea)","A single-blind randomized study compared costus root (1.5 g twice daily on cycle days 1-5 for three cycles) with another Unani herb, without placebo; pain scores fell in both groups, more with costus.",{"st":"no-estimate","mt":"exact","om":"pain severity (10 cm VAS)","dur":"cycle days 1-5 for three cycles","c":"Sumaiya S et al. Altern Ther Health Med 2024","p":"39110054","url":"https://pubmed.ncbi.nlm.nih.gov/39110054/","pl":false}],[1,12,"C","Amenorrhea caused by antipsychotic drugs","MSK cites a systematic review that found dong quai useful for antipsychotic-induced amenorrhea; trial sizes and quality are not described in MSK's summary.",{"st":"none","pl":false}],[1,13,"C","Menstrual cramps","Only a small number of studies exist, with low-quality evidence and uncertain effects.",{"st":"none","pl":false}],[1,14,"C","Menstrual cramp severity","NCCIH states research suggests ginger supplements might reduce the severity of menstrual cramps.",{"st":"none","pl":false}],[1,15,"C","Premenstrual syndrome in adolescents","One double-blind trial in 100 girls aged 14–18 (1.2 g/day for 3 months) reported fewer psychosomatic problems on a well-being questionnaire than placebo.",{"st":"no-estimate","mt":"exact","om":"psychosomatic symptoms score (General Health Questionnaire)","dur":"3 successive months","c":"Heydari N et al. Int J Adolesc Med Health 2018","p":"29369810","url":"https://pubmed.ncbi.nlm.nih.gov/29369810/","pl":false}],[1,16,"C","Period pain (primary dysmenorrhea)","A single-arm, open-label trial in 12 women (1,050 mg/day encapsulated bark for 8 weeks) reported lower pain intensity than at baseline; with no control group, the result is preliminary.",{"st":"no-estimate","mt":"exact","om":"pain intensity (VAS)","dur":"8 weeks","c":"McClure C et al. Adv Integr Med 2022","p":"36960315","url":"https://pubmed.ncbi.nlm.nih.gov/36960315/","pl":false}],[1,17,"C","Premenstrual syndrome","A randomized trial in 40 women (400 mg PS plus 400 mg phosphatidic acid daily for 3 cycles) found greater improvement in total PMS symptom score than placebo; most individual symptom scales did not differ.",{"st":"no-estimate","mt":"exact","om":"DRSP total PMS symptom score","dur":"3 menstrual cycles","c":"Schmidt K et al. Clin Nutr ESPEN 2018","p":"29576358","url":"https://pubmed.ncbi.nlm.nih.gov/29576358/","pl":false}],[1,18,"C","Premenstrual symptoms","MSK cites a randomized, triple-blind, placebo-controlled study in medical sciences students suggesting royal jelly may improve premenstrual symptoms.",{"st":"single-trial","mt":"exact","m":"MD","v":10.54,"lo":6.1,"hi":14.98,"u":"points on PMS score (Premenstrual Profile 2005)","om":"PMS score","dur":"two consecutive menstrual cycles","c":"Taavoni S et al. Complement Ther Med 2014","p":"25146061","url":"https://pubmed.ncbi.nlm.nih.gov/25146061/","pl":true,"se":"positive = larger fall in PMS score"}],[2,8,"B","Menopausal symptoms","Two placebo-controlled RCTs (145 women) favored fennel for menopausal symptoms; other trials showed no benefit for sexual function, quality of life or psychological health, and risk of bias was concerning.",{"st":"pooled","mt":"exact","m":"SMD","v":-1.32,"lo":-1.76,"hi":-0.87,"om":"menopausal symptoms","k":2,"n":145,"c":"Lee HW et al. Complement Ther Clin Pract 2021","p":"33725577","url":"https://pubmed.ncbi.nlm.nih.gov/33725577/","pl":false,"ex":"the abstract does not state the confidence level of the printed interval, so it cannot be shown as a 95% confidence interval"}],[2,19,"B","Hot flashes in peri- and postmenopausal women","A 2026 meta-analysis of nine placebo-controlled RCTs (37.1–160 mg/day isoflavones, 12 weeks to 12 months) found a small-to-moderate reduction in hot-flash frequency; most trials had low risk of bias.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.446,"lo":-0.807,"hi":-0.084,"om":"hot flash frequency","k":9,"dur":"12 weeks to 12 months","c":"Jiang W et al. Eur J Obstet Gynecol Reprod Biol 2026","p":"42269521","url":"https://pubmed.ncbi.nlm.nih.gov/42269521/","pl":true}],[2,19,"B","Daily number of hot flashes","A 2021 meta-analysis of eight trials (ten comparisons) found 1.73 fewer hot flashes per day than placebo (95% CI -3.28 to -0.18); the authors call for further well-designed studies.",{"st":"pooled","mt":"exact","m":"WMD","v":-1.73,"lo":-3.28,"hi":-0.18,"u":"hot flushes per day","om":"daily frequency of hot flushes","k":8,"c":"Kanadys W et al. Nutrients 2021","p":"33920485","url":"https://pubmed.ncbi.nlm.nih.gov/33920485/","pl":true}],[2,18,"B","Postmenopausal symptoms","A 2026 systematic review included 6 studies (471 postmenopausal women); pooling 2 studies (312 participants) showed improved symptoms versus placebo (SMD 0.73), rated moderate-quality evidence.",{"st":"pooled","mt":"exact","m":"SMD","v":0.73,"lo":0.5,"hi":0.96,"om":"postmenopausal symptoms","k":2,"n":312,"i2":0,"c":"Ferraz SD et al. Menopause 2026","p":"41401249","url":"https://pubmed.ncbi.nlm.nih.gov/41401249/","pl":true,"se":"positive = larger improvement in symptoms, as the abstract presents it"}],[2,20,"B","Hot flashes in peri- and postmenopausal women","A 2012 meta-analysis of double-blind RCTs found soy isoflavones (median 54 mg/day, 6 weeks to 12 months) reduced hot-flash frequency by 20.6% and severity by 26.2% versus placebo, with high heterogeneity.",{"st":"pooled","mt":"exact","m":"percent-change","v":-20.6,"lo":-28.38,"hi":-12.86,"u":"%","om":"hot flash frequency","i2":67,"dur":"6 weeks to 12 months","c":"Taku K et al. Menopause 2012","p":"22433977","url":"https://pubmed.ncbi.nlm.nih.gov/22433977/","pl":false,"sn":"printed without a minus sign; shown as a reduction"}],[2,3,"C","Menopausal hot flashes","A small double-blind trial in 24 postmenopausal women found no significant effect of 150 mg/day 5-HTP on objectively recorded hot-flash frequency; the author called it preliminary.",{"st":"no-estimate","mt":"exact","om":"hot flash frequency per 24 h (electronic recorder)","n":24,"c":"Freedman RR et al. Maturitas 2010","p":"20031347","url":"https://pubmed.ncbi.nlm.nih.gov/20031347/","pl":false}],[2,21,"C","Menopausal symptoms in breast cancer patients on antihormonal therapy","In a randomized crossover trial (46 patients recruited), 70.9% reported improvement with pollen-honey and 68.3% with honey alone; the difference was not significant.",{"st":"no-estimate","mt":"exact","om":"self-reported improvement in menopausal symptoms (MRS)","n":46,"c":"Münstedt K et al. Mol Clin Oncol 2015","p":"26171198","url":"https://pubmed.ncbi.nlm.nih.gov/26171198/","pl":false}],[2,22,"C","Menopausal symptoms (Cochrane review)","A 2012 Cochrane review of 16 randomized trials (2,027 women) found insufficient evidence to support or oppose black cohosh for menopausal symptoms.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.1,"lo":-0.32,"hi":0.11,"om":"menopausal symptom scores","n":357,"i2":21,"c":"Leach MJ et al. Cochrane Database Syst Rev 2012","p":"22972105","url":"https://pubmed.ncbi.nlm.nih.gov/22972105/","pl":true}],[2,22,"C","Overall menopause symptoms (2023 review)","A 2023 review of 22 studies, including combination products, found potential benefit for overall menopause symptoms and hot flashes but not for anxiety or depressive symptoms; results conflict with other reviews.",{"st":"pooled","mt":"exact","m":"SMD","v":0.575,"lo":0.283,"hi":0.867,"om":"improvement in overall menopausal symptoms","c":"Sadahiro R et al. Menopause 2023","p":"37192826","url":"https://pubmed.ncbi.nlm.nih.gov/37192826/","pl":true,"se":"positive = larger improvement in symptoms"}],[2,22,"C","Hot flashes from breast cancer treatment","NCCIH states it is uncertain whether black cohosh reduces hot flashes caused by breast cancer treatment.",{"st":"none","pl":false}],[2,7,"C","Menopausal symptoms","In combination with St. John's wort, chasteberry was ineffective for menopausal symptoms.",{"st":"no-estimate","mt":"exact","om":"hot flush episodes (primary); Greene Climacteric, Hamilton Depression, Utian QoL","n":100,"dur":"16 weeks","c":"van Die MD et al. Menopause 2009","p":"18791483","url":"https://pubmed.ncbi.nlm.nih.gov/18791483/","pl":false}],[2,12,"C","Hot flashes and other menopausal symptoms (dong quai alone)","A single 24-week double-blind trial in 71 postmenopausal women found no difference from placebo in hot flashes, Kupperman index, endometrial thickness or vaginal cell maturation.",{"st":"no-estimate","mt":"exact","om":"vasomotor flushes, Kupperman index, endometrial thickness, vaginal maturation","dur":"24 weeks","c":"Hirata JD et al. Fertil Steril 1997","p":"9418683","url":"https://pubmed.ncbi.nlm.nih.gov/9418683/","pl":false}],[2,12,"C","Menopausal symptoms (all studies, including formulas)","MSK describes findings on dong quai for menopausal symptoms as inconclusive and notes it was ineffective against hot flashes in men.",{"st":"none","pl":false}],[2,23,"C","Menopausal symptoms in postmenopausal women","A few studies suggest hops extracts may alleviate menopausal symptoms.",{"st":"none","pl":false}],[2,24,"C","Menopause-related sexual dysfunction","One preliminary study of 72 postmenopausal women aged 50–65 found an oral lavender oil product might offer some relief; more reliable evidence is needed.",{"st":"single-trial","mt":"exact","m":"MD","v":-0.35,"lo":-0.67,"hi":-0.02,"u":"points on Greene scale sexual dysfunction domain","om":"sexual dysfunction (Greene menopause scale)","dur":"60 days","c":"Haramshahi M et al. Complement Ther Med 2024","p":"38754638","url":"https://pubmed.ncbi.nlm.nih.gov/38754638/","pl":true}],[2,25,"C","Menopausal symptoms","A 2011 systematic review of four randomized trials in peri- and postmenopausal women found favorable effects on symptom scores but rated the evidence limited because of few, small and lower-quality trials.",{"st":"no-estimate","mt":"exact","om":"menopausal symptoms (Kupperman Index, Greene Climacteric Score)","k":4,"c":"Lee MS et al. Maturitas 2011","p":"21840656","url":"https://pubmed.ncbi.nlm.nih.gov/21840656/","pl":false}],[2,6,"C","Menopausal symptoms and well-being","In one long-term trial in postmenopausal women, resveratrol improved chronic pain, somatic menopausal symptoms, circulatory function and well-being.",{"st":"no-estimate","mt":"exact","om":"composite pain score, somatic menopausal symptoms, general well-being","n":125,"dur":"24 months (two-period crossover)","c":"Thaung Zaw JJ et al. Menopause 2020","p":"32881835","url":"https://pubmed.ncbi.nlm.nih.gov/32881835/","pl":false}],[2,26,"C","Menopausal hot flashes","NCCIH: a few small studies suggest common sage may reduce how often hot flashes occur.",{"st":"none","pl":false}],[2,26,"C","Hot flashes (pooled trials)","A meta-analysis of 4 trials (310 women) reported a pooled effect on hot-flash frequency of ES −1.12 (95% CI −2.37 to 0.14), which was not statistically significant, and no significant effect on severity.",{"st":"pooled","mt":"exact","m":"other","v":-1.12,"lo":-2.37,"hi":0.14,"om":"hot flash frequency","k":4,"n":310,"i2":71,"c":"Moradi M et al. Int J Community Based Nurs Midwifery 2023","p":"37489230","url":"https://pubmed.ncbi.nlm.nih.gov/37489230/","pl":false}],[2,27,"C","Menopausal symptoms","In a placebo-controlled trial (6 weeks of treatment, 12 weeks of follow-up; 36 women completed), Kupperman Index scores were lower with a Schisandra chinensis extract.",{"st":"no-estimate","mt":"exact","om":"Kupperman Index total score","n":36,"dur":"6 weeks treatment, 12 weeks follow-up","c":"Park JY, Kim KH. Climacteric 2016","p":"27763802","url":"https://pubmed.ncbi.nlm.nih.gov/27763802/","pl":false}],[2,28,"C","Vaginal atrophy after menopause","In an RCT of 116 postmenopausal women, 3 g/day oil for 3 months improved vaginal epithelial integrity versus placebo (OR 3.1); the vaginal health index showed only a trend.",{"st":"single-trial","mt":"exact","m":"OR","v":3.1,"lo":1.11,"hi":8.95,"om":"improvement in integrity of vaginal epithelium","n":116,"dur":"three months","c":"Larmo PS et al. Maturitas 2014","p":"25104582","url":"https://pubmed.ncbi.nlm.nih.gov/25104582/","pl":true}],[2,29,"C","Menopausal symptoms","An 8-week, three-arm trial (135 women aged 45 to 65) found the shatavari-plus-ashwagandha combination improved menopause rating scores more than shatavari alone or placebo; it is a single trial from one research group.",{"st":"no-estimate","mt":"exact","om":"Menopause Rating Scale score","n":135,"dur":"8 weeks","c":"Ademola J et al. Front Reprod Health 2025","p":"41394012","url":"https://pubmed.ncbi.nlm.nih.gov/41394012/","pl":false}],[2,30,"C","Menopause symptoms","Three small studies suggest valerian might help, but NCCIH states the evidence is not enough to know.",{"st":"none","pl":false}],[2,22,"X","Hot flashes and night sweats in large trials","A 12-month RCT (351 women) found no difference from placebo at 3, 6 or 12 months; a 2016 meta-analysis (4 studies, 511 women) found no significant reduction in vasomotor symptoms.",{"st":"no-estimate","mt":"partial","u":"vasomotor symptoms per day","om":"vasomotor symptoms per day","c":"Newton KM et al. Ann Intern Med 2006","p":"17179056","url":"https://pubmed.ncbi.nlm.nih.gov/17179056/","pl":false}],[3,31,"A","Neural tube defects (periconceptional use)","Clinical trials show adequate periconceptional folic acid reduces a substantial share of neural tube defects; US rates fell 28% after 1998 fortification. USPSTF recommends 400 to 800 mcg starting at least 1 month before conception.",{"st":"none","pl":false}],[3,32,"A","Anemia and iron deficiency in pregnancy","A 2015 Cochrane review found daily iron supplementation in pregnancy reduced maternal anemia at term by 70% and iron deficiency at term by 57%; low birthweight was 8.4% versus 10.3%, a difference that was not statistically clear (RR 0.84, 95% CI 0.69 to 1.03).",{"st":"pooled","mt":"exact","m":"RR","v":0.3,"lo":0.19,"hi":0.46,"om":"maternal anemia at term","k":14,"n":2199,"c":"Peña-Rosas JP et al. Cochrane Database Syst Rev 2015","p":"26198451","url":"https://pubmed.ncbi.nlm.nih.gov/26198451/","pl":true}],[3,33,"A","Birth outcomes (supplements in pregnancy)","A 2019 Cochrane review (20 trials, 141,849 women) found multiple-micronutrient supplements reduced low birthweight versus iron with or without folic acid (RR 0.88, 95% CI 0.85 to 0.91) and probably slightly reduced preterm birth (RR 0.95, 0.90 to 1.01).",{"st":"pooled","mt":"exact","m":"RR","v":0.88,"lo":0.85,"hi":0.91,"om":"low birthweight","k":18,"n":68801,"c":"Keats EC et al. Cochrane Database Syst Rev 2019","p":"30873598","url":"https://pubmed.ncbi.nlm.nih.gov/30873598/","pl":true}],[3,34,"B","Preeclampsia in pregnancy","A Cochrane review (27 RCTs, 18,064 women) reported fewer cases with at least 1,000 mg/day, mainly in women with low calcium intake; evidence quality was low and large trials were not significant.",{"st":"pooled","mt":"exact","m":"RR","v":0.45,"lo":0.31,"hi":0.65,"om":"pre-eclampsia (high-dose calcium ≥1 g/day)","k":13,"n":15730,"i2":70,"c":"Hofmeyr GJ et al. Cochrane Database Syst Rev 2018","p":"30277579","url":"https://pubmed.ncbi.nlm.nih.gov/30277579/","pl":true}],[3,35,"B","Sperm quality and fertility in men","A 2022 Cochrane review (6 trials, 1,089 men) found improved sperm motility and concentration at some time points, but no effect on live birth or pregnancy rates.",{"st":"none","pl":false}],[3,36,"B","Iron deficiency anemia in pregnancy (compared with ferrous sulfate)","A 2017 meta-analysis of 4 RCTs (600 pregnant women) found hemoglobin rose more at 4 weeks with daily oral bovine lactoferrin than with ferrous sulfate (mean difference 0.77), with fewer gastrointestinal side effects.",{"st":"pooled","mt":"exact","m":"MD","v":0.77,"lo":0.04,"hi":1.55,"om":"change in hemoglobin at 4 weeks","k":4,"n":600,"dur":"4 weeks","c":"Abu Hashim H et al. Eur J Obstet Gynecol Reprod Biol 2017","p":"29059584","url":"https://pubmed.ncbi.nlm.nih.gov/29059584/","pl":true}],[3,37,"B","Breast-milk supply","LactMed cites a meta-analysis (14 studies, 865 subjects) indicating increased serum prolactin and milk volume; other pooled analyses combined small studies, some with methodologic problems. Long-term benefit to infants is not well studied.",{"st":"none","pl":false}],[3,38,"B","Gestational diabetes and other pregnancy outcomes","A Cochrane review of 7 trials (1,319 pregnant women; 6 in Italy) found myo-inositol may reduce gestational diabetes (RR 0.53) and hypertensive disorders of pregnancy; certainty was low to very low.",{"st":"pooled","mt":"exact","m":"RR","v":0.53,"lo":0.31,"hi":0.9,"om":"incidence of gestational diabetes","k":6,"n":1140,"c":"Motuhifonua SK et al. Cochrane Database Syst Rev 2023","p":"36790138","url":"https://pubmed.ncbi.nlm.nih.gov/36790138/","pl":true}],[3,39,"B","Preterm birth (supplements in pregnancy)","A 2018 Cochrane review (70 RCTs, 19,927 women) reported 11% lower risk of birth before 37 weeks; a 2016 AHRQ review found pregnancies lasted slightly longer but no effect on risk of premature birth.",{"st":"pooled","mt":"exact","m":"RR","v":0.89,"lo":0.81,"hi":0.97,"om":"preterm birth < 37 weeks","k":26,"n":10304,"c":"Middleton P et al. Cochrane Database Syst Rev 2018","p":"30480773","url":"https://pubmed.ncbi.nlm.nih.gov/30480773/","pl":true}],[3,29,"B","Breast-milk supply after childbirth","LactMed describes clinical results as mixed, often with herbal mixtures; one small well-done trial found greater prolactin and infant weight gain than placebo, while a 4-week trial of a shatavari mixture (64 women) found no difference.",{"st":"none","pl":false}],[3,40,"C","Testosterone and sperm quality in men","NCCIH describes some limited evidence that 2 to 4 months of use may increase testosterone levels and sperm quality.",{"st":"none","pl":false}],[3,7,"C","Infertility and sexual dysfunction","There isn't enough reliable evidence to know whether chasteberry helps; it may be unsafe during pregnancy.",{"st":"none","pl":false}],[3,41,"C","Neural tube defects","Some evidence links lower maternal blood choline to higher neural tube defect risk; other research found no such relationship.",{"st":"none","pl":false}],[3,42,"C","Breast-milk supply","LactMed: cumin has been used as a galactogogue with some literature support, including in herbal mixtures; no data exist on its safety in nursing mothers or infants.",{"st":"none","pl":false}],[3,43,"C","Starting labor","Studies of oral and vaginal use to help start labor have had inconsistent results.",{"st":"none","pl":false}],[3,8,"C","Breast-milk supply","LactMed: two small studies found increases in some measures such as milk volume, fat content and infant weight gain; no increase in serum prolactin has been found.",{"st":"none","pl":false}],[3,13,"C","Breast milk supply","Cochrane 2020 (41 galactagogue trials): fenugreek was among natural products studied; milk-volume results could not be pooled, and evidence for fenugreek or fennel on infant weight was very low certainty.",{"st":"no-estimate","mt":"exact","om":"infant weight and milk volume (natural galactagogues incl. fenugreek)","k":41,"n":3005,"c":"Foong SC et al. Cochrane Database Syst Rev 2020","p":"32421208","url":"https://pubmed.ncbi.nlm.nih.gov/32421208/","pl":false}],[3,44,"C","Child development after supplementation in pregnancy","Lower maternal iodine status was linked to lower child verbal IQ in a meta-analysis, but two trials of 150–200 mcg/day in pregnancy found no effect on child cognitive, language or motor scores.",{"st":"none","pl":false}],[3,25,"C","Semen quality","A 2022 meta-analysis of five randomized trials found mixed effects and no significant increase in sperm concentration versus placebo in men with infertility.",{"st":"pooled","mt":"exact","m":"WMD","v":2.22,"lo":-2.94,"hi":7.37,"om":"sperm concentration","c":"Lee HW et al. Front Pharmacol 2022","p":"36110519","url":"https://pubmed.ncbi.nlm.nih.gov/36110519/","pl":true}],[3,45,"C","Breast milk production","NCCIH states the effect is unclear.",{"st":"none","pl":false}],[3,38,"C","Live birth and pregnancy in subfertile women with PCOS","A Cochrane review of 13 trials (1,472 women, mostly before IVF) found very low-quality evidence; it is uncertain whether myo-inositol improves live birth or clinical pregnancy rates.",{"st":"pooled","mt":"exact","m":"OR","v":2.42,"lo":0.75,"hi":7.83,"om":"live birth rate (MI vs standard treatment, IVF pre-treatment)","k":2,"n":84,"i2":0,"c":"Showell MG et al. Cochrane Database Syst Rev 2018","p":"30570133","url":"https://pubmed.ncbi.nlm.nih.gov/30570133/","pl":true}],[3,29,"C","Milk volume in the first 72 hours after delivery","A randomized, double-blind trial (113 women analyzed, 300 mg root extract twice daily for 72 hours) reported higher milk volume and earlier breast fullness than placebo; no adverse events occurred.",{"st":"no-estimate","mt":"exact","om":"milk volume at 72 h","n":113,"dur":"72 hours","c":"Ajgaonkar A et al. J Obstet Gynaecol 2025","p":"41055223","url":"https://pubmed.ncbi.nlm.nih.gov/41055223/","pl":false}],[4,40,"B","Sleep","A 2021 meta-analysis of five placebo-controlled trials (400 participants) found a small but significant effect on overall sleep (SMD −0.59, 95% CI −0.75 to −0.42), more prominent in adults with insomnia, at 600 mg/day or more and over 8 weeks or longer.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.59,"lo":-0.75,"hi":-0.42,"om":"overall sleep","k":5,"n":400,"i2":62,"c":"Cheah KL et al. PLoS One 2021","p":"34559859","url":"https://pubmed.ncbi.nlm.nih.gov/34559859/","pl":true}],[4,46,"B","Sleep quality in adults","A review of 10 RCTs pooled 7 effect sizes: inhaled rose aromatherapy improved sleep quality (SMD 2.24); most trials were of fair quality and two reported adverse effects.",{"st":"pooled","mt":"exact","m":"SMD","v":2.24,"lo":1.01,"hi":3.48,"om":"sleep quality (inhalation aromatherapy)","c":"Ghorbani Rami MS et al. Sleep Med 2021","p":"34508987","url":"https://pubmed.ncbi.nlm.nih.gov/34508987/","pl":true,"se":"positive = better sleep quality, as the abstract presents it"}],[4,47,"B","Sleep quality","A meta-analysis of randomized trials (19 articles, 897 participants) found small improvements in self-rated sleep latency, daytime dysfunction and overall sleep quality; few trials tested L-theanine alone.",{"st":"pooled","mt":"exact","m":"SMD","v":0.43,"lo":0.04,"hi":0.83,"om":"overall subjective sleep quality score","k":12,"c":"Bulman A et al. Sleep Med Rev 2025","p":"40056718","url":"https://pubmed.ncbi.nlm.nih.gov/40056718/","pl":true,"se":"positive = better sleep quality, as the abstract presents it"}],[4,48,"B","Delayed sleep-wake phase disorder","A 2018 4-week RCT (307 people) found sleep onset about 34 minutes earlier with timed melatonin plus a set bedtime; AASM's 2015 recommendation was weak.",{"st":"single-trial","mt":"partial","m":"MD","v":-34,"lo":-60,"hi":-8,"u":"minutes","om":"actigraphic sleep onset time, relative to baseline and vs placebo","n":116,"dur":"4 weeks","c":"Sletten TL et al. PLoS Med 2018","p":"29912983","url":"https://pubmed.ncbi.nlm.nih.gov/29912983/","pl":false,"sn":"printed without a minus sign; shown as a reduction"}],[4,48,"B","Jet lag","Reviews from 2010 and 2014 found melatonin may beat placebo for jet lag symptoms (4 studies, 142 travelers eastward; 2 studies, 90 travelers westward).",{"st":"none","pl":false}],[4,48,"B","Sleep problems in children","A 2019 review of 18 mostly small, 1-13 week studies (1,021 children) found faster sleep onset and longer sleep than placebo; effects on behavior were unclear and long-term effects unknown.",{"st":"no-ci","mt":"partial","m":"other","v":28,"u":"minutes","om":"sleep latency","k":19,"dur":"1-13 weeks","c":"McDonagh MS et al. J Child Neurol 2019","p":"30674203","url":"https://pubmed.ncbi.nlm.nih.gov/30674203/","pl":false}],[4,3,"C","Sleep quality in older adults","A single-blinded 12-week RCT (30 older adults, 66 ± 3 years; 100 mg/day versus no supplement) found improved subjective sleep scores in poor sleepers only.",{"st":"no-estimate","mt":"exact","om":"subjective global sleep score (PSQI) in poor sleepers","c":"Sutanto CN et al. Clin Nutr 2024","p":"38309227","url":"https://pubmed.ncbi.nlm.nih.gov/38309227/","pl":false}],[4,49,"C","Sleep (EU traditional use)","The EMA herbal committee found clinical trial evidence insufficient but accepted traditional use to aid sleep; it considered a few studies, including one in sleep disorders suggesting a positive effect.",{"st":"none","pl":false}],[4,49,"C","Insomnia (multi-ingredient product)","An open-label pilot in 40 adults (2 weeks of a product with melatonin, vitamin B6, California poppy, passionflower and lemon balm) reported better sleep-diary scores; there was no control group.",{"st":"no-estimate","mt":"exact","om":"sleep quality score (0-10 sleep diary)","n":40,"dur":"two weeks","c":"Lemoine P et al. Complement Ther Med 2019","p":"31331545","url":"https://pubmed.ncbi.nlm.nih.gov/31331545/","pl":false}],[4,50,"C","Insomnia and sleep","NCCIH reports very little information; a 2019 review found one insomnia study, which showed no benefit.",{"st":"no-estimate","mt":"exact","om":"insomnia severity index","c":"Hieu TH et al. Phytother Res 2019","p":"31006899","url":"https://pubmed.ncbi.nlm.nih.gov/31006899/","pl":false}],[4,51,"C","Sleep in stressed adults","In an 8-week placebo-controlled RCT of 100 stressed adults, Athens Insomnia Scale scores improved more than with placebo; the authors said objective sleep measures are needed to confirm this.",{"st":"no-estimate","mt":"exact","om":"Athens Insomnia Scale","dur":"8 weeks","c":"Lopresti AL et al. Front Nutr 2022","p":"36185698","url":"https://pubmed.ncbi.nlm.nih.gov/36185698/","pl":false}],[4,23,"C","Sleep","Clinical studies used hops combined with valerian, so the EU assessment could not draw firm conclusions about hops alone.",{"st":"none","pl":false}],[4,52,"C","Primary insomnia","In a non-placebo comparison (patients described as randomly selected; group allocation not stated), 15 patients given jatamansi powder 4 g three times daily for a month improved on sleep measures, but less than patients given valerian (Valeriana wallichii).",{"st":"no-estimate","mt":"exact","om":"initiation and duration of sleep, disturbed sleep, disturbance in routine work (% improvement)","dur":"1 month","c":"Toolika E et al. Ayu 2015","p":"26730138","url":"https://pubmed.ncbi.nlm.nih.gov/26730138/","pl":false}],[4,53,"C","Sleep quality","A 2022 meta-analysis (data from 4 articles) found tryptophan shortened wake after sleep onset, more so at 1 g or more per day, but did not affect other sleep components.",{"st":"pooled","mt":"exact","m":"SMD","v":-1.08,"lo":-1.89,"hi":-0.28,"om":"wake after sleep onset","k":4,"c":"Sutanto CN et al. Nutr Rev 2022","p":"33942088","url":"https://pubmed.ncbi.nlm.nih.gov/33942088/","pl":false,"ex":"the abstract does not state whether the estimate is against a control group or a change from baseline"}],[4,54,"C","Sleep quality under academic examination stress","In a double-blind RCT of 94 medical students, LcS fermented milk for 8 weeks before and 3 weeks after an exam improved some subjective sleep scores and maintained deep (N3) sleep versus placebo milk.",{"st":"no-estimate","mt":"exact","om":"subjective sleep quality (OSA inventory) and N3 sleep","dur":"8 weeks before and 3 weeks after exam","c":"Takada M et al. Benef Microbes 2017","p":"28443383","url":"https://pubmed.ncbi.nlm.nih.gov/28443383/","pl":false}],[4,15,"C","Sleep disturbance with mild to moderate anxiety","The EU assessment considered a small study suggesting improvement, but shortcomings in its design prevented firm conclusions.",{"st":"none","pl":false}],[4,48,"C","Chronic insomnia in adults","AASM (2017) and ACP (2016) guidelines found not enough strong evidence on effectiveness or safety to recommend melatonin for chronic insomnia.",{"st":"none","pl":false}],[4,48,"C","Sleep in shift workers","Two 2014 reviews (263 and 300 participants) found studies generally small or inconclusive; daytime sleep was about 24 minutes longer, with low-quality evidence.",{"st":"pooled","mt":"exact","m":"MD","v":24,"lo":9.8,"hi":38.9,"u":"minutes","om":"daytime sleep length after night shift","k":7,"n":263,"c":"Liira J et al. Cochrane Database Syst Rev 2014","p":"25113164","url":"https://pubmed.ncbi.nlm.nih.gov/25113164/","pl":true}],[4,55,"C","Insomnia in adults","A small amount of research suggests it might improve total sleep time; effects on time to fall asleep and to stay asleep are mixed.",{"st":"none","pl":false}],[4,56,"C","Sleep quality","A systematic review of seven intervention studies found three reported better sleep duration, efficiency or onset; doses, durations and populations varied widely and evidence is limited.",{"st":"no-estimate","mt":"exact","om":"sleep duration, efficiency, onset","k":7,"c":"Barforoush F et al. Food Sci Nutr 2025","p":"40964149","url":"https://pubmed.ncbi.nlm.nih.gov/40964149/","pl":false}],[4,30,"C","Sleep problems","NCCIH calls the evidence inconsistent; the American Academy of Sleep Medicine's 2017 guideline recommended against valerian for chronic insomnia in adults.",{"st":"none","pl":false}],[5,48,"A","Anxiety before surgery in adults","A 2015 review of 12 studies (774 people) found strong evidence that melatonin beats placebo for anxiety before surgery; results for anxiety after surgery were mixed.",{"st":"pooled","mt":"exact","m":"MD","v":-13.36,"lo":-16.13,"hi":-10.58,"u":"mm on 0-100 mm VAS","om":"preoperative anxiety (VAS), melatonin vs placebo","k":7,"dur":"measured 50 to 100 minutes after administration","c":"Hansen MV et al. Cochrane Database Syst Rev 2015","p":"25856551","url":"https://pubmed.ncbi.nlm.nih.gov/25856551/","pl":true}],[5,40,"B","Stress and cortisol in adults","A 2021 systematic review of seven trials (491 adults, all in India, 6 to 8 weeks) found lower stress, anxiety and serum cortisol than placebo; one 12-week trial of 120 adults found no effect on perceived stress.",{"st":"none","pl":false}],[5,46,"B","Anxiety and stress in adults","A meta-analysis of 32 publications found lower state anxiety (SMD −1.74) and stress (SMD −1.33) but no effect on trait anxiety; evidence quality ranged from very low to moderate.",{"st":"pooled","mt":"exact","m":"SMD","v":-1.74,"lo":-2.29,"hi":-1.2,"om":"state anxiety","c":"Rasooli T et al. Phytother Res 2021","p":"34405933","url":"https://pubmed.ncbi.nlm.nih.gov/34405933/","pl":true}],[5,57,"B","Anxiety symptoms","Cochrane 2003: 12 RCTs (700 participants); pooling 7 (380 participants), Hamilton Anxiety scores fell 3.9 points more than placebo (95% CI 0.1 to 7.7); the authors said the effect lacks robustness and rests on a relatively small sample.",{"st":"pooled","mt":"exact","m":"WMD","v":3.9,"lo":0.1,"hi":7.7,"u":"points on Hamilton Anxiety (HAM-A) scale","om":"HAM-A total score","k":7,"n":380,"c":"Pittler MH, Ernst E. Cochrane Database Syst Rev 2003","p":"12535473","url":"https://www.cochrane.org/CD003383/DEPRESSN_kava-extract-versus-placebo-for-treating-anxiety","pl":false,"pr":"quote segment not in abstract: Twelve double-blind RCTs (n=700) met the inclusion criteria; quote segment not in abstract: The meta-analysis was done on seven studies using the total ; quote segment not in abstract: The result suggests a significant effect towards a reduction"}],[5,47,"B","Stress responses in people under stressful conditions","A systematic review of randomized trials of pure L-theanine suggested 200–400 mg/day may help reduce stress and anxiety in people exposed to stressful conditions; longer, larger studies are needed.",{"st":"no-estimate","mt":"exact","om":"stress and anxiety","k":9,"c":"Williams JL et al. Plant Foods Hum Nutr 2020","p":"31758301","url":"https://pubmed.ncbi.nlm.nih.gov/31758301/","pl":false}],[5,24,"B","Anxiety, including anxiety with depressive symptoms (oral lavender oil product)","Studies suggest an oral lavender oil product might be beneficial; limitations include small samples, lack of independent funding and testing, and low participant diversity.",{"st":"none","pl":false}],[5,15,"B","Anxiety symptoms","A meta-analysis of randomized trials found lower anxiety scores than placebo (SMD −0.98, 95% CI −1.63 to −0.33) without serious side effects; trials were few and heterogeneity was high.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.98,"lo":-1.63,"hi":-0.33,"om":"anxiety score","c":"Ghazizadeh J et al. Phytother Res 2021","p":"34449930","url":"https://pubmed.ncbi.nlm.nih.gov/34449930/","pl":true}],[5,9,"B","Anxiety symptoms in adults","A 34-trial meta-analysis (1,769 adults) found lower self-rated anxiety (BAI, 6 trials) than placebo but no significant effect on clinician-rated anxiety (HARS); heterogeneity was high.",{"st":"pooled","mt":"exact","m":"WMD","v":-5.06,"lo":-8.44,"hi":-1.68,"u":"points on BAI","om":"Beck Anxiety Inventory score","k":6,"n":339,"i2":94.8,"dur":"at least four weeks (inclusion criterion)","c":"Mahmoudi R et al. Nutr Neurosci 2026","p":"41693488","url":"https://pubmed.ncbi.nlm.nih.gov/41693488/","pl":true}],[5,3,"C","Anxiety disorders","A double-blind trial in 45 patients found a moderate reduction of symptoms on two scales with 5-HTP, while clomipramine improved all rating scales versus placebo.",{"st":"no-estimate","mt":"exact","om":"anxiety symptoms (SCL-90, STAI State)","n":45,"c":"Kahn RS et al. Int Clin Psychopharmacol 1987","p":"3312397","url":"https://pubmed.ncbi.nlm.nih.gov/3312397/","pl":false}],[5,40,"C","Anxiety","NCCIH describes the evidence on anxiety as unclear.",{"st":"none","pl":false}],[5,49,"C","Mild-to-moderate generalized anxiety (combination product)","A 3-month RCT in 264 adults tested tablets combining California poppy, hawthorn and magnesium: Hamilton anxiety scores fell 10.6 vs 8.9 points with placebo. The poppy's own contribution cannot be separated.",{"st":"no-estimate","mt":"exact","om":"Hamilton anxiety scale total score","n":264,"dur":"3 months","c":"Hanus M et al. Curr Med Res Opin 2004","p":"14741074","url":"https://pubmed.ncbi.nlm.nih.gov/14741074/","pl":false}],[5,50,"C","Generalized anxiety disorder (mild to moderate)","One 8-week double-blind RCT (57 outpatients) found a greater reduction in Hamilton Anxiety scores with chamomile extract than placebo (P = 0.047); authors called the effect modest and needing replication.",{"st":"no-estimate","mt":"exact","om":"total HAM-A score","dur":"8 weeks","c":"Amsterdam JD et al. J Clin Psychopharmacol 2009","p":"19593179","url":"https://pubmed.ncbi.nlm.nih.gov/19593179/","pl":false}],[5,58,"C","Stress-related fatigue and reduced working capacity","In an RCT of 144 adults, adding 120 mg/day root extract to stress-management training gave, if any, negligible benefit; almost all measures improved over time without group differences.",{"st":"no-estimate","mt":"exact","om":"fatigue, stress, cognitive and quality-of-life scales","n":144,"dur":"8 weeks","c":"Schaffler K et al. Pharmacopsychiatry 2013","p":"23740477","url":"https://pubmed.ncbi.nlm.nih.gov/23740477/","pl":false}],[5,59,"C","Trait anxiety in young women","In a 28-day double-blind RCT in 83 healthy females aged 17–25, trait anxiety did not differ between GOS and placebo at the end of supplementation; GOS transiently increased Bifidobacterium.",{"st":"no-estimate","mt":"exact","om":"trait anxiety","n":83,"dur":"28 days","c":"Johnstone N et al. Brain Behav Immun 2025","p":"40532960","url":"https://pubmed.ncbi.nlm.nih.gov/40532960/","pl":false}],[5,60,"C","Anxiety","NCCIH states it is unclear whether hawthorn affects anxiety.",{"st":"none","pl":false}],[5,51,"C","Perceived stress in adults (8-week trial)","In an industry-funded RCT of 100 stressed adults (125 mg twice daily), Perceived Stress Scale scores and hair cortisol fell more than with placebo; sleep-scale scores also improved.",{"st":"no-estimate","mt":"exact","om":"Perceived Stress Scale; hair cortisol","dur":"8 weeks","c":"Lopresti AL et al. Front Nutr 2022","p":"36185698","url":"https://pubmed.ncbi.nlm.nih.gov/36185698/","pl":false}],[5,51,"C","General stress symptoms (6-week trial)","In a placebo-controlled trial of 150 adults (1,200 mg actives/day), total stress-symptom scores fell significantly more than with placebo; no adverse events were reported.",{"st":"no-ci","mt":"exact","m":"other","v":39,"u":"%","om":"total stress-related symptom score","dur":"six weeks","c":"Saxena RC et al. Evid Based Complement Alternat Med 2012","p":"21977056","url":"https://pubmed.ncbi.nlm.nih.gov/21977056/","pl":false}],[5,23,"C","Mild depression, anxiety and stress","Preliminary studies suggest hops extracts may alleviate mild depression, anxiety and stress.",{"st":"none","pl":false}],[5,61,"C","Anxiety in adults (pooled trials)","A meta-analysis of four small randomized trials (117 participants) found no difference in anxiety between kanna and control (RR 1.01, 95% CI 0.56–1.83); the authors could not confirm an effect.",{"st":"pooled","mt":"exact","m":"RR","v":1.01,"lo":0.56,"hi":1.83,"om":"anxiety","k":4,"n":117,"i2":0,"c":"Gouhie FA et al. Brain Disorders 2023","url":"https://www.sciencedirect.com/science/article/pii/S266645932300029X","pl":false,"ex":"the source has no PubMed record, so the quoted numbers could not be checked character by character against the abstract"}],[5,61,"C","Laboratory-induced stress in healthy young adults","Two placebo-controlled experiments (single 25 mg dose, 20 volunteers): no effect in the first; in the second, lower anticipatory anxiety and an altered heart-rate response. Authors called this first tentative evidence.",{"st":"no-estimate","mt":"exact","om":"subjective anxiety and heart-rate response to laboratory stress","n":20,"dur":"single 25 mg dose","c":"Reay J et al. Hum Psychopharmacol 2020","p":"32761980","url":"https://pubmed.ncbi.nlm.nih.gov/32761980/","pl":false}],[5,61,"C","Brain threat response in healthy adults","In a crossover imaging study of 16 healthy adults, a single 25 mg dose reduced amygdala reactivity to fearful faces; this is a brain-imaging measure, not a clinical outcome.",{"st":"no-estimate","mt":"exact","om":"amygdala reactivity to fearful faces (fMRI)","n":16,"dur":"single 25 mg dose","c":"Terburg D et al. Neuropsychopharmacology 2013","p":"23903032","url":"https://pubmed.ncbi.nlm.nih.gov/23903032/","pl":false}],[5,47,"C","Anxiety","Human data are limited; effects on anxiety in small studies are mixed.",{"st":"none","pl":false}],[5,55,"C","Anxiety, including anxiety before surgery or dental procedures","A small amount of research suggests oral passionflower might reduce anxiety symptoms, including before surgical or dental procedures, but conclusions are not definite.",{"st":"none","pl":false}],[5,17,"C","Cortisol response to a psychological stress test","A randomized trial (4 groups of 20, 3 weeks) found 400 mg/day of a soy PS–phosphatidic acid complex blunted ACTH and cortisol responses to a social stress test; 600 and 800 mg did not.",{"st":"no-estimate","mt":"exact","om":"ACTH and cortisol responses to the Trier Social Stress Test","dur":"three weeks","c":"Hellhammer J et al. Stress 2004","p":"15512856","url":"https://pubmed.ncbi.nlm.nih.gov/15512856/","pl":false}],[5,17,"C","Stress hormones in chronically stressed men","In a 42-day randomized trial in 75 men, 400 mg PS plus 400 mg phosphatidic acid daily normalized ACTH and cortisol stress responses only in highly stressed men, with no effect on psychological stress response.",{"st":"no-estimate","mt":"exact","om":"ACTH, salivary and serum cortisol responses to the TSST","dur":"42 days","c":"Hellhammer J et al. Lipids Health Dis 2014","p":"25081826","url":"https://pubmed.ncbi.nlm.nih.gov/25081826/","pl":false}],[5,17,"C","Cortisol response to exercise","A crossover trial in 10 healthy men (600 mg/day for 10 days) found lower peak cortisol (by 39%) and cortisol area under the curve after moderate cycling than placebo.",{"st":"no-ci","mt":"exact","m":"percent-change","v":39,"u":"%","om":"peak plasma cortisol after moderate-intensity cycling","dur":"10 days","c":"Starks MA et al. J Int Soc Sports Nutr 2008","p":"18662395","url":"https://pubmed.ncbi.nlm.nih.gov/18662395/","pl":false}],[5,30,"C","Anxiety disorders","Cochrane (2006) found one 4-week pilot trial of 36 patients with generalized anxiety disorder: no significant difference from placebo; evidence insufficient for conclusions.",{"st":"no-estimate","mt":"exact","om":"HAM-A total score","n":36,"dur":"4 week","c":"Miyasaka LS et al. Cochrane Database Syst Rev 2006","p":"17054208","url":"https://pubmed.ncbi.nlm.nih.gov/17054208/","pl":false}],[5,57,"X","Generalized anxiety disorder","A 16-week phase III RCT in 171 adults with diagnosed GAD found no significant difference from placebo; remission was 17.4% with kava versus 23.8% with placebo.",{"st":"no-ci","mt":"exact","m":"other","v":1.37,"u":"points","om":"anxiety reduction","n":171,"dur":"16 weeks","c":"Sarris J et al. Aust N Z J Psychiatry 2020","p":"31813230","url":"https://pubmed.ncbi.nlm.nih.gov/31813230/","pl":false}],[6,62,"A","Major depression","Cochrane (2008): 29 trials, 5,489 patients; extracts beat placebo, matched standard antidepressants, with fewer dropouts from side effects. Trials from German-speaking countries were more favorable, complicating interpretation.",{"st":"pooled","mt":"exact","m":"RR","v":1.28,"lo":1.1,"hi":1.49,"om":"treatment response (responder rate), nine larger placebo-controlled trials (subgroup)","k":9,"c":"Linde K, Berner MM, Kriston L. Cochrane Database Syst Rev 2008","p":"18843608","url":"https://pubmed.ncbi.nlm.nih.gov/18843608/","pl":true}],[6,46,"B","Depressive symptoms in adults","The 2021 Rasooli meta-analysis found lower depression scores (7 effect sizes; SMD −0.87); effects were not dose-dependent, and the authors called for higher-quality trials.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.87,"lo":-1.47,"hi":-0.28,"om":"depression","c":"Rasooli T et al. Phytother Res 2021","p":"34405933","url":"https://pubmed.ncbi.nlm.nih.gov/34405933/","pl":true}],[6,15,"B","Depressive symptoms","The 2021 Ghazizadeh meta-analysis found lower depression scores than placebo (SMD −0.47, 95% CI −0.73 to −0.21); the authors urged caution and called for higher-quality studies.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.47,"lo":-0.73,"hi":-0.21,"om":"depression score","c":"Ghazizadeh J et al. Phytother Res 2021","p":"34449930","url":"https://pubmed.ncbi.nlm.nih.gov/34449930/","pl":true}],[6,63,"B","Depression, added to antidepressant treatment","A 2022 meta-analysis found a small benefit of adjunctive L-methylfolate over antidepressant alone (response relative risk 1.25, 3 studies, 483 patients; symptom SMD -0.38, 4 studies, 507 patients).",{"st":"pooled","mt":"exact","m":"RR","v":1.25,"lo":1.08,"hi":1.46,"om":"HAM-D-17 response","k":3,"n":483,"c":"Maruf AA et al. Pharmacopsychiatry 2022","p":"34794190","url":"https://pubmed.ncbi.nlm.nih.gov/34794190/","pl":true}],[6,9,"B","Depressive symptoms","A meta-analysis of 23 randomized trials found large effects versus placebo (g = 0.99) and as an add-on to antidepressants; it also found evidence of publication bias and little regional diversity.",{"st":"no-ci","mt":"exact","m":"SMD","v":0.99,"om":"depressive symptoms","c":"Marx W et al. Nutr Rev 2019","p":"31135916","url":"https://pubmed.ncbi.nlm.nih.gov/31135916/","pl":false}],[6,64,"B","Depression in adults","A 2016 Cochrane review (8 RCTs, 934 adults; oral or parenteral SAMe) found no strong evidence of a difference from placebo alone, results similar to imipramine, and one trial (73 participants) favoring SAMe as an SSRI add-on. Evidence quality: low to very low.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.54,"lo":-1.54,"hi":0.46,"om":"change in depressive symptoms (SAMe vs placebo, monotherapy)","k":2,"n":142,"c":"Galizia I et al. Cochrane Database Syst Rev 2016","p":"27727432","url":"https://pubmed.ncbi.nlm.nih.gov/27727432/","pl":true}],[6,3,"C","Depression (placebo-controlled trials)","A Cochrane review located 108 trials, but only two (64 patients) of 5-HTP or tryptophan met quality criteria; they favored the supplements over placebo, but evidence was of insufficient quality to be conclusive.",{"st":"pooled","mt":"exact","m":"OR","v":4.1,"lo":1.28,"hi":13.15,"om":"alleviation of depression (response) vs placebo","n":64,"c":"Shaw K et al. Cochrane Database Syst Rev 2002","p":"11869656","url":"https://pubmed.ncbi.nlm.nih.gov/11869656/","pl":true}],[6,3,"C","Depression (2020 systematic review)","A review of 13 studies (7 meta-analyzed) reported a pooled remission rate of 0.65 with high heterogeneity; the authors rated current studies relatively weak because few include placebo groups.",{"st":"pooled","mt":"exact","m":"other","v":0.65,"lo":0.55,"hi":0.78,"om":"depression remission rate","k":13,"c":"Javelle F et al. Nutr Rev 2020","p":"31504850","url":"https://pubmed.ncbi.nlm.nih.gov/31504850/","pl":false}],[6,31,"C","Depression","Results are mixed: a 475-patient UK trial (5,000 mcg) found no improvement; a 127-patient trial found benefit only in women on fluoxetine; a meta-analysis rated adjunct evidence low quality.",{"st":"no-estimate","mt":"exact","om":"depression measures (BDI-II primary) and other outcomes","n":475,"dur":"12 weeks","c":"Bedson E et al. Health Technol Assess 2014 (FolATED)","p":"25052890","url":"https://pubmed.ncbi.nlm.nih.gov/25052890/","pl":false}],[6,65,"C","Mood measures","The 2017 Puttarak meta-analysis found higher alertness scores and lower anger scores one hour after dosing; the authors note limitations in dose, preparation and standardization.",{"st":"pooled","mt":"exact","m":"SMD","v":0.71,"lo":0.01,"hi":1.41,"om":"alertness score","i2":30.5,"c":"Puttarak P et al. Sci Rep 2017","p":"28878245","url":"https://pubmed.ncbi.nlm.nih.gov/28878245/","pl":true}],[6,53,"C","Mood in healthy adults","A 2021 systematic review of 11 RCTs of tryptophan intake found 4 showed effects on negative or happy feelings versus control; no effect on aggressive feelings was found.",{"st":"no-estimate","mt":"exact","om":"negative/happy feelings, aggressive feelings","k":11,"c":"Kikuchi AM et al. J Diet Suppl 2021","p":"32272859","url":"https://pubmed.ncbi.nlm.nih.gov/32272859/","pl":false}],[6,53,"C","Depression","A 2002 meta-analysis located 108 studies; only two (one of L-tryptophan, one of 5-HTP; 64 patients) met quality criteria, and the authors concluded these agents were insufficiently evaluated to assess effectiveness.",{"st":"pooled","mt":"exact","m":"OR","v":4.1,"lo":1.3,"hi":13.2,"om":"alleviation of depression","k":2,"n":64,"c":"Shaw K et al. Aust N Z J Psychiatry 2002","p":"12169147","url":"https://pubmed.ncbi.nlm.nih.gov/12169147/","pl":true}],[6,24,"C","Depressive symptoms","Early reports of small studies suggest oral lavender capsules or tea might reduce depressive symptoms; NCCIH urges caution. Topical lavender does not appear to affect depression symptoms.",{"st":"none","pl":false}],[6,66,"C","Depression and anxiety scores in women","30 women ate lion's mane or placebo cookies for 4 weeks; depression and complaint scores fell from baseline with lion's mane, but only two complaint items differed significantly from placebo.",{"st":"no-estimate","mt":"exact","om":"CES-D depression and Indefinite Complaints Index scores","n":30,"dur":"4 weeks","c":"Nagano M et al. Biomed Res 2010","p":"20834180","url":"https://pubmed.ncbi.nlm.nih.gov/20834180/","pl":false}],[6,67,"C","Bipolar depression (pericarp extract added to usual care)","A 24-week RCT (152 adults randomized) found overall depressive-symptom change did not substantially differ from placebo; some mood, severity and functioning measures improved at week 24, and these differences faded after stopping.",{"st":"no-estimate","mt":"exact","om":"depressive symptoms (bipolar depression)","dur":"24 weeks treatment, week-28 post-discontinuation follow-up","c":"Dean OM et al. Br J Psychiatry 2025","p":"40637133","url":"https://pubmed.ncbi.nlm.nih.gov/40637133/","pl":false}],[6,63,"C","Depression: dose comparison with SSRIs","ODS describes trials in which 15,000 mcg/day 5-methyl-THF plus an SSRI for 60 days improved depression versus SSRI plus placebo, whereas 7,500 mcg/day for 30 days then 15,000 mcg/day did not.",{"st":"no-estimate","mt":"exact","om":"response rate and change in depression symptom score","dur":"60 days","c":"Papakostas GI et al. Am J Psychiatry 2012","p":"23212058","url":"https://pubmed.ncbi.nlm.nih.gov/23212058/","pl":false}],[6,38,"C","Depression and anxiety disorders","A meta-analysis of 7 depression trials (242 people) and 4 anxiety-disorder trials (70) found no significant effect on depressive, anxiety or obsessive-compulsive symptoms; a trend appeared in PMDD.",{"st":"no-estimate","mt":"exact","om":"depressive, anxiety and obsessive-compulsive symptoms","c":"Mukai T et al. Hum Psychopharmacol 2014","p":"24424706","url":"https://pubmed.ncbi.nlm.nih.gov/24424706/","pl":false}],[6,68,"C","Compulsive disorders and depression","MSK describes the studies as mixed on whether NAC can help compulsive disorders, and on depression.",{"st":"none","pl":false}],[6,39,"C","Depression","A 2021 review of 35 studies (1,964 participants) concluded that any effect may be too small to be meaningful; evidence quality was judged low or very low.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.4,"lo":-0.64,"hi":-0.16,"om":"depressive symptomology (vs placebo)","k":33,"n":1848,"c":"Appleton KM et al. Cochrane Database Syst Rev 2021","p":"34817851","url":"https://pubmed.ncbi.nlm.nih.gov/34817851/","pl":true}],[6,69,"C","Depression and anxiety (added to usual care)","An 8-week double-blind trial in major depressive disorder found rosemary capsules twice daily lowered depression and anxiety scores more than placebo.",{"st":"no-estimate","mt":"exact","om":"HADS anxiety subscale and BDI-II scores","dur":"8 weeks","c":"Azizi S et al. Complement Ther Clin Pract 2022","p":"36343423","url":"https://pubmed.ncbi.nlm.nih.gov/36343423/","pl":false}],[6,64,"C","Depression: SAMe alone or added to antidepressants","A 2024 meta-analysis (14 trials, 1,522 subjects; 200-3,200 mg/day for 2-12 weeks) found no significant difference from placebo, imipramine or escitalopram; the authors urge caution given few studies.",{"st":"no-estimate","mt":"exact","om":"depression","n":1522,"dur":"between 2 and 12 weeks","c":"Peng TR et al. Gen Hosp Psychiatry 2024","p":"38199136","url":"https://pubmed.ncbi.nlm.nih.gov/38199136/","pl":false}],[6,62,"C","Severe depression or use beyond 12 weeks","NCCIH states it is uncertain whether benefit applies to severe depression or periods longer than 12 weeks.",{"st":"none","pl":false}],[6,70,"X","Depression","In VITAL (16,657 participants without depression history; 1,696 at increased risk), there were no significant differences in depression incidence, recurrence, symptoms or mood scores.",{"st":"single-trial","mt":"exact","m":"HR","v":0.97,"lo":0.87,"hi":1.09,"om":"depression or clinically relevant depressive symptoms (incident plus recurrent)","n":18353,"dur":"median treatment duration 5.3 years","c":"Okereke OI et al. JAMA 2020","p":"32749491","url":"https://pubmed.ncbi.nlm.nih.gov/32749491/","pl":true}],[7,71,"B","Attention and reaction time in adults","A 2014 meta-analysis of nine RCTs (518 subjects; standardized extracts for 12 weeks or longer) found faster Trail B test and choice reaction times than placebo.",{"st":"pooled","mt":"exact","m":"WMD","v":-17.9,"lo":-24.6,"hi":-11.2,"u":"ms","om":"Trail B test time","k":9,"n":437,"dur":"12 weeks or longer","c":"Kongkeaw C et al. J Ethnopharmacol 2014","p":"24252493","url":"https://pubmed.ncbi.nlm.nih.gov/24252493/","pl":true}],[7,71,"B","Memory in healthy adults","A 2026 network meta-analysis of 29 RCTs (2,107 healthy adults) reported better working memory with 600 mg/day or more than with placebo or ginkgo; it lacked direct head-to-head trials.",{"st":"pooled","mt":"exact","m":"SMD","v":2.03,"lo":1.28,"hi":2.78,"om":"working memory","k":29,"n":2107,"c":"Tiemtad P et al. Phytomedicine 2026","p":"41678913","url":"https://pubmed.ncbi.nlm.nih.gov/41678913/","pl":true}],[7,72,"B","Memory and behavior in older people with chronic cerebral disorders","A 2005 Cochrane review of 14 double-blind placebo-controlled RCTs (most lasting 3 months or less; one 12 months) found some evidence of benefit on memory and behavior but none on attention.",{"st":"no-estimate","mt":"exact","om":"memory, behavior, attention","dur":"20 days to 12 months","c":"Fioravanti M et al. Cochrane Database Syst Rev 2005","p":"15846601","url":"https://pubmed.ncbi.nlm.nih.gov/15846601/","pl":false}],[7,33,"B","Memory and cognition in older adults","A 2024 meta-analysis of three COSMOS substudies (573, 2,158 and 2,472 participants) found a daily multivitamin-mineral supplement improved global cognition (mean difference 0.07 SD units, 95% CI 0.03 to 0.11) and episodic memory versus placebo.",{"st":"pooled","mt":"exact","m":"MD","v":0.07,"lo":0.03,"hi":0.11,"u":"SD units","om":"global cognition","c":"Vyas CM et al. Am J Clin Nutr 2024","p":"38244989","url":"https://pubmed.ncbi.nlm.nih.gov/38244989/","pl":true}],[7,73,"C","Reading and behavior in underperforming schoolchildren","An RCT in healthy underperforming readers aged 7-9 (362 met criteria; 600 mg/day algal DHA) found no effect on reading overall, benefit in a pre-planned subgroup of the poorest readers, and fewer parent-rated behavior problems.",{"st":"no-estimate","mt":"exact","om":"reading (age-standardized); parent-rated behavior","n":362,"c":"Richardson AJ et al. PLoS One 2012","p":"22970149","url":"https://pubmed.ncbi.nlm.nih.gov/22970149/","pl":false}],[7,74,"C","Brain event-related potentials (P300) in healthy elderly men","A one-month double-blind crossover study in 25 men (240 mg/day ARA versus olive oil capsules) reported shorter P300 latency and higher P300 amplitude with ARA.",{"st":"no-estimate","mt":"exact","om":"P300 latency and amplitude","n":25,"dur":"1 month","c":"Ishikura Y et al. Neuropsychobiology 2009","p":"19752581","url":"https://pubmed.ncbi.nlm.nih.gov/19752581/","pl":false}],[7,75,"C","Cognitive function","A small amount of research suggests improvement in middle-aged but not young adults; memory benefit appeared to depend on adding ginkgo.",{"st":"none","pl":false}],[7,71,"C","ADHD symptoms in children and adolescents","A 2022 systematic review of seven RCTs of herbal products found a 'fair indication' for bacopa among others, but inadequate proof overall to support herbal medicines for ADHD.",{"st":"no-estimate","mt":"exact","om":"ADHD symptoms","c":"Dutta T et al. Front Pharmacol 2022","p":"35592415","url":"https://pubmed.ncbi.nlm.nih.gov/35592415/","pl":false}],[7,76,"C","Cognitive decline in mild cognitive impairment or mild Alzheimer's disease","A 12-month phase IIa RCT (70 participants) found a 43% smaller ADAS-Cog increase with benfotiamine (p = 0.125, not significant) and 77% less worsening of clinical dementia rating (p = 0.034).",{"st":"no-ci","mt":"exact","m":"other","v":43,"u":"%","om":"ADAS-Cog increase (cognitive decline)","dur":"twelve months","c":"Gibson GE et al. J Alzheimers Dis 2020","p":"33074237","url":"https://pubmed.ncbi.nlm.nih.gov/33074237/","pl":false}],[7,77,"C","Cognitive function","In a 2026 review, five RCTs found no significant differences between L-carnosine and placebo on most cognitive measures; pooled benefits came from carnosine combined with anserine or antioxidants, with low strength of evidence.",{"st":"pooled","mt":"exact","m":"other","v":0.62,"lo":0.23,"hi":1.01,"u":"points on MMSE","om":"MMSE score (L-carnosine combined with anserine or antioxidants)","i2":21.3,"c":"Hsiao YF et al. Nutrients 2026","p":"42123986","url":"https://pubmed.ncbi.nlm.nih.gov/42123986/","pl":false}],[7,41,"C","Cognitive function in healthy adults","Observational studies linked higher choline status or intake to better cognition, but a 2015 systematic review of 13 studies found no clear cognitive improvement from choline in healthy adults.",{"st":"none","pl":false}],[7,41,"C","Dementia (lecithin)","A 2003 Cochrane review of 12 trials found no clear clinical benefit of lecithin for Alzheimer's disease or Parkinsonian dementia.",{"st":"no-estimate","mt":"exact","om":"clinical benefit in Alzheimer's disease / Parkinsonian dementia","k":12,"c":"Higgins JP, Flicker L. Cochrane Database Syst Rev 2003","p":"12917896","url":"https://pubmed.ncbi.nlm.nih.gov/12917896/","pl":false}],[7,72,"C","Cognitive status in mild cognitive impairment, Alzheimer's disease or post-stroke dementia","A 2023 meta-analysis of 6 studies found improved cognitive status with citicoline, but the overall quality of the studies was poor, with significant risk of bias favoring the intervention.",{"st":"pooled","mt":"exact","m":"SMD","v":0.56,"lo":0.37,"hi":0.75,"om":"cognitive status","c":"Bonvicini M et al. Nutrients 2023","p":"36678257","url":"https://pubmed.ncbi.nlm.nih.gov/36678257/","pl":false,"ex":"the abstract reports a range of sensitivity-analysis estimates without one primary estimate"}],[7,78,"C","Alzheimer's disease and cognition","A 12-month trial (68 patients with mild Alzheimer's disease, 8 mg/day) found no cognitive difference from placebo; observational findings are mixed.",{"st":"no-estimate","mt":"exact","om":"cognition (ADAS-Cog, MMSE)","n":68,"dur":"12 months","c":"Kessler H et al. J Neural Transm 2008","p":"18587525","url":"https://pubmed.ncbi.nlm.nih.gov/18587525/","pl":false}],[7,31,"C","Cognitive function and dementia","Most trials show no benefit: 5,000 mcg for 18 months did not slow decline in 340 people with Alzheimer's; a Dutch trial (818 adults, 800 mcg, 3 years) improved some measures.",{"st":"no-estimate","mt":"exact","m":"MD","u":"points per month on ADAS-cog","om":"rate of cognitive decline (ADAS-cog)","n":340,"dur":"18 months","c":"Aisen PS et al. JAMA 2008","p":"18854539","url":"https://pubmed.ncbi.nlm.nih.gov/18854539/","pl":false}],[7,79,"C","Symptoms of dementia or cognitive impairment","Cochrane (2009): 36 trials, mostly small and under 3 months; results inconsistent, and authors found evidence of clinically significant benefit 'inconsistent and unreliable'.",{"st":"no-estimate","mt":"exact","om":"cognition, activities of daily living, mood in cognitive impairment and dementia","k":36,"c":"Birks J, Grimley Evans J. Cochrane Database Syst Rev 2009","p":"19160216","url":"https://pubmed.ncbi.nlm.nih.gov/19160216/","pl":false}],[7,79,"C","Cognitive performance in healthy people","NCCIH states it is uncertain whether ginkgo influences cognition in healthy people; much of the research is of low quality.",{"st":"none","pl":false}],[7,65,"C","Cognitive function","A 2017 meta-analysis of randomized trials (five of gotu kola alone) found no significant difference from placebo in any cognitive domain.",{"st":"no-estimate","mt":"exact","om":"cognitive function domains","c":"Puttarak P et al. Sci Rep 2017","p":"28878245","url":"https://pubmed.ncbi.nlm.nih.gov/28878245/","pl":false}],[7,80,"C","Cognitive performance after a single dose","A 2023 meta-analysis of eight placebo-controlled studies (328 participants) found a small effect on faster response time but no effect on accuracy; whether this reflects caffeine or other constituents is unknown.",{"st":"no-ci","mt":"exact","m":"SMD","v":0.202,"om":"response time on cognitive tasks (acute dose)","k":8,"n":328,"dur":"single dose","c":"Hack B et al. Nutrients 2023","p":"36678305","url":"https://pubmed.ncbi.nlm.nih.gov/36678305/","pl":false}],[7,81,"C","Attention and working memory after a single dose","A placebo-controlled crossover RCT of a single 650 mg extract dose reported better N-Back and Serial 7s performance and higher focus ratings than placebo over 2 hours, but fewer correct No-go responses.",{"st":"no-estimate","mt":"exact","om":"N-Back, Serial 7s, Go/No-go performance; subjective focus","dur":"single dose, assessed over 2 hours","c":"La Monica MB et al. Nutrients 2023","p":"38140277","url":"https://pubmed.ncbi.nlm.nih.gov/38140277/","pl":false}],[7,82,"C","Cognitive and negative symptoms in chronic schizophrenia","A 4-week double-blind RCT (six 500 mg capsules daily) reported improved cognitive-impairment scores, negative symptoms and excitement/activity versus placebo.",{"st":"no-estimate","mt":"exact","om":"SCIP cognitive impairment; PANSS negative and excitement/activity subscales","dur":"4 weeks","c":"Banazadeh M et al. Phytother Res 2022","p":"34814232","url":"https://pubmed.ncbi.nlm.nih.gov/34814232/","pl":false}],[7,51,"C","Cognitive performance in healthy adults","One 30-day placebo-controlled study (300 mg/day leaf extract) reported faster reaction times and fewer errors on Sternberg and Stroop tests.",{"st":"no-estimate","mt":"exact","om":"Sternberg and Stroop reaction time and error rate","dur":"30 days","c":"Sampath S et al. Indian J Physiol Pharmacol 2015","p":"26571987","url":"https://pubmed.ncbi.nlm.nih.gov/26571987/","pl":false}],[7,44,"C","Cognitive function in mildly deficient children","One New Zealand trial (184 children aged 10–13, 150 mcg/day, 28 weeks) reported improved perceptual reasoning and overall cognitive score vs. placebo.",{"st":"no-ci","mt":"exact","m":"other","v":0.19,"u":"SD","om":"overall cognitive score (4 WISC subtests)","n":184,"dur":"28 wk","c":"Gordon RC et al. Am J Clin Nutr 2009","p":"19726593","url":"https://pubmed.ncbi.nlm.nih.gov/19726593/","pl":false}],[7,61,"C","Cognitive function in healthy adults","A 3-week crossover trial in 21 healthy adults (mean age 54.6, 25 mg daily) reported better cognitive set flexibility and executive function than placebo.",{"st":"no-estimate","mt":"exact","om":"cognitive set flexibility and executive function (CNS Vital Signs)","n":21,"dur":"3 weeks","c":"Chiu S et al. Evid Based Complement Alternat Med 2014","p":"25389443","url":"https://pubmed.ncbi.nlm.nih.gov/25389443/","pl":false}],[7,35,"C","Mild cognitive impairment and Alzheimer's disease (acetyl-L-carnitine)","A 2003 Cochrane review of 11 trials in Alzheimer’s disease found more people improved on clinical global impression with acetyl-L-carnitine at 12 and 24 weeks but not at 52 weeks, no benefit on objective measures, and no evidence to recommend routine use.",{"st":"pooled","mt":"exact","m":"OR","v":2.33,"lo":1.25,"hi":4.35,"om":"number improved on Clinical Global Impression at 12 weeks","k":11,"dur":"12 weeks","c":"Hudson S, Tabet N. Cochrane Database Syst Rev 2003","p":"12804452","url":"https://pubmed.ncbi.nlm.nih.gov/12804452/","pl":true}],[7,66,"C","Mild cognitive impairment in older adults","RCT in 30 Japanese adults aged 50–80: tablets of dried lion's mane powder for 16 weeks raised cognitive scale scores versus placebo at weeks 8, 12 and 16; scores fell again 4 weeks after stopping.",{"st":"no-estimate","mt":"exact","om":"cognitive function scale (based on HDS-R)","n":30,"dur":"16 weeks","c":"Mori K et al. Phytother Res 2009","p":"18844328","url":"https://pubmed.ncbi.nlm.nih.gov/18844328/","pl":false}],[7,66,"C","Mild Alzheimer's disease","49-week pilot RCT (49 randomized, 41 completed): erinacine A-enriched mycelium capsules were linked to better MMSE and daily-activity scores than placebo, whose cognitive screening scores declined.",{"st":"no-estimate","mt":"exact","om":"MMSE, CASI and IADL scores","dur":"49 weeks","c":"Li IC et al. Front Aging Neurosci 2020","p":"32581767","url":"https://pubmed.ncbi.nlm.nih.gov/32581767/","pl":false}],[7,66,"C","Cognition, stress and mood in healthy young adults","Pilot RCT in 41 adults aged 18–45 (1.8 g): faster Stroop performance 60 minutes after one dose and a non-significant trend to lower stress after 28 days; other results were null.",{"st":"no-estimate","mt":"exact","om":"Stroop task speed; subjective stress","n":41,"dur":"single dose and 28-day intervention","c":"Docherty S et al. Nutrients 2023","p":"38004235","url":"https://pubmed.ncbi.nlm.nih.gov/38004235/","pl":false}],[7,83,"C","Cognitive function in adults","A 2021 meta-analysis of seven RCTs (five lutein/zeaxanthin supplement trials, two avocado trials) found no significant effect of lutein on complex attention, executive function or memory.",{"st":"pooled","mt":"exact","m":"SMD","v":0.02,"lo":-0.27,"hi":0.31,"om":"complex attention","c":"Li J, Abdel-Aal EM. Molecules 2021","p":"34641336","url":"https://pubmed.ncbi.nlm.nih.gov/34641336/","pl":true}],[7,84,"C","Cognitive function in healthy older adults","RCT in 47 Japanese adults aged 60 or older: bread with 50 g of one maitake strain for 18 weeks improved MoCA-J scores versus placebo; a second strain showed no difference.",{"st":"no-estimate","mt":"exact","om":"MoCA-J score","n":47,"dur":"18 wk","c":"Jogi EM et al. J Nutr Sci Vitaminol (Tokyo) 2026","p":"42055721","url":"https://pubmed.ncbi.nlm.nih.gov/42055721/","pl":false}],[7,67,"C","Cognition in mild to moderate Alzheimer's disease","A 24-week RCT (108 participants) of a water-soluble pericarp extract found more participants in the low-dose group than on placebo reached a clinically important ADAS-Cog improvement, with a trend at the high dose.",{"st":"no-estimate","mt":"exact","om":"proportion reaching ADAS-Cog minimum clinically important difference (-2.6 points) at 24 weeks","dur":"24 weeks","c":"Muangpaisan W et al. Alzheimers Dement (N Y) 2022","p":"35415207","url":"https://pubmed.ncbi.nlm.nih.gov/35415207/","pl":false}],[7,85,"C","Cognition in mild cognitive impairment or Alzheimer's disease","A 2023 meta-analysis (9 publications, 10 studies) found improved general cognition with oral MCT versus placebo, but not memory, language or attention; the authors say better-characterized studies are needed before a definitive conclusion.",{"st":"pooled","mt":"exact","m":"SMD","v":0.64,"lo":0.05,"hi":1.24,"om":"general cognition","k":10,"c":"Sun L et al. J Alzheimers Dis 2023","p":"37248908","url":"https://pubmed.ncbi.nlm.nih.gov/37248908/","pl":true}],[7,86,"C","Leaf extract: cognitive impairment","In a 12-week RCT of 100 adults, 500 mg/day of a purple perilla leaf ethanol extract improved cognitive test scores versus placebo; blood amyloid and BDNF did not differ. The extract maker funded the study.",{"st":"no-estimate","mt":"exact","om":"K-MMSE-2 and ADAS-Cog scores","n":100,"dur":"12 weeks","c":"Baek HI et al. Nutrients 2026","p":"41901135","url":"https://pubmed.ncbi.nlm.nih.gov/41901135/","pl":false}],[7,87,"C","Cognitive function in healthy middle-aged and older adults","A 12-week RCT (64 randomized, 58 completed; 21.5 mg/day PQQ disodium salt) reported better memory, attention and executive-function scores than placebo; no adverse events were observed.",{"st":"no-estimate","mt":"exact","om":"Cognitrax cognitive domain scores","n":58,"dur":"12 weeks","c":"Shiojima Y et al. J Am Nutr Assoc 2022","p":"34415830","url":"https://pubmed.ncbi.nlm.nih.gov/34415830/","pl":false}],[7,87,"C","Attention in healthy elderly people","A 12-week RCT in 41 elderly subjects (20 mg/day) found a smaller change in Stroop interference ratio with PQQ than placebo; visual-spatial scores rose only in a low-scoring subgroup.",{"st":"no-estimate","mt":"exact","om":"Stroop interference ratio change","n":41,"dur":"12 weeks","c":"Itoh Y et al. Adv Exp Med Biol 2016","p":"26782228","url":"https://pubmed.ncbi.nlm.nih.gov/26782228/","pl":false}],[7,69,"C","Memory speed in older adults (single doses)","A crossover trial in 28 older adults found 750 mg of dried leaf improved speed of memory versus placebo, while 6,000 mg impaired it; other measures showed less consistent harmful effects.",{"st":"no-estimate","mt":"exact","om":"speed of memory","n":28,"dur":"single doses, tested 1-6 hours post-dose","c":"Pengelly A et al. J Med Food 2012","p":"21877951","url":"https://pubmed.ncbi.nlm.nih.gov/21877951/","pl":false}],[7,9,"C","Mild cognitive impairment and Alzheimer's disease","A meta-analysis of four randomized trials found better cognitive scores than placebo, but the authors judged the evidence insufficient for any recommendation for clinical use.",{"st":"no-estimate","mt":"exact","om":"cognitive function (ADAS-cog, CDR-SB)","c":"Ayati Z et al. BMC Complement Med Ther 2020","p":"33167948","url":"https://pubmed.ncbi.nlm.nih.gov/33167948/","pl":false}],[7,26,"C","Memory and thinking in healthy people","NCCIH: a few studies suggest common sage, Spanish sage or both may improve memory or other thinking scores in healthy people; the evidence is small.",{"st":"none","pl":false}],[7,88,"C","Working memory in older adults with memory complaints","In a 90-day RCT of 90 adults with age-associated memory impairment, 900 mg/day extract improved quality of working memory (15%) and spatial working memory accuracy (9%) versus placebo; authors were funded by or employed by the manufacturer.",{"st":"no-ci","mt":"exact","m":"percent-change","v":15,"u":"%","om":"quality of working memory (CDR System)","n":90,"dur":"90 days","c":"Herrlinger KA et al. J Altern Complement Med 2018","p":"29314866","url":"https://pubmed.ncbi.nlm.nih.gov/29314866/","pl":false}],[7,88,"C","Attention in healthy young adults","In a 90-day RCT of 142 active adults, 900 mg/day extract improved sustained attention versus placebo; mood, sleep and quality of life did not differ.",{"st":"no-estimate","mt":"exact","om":"sustained attention (CNS Vital Signs)","n":142,"dur":"90 days","c":"Falcone PH et al. Nutr Res 2019","p":"30802720","url":"https://pubmed.ncbi.nlm.nih.gov/30802720/","pl":false}],[7,89,"C","Cognition in nursing-home residents with dementia","A 3-month double-blind preliminary study in 85 people aged 60–96 reported better test scores with a higher than a lower spermidine dose, mainly in mild dementia.",{"st":"no-estimate","mt":"exact","om":"MMSE score (higher-dose group, mild dementia subgroup)","n":85,"c":"Pekar T et al. Wien Klin Wochenschr 2021","p":"33211152","url":"https://pubmed.ncbi.nlm.nih.gov/33211152/","pl":false}],[7,90,"C","Cognitive function","A 2025 meta-analysis of 7 RCTs (402 individuals) found taurine, alone or with exercise training, had no significant effect on cognitive scores; the authors found insufficient evidence of benefit.",{"st":"no-estimate","mt":"exact","om":"cognitive scores","k":7,"n":402,"c":"Cao Q et al. Int J Food Sci Nutr 2025","p":"40320621","url":"https://pubmed.ncbi.nlm.nih.gov/40320621/","pl":false}],[7,91,"C","Alzheimer's disease","A 2001 Cochrane review of three trials of 3 g/day oral thiamin, each with fewer than 20 patients, could not draw conclusions because the studies were small.",{"st":"no-estimate","mt":"exact","om":"cognition (MMSE, ADAS-Cog)","k":3,"c":"Rodríguez-Martín JL et al. Cochrane Database Syst Rev 2001","p":"11405995","url":"https://pubmed.ncbi.nlm.nih.gov/11405995/","pl":false}],[7,10,"C","Cognitive function","A systematic review of 14 RCTs found insufficient evidence of an effect; a Cochrane review found no evidence that 5–12 weeks of supplementation improved cognitive function or mood.",{"st":"no-estimate","mt":"exact","om":"cognitive function","k":14,"c":"Balk EM et al. Arch Intern Med 2007","p":"17210874","url":"https://pubmed.ncbi.nlm.nih.gov/17210874/","pl":false}],[7,92,"C","Cognitive decline and Alzheimer's disease","In 341 people with moderate Alzheimer's, 2,000 IU/day for 2 years delayed functional decline but increased falls; trials in 769 people with mild cognitive impairment and in women found no benefit.",{"st":"no-estimate","mt":"exact","om":"time to death, institutionalization, loss of basic ADLs or severe dementia","c":"Sano M et al. N Engl J Med 1997","p":"9110909","url":"https://pubmed.ncbi.nlm.nih.gov/9110909/","pl":false}],[7,79,"X","Dementia risk in older adults","In the GEM trial, more than 3,000 people aged 75 or older took ginkgo or placebo for a median of 6 years; dementia and Alzheimer's rates did not differ.",{"st":"single-trial","mt":"exact","m":"HR","v":1.12,"lo":0.94,"hi":1.33,"om":"incident all-cause dementia","n":3069,"dur":"median follow-up of 6.1 years","c":"DeKosky ST et al. (GEM) JAMA 2008","p":"19017911","url":"https://pubmed.ncbi.nlm.nih.gov/19017911/","pl":true}],[7,39,"X","Cognitive function in healthy older adults","ODS summarizes that trials found long-chain omega-3 supplementation does not affect cognitive function in healthy older adults; trials in people with Alzheimer's disease also found no benefit.",{"st":"none","pl":false}],[7,86,"X","Seed oil: cognition in mild to moderate dementia","In a 6-month add-on RCT (182 completers), perilla seed oil did not improve cognitive function versus placebo; total and LDL cholesterol were lower.",{"st":"no-estimate","mt":"exact","om":"cognitive function","n":182,"dur":"six months add-on","c":"Kamalashiran C et al. Curr Alzheimer Res 2019","p":"30543172","url":"https://pubmed.ncbi.nlm.nih.gov/30543172/","pl":false}],[7,17,"X","Memory in older adults with age-associated memory impairment","A 12-week randomized trial in 120 adults over 57 (300 or 600 mg/day soy-derived PS) found no effect on memory or other cognitive functions.",{"st":"no-estimate","mt":"exact","om":"delayed recall and recognition (memory) and other cognitive functions","dur":"12 weeks","c":"Jorissen BL et al. Nutr Neurosci 2001","p":"11842880","url":"https://pubmed.ncbi.nlm.nih.gov/11842880/","pl":false}],[7,6,"X","Memory and cognition","A meta-analysis found no significant effect on memory or cognitive performance, and recent double-blind trials found no cognitive benefit in older adults.",{"st":"no-estimate","mt":"exact","om":"memory and cognitive performance (auditory verbal learning tests)","k":4,"n":226,"c":"Farzaei MH et al. Pharmacol Res 2018","p":"28844841","url":"https://pubmed.ncbi.nlm.nih.gov/28844841/","pl":false}],[7,93,"X","Cognitive decline and dementia","PREADVISE (about 7,540 men aged 60+, 200 mcg/day for 5.4 years) found no change in dementia incidence; a 2022 meta-analysis of 11 trials found no improvement in cognitive scores.",{"st":"single-trial","mt":"exact","m":"HR","v":0.83,"lo":0.6,"hi":1.13,"om":"dementia incidence","n":7338,"c":"Kryscio RJ et al. JAMA Neurol 2017","p":"28319243","url":"https://pubmed.ncbi.nlm.nih.gov/28319243/","pl":true}],[7,89,"X","Memory in older adults with subjective cognitive decline","A 12-month randomized trial in 100 adults aged 60–90 (0.9 mg/day from wheat germ extract) found no effect on memory or biomarkers versus placebo; exploratory signals need confirmation.",{"st":"single-trial","mt":"exact","m":"MD","v":-0.03,"lo":-0.11,"hi":0.05,"om":"mnemonic discrimination performance (memory)","n":100,"dur":"12 months","c":"Schwarz C et al. JAMA Netw Open 2022","p":"35616942","url":"https://pubmed.ncbi.nlm.nih.gov/35616942/","pl":true}],[7,94,"X","Cognitive function and dementia","A Cochrane review of 14 studies (27,882 participants) found little to no effect on global cognition for up to 5 years; a 2,919-adult RCT (500 mcg B12 plus folic acid, 2 years) found no difference.",{"st":"no-estimate","mt":"exact","m":"SMD","om":"global cognitive function","k":14,"n":27882,"c":"Rutjes AW et al. Cochrane Database Syst Rev 2018","p":"30556597","url":"https://pubmed.ncbi.nlm.nih.gov/30556597/","pl":false}],[8,95,"A","Endurance and prolonged intermittent exercise performance","ODS describes numerous trials with mostly consistent results; in one review 30 of 33 time-trial studies showed improvements, though only half were statistically significant.",{"st":"no-ci","mt":"partial","m":"percent-change","v":3.2,"u":"%","om":"time-trial endurance performance","k":21,"c":"Ganio MS et al. J Strength Cond Res 2009","p":"19077738","url":"https://pubmed.ncbi.nlm.nih.gov/19077738/","pl":false}],[8,96,"A","Strength, power and repeated high-intensity efforts","ODS describes numerous clinical trials generally showing a benefit for high-intensity, intermittent activity such as sprints and resistance exercise, with variation in individual responses.",{"st":"none","pl":false}],[8,97,"B","Cancer-related fatigue","A double-blind RCT of 364 fatigued cancer survivors found 2,000 mg/day for 8 weeks improved fatigue scores versus placebo at 8 weeks; the 4-week difference was not significant (P =.07).",{"st":"no-estimate","mt":"exact","om":"MFSI-SF general fatigue subscale (change score; higher change = improvement)","dur":"8 weeks","c":"Barton DL et al. J Natl Cancer Inst 2013","p":"23853057","url":"https://pubmed.ncbi.nlm.nih.gov/23853057/","pl":false}],[8,98,"B","Endurance exercise performance","Beetroot has generally improved performance and endurance to different extents compared with placebo; benefits are more likely in recreationally active nonathletes than in elite athletes.",{"st":"none","pl":false}],[8,99,"B","High-intensity exercise lasting about 30 seconds to 10 minutes","A review of 40 placebo-controlled studies (1,461 participants) reported a significant positive effect, but the literature is dominated by small, short, heterogeneous studies; a Department of Defense review found insufficient support.",{"st":"pooled","mt":"exact","m":"SMD","v":0.18,"lo":0.08,"hi":0.28,"om":"exercise capacity and performance","k":40,"n":1461,"c":"Saunders B et al. Br J Sports Med 2017","p":"27797728","url":"https://pubmed.ncbi.nlm.nih.gov/27797728/","pl":true}],[8,100,"B","Muscular strength and power","A 2024 meta-analysis of 17 placebo-controlled studies (317 participants) found chronic betaine improved maximal strength (effect size 0.47), mainly lower body, but not upper-body strength, cycling sprint power or muscular endurance.",{"st":"pooled","mt":"exact","m":"other","v":0.47,"lo":0.04,"hi":0.89,"om":"maximal strength (1RM, 3RM, maximal isokinetic or isometric force)","k":17,"n":317,"c":"Zawieja E et al. J Sports Sci 2024","p":"39514262","url":"https://pubmed.ncbi.nlm.nih.gov/39514262/","pl":false}],[8,101,"B","Muscle soreness and muscle-damage markers after strenuous exercise","A 2024 meta-analysis of 18 RCTs in healthy active people found lower soreness 24–96 h after damaging exercise and lower creatine kinase at some time points, but no effect on lactate dehydrogenase.",{"st":"no-ci","mt":"exact","m":"SMD","v":-1.75,"om":"delayed onset muscle soreness (DOMS) at 48 h post exercise-induced muscle damage","c":"Salem A et al. Sports Med Open 2024","p":"38625669","url":"https://pubmed.ncbi.nlm.nih.gov/38625669/","pl":false}],[8,95,"B","Short, high-intensity exercise","ODS reports benefits are strongest for endurance and long intermittent activity and less consistent for short, intense efforts.",{"st":"none","pl":false}],[8,102,"B","Fat-free mass and strength with resistance training","A 2024 meta-analysis of 19 studies (768 adults) found gains in fat-free mass (SMD 0.48, moderate certainty) and maximal strength (SMD 0.19, low certainty) alongside training.",{"st":"no-ci","mt":"exact","m":"SMD","v":0.48,"om":"fat-free mass","k":19,"n":768,"dur":"minimum of 8 weeks","c":"Bischof K et al. Sports Med 2024","p":"39060741","url":"https://pubmed.ncbi.nlm.nih.gov/39060741/","pl":false}],[8,103,"B","Fat-free (lean) mass in older adults","A 2021 meta-analysis of 9 RCTs (448 older adults) found higher fat-free mass with HMB than control and no effect on fat mass; HMB combined with exercise showed no additional fat-free mass change.",{"st":"pooled","mt":"exact","m":"other","v":0.37,"lo":0.16,"hi":0.58,"om":"fat-free mass","k":9,"n":448,"c":"Lin Z et al. Eur Geriatr Med 2021","p":"33034021","url":"https://pubmed.ncbi.nlm.nih.gov/33034021/","pl":false}],[8,103,"B","Muscle mass and strength in clinical conditions with muscle loss","A 2019 meta-analysis of 15 RCTs (2,137 patients) of HMB alone or HMB-containing supplements found small increases in muscle mass and strength; no study had low risk of bias in all categories.",{"st":"pooled","mt":"exact","m":"SMD","v":0.25,"lo":-0.0,"hi":0.5,"om":"skeletal muscle mass","k":15,"n":2137,"i2":58,"c":"Bear DE et al. Am J Clin Nutr 2019","p":"30982854","url":"https://pubmed.ncbi.nlm.nih.gov/30982854/","pl":true}],[8,103,"B","Recovery from exercise","ODS reports general agreement that HMB helps speed recovery from exercise intense enough to damage skeletal muscle, but summarizes numerous clinical trials as having conflicting results; there is no expert consensus on taking it for months.",{"st":"none","pl":false}],[8,104,"B","Exercise performance (citrulline malate)","A 2026 meta-analysis of 30 RCTs (644 participants) found a small improvement in overall exercise performance (g = 0.16) with citrulline malate and no significant effect on perceived exertion; GRADE certainty was low to very low.",{"st":"no-ci","mt":"exact","m":"SMD","v":0.16,"om":"overall exercise performance","k":30,"n":644,"c":"Wang X et al. Nutrients 2026","p":"42356270","url":"https://pubmed.ncbi.nlm.nih.gov/42356270/","pl":false}],[8,105,"B","Endurance exercise capacity","A 2011 meta-analysis of 11 studies (254 subjects; median 1000 mg/day for 11 days) found a statistically significant but trivial-to-small benefit (about 2%) over placebo on VO2max and endurance performance.",{"st":"pooled","mt":"exact","m":"SMD","v":0.15,"lo":0.02,"hi":0.27,"om":"VO2max and endurance performance combined","k":11,"n":254,"dur":"median 11 d","c":"Kressler J et al. Med Sci Sports Exerc 2011","p":"21606866","url":"https://pubmed.ncbi.nlm.nih.gov/21606866/","pl":true}],[8,106,"B","Sodium bicarbonate and strenuous exercise","Athletes who take sodium bicarbonate might improve performance a little in strenuous exercise lasting several minutes; some people get no benefit, and it can even reduce performance.",{"st":"none","pl":false}],[8,56,"B","Recovery after strenuous exercise","A meta-analysis found a small reduction in muscle soreness (ES −0.44) and moderate benefits for recovery of strength (ES −0.78) and power; no significant effect on creatine kinase.",{"st":"pooled","mt":"exact","m":"other","v":-0.44,"lo":-0.87,"hi":-0.02,"om":"muscle soreness","k":14,"c":"Hill JA et al. Int J Sport Nutr Exerc Metab 2021","p":"33440334","url":"https://pubmed.ncbi.nlm.nih.gov/33440334/","pl":false}],[8,107,"B","Muscle strength, physical performance and body composition in older adults","A 2024 meta-analysis (26 RCTs pooled, adults 60 and older) found no significant effect on handgrip strength, walking tests, lean or fat mass; with resistance training, lower-body strength improved (SMD 0.25).",{"st":"pooled","mt":"exact","m":"SMD","v":0.25,"lo":0.05,"hi":0.45,"om":"lower body strength, interventions incorporating resistance exercise","k":11,"i2":0,"c":"Al-Rawhani AH et al. Clin Nutr 2024","p":"39303495","url":"https://pubmed.ncbi.nlm.nih.gov/39303495/","pl":true}],[8,107,"B","Muscle mass and function in older adults with sarcopenia","A 2024 meta-analysis of 10 RCTs (1,154 participants) of whey-protein-enriched supplements reported higher appendicular muscle mass and gait speed than placebo or routine care, and higher handgrip strength when combined with resistance training.",{"st":"pooled","mt":"exact","m":"SMD","v":0.28,"lo":0.11,"hi":0.45,"om":"appendicular skeletal muscle mass","k":10,"n":1154,"c":"Li ML et al. J Nutr Health Aging 2024","p":"38350303","url":"https://pubmed.ncbi.nlm.nih.gov/38350303/","pl":true}],[8,107,"B","Body composition in healthy adults, with or without resistance exercise","A 2014 meta-analysis of 14 RCTs (626 completers) found lean mass rose 2.24 kg from baseline (within-group) in whey groups that also did resistance exercise, but differences versus other proteins or carbohydrate were not statistically significant.",{"st":"pooled","mt":"exact","m":"WMD","v":2.24,"lo":0.66,"hi":3.81,"u":"kg","om":"lean body mass","k":14,"n":626,"c":"Miller PE et al. J Am Coll Nutr 2014","p":"24724774","url":"https://pubmed.ncbi.nlm.nih.gov/24724774/","pl":false,"ex":"the lean-mass estimate is a resistance-exercise subgroup, and the abstract does not say it is a between-group comparison"}],[8,108,"C","Muscle strength in adults aged 60 or older (pasteurized strain HB05P)","In a 12-week double-blind RCT of 100 adults, pasteurized HB05P (1.0 x 10^10 cells/day) improved left-leg extensor peak torque versus placebo.",{"st":"no-estimate","mt":"exact","om":"left leg extensor peak torque","n":100,"dur":"12 weeks","c":"Kang CH et al. Nutrients 2024","p":"39683431","url":"https://pubmed.ncbi.nlm.nih.gov/39683431/","pl":false}],[8,74,"C","Strength, power and lean mass with resistance training","In an 8-week RCT of 30 strength-trained men, lean body mass, upper-body strength and peak power increased only in the ARA group.",{"st":"no-estimate","mt":"exact","om":"lean body mass, upper-body strength, peak power","n":30,"dur":"8 weeks","c":"De Souza EO et al. PLoS One 2016","p":"27182886","url":"https://pubmed.ncbi.nlm.nih.gov/27182886/","pl":false}],[8,74,"C","Muscle protein synthesis after resistance exercise","In a 4-week double-blind RCT (19 trained men, 1.5 g ARA/day versus corn-soy oil), ARA did not change muscle protein synthesis or anabolic signaling after exercise; ribosome biogenesis rose at 48 h only with ARA.",{"st":"no-estimate","mt":"exact","om":"muscle protein synthesis after resistance exercise","n":19,"dur":"4 weeks","c":"Mitchell CJ et al. J Appl Physiol 2018","p":"29389245","url":"https://pubmed.ncbi.nlm.nih.gov/29389245/","pl":false}],[8,75,"C","General fatigue","A 2023 review of 19 studies (2,413 participants) suggested a small benefit for general fatigue from ginseng alone; not all research agrees.",{"st":"pooled","mt":"partial","m":"SMD","v":-0.48,"lo":-0.71,"hi":-0.25,"om":"general (non-disease-specific) fatigue","c":"Li X et al. J Integr Complement Med 2023","p":"36730693","url":"https://pubmed.ncbi.nlm.nih.gov/36730693/","pl":true}],[8,109,"C","Fatigue, cognition and exercise performance","2024 meta-analysis of 11 RCTs (346 healthy participants): no significant effect on reaction time and a marginal effect on cognitive accuracy; combined with regular training, physical performance improved (SMD 0.62).",{"st":"pooled","mt":"exact","m":"SMD","v":0.62,"lo":0.17,"hi":1.06,"om":"physical performance (astaxanthin combined with regular training)","k":11,"n":346,"c":"Liu C et al. Biol Res Nurs 2024","p":"38243785","url":"https://pubmed.ncbi.nlm.nih.gov/38243785/","pl":true}],[8,21,"C","Athletic performance","MSK states that, aside from nutritional value, bee pollen had limited effects on athletic performance.",{"st":"none","pl":false}],[8,99,"C","Endurance exercise","Evidence for endurance activities is conflicting, with little consistent dose-response relationship.",{"st":"none","pl":false}],[8,110,"C","Athletic performance","Several small studies, with or without caffeine, were inconsistent, and most did not show a benefit.",{"st":"none","pl":false}],[8,111,"C","Physical fitness in adolescent athletes","One 12-week RCT in 194 male student-athletes (360 mg/day) reported greater grip and back-leg strength, VO2 max and sprint speed, with no change in flexibility or agility.",{"st":"no-estimate","mt":"exact","om":"grip strength, back-leg strength, VO2 max, 50 m sprint time","n":194,"dur":"12 weeks","c":"Sripanidkulchai B et al. J Diet Suppl 2022","p":"33272042","url":"https://pubmed.ncbi.nlm.nih.gov/33272042/","pl":false}],[8,101,"C","Endurance performance and muscle gains with training","ODS describes a limited number of short-term trials with little evidence of better endurance performance; about 10–14 g/day might enhance training gains in muscle mass and strength, and effects on muscle protein synthesis are inconsistent.",{"st":"none","pl":false}],[8,112,"C","Muscle pain and swelling after exercise (topical gel)","A 2022 review cites one double-blind, placebo-controlled study in 30 men (a 2002 research-unit report) in which an A. betulina oil gel applied three times daily reduced swelling and pain from exercise-induced muscle damage.",{"st":"none","pl":false}],[8,102,"C","Muscle protein synthesis versus other proteins","A 2021 systematic review found collagen did not significantly raise muscle protein synthesis compared with equal-nitrogen, higher-quality proteins such as whey.",{"st":"no-estimate","mt":"exact","om":"muscle protein synthesis vs isonitrogenous higher-quality protein","k":15,"c":"Khatri M et al. Amino Acids 2021","p":"34491424","url":"https://pubmed.ncbi.nlm.nih.gov/34491424/","pl":false}],[8,113,"C","Endurance performance in trained cyclists (Cs-4)","RCT in 22 endurance-trained male cyclists: a Cs-4 product (labeled Cordyceps sinensis) 3 g/day for 5 weeks did not change VO2peak, ventilatory threshold or time-trial performance.",{"st":"no-estimate","mt":"exact","om":"VO2peak, ventilatory threshold, time-trial performance","n":22,"dur":"5 weeks","c":"Parcell AC et al. Int J Sport Nutr Exerc Metab 2004","p":"15118196","url":"https://pubmed.ncbi.nlm.nih.gov/15118196/","pl":false}],[8,113,"C","Exercise capacity in healthy older adults (Cs-4)","Pilot RCT in 20 adults aged 50–75: Cs-4 333 mg three times daily for 12 weeks raised metabolic and ventilatory thresholds; VO2max did not change in either group.",{"st":"no-estimate","mt":"exact","om":"metabolic and ventilatory threshold; VO2max","n":20,"dur":"12 weeks","c":"Chen S et al. J Altern Complement Med 2010","p":"20804368","url":"https://pubmed.ncbi.nlm.nih.gov/20804368/","pl":false}],[8,113,"C","High-intensity exercise (C. militaris mushroom blend)","RCT in 28 young adults: a 4 g/day blend containing C. militaris did not change outcomes after 1 week; in 10 who continued 3 weeks, VO2max improved versus placebo.",{"st":"no-estimate","mt":"exact","om":"VO2max, time to exhaustion, ventilatory threshold","n":28,"dur":"1 week (3 weeks in subset of 10)","c":"Hirsch KR et al. J Diet Suppl 2017","p":"27408987","url":"https://pubmed.ncbi.nlm.nih.gov/27408987/","pl":false}],[8,96,"C","Endurance exercise performance","ODS states that creatine appears to offer little value for endurance sports.",{"st":"none","pl":false}],[8,114,"C","Repeated sprint performance","A randomized crossover study in men (32 g over 36 hours versus cellulose) found ribose did not produce reproducible increases across six cycle sprints; authors concluded no consistent or substantial effect.",{"st":"no-ci","mt":"exact","m":"percent-change","v":10.9,"u":"%","om":"mean power, sprint 2 of six 10-s cycle sprints","dur":"32 g over 36 hours","c":"Berardi JM, Ziegenfuss TN. J Strength Cond Res 2003","p":"12580655","url":"https://pubmed.ncbi.nlm.nih.gov/12580655/","pl":false}],[8,114,"C","Muscle soreness after plyometric exercise","In 21 untrained male students given 15 g doses around exercise, soreness fell versus their first session, and creatine kinase, LDH, myoglobin and malondialdehyde at 24 h were lower than with placebo; strength did not differ.",{"st":"no-estimate","mt":"exact","om":"muscle soreness and blood markers of muscle damage (CK, LDH, myoglobin, MDA) at 24 h","c":"Cao W et al. J Int Soc Sports Nutr 2020","p":"32778175","url":"https://pubmed.ncbi.nlm.nih.gov/32778175/","pl":false}],[8,114,"C","Exercise tolerance in McArdle disease","A double-blind placebo-controlled crossover trial in 5 patients (60 g/day for 7 days) found no benefit on exercise tolerance; patients did not like taking the ribose.",{"st":"no-estimate","mt":"exact","om":"exercise tolerance (peak oxygen consumption, leg fatigue)","n":5,"dur":"seven days per period","c":"Steele IC et al. J Neurol Sci 1996","p":"8815168","url":"https://pubmed.ncbi.nlm.nih.gov/8815168/","pl":false}],[8,115,"C","Cycling and sprint performance (single dose)","In a crossover RCT in 12 trained male cyclists, 263 mg extract before exercise did not improve sprint power or other measured responses; blood glucose was slightly higher overall.",{"st":"single-trial","mt":"exact","m":"MD","v":-2.58,"lo":-29.51,"hi":24.35,"u":"W","om":"peak sprint power","c":"Ali Y et al. Nutrients 2026","p":"42943001","url":"https://pubmed.ncbi.nlm.nih.gov/42943001/","pl":true}],[8,58,"C","Chronic fatigue in adults","RCT of 96 adults with fatigue for 6 months or longer: fatigue fell in both groups and differences versus placebo were not significant; overall efficacy was not demonstrated.",{"st":"no-estimate","mt":"exact","om":"fatigue severity","n":96,"dur":"2 months follow-up","c":"Hartz AJ et al. Psychol Med 2004","p":"14971626","url":"https://pubmed.ncbi.nlm.nih.gov/14971626/","pl":false}],[8,58,"C","Aerobic exercise performance in trained runners","In an 8-week double-blind trial in 20 highly trained distance runners, the extract did not differ from placebo on heart rate, oxygen uptake, time to exhaustion, lactate or perceived exertion.",{"st":"no-estimate","mt":"exact","om":"HR, VO2, time to exhaustion, lactate, RPE","n":20,"dur":"8-wk study (6 wk supplementation)","c":"Dowling EA et al. Med Sci Sports Exerc 1996","p":"8778554","url":"https://pubmed.ncbi.nlm.nih.gov/8778554/","pl":false}],[8,58,"C","Fatigue and weakness (EU traditional use)","The EU monograph accepts use for symptoms of asthenia such as fatigue and weakness exclusively on the basis of long-standing use, not clinical-trial proof of efficacy.",{"st":"none","pl":false}],[8,116,"C","Athletic performance","Evidence was insufficient to draw conclusions; almost no new human research has been done since the 2004 ban.",{"st":"no-estimate","mt":"partial","om":"athletic performance","c":"Shekelle PG et al. JAMA 2003","p":"12672771","url":"https://pubmed.ncbi.nlm.nih.gov/12672771/","pl":false}],[8,80,"C","Cancer-related fatigue","A 2021 systematic review (seven studies, 427 cancer patients) found guarana did not reduce fatigue compared with placebo in a meta-analysis of three breast cancer studies; evidence quality was very low.",{"st":"pooled","mt":"exact","m":"other","v":-0.02,"lo":-1.54,"hi":1.5,"om":"cancer-related fatigue","k":3,"c":"de Araujo DP et al. Support Care Cancer 2021","p":"34146166","url":"https://pubmed.ncbi.nlm.nih.gov/34146166/","pl":false}],[8,81,"C","Mood, energy and motor performance after a single dose","In a crossover RCT in 25 young adults, 600 mg leaf extract improved mood disturbance, fatigue and perceived energy versus placebo; 600 mg and 1,200 mg both raised blood pressure by 4-5 mmHg.",{"st":"no-ci","mt":"exact","m":"MD","v":-6.9,"u":"au","om":"total mood disturbance","n":25,"dur":"single dose","c":"Helwig NJ et al. J Int Soc Sports Nutr 2024","p":"39014963","url":"https://pubmed.ncbi.nlm.nih.gov/39014963/","pl":false}],[8,117,"C","Athletic performance","ODS calls the evidence limited and conflicting: 2–20 g/day appears to have little to no effect on aerobic or anaerobic performance, and a review of 54 mostly small studies found little or no enhancement.",{"st":"none","pl":false}],[8,35,"C","Athletic performance","Evidence is mixed: reviews found some benefits, such as lower lactate and faster recovery, while other studies showed no effect.",{"st":"none","pl":false}],[8,118,"C","Athletic performance, body composition and immune measures in athletes","A 2019 meta-analysis (25 trials) found glutamine generally had no effect on immune measures, aerobic performance or body composition in athletes, but reported greater weight reduction (weighted mean difference −1.36).",{"st":"pooled","mt":"exact","m":"WMD","v":-1.36,"lo":-2.55,"hi":-0.16,"om":"body weight","k":25,"c":"Ramezani Ahmadi A et al. Clin Nutr 2019","p":"29784526","url":"https://pubmed.ncbi.nlm.nih.gov/29784526/","pl":true}],[8,118,"C","Strength and muscle recovery","ODS: few studies tested glutamine alone; in a 6-week trial (31 weightlifters, about 45 g/day) groups did not differ in strength or lean mass, and ODS concludes research does not support glutamine alone for performance.",{"st":"no-estimate","mt":"partial","om":"strength, torque and lean tissue mass after resistance training","dur":"6 weeks","c":"Candow DG et al. Eur J Appl Physiol 2001","p":"11822473","url":"https://pubmed.ncbi.nlm.nih.gov/11822473/","pl":false}],[8,67,"C","Exercise fatigue (single dose of a mangosteen-based juice)","A crossover RCT in 12 healthy adults found a single 250 mL dose of mangosteen-based juice taken before cycling did not alleviate physical fatigue versus placebo, apart from a mood-questionnaire difference.",{"st":"no-estimate","mt":"exact","om":"physical fatigue during cycle exercise (time to exhaustion, biomarkers, POMS)","n":12,"dur":"single dose 1 h before exercise","c":"Chang CW et al. J Int Soc Sports Nutr 2016","p":"27152103","url":"https://pubmed.ncbi.nlm.nih.gov/27152103/","pl":false}],[8,119,"C","Exercise-induced muscle damage, oxidative stress and pain","In an RCT of 22 half-marathon runners, 3 g/day did not reduce oxidative-stress or muscle-damage markers; muscle and joint pain fell by clinically meaningful amounts that were not statistically significant.",{"st":"no-estimate","mt":"exact","om":"8-OHdG, MDA, CK, LDH; muscle and joint pain (100 mm VAS)","n":22,"dur":"21 days before race plus 2 days after","c":"Withee ED et al. J Int Soc Sports Nutr 2017","p":"28736511","url":"https://pubmed.ncbi.nlm.nih.gov/28736511/","pl":false}],[8,120,"C","Muscle mass and function in adults over 60","A meta-analysis concluded current evidence does not support NR or NMN for preserving muscle mass and function; in people with mild cognitive impairment, some physical scores were lower with NR.",{"st":"no-estimate","mt":"exact","om":"muscle mass and physical function (NR arms)","c":"Prokopidis K et al. J Cachexia Sarcopenia Muscle 2025","p":"40275690","url":"https://pubmed.ncbi.nlm.nih.gov/40275690/","pl":false}],[8,121,"C","Muscle mass and function in adults over 60","A meta-analysis of randomized trials found no significant effects on skeletal muscle index, grip strength, gait speed or chair-stand time; NMN did not improve knee-extension strength.",{"st":"pooled","mt":"exact","m":"MD","v":-0.42,"lo":-0.99,"hi":0.14,"om":"skeletal muscle index (SMI)","i2":63,"c":"Prokopidis K et al. J Cachexia Sarcopenia Muscle 2025","p":"40275690","url":"https://pubmed.ncbi.nlm.nih.gov/40275690/","pl":true}],[8,87,"C","Aerobic performance with endurance training","A 6-week RCT in 23 untrained men (20 mg/day) found no difference from placebo in aerobic performance after training, although PGC-1alpha protein rose with PQQ.",{"st":"no-estimate","mt":"exact","om":"aerobic performance after endurance training","dur":"six weeks","c":"Hwang PS et al. J Am Coll Nutr 2020","p":"31860387","url":"https://pubmed.ncbi.nlm.nih.gov/31860387/","pl":false}],[8,27,"C","Muscle strength in adults over 50 doing low-intensity exercise","A 12-week placebo-controlled trial in 54 adults (1 g extract daily) found greater knee-extensor strength gains; muscle mass, inflammatory and antioxidant markers did not differ.",{"st":"single-trial","mt":"exact","m":"MD","v":10.2,"lo":3.7,"hi":16.8,"u":"Nm","om":"right knee extensor strength","dur":"12 wk","c":"Cho YH et al. Am J Clin Nutr 2021","p":"33710261","url":"https://pubmed.ncbi.nlm.nih.gov/33710261/","pl":true}],[8,27,"C","Quadriceps strength in postmenopausal women","A 12-week placebo-controlled trial in 45 women (1,000 mg extract daily) reported increased quadriceps strength and lower resting lactate; other measures did not differ.",{"st":"no-estimate","mt":"exact","om":"quadriceps muscle strength","dur":"12 weeks","c":"Park J et al. Int J Environ Res Public Health 2020","p":"32260466","url":"https://pubmed.ncbi.nlm.nih.gov/32260466/","pl":false}],[8,88,"C","Reactive agility","In a 90-day RCT of 142 active adults (900 mg/day extract), the extract improved some reactive-agility measures versus placebo; other agility tests did not differ.",{"st":"no-estimate","mt":"exact","om":"reactive agility (Makoto Arena II hits and average reaction time)","n":142,"dur":"90 days","c":"Falcone PH et al. J Int Soc Sports Nutr 2018","p":"30541572","url":"https://pubmed.ncbi.nlm.nih.gov/30541572/","pl":false}],[8,56,"C","Exercise recovery and aerobic performance (overall)","ODS: a few clinical trials with conflicting results; variable effects on strength recovery, soreness and inflammation, and insufficient research on aerobic performance.",{"st":"none","pl":false}],[8,122,"C","Athletic performance","LiverTox notes that reported testosterone increases have not been linked to improved athletic performance.",{"st":"none","pl":false}],[8,123,"C","Sport and health biomarkers in physically active men","A 2022 systematic review of 7 studies found no clear effect on muscle-damage markers or hormones; lipid profiles improved, and no toxicity was reported.",{"st":"no-estimate","mt":"exact","om":"muscle damage markers, hormones, lipid profile","k":7,"c":"Fernández-Lázaro D et al. Int J Environ Res Public Health 2022","p":"35954909","url":"https://pubmed.ncbi.nlm.nih.gov/35954909/","pl":false}],[8,124,"C","Blood and inflammatory markers around strenuous exercise","In 100 well-trained firefighters given ubiquinol or placebo before two strenuous exercise tests, ubiquinol raised red blood cells, hemoglobin and some anti-inflammatory markers and lowered IL-1, IL-8 and MCP-1.",{"st":"no-estimate","mt":"exact","om":"hematological parameters and inflammatory cytokines","c":"Diaz-Castro J et al. Nutrients 2020","p":"32041223","url":"https://pubmed.ncbi.nlm.nih.gov/32041223/","pl":false}],[8,94,"C","Energy and athletic performance","ODS states that B12 supplementation appears to have no beneficial effect on performance in the absence of a nutritional deficit; no trial details are given.",{"st":"none","pl":false}],[8,3,"X","Fatigue in inflammatory bowel disease in remission","In a 13-hospital crossover RCT (166 patients; 100 mg twice daily for 8 weeks), 5-HTP raised serum 5-HTP and serotonin but did not reduce fatigue better than placebo.",{"st":"single-trial","mt":"exact","m":"MD","v":-0.18,"lo":-0.81,"hi":0.46,"om":"fatigue visual analog scale (fVAS) reduction","c":"Truyens M et al. Gastroenterology 2022","p":"35940251","url":"https://pubmed.ncbi.nlm.nih.gov/35940251/","pl":true}],[8,75,"X","Athletic performance","NCCIH states the majority of research shows Asian ginseng does not improve athletic performance.",{"st":"none","pl":false}],[8,103,"X","Body composition and strength gains during resistance training in young adults","A 2020 meta-analysis (11 studies analyzed; 302 participants aged 18–45) found a small effect on total body mass but no significant effect on fat-free mass, fat mass or strength.",{"st":"no-estimate","mt":"exact","om":"fat-free mass, fat mass, strength","k":11,"n":302,"c":"Jakubowski JS et al. Nutrients 2020","p":"32456217","url":"https://pubmed.ncbi.nlm.nih.gov/32456217/","pl":false}],[8,104,"X","Endurance performance in young healthy adults","A 2023 meta-analysis of 9 RCTs (158 participants) found no significant difference in time to exhaustion or time to completion after acute citrulline versus control; the authors call the evidence base small.",{"st":"pooled","mt":"exact","m":"SMD","v":0.03,"lo":-0.27,"hi":0.33,"om":"time to exhaustion","k":5,"i2":0,"dur":"acute ingestion","c":"Harnden CS et al. J Int Soc Sports Nutr 2023","p":"37155582","url":"https://pubmed.ncbi.nlm.nih.gov/37155582/","pl":false,"ex":"the abstract does not state the confidence level of the printed interval, so it cannot be shown as a 95% confidence interval"}],[8,104,"X","Aerobic performance, oxygen uptake and lactate","A 2022 meta-analysis of 10 randomized placebo-controlled crossover trials (173 subjects; L-citrulline, citrulline malate or watermelon juice) found no effect on aerobic performance, perceived exertion, oxygen-uptake kinetics or lactate.",{"st":"pooled","mt":"exact","m":"SMD","v":0.15,"lo":-0.02,"hi":0.32,"om":"aerobic exercise performance","k":10,"i2":0,"c":"Viribay A et al. Nutrients 2022","p":"36079738","url":"https://pubmed.ncbi.nlm.nih.gov/36079738/","pl":true}],[8,85,"X","Endurance exercise performance","A 2022 systematic review found most studies reported MCT oil did not improve exercise performance or fuel use in healthy people; the body could not use MCT-induced ketones as its primary fuel.",{"st":"no-estimate","mt":"exact","om":"endurance exercise performance and substrate utilization","c":"Chapman-Lopez TJ, Koh Y. J Obes Metab Syndr 2022","p":"36096496","url":"https://pubmed.ncbi.nlm.nih.gov/36096496/","pl":false}],[9,106,"A","Dehydration from diarrhea (oral rehydration salts)","WHO: dehydration from diarrhea can be managed effectively with ORS in all age groups and in all but the most severe cases; WHO and UNICEF recommend a newer formula of improved effectiveness since 2003.",{"st":"none","pl":false}],[9,125,"C","Rehydration after exercise-induced dehydration","In a randomized crossover study of 23 collegiate wrestlers dehydrated by 3% of body mass, rooibos tea was no more effective than plain water for rehydration.",{"st":"no-estimate","mt":"exact","om":"plasma/urine osmolality, urine specific gravity, plasma volume","dur":"1 h rehydration","c":"Utter AC et al. Res Sports Med 2010","p":"20397112","url":"https://pubmed.ncbi.nlm.nih.gov/20397112/","pl":false}],[10,126,"B","Knee and other osteoarthritis pain and function","Cochrane: two high-quality trials (85 people) of 100 mg/day enriched extract for 90 days cut pain by 17 points (0–100 scale) and improved function by 8 points versus placebo.",{"st":"pooled","mt":"exact","m":"MD","v":17,"lo":8,"hi":26,"u":"points on 0-100 VAS","om":"pain","k":2,"n":85,"dur":"90 days","c":"Cameron M et al. Cochrane Database Syst Rev 2014","p":"24848732","url":"https://pubmed.ncbi.nlm.nih.gov/24848732/","pl":true,"se":"positive = less pain"}],[10,127,"B","Pain and recovery after wisdom tooth (third molar) surgery","A 2019 meta-analysis (6 RCTs) found less pain in the first 24 hours and at 7 days and better quality-of-life scores, but no evidence that bromelain reduced trismus or facial swelling.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.49,"lo":-0.82,"hi":-0.17,"om":"pain intensity in first 24 h after surgery","k":6,"c":"Mendes ML et al. Med Oral Patol Oral Cir Bucal 2019","p":"30573710","url":"https://pubmed.ncbi.nlm.nih.gov/30573710/","pl":true}],[10,102,"B","Knee osteoarthritis pain and function","A 2025 meta-analysis of 11 RCTs (870 participants) found improved pain and function scores versus placebo, with high heterogeneity between trials (I² 75% and 88%).",{"st":"pooled","mt":"exact","m":"MD","v":-13.63,"lo":-20.67,"hi":-6.58,"om":"knee OA pain score","k":11,"n":870,"i2":88,"c":"Simental-Mendía M et al. Clin Exp Rheumatol 2025","p":"39212129","url":"https://pubmed.ncbi.nlm.nih.gov/39212129/","pl":true}],[10,128,"B","Non-specific low back pain in adults","A Cochrane review found that daily extracts standardized to 50 mg or 100 mg harpagoside may beat placebo for short-term pain and rescue-medication use (two trials, 315 participants, low-quality evidence).",{"st":"no-estimate","mt":"exact","om":"short-term pain and rescue medication use","k":2,"n":315,"c":"Oltean H et al. Cochrane Database Syst Rev 2014","p":"25536022","url":"https://pubmed.ncbi.nlm.nih.gov/25536022/","pl":false}],[10,129,"B","Rheumatoid arthritis pain and disability","A 2011 Cochrane review pooled 7 studies of GLA from evening primrose, borage or blackcurrant seed oil: lower pain intensity (-32.83 points, 100-point scale) and less disability; authors judged the evidence moderate.",{"st":"pooled","mt":"exact","m":"MD","v":-32.83,"lo":-56.25,"hi":-9.42,"u":"points on 100-point pain scale","om":"pain intensity","k":7,"c":"Cameron M et al. Cochrane Database Syst Rev 2011","p":"21328257","url":"https://pubmed.ncbi.nlm.nih.gov/21328257/","pl":true}],[10,130,"B","Inflammation and oxidative stress markers","A 2026 meta-analysis of 10 RCTs (532 participants) found lower C-reactive protein (SMD -0.43) and TNF-α (SMD -0.51), but no significant effect on IL-6 overall.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.43,"lo":-0.71,"hi":-0.15,"om":"C-reactive protein or high-sensitivity CRP","k":10,"n":532,"c":"Ouyang L et al. Br J Nutr 2026","p":"41883255","url":"https://pubmed.ncbi.nlm.nih.gov/41883255/","pl":true}],[10,119,"B","Knee osteoarthritis pain and function","A 2018 meta-analysis of placebo-controlled RCTs of oral supplements found statistically significant improvements in osteoarthritis pain with MSM, but of unclear clinical importance.",{"st":"no-estimate","mt":"exact","om":"osteoarthritis pain (MSM among six supplements with statistically significant improvement)","c":"Liu X et al. Br J Sports Med 2018","p":"29018060","url":"https://pubmed.ncbi.nlm.nih.gov/29018060/","pl":false}],[10,68,"B","Inflammatory markers in adults","A 2020 meta-analysis of 24 RCTs (1,057 participants; 400–2000 mg/day for 1–80 weeks) found oral NAC lowered CRP (−0.61 mg/L) and IL-6, with high heterogeneity; other inflammatory markers did not change.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.61,"lo":-1.18,"hi":-0.03,"u":"mg/L","om":"serum C-reactive protein","k":24,"n":1057,"i2":79.6,"dur":"1 to 80 weeks","c":"Askari M et al. Cytokine 2020","p":"32799012","url":"https://pubmed.ncbi.nlm.nih.gov/32799012/","pl":true}],[10,131,"B","Chronic pain","A 2023 meta-analysis of 11 double-blind RCTs (774 patients; 4 tested PEA with transpolydatin) found lower pain scores than comparators (SMD 1.68); no major side effects were attributed to PEA.",{"st":"pooled","mt":"exact","m":"SMD","v":1.68,"lo":1.05,"hi":2.31,"om":"pain intensity scores","k":11,"n":774,"c":"Lang-Illievich K et al. Nutrients 2023","p":"36986081","url":"https://pubmed.ncbi.nlm.nih.gov/36986081/","pl":true,"se":"positive = more pain reduction"}],[10,131,"B","Acute or chronic pain versus inactive control","A 2017 meta-analysis pooled 8 RCTs with inactive controls and found greater pain reduction with PEA; the authors note few trials, varied conditions and often poor study quality.",{"st":"pooled","mt":"exact","m":"WMD","v":2.03,"lo":1.19,"hi":2.87,"u":"points on visual analog pain scale","om":"pain score reduction","k":8,"c":"Artukoglu BB et al. Pain Physician 2017","p":"28727699","url":"https://pubmed.ncbi.nlm.nih.gov/28727699/","pl":true,"se":"positive = more pain reduction"}],[10,132,"B","Osteoarthritis pain","A 2008 meta-analysis of three placebo-controlled RCTs (287 patients, median 3 months) found reduced pain (effect size 0.37), with patients about twice as likely to respond (OR 2.19); all trials were manufacturer-supported, and independent replication was called for.",{"st":"pooled","mt":"exact","m":"SMD","v":0.37,"lo":0.13,"hi":0.6,"om":"reduction in pain scores (osteoarthritis)","k":3,"n":287,"i2":0,"dur":"median 3 months","c":"Christensen R et al. Osteoarthritis Cartilage 2008","p":"18407528","url":"https://pubmed.ncbi.nlm.nih.gov/18407528/","pl":true,"se":"positive = more pain reduction"}],[10,133,"B","Knee osteoarthritis pain and function (oral)","Several meta-analyses evaluated oral turmeric or curcumin; NCCIH calls the initial evidence positive but says higher-quality evidence is needed for definitive conclusions.",{"st":"none","pl":false}],[10,134,"B","Knee osteoarthritis pain and function","A 2023 review of 8 RCTs (3–6 months) pooled 6 for WOMAC (MD -8.91) and 3 for VAS pain (MD -1.65), both favoring the collagen over placebo or control; Lequesne index did not differ. Authors call for larger trials.",{"st":"no-estimate","mt":"exact","om":"WOMAC and VAS scores","k":8,"dur":"3 to 6 months","c":"Kumar P et al. Am J Transl Res 2023","p":"37854210","url":"https://pubmed.ncbi.nlm.nih.gov/37854210/","pl":false}],[10,134,"B","Knee osteoarthritis (180-day trial versus placebo and glucosamine-chondroitin)","In an RCT of 191 volunteers, 40 mg/day for 180 days reduced total WOMAC score versus placebo (p = 0.002) and versus glucosamine plus chondroitin (p = 0.04); safety outcomes did not differ among groups.",{"st":"no-estimate","mt":"exact","om":"total WOMAC score","n":191,"dur":"180-day period","c":"Lugo JP et al. Nutr J 2016","p":"26822714","url":"https://pubmed.ncbi.nlm.nih.gov/26822714/","pl":false}],[10,134,"B","Osteoarthritis pain across supplements (meta-analysis)","A 2018 meta-analysis of 69 placebo-controlled RCTs of 20 supplements found only green-lipped mussel extract and undenatured type II collagen had clinically important effects on pain at medium term.",{"st":"no-estimate","mt":"exact","om":"osteoarthritis pain (medium term)","k":69,"c":"Liu X et al. Br J Sports Med 2018","p":"29018060","url":"https://pubmed.ncbi.nlm.nih.gov/29018060/","pl":false}],[10,135,"C","Rheumatoid arthritis symptoms","Small trials suggested reduced rheumatoid factors and arthritis symptoms; MSK states additional studies are needed to confirm these effects.",{"st":"no-estimate","mt":"partial","om":"joint pain (VAPS), rheumatoid factor","dur":"14 weeks","c":"Burgos RA et al. Clin Rheumatol 2009","p":"19408036","url":"https://pubmed.ncbi.nlm.nih.gov/19408036/","pl":false}],[10,136,"C","Knee osteoarthritis symptoms","In one randomized trial of 100 patients with knee osteoarthritis, 30 ml/day of culinary argan oil for 8 weeks improved pain, function and walking distance versus no treatment; there was no placebo.",{"st":"no-estimate","mt":"exact","om":"VAS pain, WOMAC pain and function, walking distance, Lequesne index","n":100,"dur":"8 weeks","c":"Essouiri J et al. Curr Rheumatol Rev 2017","p":"28699499","url":"https://pubmed.ncbi.nlm.nih.gov/28699499/","pl":false}],[10,137,"C","Hand osteoarthritis pain (gel on the skin)","In a double-blind RCT of 204 patients over 21 days, an arnica gel (50 g tincture/100 g) was not inferior to 5% ibuprofen gel for pain and hand function.",{"st":"no-estimate","mt":"exact","om":"pain intensity and hand function","dur":"21 days","c":"Widrig R et al. Rheumatol Int 2007","p":"17318618","url":"https://pubmed.ncbi.nlm.nih.gov/17318618/","pl":false}],[10,137,"C","Pain and inflammation (overall evidence)","LiverTox states there is little evidence for efficacy of either oral homeopathic or topical herbal arnica, and clinical studies have not confirmed its effects on inflammation or pain.",{"st":"none","pl":false}],[10,138,"C","Inflammation markers and antioxidant enzymes","A 2025 systematic review of 18 studies (aronia juice, extract or powder for 4 to 13 weeks) reported lower CRP, TNF-alpha and IL-6, higher IL-10 and higher antioxidant enzyme activity.",{"st":"no-estimate","mt":"exact","om":"CRP, TNF-alpha, IL-6, IL-10, antioxidant enzymes","k":18,"dur":"4 to 13 weeks","c":"Sarıkaya B et al. Nutr Rev 2025","p":"39499790","url":"https://pubmed.ncbi.nlm.nih.gov/39499790/","pl":false}],[10,139,"C","Metabolic syndrome biomarkers","A 12-week double-blind trial in 37 adults with metabolic syndrome lowered two markers of inflammation and oxidative stress versus placebo, with no change in glucose or lipid metabolism; authors called it a weak indication.",{"st":"no-estimate","mt":"exact","om":"plasma IFN-γ and urinary 8-isoprostane","n":37,"dur":"12 weeks","c":"Kim H et al. Food Funct 2018","p":"29850709","url":"https://pubmed.ncbi.nlm.nih.gov/29850709/","pl":false}],[10,140,"C","Rheumatoid arthritis, alongside standard medication (strain GBI-30, 6086)","In a pilot RCT of 45 adults, 60 days of GBI-30, 6086 gave a borderline improvement in patient pain assessment (P =.052) and a significant pain-scale improvement versus placebo; authors call for larger trials.",{"st":"no-estimate","mt":"exact","om":"Patient Pain Assessment score and Pain Scale","n":45,"dur":"60 days","c":"Mandel DR et al. BMC Complement Altern Med 2010","p":"20067641","url":"https://pubmed.ncbi.nlm.nih.gov/20067641/","pl":false}],[10,141,"C","Osteoarthritis symptoms (multi-ingredient supplement)","MSK reports that an herbal supplement containing S. baicalensis reduced osteoarthritis symptoms, but it is not known whether the herb alone would have similar effects.",{"st":"none","pl":false}],[10,100,"C","Inflammatory markers","A 2023 meta-analysis of 6 RCTs (277 participants) found a slight reduction in IL-1β with high heterogeneity and no significant change in CRP, IL-6 or TNF-α; the authors found insufficient evidence.",{"st":"pooled","mt":"exact","m":"MD","v":0.65,"lo":-1.23,"hi":-0.06,"u":"pg/mL","om":"circulating IL-1β","k":6,"n":277,"i2":95,"c":"Xu J et al. Int J Food Sci Nutr 2023","p":"37733077","url":"https://pubmed.ncbi.nlm.nih.gov/37733077/","pl":false,"pr":"estimate outside its interval as printed"}],[10,142,"C","Osteoarthritis symptoms","Small trials (20–60 participants, 2–8 weeks, 1.5–12 mg/day) reported reduced symptoms or inflammatory markers; ODS says confirmation is needed from additional controlled trials.",{"st":"none","pl":false}],[10,143,"C","Chronic knee pain (injection into the joint)","In a retrospective study of intra-articular BPC-157 injection for knee pain, 7 of 12 patients reported relief for more than 6 months; the 2025 review rated the available studies level IV and V evidence.",{"st":"no-estimate","mt":"exact","om":"patient-reported knee pain relief > 6 months","n":12,"c":"Vasireddi N et al. HSS J 2025","p":"40756949","url":"https://pubmed.ncbi.nlm.nih.gov/40756949/","pl":false}],[10,127,"C","Pain (oral bromelain across conditions)","A 2023 meta-analysis found pain reduction from oral bromelain slightly but significantly better than controls (mean difference -0.27; 9 studies); bromelain was not effective for cardiovascular diseases.",{"st":"pooled","mt":"exact","m":"MD","v":-0.27,"lo":-0.45,"hi":-0.08,"om":"pain score (oral bromelain, across conditions)","k":9,"i2":29,"c":"Leelakanok N et al. Nutr Health 2023","p":"37157782","url":"https://pubmed.ncbi.nlm.nih.gov/37157782/","pl":true}],[10,77,"C","Inflammation and oxidative stress markers","A 2024 meta-analysis of 9 trials (350 participants) of carnosine or other histidine-containing dipeptides found lower CRP, TNF-α and MDA but no effect on IL-6, adiponectin, GSH, SOD or TAC.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.97,"lo":-1.59,"hi":-0.36,"u":"mg/L","om":"C-reactive protein","k":9,"n":350,"c":"Saadati S et al. Nutr Rev 2024","p":"38086332","url":"https://pubmed.ncbi.nlm.nih.gov/38086332/","pl":true}],[10,144,"C","Rheumatoid arthritis (adults also taking sulfasalazine or hydroxychloroquine)","A 24-week placebo-controlled trial in 40 patients found fewer painful joints with a pentacyclic-chemotype extract (53.2% vs 24.1% reduction); the authors called it a small preliminary study.",{"st":"no-estimate","mt":"exact","om":"number of painful joints","n":40,"dur":"24 weeks","c":"Mur E et al. J Rheumatol 2002","p":"11950006","url":"https://pubmed.ncbi.nlm.nih.gov/11950006/","pl":false}],[10,144,"C","Knee osteoarthritis (Uncaria guianensis)","A 4-week trial in 45 patients (30 freeze-dried U. guianensis, 15 placebo) reported less pain with activity; knee pain at rest or at night did not change significantly.",{"st":"no-estimate","mt":"exact","om":"knee pain with activity","n":45,"dur":"four weeks","c":"Piscoya J et al. Inflamm Res 2001","p":"11603848","url":"https://pubmed.ncbi.nlm.nih.gov/11603848/","pl":false}],[10,128,"C","Knee and hip osteoarthritis","In a 4-month double-blind trial of 122 patients, powdered root was comparable to diacerhein 100 mg/day for pain and function, with less diarrhea; there was no placebo group.",{"st":"no-estimate","mt":"exact","om":"pain (VAS) and Lequesne functional index","c":"Chantre P et al. Phytomedicine 2000","p":"11185727","url":"https://pubmed.ncbi.nlm.nih.gov/11185727/","pl":false}],[10,128,"C","Osteoarthritis and back pain (systematic review)","A 2004 review of 12 trials could not pool data; it rated evidence limited for low-harpagoside ethanolic extracts and moderate for powder at 60 mg harpagoside in osteoarthritis.",{"st":"no-estimate","mt":"exact","om":"pain in osteoarthritis and low back pain","k":12,"c":"Gagnier JJ et al. BMC Complement Altern Med 2004","p":"15369596","url":"https://pubmed.ncbi.nlm.nih.gov/15369596/","pl":false}],[10,14,"C","Knee osteoarthritis symptoms","Oral supplements might help, but much of the research is of poor quality; topical ginger has not been shown to help.",{"st":"none","pl":false}],[10,145,"C","Knee osteoarthritis pain and function","A 2018 analysis of 29 studies (6,120 participants) found pain reduced by glucosamine or chondroitin alone but not by the combination; individual studies were inconsistent, and NCCIH calls the benefit uncertain.",{"st":"pooled","mt":"partial","m":"WMD","v":-7.41,"lo":-14.31,"hi":-0.51,"u":"mm","om":"knee pain on VAS","c":"Simental-Mendía M et al. Rheumatol Int 2018","p":"29947998","url":"https://pubmed.ncbi.nlm.nih.gov/29947998/","pl":false,"ex":"the estimate is for glucosamine alone, not the combination"}],[10,145,"C","Joint structure (joint-space narrowing) in knee osteoarthritis","Two large 2-year trials conflicted: an Australian trial (605 participants) found less narrowing with the combination; a US trial (572 participants) found no difference from placebo.",{"st":"single-trial","mt":"partial","m":"MD","v":0.1,"lo":0.002,"hi":0.2,"u":"mm","om":"reduction in 2-year joint space narrowing vs placebo","n":605,"dur":"2 years","c":"Fransen M et al. Ann Rheum Dis 2015","p":"24395557","url":"https://pubmed.ncbi.nlm.nih.gov/24395557/","pl":true,"se":"positive = less joint-space narrowing over 2 years"}],[10,145,"C","Hand osteoarthritis (chondroitin)","One 6-month study in 162 participants found less hand pain and better function with chondroitin than placebo.",{"st":"no-ci","mt":"exact","m":"MD","v":-8.7,"u":"mm","om":"global spontaneous hand pain (0-100 mm VAS)","n":162,"dur":"6 months","c":"Gabay C et al. Arthritis Rheum 2011","p":"21898340","url":"https://pubmed.ncbi.nlm.nih.gov/21898340/","pl":false}],[10,145,"C","Temporomandibular joint osteoarthritis (glucosamine)","A review of 8 studies (538 participants) could not reach definite conclusions; studies differed in methods and products and some may have been biased.",{"st":"no-estimate","mt":"exact","om":"TMJ pain and maximum mouth opening","k":8,"c":"Derwich M et al. Int J Mol Sci 2023","p":"36902359","url":"https://pubmed.ncbi.nlm.nih.gov/36902359/","pl":false}],[10,82,"C","Knee joint discomfort with activity in overweight adults","An 84-day RCT in 105 overweight, otherwise healthy adults found a standardized aqueous fruit extract (250 or 500 mg twice daily) improved knee-joint scores (mKOOS global) versus placebo.",{"st":"no-estimate","mt":"exact","om":"mKOOS global score","n":105,"dur":"84 days","c":"Lopez HL et al. BMC Complement Altern Med 2017","p":"28969626","url":"https://pubmed.ncbi.nlm.nih.gov/28969626/","pl":false}],[10,146,"C","Osteoarthritis and low back pain","A 2024 systematic review of 11 trials (597 patients) found improvement in 9; only 2 trials gave oral hyaluronic acid alone, while 9 combined it with substances such as glucosamine, chondroitin or collagen.",{"st":"no-estimate","mt":"exact","om":"VAS pain, WOMAC, joint function and related outcomes","k":11,"n":597,"dur":"4 weeks to 12 months","c":"de Carvalho JF, Davidson J. Mediterr J Rheumatol 2024","p":"39886281","url":"https://pubmed.ncbi.nlm.nih.gov/39886281/","pl":false}],[10,147,"C","Knee pain, stiffness and function","A 2024 meta-analysis (5 RCTs, 700 patients) found no significant difference from placebo for knee pain, stiffness or lipids, and a small improvement in knee physical function (SMD -0.24).",{"st":"pooled","mt":"exact","m":"SMD","v":-0.24,"lo":-0.41,"hi":-0.08,"om":"knee physical function","k":5,"n":700,"i2":0,"c":"Pimentel T et al. Inflammopharmacology 2024","p":"39126570","url":"https://pubmed.ncbi.nlm.nih.gov/39126570/","pl":true}],[10,119,"C","Knee pain during military training","In an RCT of 180 military trainees, 3 g/day for 8 weeks did not significantly improve knee outcome or mood scores versus placebo.",{"st":"no-estimate","mt":"exact","om":"KOOS subscales and POMS subscales","n":180,"dur":"8 weeks","c":"Tennent DJ et al. US Army Med Dep J 2017","p":"29214616","url":"https://pubmed.ncbi.nlm.nih.gov/29214616/","pl":false}],[10,119,"C","Mild knee pain in healthy adults","In an RCT of 88 healthy Japanese adults with mild knee pain, 2 g/day (ten 200 mg tablets) for 12 weeks improved a knee quality-of-life score versus placebo (p = 0.046).",{"st":"no-estimate","mt":"exact","om":"JKOM total score at 12 weeks","n":88,"dur":"12 weeks","c":"Toguchi A et al. Nutrients 2023","p":"37447322","url":"https://pubmed.ncbi.nlm.nih.gov/37447322/","pl":false}],[10,86,"C","Extract (var. frutescens): mild knee joint pain","In an 8-week RCT of 80 adults without radiographic arthritis, a 700 mg extract capsule twice daily reduced pain and WOMAC scores more than placebo; inflammation markers did not change.",{"st":"no-estimate","mt":"exact","om":"knee pain VAS and total WOMAC score change","n":80,"dur":"eight weeks","c":"Kim N et al. Front Pharmacol 2023","p":"36998613","url":"https://pubmed.ncbi.nlm.nih.gov/36998613/","pl":false}],[10,148,"C","Rheumatoid arthritis disease activity","MSK reports that a double-blind RCT of Brazilian propolis found no benefit for rheumatoid arthritis.",{"st":"single-trial","mt":"exact","m":"MD","v":0.14,"lo":-0.21,"hi":0.49,"u":"points on DAS28-ESR","om":"change in DAS28-ESR (disease activity)","n":80,"dur":"24 weeks","c":"Matsumoto Y et al. PLoS One 2021 (BeeDAI)","p":"34043719","url":"https://pubmed.ncbi.nlm.nih.gov/34043719/","pl":true}],[10,132,"C","Knee function during walking","In one 12-week RCT of 100 adults with knee-related walking limitations, rose hip powder capsules improved the peak resultant knee moment during walking versus placebo (0.06 Nm/kg).",{"st":"single-trial","mt":"exact","m":"MD","v":0.06,"lo":0.0,"hi":0.12,"u":"nm/kg","om":"peak resultant knee moment during walking","n":100,"dur":"12 weeks","c":"Ginnerup-Nielsen E et al. Gait Posture 2015","p":"26234471","url":"https://pubmed.ncbi.nlm.nih.gov/26234471/","pl":true}],[10,132,"C","Rheumatoid arthritis","In one 6-month RCT of 89 patients, 5 g/day rose hip powder improved a disability score (HAQ-DI) versus placebo; pain scores and pain-medication use did not differ.",{"st":"no-estimate","mt":"exact","om":"HAQ-DI disability score","n":89,"dur":"6 months","c":"Willich SN et al. Phytomedicine 2010","p":"19818588","url":"https://pubmed.ncbi.nlm.nih.gov/19818588/","pl":false}],[10,64,"C","Osteoarthritis of the knee or hip","A 2009 Cochrane review (4 placebo-controlled trials, 656 patients) found a small, non-significant pain difference (0.4 cm on a 10 cm scale), called the evidence inconclusive and advised against routine use.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.17,"lo":-0.34,"hi":0.01,"om":"pain (knee or hip osteoarthritis)","k":4,"n":656,"i2":0,"c":"Rutjes AW et al. Cochrane Database Syst Rev 2009","p":"19821403","url":"https://pubmed.ncbi.nlm.nih.gov/19821403/","pl":true}],[10,149,"C","Trismus, swelling and pain after impacted molar surgery","A 2018 meta-analysis (5 studies) found serratiopeptidase improved trismus more than corticosteroids (mean difference 4.42) with no difference in swelling; too few studies allowed conclusions on other outcomes or comparators.",{"st":"pooled","mt":"exact","m":"MD","v":4.42,"lo":3.84,"hi":5,"om":"trismus","k":5,"c":"Sivaramakrishnan G et al. J Maxillofac Oral Surg 2018","p":"29618875","url":"https://pubmed.ncbi.nlm.nih.gov/29618875/","pl":true}],[10,149,"C","Anti-inflammatory and pain-relief use overall","A 2013 systematic review (24 clinical studies) found the evidence rests on studies of poor methodology, with only a few small, usually placebo-controlled RCTs, and judged it insufficient to support use as an analgesic or health supplement.",{"st":"no-estimate","mt":"exact","om":"anti-inflammatory and analgesic efficacy","k":24,"c":"Bhagat S et al. Int J Surg 2013","p":"23380245","url":"https://pubmed.ncbi.nlm.nih.gov/23380245/","pl":false}],[10,88,"C","Knee osteoarthritis pain","In a 16-week randomized trial (62 enrolled), high-rosmarinic-acid spearmint tea reduced pain from baseline but a commercial spearmint tea did not; both teas improved stiffness and physical disability.",{"st":"no-estimate","mt":"exact","om":"WOMAC pain, stiffness, physical disability","n":62,"dur":"16 weeks","c":"Connelly AE et al. J Med Food 2014","p":"25058311","url":"https://pubmed.ncbi.nlm.nih.gov/25058311/","pl":false}],[10,150,"C","Hip and knee osteoarthritis pain","Pilot RCT (42 patients, 12 weeks): 150 mg extract twice daily improved WOMAC and pain scores from baseline; 300 mg twice daily and placebo did not. Authors called for further studies.",{"st":"no-ci","mt":"exact","m":"other","v":-12.2,"u":"points on WOMAC total","om":"WOMAC total score","n":42,"dur":"12 weeks","c":"Stebbings S et al. Clin Rheumatol 2016","p":"26631103","url":"https://pubmed.ncbi.nlm.nih.gov/26631103/","pl":false}],[10,151,"C","Inflammation and oxidative-stress markers","A 2021 meta-analysis (19 RCTs reviewed, 13 pooled) found lower CRP, attributed to a single delta-tocotrienol study, and no effect on IL-6, TNF-alpha or malondialdehyde.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.52,"lo":-0.73,"hi":-0.32,"u":"mg/L","om":"C-reactive protein","k":13,"c":"Khor BH et al. PLoS One 2021","p":"34297765","url":"https://pubmed.ncbi.nlm.nih.gov/34297765/","pl":true}],[10,133,"C","Knee osteoarthritis pain (topical ointment)","NCCIH states it is unclear whether topical curcumin ointment affects knee osteoarthritis pain.",{"st":"none","pl":false}],[10,134,"C","Exercise-related knee discomfort in healthy adults","In an RCT of 55 healthy adults, 40 mg/day for 120 days improved knee extension versus placebo (81.0° vs 74.0°; p = 0.011); time exercised before joint discomfort lengthened versus baseline.",{"st":"no-estimate","mt":"exact","om":"average knee extension","n":55,"dur":"120 days","c":"Lugo JP et al. J Int Soc Sports Nutr 2013","p":"24153020","url":"https://pubmed.ncbi.nlm.nih.gov/24153020/","pl":false}],[10,134,"C","Knee flexibility in healthy adults with activity-related joint discomfort","In a multicenter RCT of 96 adults, 40 mg/day for 24 weeks increased knee flexion range of motion versus placebo (3.23° vs 0.21°; p = 0.025).",{"st":"no-estimate","mt":"exact","om":"knee ROM flexion","n":96,"dur":"24 weeks","c":"Schön C et al. J Integr Complement Med 2022","p":"35377244","url":"https://pubmed.ncbi.nlm.nih.gov/35377244/","pl":false}],[10,134,"C","Joint function in healthy adults with activity-related discomfort (180 days)","In an RCT of 74 healthy adults, KOOS joint-function scores improved in both the native type II collagen and placebo groups by day 180; improvements from baseline appeared earlier with the collagen.",{"st":"no-estimate","mt":"exact","om":"KOOS joint function","n":74,"dur":"180 days","c":"Möller I et al. Nutr J 2026","p":"41787523","url":"https://pubmed.ncbi.nlm.nih.gov/41787523/","pl":false}],[10,152,"D","Inflammation and pain","Anti-inflammatory effects were seen in colitis models in mice, and pain-relieving effects in cell and animal studies; not studied in people.",{"st":"not-human","pl":false}],[10,145,"X","Hip osteoarthritis (glucosamine sulfate)","A 2-year trial in 222 participants found glucosamine sulfate no better than placebo for pain, function or joint-space narrowing.",{"st":"single-trial","mt":"exact","m":"MD","v":-1.54,"lo":-5.43,"hi":2.36,"u":"points on WOMAC pain subscale","om":"WOMAC pain","n":222,"dur":"2 years","c":"Rozendaal RM et al. Ann Intern Med 2008","p":"18283204","url":"https://pubmed.ncbi.nlm.nih.gov/18283204/","pl":true}],[11,109,"B","Skin aging (moisture, elasticity, wrinkles)","2021 meta-analysis of 9 RCTs of oral astaxanthin: skin moisture (SMD 0.53) and elasticity (SMD 0.77) improved versus placebo; wrinkle depth did not change significantly.",{"st":"pooled","mt":"exact","m":"SMD","v":0.53,"lo":0.05,"hi":1.01,"om":"skin moisture content","k":9,"i2":52,"c":"Zhou X et al. Nutrients 2021","p":"34578794","url":"https://pubmed.ncbi.nlm.nih.gov/34578794/","pl":true}],[11,153,"B","Skin lightening (melanin index) in healthy people","A 2025 systematic review describes five RCTs and one open-arm study in which oral glutathione (250-500 mg/day) reduced melanin index versus placebo; it judged topical and oral effects moderate and not sustained.",{"st":"no-estimate","mt":"exact","om":"melanin index","c":"Sarkar R et al. Int J Dermatol 2025","p":"39444151","url":"https://pubmed.ncbi.nlm.nih.gov/39444151/","pl":false}],[11,146,"B","Skin hydration in healthy adults","A meta-analysis of 4 RCTs (196 participants, 4–12 weeks) found improved skin hydration versus placebo (SMD +0.40); trial designs were poorly reported and one trial had high risk of other bias.",{"st":"no-estimate","mt":"partial","om":"skin hydration (hyaluronan)","c":"Sun Q et al. Front Nutr 2022","p":"35719159","url":"https://pubmed.ncbi.nlm.nih.gov/35719159/","pl":false}],[11,136,"C","Skin elasticity in postmenopausal women","In 60 postmenopausal women, 60 days of dietary argan oil (versus olive oil) and topical argan oil both increased instrument-measured skin elasticity.",{"st":"no-estimate","mt":"exact","om":"skin elasticity (R2, R5, R7) and resonance running time","n":60,"dur":"60 days","c":"Boucetta KQ et al. Clin Interv Aging 2015","p":"25673976","url":"https://pubmed.ncbi.nlm.nih.gov/25673976/","pl":false}],[11,154,"C","Brittle nails","Small uncontrolled studies of 2.5 mg/day for about 5.5–15 months (22 to 45 patients each) reported firmer nails or improvement in 63%–91%; ODS calls the support few case reports and small studies.",{"st":"none","pl":false}],[11,154,"C","Hair and skin","Evidence consists of case reports in children (3–5 mg/day for uncombable hair syndrome) and infants (100 mcg to 10 mg/day for rash and alopecia); ODS states future studies are needed.",{"st":"none","pl":false}],[11,155,"C","Acute radiation dermatitis during radiotherapy (topical, pooled trials)","A 2023 meta-analysis of RCTs of natural agents applied during radiotherapy found calendula did not significantly lower the incidence of grade 2+ radiation dermatitis; the authors called the evidence for natural agents inconsistent.",{"st":"no-estimate","mt":"exact","om":"incidence of RTOG grade 2+ radiation dermatitis (calendula)","c":"Robijns J et al. Support Care Cancer 2023","p":"36859690","url":"https://pubmed.ncbi.nlm.nih.gov/36859690/","pl":false}],[11,155,"C","Radiation dermatitis in breast cancer radiotherapy versus trolamine (topical)","A phase III RCT in 254 breast cancer patients found grade 2 or higher acute dermatitis was less frequent with calendula ointment than trolamine (41% vs 63%), with less radiation-induced pain.",{"st":"no-estimate","mt":"exact","om":"acute dermatitis grade 2 or higher","n":254,"c":"Pommier P et al. J Clin Oncol 2004","p":"15084618","url":"https://pubmed.ncbi.nlm.nih.gov/15084618/","pl":false}],[11,155,"C","Wound healing (topical)","A 2019 systematic review of calendula extract alone (7 clinical trials, 7 animal studies) found some evidence for acute wounds and mixed results for venous and diabetic ulcers and burns; larger trials are needed.",{"st":"no-estimate","mt":"exact","om":"wound healing (acute, chronic, burns)","k":14,"c":"Givol O et al. Wound Repair Regen 2019","p":"31145533","url":"https://pubmed.ncbi.nlm.nih.gov/31145533/","pl":false}],[11,155,"C","Diaper dermatitis in infants (topical)","In a 100-infant RCT, bentonite cream worked faster and more completely than calendula cream (86% vs 52% of infants with lesions completely improved within three days).",{"st":"no-estimate","mt":"exact","om":"complete improvement of diaper dermatitis lesions within three days","n":100,"dur":"three days","c":"Mahmoudi M et al. Indian J Med Res 2015","p":"26831423","url":"https://pubmed.ncbi.nlm.nih.gov/26831423/","pl":false}],[11,102,"C","Skin hydration, elasticity and wrinkles","A 2025 meta-analysis of 23 RCTs (1,474 participants) found overall improvements, but trials without pharmaceutical-company funding and high-quality trials showed no significant effect.",{"st":"no-estimate","mt":"exact","om":"skin hydration, elasticity and wrinkles","k":23,"n":1474,"c":"Myung SK, Park Y. Am J Med 2025","p":"40324552","url":"https://pubmed.ncbi.nlm.nih.gov/40324552/","pl":false}],[11,156,"C","Mild chronic plaque psoriasis","In a 12-week double-blind RCT in 34 adults, D. bardawil capsules reduced PASI scores more than placebo at 6 weeks (61.3% vs 34%); quality-of-life scores did not differ.",{"st":"no-estimate","mt":"exact","om":"PASI score reduction at 6 weeks","dur":"12 weeks","c":"Greenberger S et al. J Am Coll Nutr 2012","p":"23529989","url":"https://pubmed.ncbi.nlm.nih.gov/23529989/","pl":false}],[11,82,"C","Facial sebum, redness and wrinkles in healthy women","An 8-week placebo-controlled RCT of 250 mg capsules twice daily reported less forehead sebum in women with high baseline sebum, less cheek redness and lower facial wrinkle severity than placebo.",{"st":"no-estimate","mt":"exact","om":"forehead sebum excretion rate; cheek erythema; facial wrinkle severity","dur":"eight weeks","c":"Chakkalakal M et al. J Clin Med 2023","p":"36836126","url":"https://pubmed.ncbi.nlm.nih.gov/36836126/","pl":false}],[11,157,"C","Facial wrinkles and skin aging (oral extract)","In one 12-week randomized, placebo-controlled trial in 120 Korean adults, 400 or 800 mg/day of fermented C. intermedia extract improved wrinkle grade, elasticity and hydration versus placebo.",{"st":"no-estimate","mt":"exact","om":"global skin wrinkle grade, elasticity, hydration","n":120,"dur":"12 weeks","c":"Choi SY et al. J Cosmet Laser Ther 2018","p":"29388846","url":"https://pubmed.ncbi.nlm.nih.gov/29388846/","pl":false}],[11,157,"C","Skin smoothness and hydration (topical cream)","In a 2-week forearm study, 2% C. maculata or C. genistoides creams improved skin smoothness but did not improve hydration compared with placebo; the formulations were unstable over 3 months.",{"st":"no-estimate","mt":"exact","om":"skin smoothness and hydration","dur":"2 weeks","c":"Gerber GS et al. Pharmacogn Mag 2015","p":"26664024","url":"https://pubmed.ncbi.nlm.nih.gov/26664024/","pl":false}],[11,146,"C","Skin photoaging and elasticity","A 2025 meta-analysis identified 4 studies (178 participants); pooling 2 (100 participants) found no significant difference from placebo in overall skin elasticity, with high heterogeneity.",{"st":"no-estimate","mt":"partial","om":"skin photoaging / overall skin elasticity (R2)","c":"Yang Q et al. Front Med (Lausanne) 2025","p":"40761858","url":"https://pubmed.ncbi.nlm.nih.gov/40761858/","pl":false}],[11,158,"C","Wound healing (applied to the skin)","MSK: small clinical studies suggest benefit, but randomized trials did not find manuka honey more effective than standard treatments for venous leg ulcers, eyelid surgical wounds or catheter-associated infections.",{"st":"none","pl":false}],[11,119,"C","Facial wrinkles and skin texture","In a 16-week pilot of 20 participants, 3 g/day MSM reduced facial wrinkles and skin roughness versus placebo; a second part compared 1 g and 3 g/day without a placebo group.",{"st":"no-estimate","mt":"exact","om":"facial wrinkles and skin roughness","n":20,"dur":"16 weeks","c":"Muizzuddin N, Benjamin R. Int J Vitam Nutr Res 2022","p":"32083522","url":"https://pubmed.ncbi.nlm.nih.gov/32083522/","pl":false}],[11,148,"C","Warts and fungal foot infections","MSK states that data in humans are limited; small trials suggest benefit for warts and fungal foot infections.",{"st":"none","pl":false}],[11,159,"C","Male pattern hair loss","In a 24-week double-blind RCT in 76 men, 400 mg/day of a pumpkin seed oil product increased hair counts by 40% versus 10% with placebo.",{"st":"no-estimate","mt":"exact","u":"%","om":"hair count increase","dur":"24 weeks","c":"Cho YH et al. Evid Based Complement Alternat Med 2014","p":"24864154","url":"https://pubmed.ncbi.nlm.nih.gov/24864154/","pl":false}],[11,160,"C","Chronic hand eczema (oral syrup)","A 4-week RCT in 70 adults found purslane syrup plus topical Vaseline lowered fissure, itching and dryness scores versus placebo syrup plus Vaseline.",{"st":"single-trial","mt":"exact","m":"MD","v":-0.5,"lo":-3.93,"hi":-0.34,"u":"points on physician-reported fissure score","om":"physician-reported fissure score","dur":"4 weeks","c":"Heydarirad G et al. Explore (NY) 2024","p":"37872023","url":"https://pubmed.ncbi.nlm.nih.gov/37872023/","pl":true}],[11,132,"C","Facial wrinkles and skin moisture","In one 8-week randomized study of 34 adults, rose hip powder and the comparator astaxanthin both improved crow's-feet wrinkles, moisture and elasticity; there was no placebo group.",{"st":"no-estimate","mt":"exact","om":"crow's-feet wrinkles, skin moisture, elasticity","dur":"8 weeks","c":"Phetcharat L et al. Clin Interv Aging 2015","p":"26604725","url":"https://pubmed.ncbi.nlm.nih.gov/26604725/","pl":false}],[11,69,"C","Androgenetic alopecia (pattern hair loss)","A 6-month randomized trial in 100 patients found similar hair-count gains with topical rosemary oil and 2% minoxidil; there was no placebo group.",{"st":"no-estimate","mt":"exact","om":"hair count","dur":"6 months","c":"Panahi Y et al. Skinmed 2015","p":"25842469","url":"https://pubmed.ncbi.nlm.nih.gov/25842469/","pl":false}],[11,161,"C","Insect bites and minor skin reactions (topical balm)","Pest-control workers preferred a sangre de grado balm over placebo for itching, pain and swelling from insect bites, cuts and plant reactions; the published abstract gives few trial details.",{"st":"no-estimate","mt":"exact","om":"relief of itching, pain, swelling from bites and minor skin reactions","c":"Miller MJ et al. J Invest Dermatol 2001","p":"11564183","url":"https://pubmed.ncbi.nlm.nih.gov/11564183/","pl":false}],[11,162,"C","Male-pattern hair loss","A few small oral or scalp-applied studies; NCCIH states the evidence is too limited for conclusions.",{"st":"none","pl":false}],[11,88,"C","Androgen levels and hirsutism in women with PCOS","In a 30-day RCT of 42 women, spearmint tea twice daily lowered free and total testosterone and self-rated hirsutism versus placebo tea, but not the clinician-rated hirsutism score.",{"st":"no-estimate","mt":"exact","om":"free and total testosterone; self-rated (modified DQLI) and Ferriman-Galwey hirsutism","n":42,"dur":"30 days","c":"Grant P. Phytother Res 2010","p":"19585478","url":"https://pubmed.ncbi.nlm.nih.gov/19585478/","pl":false}],[11,88,"C","Androgen levels in women with hirsutism (uncontrolled study)","In a 5-day study without a control group (21 women), spearmint tea twice daily lowered free testosterone and raised LH, FSH and estradiol; total testosterone did not change.",{"st":"no-estimate","mt":"exact","om":"free testosterone, LH, FSH, estradiol, total testosterone","n":21,"dur":"5 days","c":"Akdoğan M et al. Phytother Res 2007","p":"17310494","url":"https://pubmed.ncbi.nlm.nih.gov/17310494/","pl":false}],[11,6,"D","Lifespan and aging","Marketing as an anti-aging supplement rests on longer life span in yeast cells; this effect has not been demonstrated in humans.",{"st":"not-human","pl":false}],[11,129,"X","Atopic eczema","A 2013 Cochrane review (27 RCTs, 1,596 participants; 8 of borage oil) found borage oil did not improve global eczema symptoms versus placebo and concluded oral borage oil lacks effect on eczema.",{"st":"no-estimate","mt":"exact","om":"global eczema symptoms (borage oil)","c":"Bamford JT et al. Cochrane Database Syst Rev 2013","p":"23633319","url":"https://pubmed.ncbi.nlm.nih.gov/23633319/","pl":false}],[11,129,"X","Atopic eczema in children and adults (single large trial)","A 12-week RCT (151 patients, 140 evaluable; adults 920 mg GLA/day) found no benefit of borage oil over placebo on eczema sign scores (difference 1.4 points in favor of placebo, P = 0.45).",{"st":"single-trial","mt":"exact","m":"MD","v":1.4,"lo":-2.2,"hi":5.0,"u":"points on SASSAD","om":"change in total SASSAD sign score","dur":"12 weeks","c":"Takwale A et al. BMJ 2003","p":"14670885","url":"https://pubmed.ncbi.nlm.nih.gov/14670885/","pl":true,"se":"positive = larger improvement with placebo"}],[11,163,"X","Eczema risk in young children","A meta-analysis of five RCTs (889 participants) found LGG, given to children or to mothers in pregnancy or breastfeeding, did not reduce eczema risk up to age 4.",{"st":"no-estimate","mt":"exact","om":"eczema (risk)","k":5,"n":889,"c":"Szajewska H et al. Nutrients 2018","p":"30231505","url":"https://pubmed.ncbi.nlm.nih.gov/30231505/","pl":false}],[12,164,"A","LDL cholesterol (oat beta-glucan)","A 2016 meta-analysis of 58 RCTs (3,974 participants; median 3.5 g/day, 3 weeks or longer) found oat beta-glucan lowered LDL cholesterol by 0.19 mmol/L, non-HDL cholesterol by 0.20 mmol/L and apoB by 0.03 g/L versus control.",{"st":"pooled","mt":"exact","m":"MD","v":-0.19,"lo":-0.23,"hi":-0.14,"u":"mmol/l","om":"LDL cholesterol","k":58,"n":3974,"i2":79,"dur":"≥3 weeks","c":"Ho HV et al. Br J Nutr 2016","p":"27724985","url":"https://pubmed.ncbi.nlm.nih.gov/27724985/","pl":true}],[12,164,"A","LDL cholesterol (barley beta-glucan)","A 2016 meta-analysis of 14 RCTs (615 participants; median 6.5–6.9 g/day for a median 4 weeks) found barley beta-glucan lowered LDL cholesterol by 0.25 mmol/L and non-HDL cholesterol by 0.31 mmol/L; apoB did not change significantly.",{"st":"pooled","mt":"exact","m":"MD","v":-0.25,"lo":-0.3,"hi":-0.2,"u":"mmol/l","om":"LDL cholesterol","k":14,"n":615,"dur":"median 4 weeks","c":"Ho HV et al. Eur J Clin Nutr 2016","p":"27273067","url":"https://pubmed.ncbi.nlm.nih.gov/27273067/","pl":true}],[12,165,"A","LDL and non-HDL cholesterol","A 2017 meta-analysis of 12 RCTs (370 participants; 8 in adults, 4 in children) found LDL cholesterol fell 0.35 mmol/L and non-HDL 0.32 mmol/L; about 3 g/day lowered them by 10% and 7%.",{"st":"pooled","mt":"exact","m":"MD","v":-0.35,"lo":-0.46,"hi":-0.25,"u":"mmol/L","om":"LDL cholesterol","k":12,"n":370,"c":"Ho HVT et al. Am J Clin Nutr 2017","p":"28356275","url":"https://pubmed.ncbi.nlm.nih.gov/28356275/","pl":true}],[12,166,"A","Blood lipids (omega-6 fats overall)","The 2018 Cochrane review found high-quality evidence that more omega-6 fat lowers total cholesterol a little (mean -0.33 mmol/L; 10 trials, 4,280 people), with little or no difference in triglycerides, HDL or LDL.",{"st":"pooled","mt":"exact","m":"MD","v":-0.33,"lo":-0.5,"hi":-0.16,"u":"mmol/L","om":"total serum cholesterol","k":10,"n":4280,"i2":81,"c":"Hooper L et al. Cochrane Database Syst Rev 2018","p":"30488422","url":"https://pubmed.ncbi.nlm.nih.gov/30488422/","pl":true}],[12,167,"A","Blood lipid profile (nicotinic acid)","ODS summarizes the trials as showing that nicotinic acid improves blood lipid profiles but has no significant effects on risk of cardiovascular events.",{"st":"none","pl":false}],[12,39,"A","Blood triglyceride levels","A 2020 review of 23 studies (43,998 participants) found EPA and DHA lowered triglycerides by about 15 percent but did not affect body fat or other blood lipids.",{"st":"no-ci","mt":"partial","m":"percent-change","v":15,"u":"%","om":"serum triglycerides","dur":"trials of 12 to 88 months","c":"Abdelhamid AS et al. Cochrane Database Syst Rev 2020","p":"32114706","url":"https://pubmed.ncbi.nlm.nih.gov/32114706/","pl":false}],[12,168,"A","LDL cholesterol","A 2014 meta-analysis of 124 randomized studies (201 strata) found intakes of 0.6–3.3 g/day lowered LDL cholesterol by 6–12% on average, increasing with dose up to about 3 g/day; sterols and stanols showed comparable dose-response.",{"st":"no-ci","mt":"exact","m":"percent-change","v":12,"u":"%","om":"LDL cholesterol","k":124,"c":"Ras RT et al. Br J Nutr 2014","p":"24780090","url":"https://pubmed.ncbi.nlm.nih.gov/24780090/","pl":false}],[12,169,"A","LDL cholesterol in adults with or without high cholesterol","Meta-analysis of 28 randomized trials (1,924 participants; median dose ~10.2 g; at least 3 weeks): LDL cholesterol fell by 0.33 mmol/L (95% CI −0.38 to −0.27) versus control; certainty rated moderate.",{"st":"pooled","mt":"exact","m":"MD","v":-0.33,"lo":-0.38,"hi":-0.27,"u":"mmol/L","om":"LDL cholesterol","k":28,"n":1924,"c":"Jovanovski E et al. Am J Clin Nutr 2018","p":"30239559","url":"https://pubmed.ncbi.nlm.nih.gov/30239559/","pl":true}],[12,169,"A","Non-HDL cholesterol and apolipoprotein B","Same meta-analysis: non-HDL cholesterol fell by 0.39 mmol/L (95% CI −0.50 to −0.27) and apoB by 0.05 g/L (95% CI −0.08 to −0.03); certainty moderate and high.",{"st":"pooled","mt":"exact","m":"MD","v":-0.39,"lo":-0.5,"hi":-0.27,"u":"mmol/L","om":"non-HDL cholesterol","k":28,"n":1924,"c":"Jovanovski E et al. Am J Clin Nutr 2018","p":"30239559","url":"https://pubmed.ncbi.nlm.nih.gov/30239559/","pl":true}],[12,170,"A","LDL cholesterol","A 2015 meta-analysis of 20 randomized studies of red yeast rice with known monacolin K content found LDL cholesterol fell 1.02 mmol/L versus placebo, similar to statins; safety assessment quality was low in most studies.",{"st":"pooled","mt":"exact","m":"MD","v":1.02,"lo":-1.2,"hi":-0.83,"u":"mmol/L","om":"LDL cholesterol","k":20,"c":"Gerards MC et al. Atherosclerosis 2015","p":"25897793","url":"https://pubmed.ncbi.nlm.nih.gov/25897793/","pl":false,"pr":"estimate outside its interval as printed"}],[12,106,"A","Lowering sodium intake: blood pressure and cardiovascular disease","High strength of evidence from randomized trials that reducing sodium intake lowers systolic and diastolic blood pressure; moderate strength for fewer cardiovascular events and less hypertension.",{"st":"none","pl":false}],[12,73,"B","Blood lipids in people without coronary heart disease","A 2012 meta-analysis (11 RCTs, 485 participants) found algal-oil DHA lowered triglycerides (-0.20 mmol/L) and raised HDL (+0.07 mmol/L) and LDL cholesterol (+0.23 mmol/L).",{"st":"pooled","mt":"exact","m":"other","v":-0.2,"lo":-0.27,"hi":-0.14,"u":"mmol/L","om":"serum triglycerides","k":11,"n":485,"c":"Bernstein AM et al. J Nutr 2012","p":"22113870","url":"https://pubmed.ncbi.nlm.nih.gov/22113870/","pl":false}],[12,97,"B","Heart failure (Xinyue Capsule, a saponin extract of American ginseng stems and leaves, added to standard care)","A 2025 meta-analysis of nine RCTs (952 patients; one also added a multi-herb capsule) found higher ejection fraction and walking distance and lower BNP/NT-proBNP with add-on saponin; authors advised cautious interpretation.",{"st":"pooled","mt":"exact","m":"MD","v":6.23,"lo":4.35,"hi":8.12,"om":"left ventricular ejection fraction","n":952,"c":"Wang J et al. Front Pharmacol 2025","p":"40093323","url":"https://pubmed.ncbi.nlm.nih.gov/40093323/","pl":true}],[12,171,"B","Blood lipids and C-reactive protein in adults","A 2023 meta-analysis of nine RCTs (535 adults; 500-1,500 mg/day for 14-84 days) found lower LDL-C (-15.08 mg/dL), triglycerides and hsCRP than placebo; heterogeneity was high and authors urged caution.",{"st":"pooled","mt":"exact","m":"MD","v":-15.08,"lo":-25.43,"hi":-4.73,"u":"mg/dL","om":"LDL cholesterol","k":9,"n":535,"i2":77,"dur":"14 to 84 days","c":"Brown PDS et al. BMC Complement Med Ther 2023","p":"37296402","url":"https://pubmed.ncbi.nlm.nih.gov/37296402/","pl":true}],[12,136,"B","Blood lipids","A meta-analysis of 5 randomized trials (292 participants) found lower total cholesterol (−16.85 mg/dl), LDL (−11.67 mg/dl) and triglycerides and higher HDL (+4.14 mg/dl) with argan oil than control.",{"st":"pooled","mt":"exact","m":"WMD","v":-16.85,"lo":-25.1,"hi":-8.6,"u":"mg/dl","om":"total cholesterol","k":5,"n":292,"c":"Ursoniu S et al. Phytother Res 2018","p":"29130532","url":"https://pubmed.ncbi.nlm.nih.gov/29130532/","pl":true}],[12,98,"B","Blood pressure in adults","A meta-analysis of 16 short crossover trials (254 adults, 2 hours to 15 days) found systolic pressure fell 4.4 mm Hg versus placebo; diastolic change was not significant.",{"st":"pooled","mt":"exact","m":"MD","v":-4.4,"lo":-5.9,"hi":-2.8,"u":"mm Hg","om":"systolic blood pressure","k":16,"n":254,"dur":"2 h to 15 d","c":"Siervo M et al. J Nutr 2013","p":"23596162","url":"https://pubmed.ncbi.nlm.nih.gov/23596162/","pl":true}],[12,98,"B","Blood pressure in people with hypertension","A meta-analysis of 11 randomized trials (349 patients) found clinic systolic pressure fell 5.31 mm Hg versus placebo, with no significant effect on diastolic or 24-hour pressure; certainty was low.",{"st":"pooled","mt":"exact","m":"MD","v":-5.31,"lo":-7.46,"hi":-3.16,"u":"mmHg","om":"clinical systolic blood pressure","k":11,"n":349,"i2":64,"c":"Grönroos R et al. Nutr Metab Cardiovasc Dis 2024","p":"39069465","url":"https://pubmed.ncbi.nlm.nih.gov/39069465/","pl":true}],[12,172,"B","Cholesterol","NCCIH reports some evidence that berberine may lower cholesterol.",{"st":"none","pl":false}],[12,173,"B","Blood lipids","A 2024 meta-analysis of eight RCTs (423 participants) found lower total cholesterol (-9.71 mg/dL) and triglycerides (-10.24 mg/dL), with no significant change in LDL or HDL cholesterol; trials were shorter than 3 months.",{"st":"pooled","mt":"exact","m":"WMD","v":-9.71,"lo":-17.69,"hi":-1.74,"u":"mg/dL","om":"total cholesterol (TC)","k":8,"n":423,"dur":"short-term trials (less than 3 months)","c":"Amini MR et al. Phytother Res 2024","p":"39444254","url":"https://pubmed.ncbi.nlm.nih.gov/39444254/","pl":true}],[12,174,"B","Blood pressure in adults","A 2023 meta-analysis of randomized trials found systolic pressure 3.06 mmHg and diastolic 2.69 mmHg lower than control, with very high heterogeneity between trials (I² 84.7% and 97.3%).",{"st":"pooled","mt":"exact","m":"WMD","v":-3.06,"lo":-3.89,"hi":-2.22,"u":"mmHg","om":"systolic blood pressure","i2":84.7,"c":"Kavyani Z et al. Phytother Res 2023","p":"37341696","url":"https://pubmed.ncbi.nlm.nih.gov/37341696/","pl":true}],[12,174,"B","Blood lipids, body weight and other cardiovascular risk factors","A 2025 meta-analysis of 82 studies (5,026 participants; 200–4,600 mg/day for 1–48 weeks) reported improvements in lipids, weight measures, blood pressure, glucose and inflammatory markers.",{"st":"no-estimate","mt":"exact","om":"lipids, anthropometrics, blood pressure, glycemic and inflammatory markers","k":82,"n":5026,"dur":"1 to 48 weeks","c":"Jafari A et al. Pharmacol Res 2025","p":"40714301","url":"https://pubmed.ncbi.nlm.nih.gov/40714301/","pl":false}],[12,34,"B","Blood pressure in adults","A Cochrane review (16 trials, 3,048 adults, 1,000–2,000 mg/day) reported systolic blood pressure 1.43 mmHg and diastolic 0.98 mmHg lower than control.",{"st":"pooled","mt":"exact","m":"MD","v":-1.43,"lo":-2.15,"hi":-0.72,"u":"mmHg","om":"systolic blood pressure","k":16,"n":3048,"c":"Cormick G et al. Cochrane Database Syst Rev 2015","p":"26126003","url":"https://pubmed.ncbi.nlm.nih.gov/26126003/","pl":true}],[12,175,"B","Cholesterol, blood pressure and fasting glucose","2018 meta-analysis of 19 RCTs (797 participants): total cholesterol −9.09 mg/dL, LDL −8.32 mg/dL, systolic −4.51 mmHg, diastolic −1.64 mmHg, fasting glucose −4.23 mg/dL; triglycerides, HDL and BMI unchanged.",{"st":"pooled","mt":"exact","m":"MD","v":-9.09,"lo":-12.91,"hi":-5.26,"u":"mg/dl","om":"total cholesterol","k":19,"n":797,"c":"Fallah AA et al. Clin Nutr 2018","p":"29037431","url":"https://pubmed.ncbi.nlm.nih.gov/29037431/","pl":true}],[12,175,"B","Blood lipids with Chlorella vulgaris","2022 meta-analysis of 10 RCTs (539 adults): total cholesterol −7.47 mg/dL and LDL −7.71 mg/dL; no significant effect on triglycerides or HDL. Only 2 trials verified supplement content and purity.",{"st":"pooled","mt":"exact","m":"MD","v":-7.47,"lo":-12.98,"hi":-1.96,"u":"mg/dL","om":"total cholesterol","k":10,"n":539,"c":"Sherafati N et al. Complement Ther Med 2022","p":"35331862","url":"https://pubmed.ncbi.nlm.nih.gov/35331862/","pl":true}],[12,176,"B","Blood pressure in adults","A 2017 Cochrane review (35 RCTs, 1,804 mainly healthy adults, 2-18 weeks) found a small reduction (about 2 mmHg systolic and diastolic); moderate-quality evidence, with unexplained heterogeneity.",{"st":"pooled","mt":"exact","m":"MD","v":-1.76,"lo":-3.09,"hi":-0.43,"u":"mmHg","om":"systolic blood pressure","k":35,"n":1804,"dur":"two to 18 weeks","c":"Ried K et al. Cochrane Database Syst Rev 2017","p":"28439881","url":"https://pubmed.ncbi.nlm.nih.gov/28439881/","pl":true}],[12,176,"B","Blood pressure and vascular function","A 2026 meta-analysis of 25 studies (1,167 participants; 10.6-1,680 mg/day) found systolic -2.73 and diastolic -1.85 mmHg, and better flow-mediated dilation; several authors work for a cocoa-food company.",{"st":"pooled","mt":"exact","m":"MD","v":-2.734,"lo":-3.446,"hi":-2.023,"u":"mmHg","om":"systolic blood pressure","k":25,"n":1167,"c":"Sakuda M et al. J Nutr Health Aging 2026","p":"42679502","url":"https://pubmed.ncbi.nlm.nih.gov/42679502/","pl":true}],[12,176,"B","Endothelial function (flow-mediated dilation)","A 2019 meta-analysis of 15 articles (18 intervention arms) found FMD improved by 1.17%, with an inverted U-shaped dose response; most studies had risk-of-bias concerns.",{"st":"pooled","mt":"exact","m":"MD","v":1.17,"lo":0.76,"hi":1.57,"u":"%","om":"flow-mediated dilation","k":15,"c":"Sun Y et al. Food Funct 2019","p":"31524216","url":"https://pubmed.ncbi.nlm.nih.gov/31524216/","pl":true}],[12,42,"B","Metabolic syndrome components","A 2025 meta-analysis of 9 RCTs of oral essential oil (8–24 weeks; 2 trials tested caraway or black caraway) in adults with metabolic disorders found lower fasting glucose, triglycerides and waist size and higher HDL; heterogeneity was high.",{"st":"pooled","mt":"exact","m":"SMD","v":-1.38,"lo":-2.26,"hi":-0.5,"om":"fasting blood sugar","i2":94.6,"dur":"8 to 24 weeks","c":"Liu M et al. Front Nutr 2025","p":"41608519","url":"https://pubmed.ncbi.nlm.nih.gov/41608519/","pl":true}],[12,31,"B","Stroke","A Chinese trial in 20,702 adults with hypertension found 800 mcg folic acid plus enalapril lowered stroke risk 21% versus enalapril alone; ODS notes effects appear greater with low folate status.",{"st":"single-trial","mt":"exact","m":"HR","v":0.79,"lo":0.68,"hi":0.93,"om":"first stroke","n":20702,"dur":"median treatment duration of 4.5 years","c":"Huo Y et al. JAMA 2015 (CSPPT)","p":"25771069","url":"https://pubmed.ncbi.nlm.nih.gov/25771069/","pl":true}],[12,177,"B","Blood lipids","A 2024 meta-analysis of 14 trials (623 subjects) found lower total cholesterol (-6.76 mg/dL) and triglycerides (-24.21 mg/dL) and higher HDL (+2.95 mg/dL); LDL was not significantly affected, and heterogeneity was significant.",{"st":"pooled","mt":"exact","m":"WMD","v":-6.76,"lo":-12.39,"hi":-0.59,"u":"mg/dL","om":"total cholesterol","k":14,"n":623,"c":"Amini MR et al. Phytother Res 2024","p":"38151892","url":"https://pubmed.ncbi.nlm.nih.gov/38151892/","pl":true}],[12,178,"B","Total and LDL cholesterol in people with high cholesterol","NCCIH states garlic supplements may reduce total and LDL cholesterol to a small extent.",{"st":"none","pl":false}],[12,179,"B","LDL cholesterol and triglycerides","A 2020 review of 11 studies (536 participants) found lower LDL cholesterol and triglycerides but no change in total or HDL cholesterol; studies were small and products varied.",{"st":"pooled","mt":"exact","m":"MD","v":-0.17,"lo":-0.34,"hi":-0.01,"u":"mmol/l","om":"LDL cholesterol","k":11,"n":536,"c":"Anjom-Shoae J et al. Br J Nutr 2020","p":"32138795","url":"https://pubmed.ncbi.nlm.nih.gov/32138795/","pl":true}],[12,179,"B","Blood pressure","A 2022 review of 19 studies (1,080 participants) found lower diastolic but not systolic blood pressure; results of individual studies differed.",{"st":"pooled","mt":"exact","m":"WMD","v":-2.2,"lo":-3.79,"hi":-0.6,"u":"mmHg","om":"diastolic blood pressure","k":19,"i2":88.8,"c":"Foshati S et al. Pharmacol Res 2022","p":"34798267","url":"https://pubmed.ncbi.nlm.nih.gov/34798267/","pl":true}],[12,180,"B","Total and LDL cholesterol in adults","A meta-analysis of randomized, placebo-controlled trials, mostly of extract supplements, found small reductions in total and LDL cholesterol and no effect on HDL cholesterol or triglycerides.",{"st":"pooled","mt":"partial","m":"WMD","v":-4.55,"lo":-6.31,"hi":-2.8,"u":"mg/dL","om":"LDL cholesterol","k":31,"n":3321,"c":"Xu R et al. Nutr J 2020","p":"32434539","url":"https://pubmed.ncbi.nlm.nih.gov/32434539/","pl":true}],[12,181,"B","Blood lipids and blood pressure","The 2023 Zamani meta-analysis of six randomized trials reported lower triglycerides, total and LDL cholesterol and diastolic blood pressure; the authors cite notable heterogeneity and low study quality.",{"st":"no-estimate","mt":"exact","om":"triglycerides, total cholesterol, LDL, diastolic blood pressure","c":"Zamani M et al. Phytother Res 2023","p":"36580574","url":"https://pubmed.ncbi.nlm.nih.gov/36580574/","pl":false}],[12,60,"B","Symptoms and exercise capacity in chronic heart failure (NYHA I–III), added to usual care","Cochrane meta-analysis of 10 trials (855 patients): maximal workload rose 5.35 W versus placebo, and shortness of breath and fatigue improved; no relevant mortality or morbidity data were reported, apart from one trial that reported deaths (three hawthorn, one placebo) without further detail.",{"st":"pooled","mt":"exact","m":"WMD","v":5.35,"lo":0.71,"hi":10.0,"u":"Watt","om":"maximal workload","n":380,"c":"Pittler MH, Guo R, Ernst E. Cochrane Database Syst Rev 2008","p":"18254076","url":"https://pubmed.ncbi.nlm.nih.gov/18254076/","pl":true}],[12,130,"B","Blood lipids","A 2024 meta-analysis of 12 trials (589 participants) found lower LDL (-0.22 mmol/L) and total cholesterol (-0.20 mmol/L), with small changes in fasting glucose, QUICKI, ICAM-1, VCAM-1 and CRP; other risk factors showed no effect.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.22,"lo":-0.33,"hi":-0.11,"u":"mmol/L","om":"LDL cholesterol","k":12,"n":589,"c":"Huang H et al. Curr Dev Nutr 2024","p":"39279783","url":"https://pubmed.ncbi.nlm.nih.gov/39279783/","pl":true}],[12,182,"B","Blood pressure, lipids and glucose (umbrella review)","Pooling 26 randomized trials (1,797 participants), a 2025 umbrella review found dose-dependent reductions in systolic and diastolic pressure versus placebo and other teas, plus lower total and LDL cholesterol and fasting glucose and higher HDL.",{"st":"no-estimate","mt":"exact","om":"systolic and diastolic blood pressure","k":26,"n":1797,"c":"Norouzzadeh M et al. Complement Ther Med 2025","p":"39870328","url":"https://pubmed.ncbi.nlm.nih.gov/39870328/","pl":false}],[12,183,"B","LDL cholesterol and triglycerides in adults","A 2024 meta-analysis found inulin-type fructans lowered LDL cholesterol by 0.14 mmol/L (38 RCTs, 1,879 participants; very low certainty) and triglycerides by 0.06 mmol/L (40 RCTs; low certainty); other risk factors changed little.",{"st":"pooled","mt":"exact","m":"MD","v":-0.14,"lo":-0.24,"hi":-0.05,"u":"mmol/L","om":"LDL cholesterol","k":38,"n":1879,"c":"Talukdar JR et al. Am J Clin Nutr 2024","p":"38309832","url":"https://pubmed.ncbi.nlm.nih.gov/38309832/","pl":true}],[12,147,"B","Blood lipids","A 2017 meta-analysis (7 RCTs, 662 participants) found lower LDL cholesterol (-15.52 mg/dL) and triglycerides (-14.03 mg/dL) and higher HDL (+6.65 mg/dL); the change in total cholesterol was not significant.",{"st":"pooled","mt":"exact","m":"WMD","v":-15.52,"lo":-28.43,"hi":-2.61,"u":"mg/dL","om":"LDL cholesterol","k":7,"n":662,"c":"Ursoniu S et al. Nutr Rev 2017","p":"28371906","url":"https://pubmed.ncbi.nlm.nih.gov/28371906/","pl":true}],[12,117,"B","Blood pressure in adults","A 2022 meta-analysis of 22 RCTs (30 effect sizes) of oral L-arginine found lower systolic (−6.40 mmHg) and diastolic (−2.64 mmHg) pressure than placebo; no significant change was seen at doses above 9 g/day.",{"st":"pooled","mt":"exact","m":"WMD","v":-6.4,"lo":-8.74,"hi":-4.05,"u":"mmHg","om":"systolic blood pressure","c":"Shiraseb F et al. Adv Nutr 2022","p":"34967840","url":"https://pubmed.ncbi.nlm.nih.gov/34967840/","pl":true}],[12,117,"B","24-hour ambulatory blood pressure","A 2026 meta-analysis of 5 RCTs (202 participants) reported lower 24-hour systolic (−4.23 mmHg) and diastolic (−3.04 mmHg) pressure with oral L-arginine; the authors note the number of included studies was limited.",{"st":"pooled","mt":"exact","m":"WMD","v":-4.23,"lo":-5.87,"hi":-2.58,"u":"mmHg","om":"24-hour systolic blood pressure","k":5,"n":202,"c":"Shi Y et al. Nitric Oxide 2026","p":"42520885","url":"https://pubmed.ncbi.nlm.nih.gov/42520885/","pl":true}],[12,35,"B","Outcomes after acute myocardial infarction","A meta-analysis of 13 trials (3,629 adults) found lower all-cause mortality, ventricular arrhythmias and new angina, but no effect on heart failure or reinfarction.",{"st":"pooled","mt":"exact","m":"OR","v":0.73,"lo":0.54,"hi":0.99,"om":"all-cause mortality","k":13,"n":3629,"c":"DiNicolantonio JJ et al. Mayo Clin Proc 2013","p":"23597877","url":"https://pubmed.ncbi.nlm.nih.gov/23597877/","pl":true}],[12,104,"B","Blood pressure in middle-aged and older adults","A 2025 meta-analysis of 15 RCTs (415 participants) of L-citrulline or watermelon reported lower systolic (−4.02 mmHg) and diastolic (−2.54 mmHg) pressure; the authors rate L-citrulline plus L-arginine superior to L-citrulline or watermelon alone.",{"st":"pooled","mt":"exact","m":"WMD","v":-4.02,"lo":-6.54,"hi":-1.5,"u":"mmHg","om":"systolic blood pressure","k":15,"n":415,"c":"Luo P et al. Clin Nutr ESPEN 2025","p":"40789388","url":"https://pubmed.ncbi.nlm.nih.gov/40789388/","pl":true}],[12,184,"B","Blood pressure in adults","A 2015 meta-analysis of 30 RCTs found systolic -2.95 and diastolic -1.51 mmHg; 24-hour ambulatory pressure did not change significantly, and publication bias and small-study effects weakened the result.",{"st":"pooled","mt":"exact","m":"MD","v":-2.95,"lo":-4.17,"hi":-1.73,"u":"mmHg","om":"systolic blood pressure","k":30,"c":"Fekete AA et al. Nutrients 2015","p":"25608938","url":"https://pubmed.ncbi.nlm.nih.gov/25608938/","pl":true}],[12,184,"B","Blood pressure in European adults","A 2013 meta-analysis of 14 trials (15 data sets, 1,306 subjects) found systolic -1.28 mmHg and diastolic -0.59 mmHg versus placebo, with no evidence of publication bias.",{"st":"pooled","mt":"exact","m":"MD","v":-1.28,"lo":-2.09,"hi":-0.48,"u":"mmHg","om":"systolic blood pressure","k":14,"n":1306,"c":"Cicero AF et al. Am J Hypertens 2013","p":"23382495","url":"https://pubmed.ncbi.nlm.nih.gov/23382495/","pl":false,"sn":"printed without a minus sign; shown as a reduction"}],[12,184,"B","Systolic blood pressure in Japanese adults","A 2015 meta-analysis of 18 studies (1,194 subjects) found systolic -5.63 mmHg versus placebo, larger in hypertensive subjects; the authors disclosed industry payment for performing the review.",{"st":"pooled","mt":"exact","m":"MD","v":-5.63,"lo":-6.87,"hi":-4.39,"u":"mmHg","om":"systolic blood pressure","k":18,"n":1194,"c":"Chanson-Rolle A et al. PLoS One 2015","p":"26536628","url":"https://pubmed.ncbi.nlm.nih.gov/26536628/","pl":true}],[12,1,"B","Blood pressure in adults","A meta-analysis (22 studies, 1,173 adults, 3–24 weeks) reported systolic 3–4 mmHg and diastolic 2–3 mmHg lower; a Cochrane review (12 trials, 545 adults with hypertension) found only a small diastolic reduction.",{"st":"pooled","mt":"exact","m":"SMD","v":0.32,"lo":0.23,"hi":0.41,"om":"systolic blood pressure","k":22,"n":1173,"dur":"3 to 24 weeks","c":"Kass L et al. Eur J Clin Nutr 2012","p":"22318649","url":"https://pubmed.ncbi.nlm.nih.gov/22318649/","pl":true,"se":"positive = larger fall in systolic blood pressure (Hedges g)"}],[12,185,"B","Blood pressure in prehypertension or stage 1 hypertension","An 8-week RCT (86 adults, 2,000 FU/day; 73 completed) lowered systolic blood pressure by 5.55 mmHg and diastolic by 2.84 mmHg versus placebo; a 2023 meta-analysis of six RCTs also reported lower blood pressure.",{"st":"single-trial","mt":"exact","m":"MD","v":-5.55,"lo":-10.5,"hi":-0.57,"u":"mmHg","om":"systolic blood pressure","dur":"8 weeks","c":"Kim JY et al. Hypertens Res 2008","p":"18971533","url":"https://pubmed.ncbi.nlm.nih.gov/18971533/","pl":true}],[12,186,"B","Angina in coronary heart disease (oral preparations added to usual care)","A 2013 systematic review of 17 RCTs (1,747 participants) found oral P. notoginseng eased angina symptoms but did not significantly reduce cardiovascular events; small samples and potential bias limited confidence.",{"st":"pooled","mt":"exact","m":"RR","v":1.2,"lo":1.12,"hi":1.28,"om":"improvement in angina symptoms","k":7,"n":791,"c":"Shang Q et al. Evid Based Complement Alternat Med 2013","p":"24023585","url":"https://pubmed.ncbi.nlm.nih.gov/24023585/","pl":true}],[12,186,"B","Unstable angina (oral Panax notoginseng saponins)","A 2018 meta-analysis of 17 RCTs reported fewer and shorter angina attacks and lower nitroglycerin use; authors called for multi-center, large, high-quality trials.",{"st":"pooled","mt":"exact","m":"MD","v":-1.88,"lo":-2.03,"hi":-1.72,"om":"frequency and duration of angina attacks (as printed, one combined estimate)","c":"Duan L et al. Phytomedicine 2018","p":"30166105","url":"https://pubmed.ncbi.nlm.nih.gov/30166105/","pl":false,"ex":"the estimate combines angina frequency and duration into one unitless figure, with no interpretable scale"}],[12,186,"B","Acute ischemic stroke (Xuesaitong, a Panax notoginseng saponin product, mostly given by intravenous injection)","A 2023 meta-analysis of 46 RCTs (7,957 patients; 43 used intravenous injection, 3 oral forms) reported better functional outcomes; certainty was moderate to very low, risk of bias was high, and mortality did not differ.",{"st":"pooled","mt":"exact","m":"MD","v":-0.67,"lo":-0.92,"hi":-0.42,"u":"points on modified Rankin Scale","om":"long-term mRS score","k":46,"n":7957,"c":"Shi X et al. Front Pharmacol 2023","p":"37908976","url":"https://pubmed.ncbi.nlm.nih.gov/37908976/","pl":true}],[12,39,"B","Major cardiovascular events","Results differ by trial: VITAL (25,871 adults, 1 g/day) found no significant drop in combined major events; REDUCE-IT (8,179, 4 g/day icosapent ethyl) reported 25% fewer; STRENGTH (13,078, 4 g/day) found no significant benefit.",{"st":"single-trial","mt":"partial","m":"HR","v":0.75,"lo":0.68,"hi":0.83,"om":"composite of cardiovascular death, nonfatal MI, nonfatal stroke, coronary revascularization or unstable angina (REDUCE-IT primary end point)","n":8179,"dur":"median 4.9 years","c":"Bhatt DL et al. (REDUCE-IT) N Engl J Med 2019","p":"30415628","url":"https://pubmed.ncbi.nlm.nih.gov/30415628/","pl":true}],[12,187,"B","Triglycerides (pantethine)","A 2005 review of 28 small trials (646 adults; median 900 mg/day, 12.7 weeks) reported triglyceride declines of 14.2% at 1 month and 32.9% at 4 months; a 216-adult trial's declines may partly reflect dietary counseling.",{"st":"none","pl":false}],[12,187,"B","LDL and total cholesterol (pantethine)","Two randomized placebo-controlled studies (152 adults; 600 then 900 mg/day, 16 weeks, with diet) found small but significant reductions. Pantothenic acid itself does not appear to have the same effects.",{"st":"no-ci","mt":"partial","m":"MD","v":-4,"u":"mg/dL","om":"LDL cholesterol","n":120,"dur":"16 weeks","c":"Rumberger JA et al. Nutr Res 2011","p":"21925346","url":"https://pubmed.ncbi.nlm.nih.gov/21925346/","pl":false,"sn":"printed without a minus sign; shown as a reduction"}],[12,168,"B","LDL cholesterol in people taking statins","A European Atherosclerosis Society consensus panel reported that at 2 g/day, plant sterol/stanol LDL lowering is additive to that of statins in people with dyslipidemia, equivalent to doubling the statin dose.",{"st":"no-estimate","mt":"exact","om":"LDL cholesterol lowering on top of statins","c":"Gylling H et al. (EAS Consensus Panel) Atherosclerosis 2014","p":"24468148","url":"https://pubmed.ncbi.nlm.nih.gov/24468148/","pl":false}],[12,188,"B","Blood pressure in adults","A 2024 meta-analysis of 22 RCTs found lower systolic (-7.87 mmHg) and diastolic (-3.23 mmHg) pressure, with very high heterogeneity (I² about 90%); authors called for higher-quality studies.",{"st":"pooled","mt":"exact","m":"WMD","v":-7.87,"lo":-10.34,"hi":-5.39,"u":"mmHg","om":"systolic blood pressure","k":22,"i2":90.0,"c":"Bahari H et al. Phytother Res 2024","p":"38410857","url":"https://pubmed.ncbi.nlm.nih.gov/38410857/","pl":true}],[12,189,"B","Blood pressure in adults","A meta-analysis (25 RCTs, 1,163 adults with hypertension, 30–120 mmol/day, 4–15 weeks) reported systolic 4.48 and diastolic 2.96 mmHg lower; a Cochrane review of six high-quality trials found nonsignificant reductions.",{"st":"pooled","mt":"partial","m":"MD","v":4.48,"lo":3.07,"hi":5.9,"u":"mmHg","om":"decrease in systolic blood pressure","c":"Filippini T et al. Int J Cardiol 2017","p":"28024910","url":"https://pubmed.ncbi.nlm.nih.gov/28024910/","pl":true,"se":"positive = larger fall in systolic blood pressure"}],[12,190,"B","Body fat, blood pressure and total cholesterol","The 2015 Onakpoya meta-analysis reported significant reductions in body mass index, percentage body fat, systolic and diastolic blood pressure and total cholesterol, but few trials had been published and their quality was inconsistent.",{"st":"no-estimate","mt":"exact","om":"BMI, percentage body fat, systolic and diastolic blood pressure, total cholesterol","k":5,"c":"Onakpoya IJ et al. Nutrition 2015","p":"25837206","url":"https://pubmed.ncbi.nlm.nih.gov/25837206/","pl":false}],[12,148,"B","Blood pressure and blood lipids in adults","A 2025 dose-response meta-analysis of randomized trials reported lower triglycerides, LDL cholesterol and systolic blood pressure (-2.24 mmHg) versus control, with no significant effect on total cholesterol or diastolic pressure.",{"st":"pooled","mt":"exact","m":"WMD","v":-2.24,"lo":-4.08,"hi":-0.39,"u":"mmHg","om":"systolic blood pressure","c":"Bahari H et al. Br J Nutr 2025","p":"39610126","url":"https://pubmed.ncbi.nlm.nih.gov/39610126/","pl":true}],[12,160,"B","Blood lipids and C-reactive protein","A 2023 meta-analysis of 13 RCTs found lower triglycerides (-16.72 mg/dL), total cholesterol (-9.97 mg/dL) and CRP (-1.22 mg/L) and higher HDL (+4.09 mg/dL); LDL was not affected.",{"st":"pooled","mt":"exact","m":"WMD","v":-16.72,"lo":-22.49,"hi":-10.96,"u":"mg/dL","om":"serum triglycerides","k":13,"c":"Jafari N et al. Food Sci Nutr 2023","p":"37970383","url":"https://pubmed.ncbi.nlm.nih.gov/37970383/","pl":true}],[12,160,"B","Blood pressure and body weight","A 2023 meta-analysis of seven RCTs found lower body weight (-0.73 kg), BMI (-0.35 kg/m2) and systolic blood pressure (-3.64 mmHg), with no significant effect on waist circumference or diastolic pressure.",{"st":"pooled","mt":"exact","m":"WMD","v":-3.64,"lo":-6.42,"hi":-0.87,"u":"mmHg","om":"systolic blood pressure","k":7,"c":"Narimani B et al. J Nutr Sci 2023","p":"38155802","url":"https://pubmed.ncbi.nlm.nih.gov/38155802/","pl":true}],[12,105,"B","Blood pressure","A 2016 meta-analysis of placebo-controlled RCTs (7 trials, 9 arms, 587 patients) found quercetin lowered systolic BP by 3.04 and diastolic by 2.63 mmHg; significant effects appeared at doses of 500 mg/day or more.",{"st":"pooled","mt":"exact","m":"WMD","v":-3.04,"lo":-5.75,"hi":-0.33,"u":"mm Hg","om":"systolic blood pressure","k":7,"n":587,"c":"Serban MC et al. J Am Heart Assoc 2016","p":"27405810","url":"https://pubmed.ncbi.nlm.nih.gov/27405810/","pl":true}],[12,19,"B","Blood lipids in peri- and postmenopausal women","A 2020 meta-analysis of ten studies (910 women) found lower total cholesterol (-0.29 mmol/L) but no significant change in LDL, HDL or triglycerides, with high heterogeneity between studies.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.29,"lo":-0.53,"hi":-0.06,"u":"mmol/L","om":"total cholesterol","k":10,"n":910,"c":"Kanadys W et al. Maturitas 2020","p":"31883666","url":"https://pubmed.ncbi.nlm.nih.gov/31883666/","pl":true}],[12,191,"B","Total and LDL cholesterol","A 2018 meta-analysis of 20 trials (14 articles) found resistant starch lowered total cholesterol by 7.33 mg/dL and LDL cholesterol by 3.40 mg/dL; effects were clearer with supplementation longer than 4 weeks.",{"st":"pooled","mt":"exact","m":"MD","v":-7.33,"lo":-12.15,"hi":-2.52,"u":"mg/dL","om":"total cholesterol","k":19,"c":"Yuan HC et al. Nutr Res 2018","p":"29914662","url":"https://pubmed.ncbi.nlm.nih.gov/29914662/","pl":true}],[12,192,"B","Seed oil: LDL and total cholesterol compared with other oils and fats","A 2018 network meta-analysis of 54 randomized trials comparing oils and solid fats ranked safflower oil highest for lowering LDL cholesterol (SUCRA 82%) and total cholesterol (SUCRA 90%).",{"st":"no-estimate","mt":"exact","om":"LDL-C and total cholesterol (SUCRA ranking)","k":54,"c":"Schwingshackl L et al. J Lipid Res 2018","p":"30006369","url":"https://pubmed.ncbi.nlm.nih.gov/30006369/","pl":false}],[12,192,"B","Safflower yellow (a flower pigment preparation, injected in cited trials): acute ischemic stroke","A 2014 systematic review of 7 RCTs (762 participants; cited trial reports describe injections, not oral use) found a higher neurological improvement rate than control; none of the trials was of high methodological quality.",{"st":"pooled","mt":"exact","m":"OR","v":3.11,"lo":2.06,"hi":4.68,"om":"neurological improvement rate","k":7,"n":762,"c":"Fan S et al. Complement Ther Med 2014","p":"24731908","url":"https://pubmed.ncbi.nlm.nih.gov/24731908/","pl":true}],[12,28,"B","Blood lipids in adults","A meta-analysis of 15 RCTs found lower triglycerides, total and LDL cholesterol and higher HDL; subgroup analysis showed lipid reductions only in people with abnormal lipids. Heterogeneity was high.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.722,"lo":-1.129,"hi":-0.316,"om":"triglycerides","k":15,"c":"Geng Y et al. Phytother Res 2022","p":"36043374","url":"https://pubmed.ncbi.nlm.nih.gov/36043374/","pl":true}],[12,193,"B","Blood lipids in adults","2023 meta-analysis of 20 trials (23 arms, 1,076 participants): spirulina lowered LDL cholesterol, total cholesterol and triglycerides (each SMD −0.6) and raised HDL (SMD 0.3).",{"st":"pooled","mt":"exact","m":"SMD","v":-0.6,"lo":-0.9,"hi":-0.2,"om":"LDL-C","k":20,"n":1076,"c":"Rahnama I et al. Pharmacol Res 2023","p":"37263369","url":"https://pubmed.ncbi.nlm.nih.gov/37263369/","pl":true}],[12,193,"B","Blood pressure in adults","2025 meta-analysis of RCTs: systolic −4.41 mmHg and diastolic −2.84 mmHg versus control, with substantial heterogeneity; authors rated certainty moderate and called for more high-quality trials.",{"st":"pooled","mt":"exact","m":"WMD","v":-4.41,"lo":-6.74,"hi":-2.07,"u":"mmHg","om":"systolic blood pressure (SBP)","i2":66.1,"c":"Shiri H et al. Phytother Res 2025","p":"39529406","url":"https://pubmed.ncbi.nlm.nih.gov/39529406/","pl":true}],[12,194,"B","Blood lipids and blood pressure in adults","A 2025 meta-analysis of 17 trials (1,170 participants, mostly in Iran) found LDL −9.62 mg/dL, triglycerides −8.96 mg/dL, HDL +2.95 mg/dL and diastolic pressure −2.87 mmHg versus control; systolic pressure did not change.",{"st":"pooled","mt":"exact","m":"WMD","v":-9.62,"lo":-14.59,"hi":-4.65,"u":"mg/dL","om":"LDL cholesterol","k":17,"n":1170,"c":"Huang H et al. BMC Complement Med Ther 2025","p":"41372916","url":"https://pubmed.ncbi.nlm.nih.gov/41372916/","pl":true}],[12,90,"B","Heart rate, blood pressure and heart function","A 2024 meta-analysis of 20 RCTs (808 participants) reported lower heart rate (−3.579 bpm) and systolic pressure (−3.999 mm Hg), and higher LVEF in heart failure; no significant adverse effects versus controls.",{"st":"pooled","mt":"exact","m":"WMD","v":-3.999,"lo":-7.293,"hi":-0.706,"u":"mm Hg","om":"systolic blood pressure","k":20,"n":808,"c":"Tzang CC et al. Nutr J 2024","p":"39148075","url":"https://pubmed.ncbi.nlm.nih.gov/39148075/","pl":true}],[12,107,"B","Blood pressure in adults","A 2023 meta-analysis of 18 studies (1,177 subjects) found systolic pressure 1.54 mmHg lower with whey, with significant heterogeneity, and no overall change in diastolic pressure.",{"st":"pooled","mt":"exact","m":"WMD","v":-1.54,"lo":-2.85,"hi":-0.23,"u":"mmHg","om":"systolic blood pressure","k":18,"n":1177,"i2":64.2,"c":"Vajdi M et al. Nutr Metab Cardiovasc Dis 2023","p":"37419751","url":"https://pubmed.ncbi.nlm.nih.gov/37419751/","pl":true}],[12,135,"C","Triglycerides in adults with modestly raised levels","One trial reported triglyceride reductions with a high-dose extract comparable to gemfibrozil.",{"st":"single-trial","mt":"exact","m":"other","v":41.6,"lo":1.2,"hi":82,"om":"triglycerides","dur":"8 weeks","c":"Phunikhom K et al. J Med Assoc Thai 2015","p":"26434249","url":"https://pubmed.ncbi.nlm.nih.gov/26434249/","pl":false}],[12,195,"C","Heart failure (as add-on to standard therapy)","A 2026 meta-analysis of nine studies (537 patients) found lower left ventricular mass and higher HDL cholesterol, but no significant change in ejection fraction, blood pressure, triglycerides or LDL.",{"st":"no-ci","mt":"exact","m":"MD","v":-44.32,"om":"left ventricular mass","k":9,"n":537,"c":"Kumar A et al. Ann Afr Med 2026","p":"42389976","url":"https://pubmed.ncbi.nlm.nih.gov/42389976/","pl":false}],[12,195,"C","Chronic stable angina","A 2014 systematic review found studies of poor methodological design and no significant difference from control in pooled outcomes; it judged the evidence insufficient for any conclusion.",{"st":"no-estimate","mt":"exact","om":"pooled outcomes in chronic stable angina","c":"Kaur N et al. Cardiol Res Pract 2014","p":"24600529","url":"https://pubmed.ncbi.nlm.nih.gov/24600529/","pl":false}],[12,195,"C","Cholesterol in coronary heart disease","In a 30-day randomized trial of 105 patients, 500 mg/day bark powder lowered total cholesterol (-9.7%) and LDL (-15.8%) within the group; placebo and vitamin E groups showed no lipid changes.",{"st":"no-estimate","mt":"exact","om":"total and LDL cholesterol","n":105,"dur":"30 days","c":"Gupta R et al. J Assoc Physicians India 2001","p":"11225136","url":"https://pubmed.ncbi.nlm.nih.gov/11225136/","pl":false}],[12,195,"C","Blood pressure in stage 1 hypertension","In a 28-day triple-blind RCT of 44 patients on telmisartan, 3 g/day arjuna lowered systolic and diastolic blood pressure more than placebo.",{"st":"no-estimate","mt":"exact","om":"systolic and diastolic blood pressure","n":44,"dur":"28 days","c":"Nazir A et al. Explore (NY) 2026","p":"42753288","url":"https://pubmed.ncbi.nlm.nih.gov/42753288/","pl":false}],[12,195,"C","Heart pumping measures in healthy adults","In an 8-week RCT of 72 healthy adults aged 30-70, 400 mg/day of a proprietary aqueous bark extract raised ejection fraction 6.28% from baseline versus 0.24% with placebo; one author reported a company affiliation and personal fees.",{"st":"no-estimate","mt":"exact","om":"left ventricular ejection fraction","n":72,"dur":"8 weeks","c":"Srivastava S et al. J Multidiscip Healthc 2022","p":"36349244","url":"https://pubmed.ncbi.nlm.nih.gov/36349244/","pl":false}],[12,195,"C","Heart measures in young men who exercise","In a 56-day RCT of 32 healthy male endurance exercisers, 400 mg/day of the same proprietary bark extract improved left ventricular ejection fraction versus placebo.",{"st":"no-estimate","mt":"exact","om":"left ventricular ejection fraction","n":32,"dur":"56 days","c":"Girandola RN et al. Am J Ther 2017","p":"27930383","url":"https://pubmed.ncbi.nlm.nih.gov/27930383/","pl":false}],[12,138,"C","Cardiometabolic markers in adults (weight, glucose, lipids, blood pressure)","A 2025 meta-analysis of 10 placebo-controlled trials (666 participants) found no significant effect on any cardiometabolic outcome; risk of bias was often unclear or high and certainty was very low.",{"st":"no-estimate","mt":"exact","om":"cardiometabolic outcomes (anthropometrics, glycemia, lipids, blood pressure)","n":666,"c":"Frumuzachi O et al. Nutrients 2025","p":"40362797","url":"https://pubmed.ncbi.nlm.nih.gov/40362797/","pl":false}],[12,109,"C","Weight, blood pressure, glucose and lipids","2020 meta-analysis of 14 articles: no effect on glucose, HbA1c, total or LDL cholesterol, triglycerides, weight or blood pressure; HDL rose 1.47 mg/dL; CRP fell only with ≥12 weeks or >12 mg/day.",{"st":"pooled","mt":"exact","m":"WMD","v":1.473,"lo":0.319,"hi":2.627,"u":"mg/dl","om":"HDL cholesterol","k":14,"c":"Xia W et al. Pharmacol Res 2020","p":"32755613","url":"https://pubmed.ncbi.nlm.nih.gov/32755613/","pl":true}],[12,139,"C","Blood cholesterol and triglycerides","A 2025 meta-analysis (8 studies, 411 participants, including nonrandomized trials) found no significant effect on LDL, HDL, total cholesterol or triglycerides; certainty of evidence was low to very low.",{"st":"pooled","mt":"exact","m":"MD","v":6.06,"lo":-0.03,"hi":12.48,"u":"mg/dL","om":"LDL cholesterol","k":8,"n":411,"c":"Candeloro BM et al. Nutr Bull 2025","p":"39960343","url":"https://pubmed.ncbi.nlm.nih.gov/39960343/","pl":false,"ex":"the review admits non-randomized designs, and the abstract does not confirm the estimate is against a control group"}],[12,141,"C","Blood lipids in coronary artery disease with rheumatoid arthritis (purified baicalin)","A 12-week placebo-controlled trial in 374 patients found 500 mg/day purified baicalin lowered triglycerides, total cholesterol and hs-CRP; this tested one compound, not the whole herb.",{"st":"no-estimate","mt":"exact","om":"triglycerides, total and LDL cholesterol, hs-CRP","n":374,"dur":"12 weeks","c":"Hang Y et al. Lipids Health Dis 2018","p":"29935544","url":"https://pubmed.ncbi.nlm.nih.gov/29935544/","pl":false}],[12,172,"C","Blood pressure (with amlodipine)","NCCIH reports berberine may offer additional benefit when combined with the blood pressure drug amlodipine.",{"st":"none","pl":false}],[12,127,"C","Fibrinogen and cardiovascular risk factors","MSK: bromelain does not appear to reduce fibrinogen or influence other cardiovascular disease risk factors.",{"st":"none","pl":false}],[12,34,"C","Cardiovascular disease","A 2021 meta-analysis of 13 double-blind, placebo-controlled trials reported a 15% higher risk of cardiovascular disease with calcium supplements (RR 1.15, 95% CI 1.06 to 1.25), specifically in healthy postmenopausal women; other analyses have reached different conclusions, so the question remains unsettled.",{"st":"pooled","mt":"exact","m":"RR","v":1.15,"lo":1.06,"hi":1.25,"om":"cardiovascular disease","k":14,"i2":0,"c":"Myung SK et al. Nutrients 2021","p":"33530332","url":"https://pubmed.ncbi.nlm.nih.gov/33530332/","pl":true}],[12,41,"C","Cardiovascular disease","Large observational studies found no significant link between choline intake and cardiovascular or peripheral artery disease; one analysis of about 120,000 people linked higher intake to higher mortality.",{"st":"none","pl":false}],[12,196,"C","Blood lipids","Trials conflict; meta-analyses found no significant change in total or LDL cholesterol, with some HDL increases and triglyceride decreases.",{"st":"none","pl":false}],[12,176,"C","Cardiovascular events in older adults","COSMOS (21,442 older US adults, 500 mg flavanols/day, median 3.6 years) found no significant reduction in total cardiovascular events (HR 0.90); cardiovascular death was lower (HR 0.73), a secondary endpoint.",{"st":"single-trial","mt":"exact","m":"HR","v":0.9,"lo":0.78,"hi":1.02,"om":"total cardiovascular events","n":21442,"dur":"median follow-up of 3.6 y","c":"Sesso HD et al. Am J Clin Nutr 2022 (COSMOS)","p":"35294962","url":"https://pubmed.ncbi.nlm.nih.gov/35294962/","pl":true}],[12,197,"C","Heart failure","A 2021 Cochrane review (11 studies, 1,573 people) found moderate-quality evidence of lower mortality and hospitalization, but most trials were small with bias risk; it found no convincing evidence to support or refute use.",{"st":"pooled","mt":"exact","m":"RR","v":0.62,"lo":0.49,"hi":0.78,"om":"hospitalisation for heart failure","k":2,"n":1061,"c":"Al Saadi T et al. Cochrane Database Syst Rev 2021","p":"35608922","url":"https://pubmed.ncbi.nlm.nih.gov/35608922/","pl":true}],[12,197,"C","Blood pressure in primary hypertension","A 2016 Cochrane review (2 pooled RCTs, 50 participants) found moderate-quality evidence of no clinically significant effect on blood pressure; authors said more well-conducted trials are needed because of the small numbers.",{"st":"pooled","mt":"exact","m":"MD","v":-3.68,"lo":-8.86,"hi":1.49,"u":"mm Hg","om":"systolic blood pressure","k":2,"n":50,"c":"Ho MJ et al. Cochrane Database Syst Rev 2016","p":"26935713","url":"https://pubmed.ncbi.nlm.nih.gov/26935713/","pl":true}],[12,198,"C","Blood lipids","NIH ODS states CLA might adversely affect lipid profiles, although study results are inconsistent; some isomers may lower HDL cholesterol and raise lipoprotein(a).",{"st":"none","pl":false}],[12,78,"C","Cardiovascular disease","Observational studies are mixed (e.g., higher serum copper linked to coronary death in NHANES II), and small supplementation trials showed little effect on markers; ODS finds evidence insufficient to support any conclusions.",{"st":"none","pl":false}],[12,114,"C","Heart function and quality of life in heart failure","A double-blind randomized crossover study in 15 patients with coronary disease and congestive heart failure (3 weeks per period) reported better diastolic echocardiography measures and quality of life with D-ribose than placebo.",{"st":"no-estimate","mt":"exact","om":"diastolic echocardiographic parameters; SF-36 quality of life","n":15,"dur":"two 3-week treatment periods","c":"Omran H et al. Eur J Heart Fail 2003","p":"14607200","url":"https://pubmed.ncbi.nlm.nih.gov/14607200/","pl":false}],[12,199,"C","Acute myocardial infarction (danshen preparations plus usual care)","Cochrane (2008): six studies (2,368 participants), most testing multi-herb formulas (per EMA) and only one a genuine RCT; the evidence was too weak to judge effects and the safety of danshen preparations is unproven.",{"st":"pooled","mt":"exact","m":"OR","v":0.46,"lo":0.28,"hi":0.75,"om":"total mortality","c":"Wu T et al. Cochrane Database Syst Rev 2008","p":"18425903","url":"https://pubmed.ncbi.nlm.nih.gov/18425903/","pl":false,"ex":"the pooled estimate combines a randomized and a quasi-randomized trial"}],[12,115,"C","Body fat and blood lipids in overweight adults","In a 12-week RCT of 97 overweight Korean adults, 72 or 144 mg/day polyphenol extract lowered BMI, body fat, waist size, total and LDL cholesterol versus placebo.",{"st":"no-estimate","mt":"exact","om":"BMI, body fat, waist circumference, total and LDL cholesterol","dur":"12 weeks","c":"Shin HC et al. Phytother Res 2012","p":"21717516","url":"https://pubmed.ncbi.nlm.nih.gov/21717516/","pl":false}],[12,200,"C","Blood pressure and LDL cholesterol in overweight adults","In overweight or obese adults, fucoidan for 3 months decreased diastolic blood pressure and LDL cholesterol and increased insulin secretion (studies summarized by MSK).",{"st":"no-estimate","mt":"partial","om":"diastolic blood pressure; LDL cholesterol","dur":"3 months","c":"Hernández-Corona DM et al. J Med Food 2014","p":"24611906","url":"https://pubmed.ncbi.nlm.nih.gov/24611906/","pl":false}],[12,178,"C","Blood pressure in people with high blood pressure","Limited evidence suggests a small reduction.",{"st":"none","pl":false}],[12,201,"C","Blood lipids with a healthy diet in middle-aged and older adults","In a 16-week trial in 40 adults following healthy-diet advice, adding 15 g/day dried wolfberry raised HDL cholesterol compared with diet alone; other vascular measures did not differ.",{"st":"no-estimate","mt":"exact","om":"HDL cholesterol","dur":"16 weeks","c":"Toh DWK et al. Am J Clin Nutr 2021","p":"33964853","url":"https://pubmed.ncbi.nlm.nih.gov/33964853/","pl":false}],[12,180,"C","Coronary heart disease risk","A meta-analysis of cohort (observational) studies linked green tea drinking to lower risk in Asian populations but not in Western populations.",{"st":"pooled","mt":"partial","m":"RR","v":0.89,"lo":0.83,"hi":0.96,"om":"coronary heart disease risk","k":7,"n":772922,"c":"Wang ZM et al. Nutr Metab Cardiovasc Dis 2023","p":"36849317","url":"https://pubmed.ncbi.nlm.nih.gov/36849317/","pl":false,"ex":"the estimate is for one cup a day versus none from a dose-response model in East Asian cohorts, not an overall comparison"}],[12,202,"C","Blood cholesterol in adults with high cholesterol (US trial)","In a US RCT (103 adults, 8 weeks), guggulipid raised LDL-C by 4-5% while it fell 5% on placebo, with no significant change in other lipids.",{"st":"no-estimate","mt":"exact","u":"%","om":"LDL-C percentage change","dur":"8 weeks","c":"Szapary PO et al. JAMA 2003","p":"12915429","url":"https://pubmed.ncbi.nlm.nih.gov/12915429/","pl":false}],[12,202,"C","Blood cholesterol (pooled trials)","A 2021 meta-analysis of Ayurvedic herbs reported that guggulu lowered total cholesterol by 16.78 mg/dL and LDL by 18.78 mg/dL; this conflicts with the US trial.",{"st":"pooled","mt":"exact","m":"MD","v":18.78,"lo":34.07,"hi":3.48,"u":"mg/dL","om":"reduction in LDL cholesterol","c":"Gyawali D et al. Medicina (Kaunas) 2021","p":"34071454","url":"https://pubmed.ncbi.nlm.nih.gov/34071454/","pl":false,"pr":"interval printed with lower > upper"}],[12,202,"C","Cholesterol with a guggulu-Triphala combination","A 3-month RCT in 90 adults found no advantage over placebo for total or LDL cholesterol, BMI or waist circumference.",{"st":"no-estimate","mt":"exact","u":"%","om":"total and LDL cholesterol","dur":"3 months","c":"Donato F et al. Complement Med Res 2021","p":"33242870","url":"https://pubmed.ncbi.nlm.nih.gov/33242870/","pl":false}],[12,82,"C","Endothelial function in type 2 diabetes","A 12-week RCT in 60 patients found an aqueous extract (250 or 500 mg twice daily) improved endothelial function (reflection index) and other cardiovascular risk markers versus placebo.",{"st":"no-estimate","mt":"exact","om":"endothelial function (reflection index)","n":60,"dur":"12 weeks","c":"Pingali U et al. Phytother Res 2020","p":"32618037","url":"https://pubmed.ncbi.nlm.nih.gov/32618037/","pl":false}],[12,60,"C","Heart failure outcomes in later research","NCCIH describes the evidence on heart failure as conflicting; one study of a specific preparation suggested a possible early risk of heart failure progression.",{"st":"none","pl":false}],[12,60,"C","Heart disease, angina, abnormal heartbeat, plaque buildup","NCCIH states there is not enough evidence to know whether hawthorn helps these conditions.",{"st":"none","pl":false}],[12,130,"C","Blood pressure","A 2019 meta-analysis of 10 RCTs (577 participants) found no effect on systolic (-0.85 mmHg) or diastolic (-0.48 mmHg) blood pressure, or on blood lipids.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.85,"lo":-3.07,"hi":1.36,"u":"mmHg","om":"systolic blood pressure","k":10,"n":577,"c":"Mohammadi M et al. Phytother Res 2019","p":"30632207","url":"https://pubmed.ncbi.nlm.nih.gov/30632207/","pl":true}],[12,182,"C","Blood pressure in adults with hypertension (Cochrane)","A 2021 Cochrane review found only one eligible placebo-controlled trial (60 people with type 2 diabetes, 8 weeks) and judged the evidence insufficient, of very low certainty, to determine an effect on blood pressure.",{"st":"single-trial","mt":"exact","m":"MD","v":1.65,"lo":-7.89,"hi":11.19,"u":"mmHg","om":"systolic blood pressure","k":1,"n":52,"dur":"eight weeks","c":"Pattanittum P et al. Cochrane Database Syst Rev 2021","p":"34837382","url":"https://pubmed.ncbi.nlm.nih.gov/34837382/","pl":true}],[12,52,"C","Blood pressure in stage 1 hypertension","In a single-blind RCT of 40 adults, 3 g/day for 4 weeks lowered mean blood pressure from about 144/95 to 134/83 mmHg, while placebo produced no significant change.",{"st":"no-estimate","mt":"exact","om":"systolic and diastolic blood pressure","dur":"4 weeks","c":"Bhat MDA, Malik SA. Complement Ther Med 2020","p":"33066862","url":"https://pubmed.ncbi.nlm.nih.gov/33066862/","pl":false}],[12,203,"C","Metabolic syndrome measures","An 8-week trial (30 g/day jujube powder) found no change in fasting glucose, LDL cholesterol or blood pressure, but improved waist size, triglycerides and HDL; authors noted blinding weaknesses.",{"st":"no-estimate","mt":"exact","om":"waist circumference, TG, HDL-C (FBG, LDL-C, BP unchanged)","dur":"eight weeks","c":"Parastouei K et al. Complement Ther Med 2024","p":"38648942","url":"https://pubmed.ncbi.nlm.nih.gov/38648942/","pl":false}],[12,204,"C","Blood lipids (five-herb combination)","A pilot study in 19 patients of a tablet combining garlic, fenugreek, guggul, Picrorhiza (200 mg) and black pepper reported lower total cholesterol and triglycerides; the herb's own effect cannot be separated.",{"st":"no-ci","mt":"exact","m":"percent-change","v":25.36,"u":"%","om":"total cholesterol","dur":"106 days","c":"Shaikh RF et al. Cureus 2022","p":"35936152","url":"https://pubmed.ncbi.nlm.nih.gov/35936152/","pl":false}],[12,166,"C","All-cause mortality and cardiovascular events","A 2018 Cochrane review found low-quality evidence that more omega-6 fat (12 of 19 trials tested linoleic acid) makes little or no difference to all-cause mortality (10 trials, 4,506 people) or cardiovascular events (7 trials).",{"st":"pooled","mt":"exact","m":"RR","v":1.0,"lo":0.88,"hi":1.12,"om":"all-cause mortality","k":10,"n":4506,"c":"Hooper L et al. Cochrane Database Syst Rev 2018","p":"30488422","url":"https://pubmed.ncbi.nlm.nih.gov/30488422/","pl":true}],[12,166,"C","Replacing saturated fat with linoleic-acid-rich corn oil (Minnesota Coronary Experiment, 1968-73)","Recovered data from this double-blind RCT (9,423 adults) showed lower serum cholesterol but no mortality benefit; each 30 mg/dL cholesterol reduction was associated with a 22% higher risk of death.",{"st":"single-trial","mt":"exact","m":"HR","v":1.22,"lo":1.14,"hi":1.32,"om":"death per 30 mg/dL reduction in serum cholesterol (covariate-adjusted Cox model)","n":9423,"c":"Ramsden CE et al. BMJ 2016","p":"27071971","url":"https://pubmed.ncbi.nlm.nih.gov/27071971/","pl":false,"ex":"an association between cholesterol change and death inside the trial, not the randomized comparison"}],[12,166,"C","Men after a coronary event: safflower-oil linoleic acid replacing saturated fat (Sydney Diet Heart Study, 1966-73)","Recovered data from this RCT (458 men) showed higher death rates with linoleic acid than controls (all-cause 17.6% vs 11.8%; hazard ratio 1.62, 95% CI 1.00 to 2.64).",{"st":"single-trial","mt":"exact","m":"HR","v":1.62,"lo":1.0,"hi":2.64,"om":"all-cause mortality","n":458,"c":"Ramsden CE et al. BMJ 2013","p":"23386268","url":"https://pubmed.ncbi.nlm.nih.gov/23386268/","pl":true}],[12,205,"C","Cardiovascular risk factors (tomato products and lycopene supplements)","A 2017 meta-analysis of 21 intervention trials found lycopene supplementation reduced systolic blood pressure by 5.66 mmHg; tomato interventions reduced LDL cholesterol and IL-6 and improved flow-mediated dilation.",{"st":"no-ci","mt":"exact","m":"MD","v":-5.66,"u":"mmHg","om":"systolic blood pressure","c":"Cheng HM et al. Atherosclerosis 2017","p":"28129549","url":"https://pubmed.ncbi.nlm.nih.gov/28129549/","pl":false}],[12,205,"C","Blood pressure and blood lipids (dietary or supplemental lycopene)","A 2020 review of 43 studies (1.44 to 75 mg/day, food or supplement) found no significant differences between lycopene and control groups for blood pressure or lipids; findings across studies conflicted.",{"st":"no-estimate","mt":"exact","om":"blood pressure and blood lipids","c":"Tierney AC et al. Adv Nutr 2020","p":"32652029","url":"https://pubmed.ncbi.nlm.nih.gov/32652029/","pl":false}],[12,158,"C","Blood cholesterol","MSK reports that manuka honey did not reduce cholesterol levels in people with hypercholesterolemia.",{"st":"none","pl":false}],[12,37,"C","Blood pressure in adults","The 2025 Crișan meta-analysis of nine randomized trials found a modest reduction in diastolic blood pressure that was not robust in sensitivity analyses.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.41,"lo":-0.75,"hi":-0.07,"om":"diastolic blood pressure","i2":19,"c":"Crișan D et al. Nutrients 2025","p":"41305552","url":"https://pubmed.ncbi.nlm.nih.gov/41305552/","pl":true}],[12,119,"C","Blood lipids in overweight and obese adults","In an RCT of 22 overweight or obese adults, 3 g/day MSM for 16 weeks raised HDL cholesterol at 8 and 16 weeks compared with baseline.",{"st":"no-estimate","mt":"exact","om":"HDL cholesterol (within-group change from baseline)","n":22,"dur":"16 weeks","c":"Miller L et al. Nutrients 2021","p":"34684621","url":"https://pubmed.ncbi.nlm.nih.gov/34684621/","pl":false}],[12,185,"C","Blood lipids","A 2023 meta-analysis (6 RCTs, 546 participants) found no lipid-lowering effect; with lower total doses, total and LDL cholesterol were higher and HDL cholesterol lower than with control, higher doses also had higher total cholesterol, blood glucose rose slightly, and triglycerides did not differ.",{"st":"pooled","mt":"exact","m":"MD","v":5.27,"lo":3.74,"hi":6.81,"om":"total cholesterol","c":"Li X et al. Rev Cardiovasc Med 2023","p":"39076715","url":"https://pubmed.ncbi.nlm.nih.gov/39076715/","pl":true}],[12,121,"C","Blood pressure in adults","In the 2026 Yang meta-analysis of 15 randomized trials, systolic blood pressure did not change significantly; diastolic pressure decreased slightly. Larger, longer trials are needed.",{"st":"no-estimate","mt":"exact","om":"systolic and diastolic blood pressure","dur":"14 days to 24 weeks","c":"Yang W et al. Nutrients 2026","p":"42514320","url":"https://pubmed.ncbi.nlm.nih.gov/42514320/","pl":false}],[12,206,"C","Blood lipids in cigarette smokers","MSK cites a small clinical study suggesting noni juice may lessen smoking-related dyslipidemia; further research is needed to confirm the effect.",{"st":"no-estimate","mt":"partial","om":"serum cholesterol, triglycerides, LDL, HDL","dur":"one month","c":"Wang MY et al. ScientificWorldJournal 2012","p":"23097636","url":"https://pubmed.ncbi.nlm.nih.gov/23097636/","pl":false}],[12,207,"C","Blood pressure in prehypertensive men","Double-blind crossover RCT in 60 men: 6 weeks of extract (136 mg oleuropein daily) lowered daytime and 24-hour systolic and diastolic blood pressure versus control (24-h systolic -3.33 mmHg).",{"st":"no-ci","mt":"exact","m":"MD","v":-3.33,"u":"mmHg","om":"24-h systolic blood pressure","n":60,"dur":"6 weeks","c":"Lockyer S et al. Eur J Nutr 2017","p":"26951205","url":"https://pubmed.ncbi.nlm.nih.gov/26951205/","pl":false}],[12,207,"C","Blood pressure in stage-1 hypertension (versus captopril)","In an 8-week double-blind trial, 500 mg extract twice daily lowered systolic pressure by 11.5 mmHg versus 13.7 mmHg with captopril; the difference between groups was not significant.",{"st":"no-estimate","mt":"exact","om":"systolic blood pressure","dur":"8 weeks","c":"Susalit E et al. Phytomedicine 2011","p":"21036583","url":"https://pubmed.ncbi.nlm.nih.gov/21036583/","pl":false}],[12,207,"C","Blood lipids and blood pressure in overweight adults","In an 8-week RCT of 77 overweight adults with mildly raised cholesterol, 500 mg/day extract did not change lipids, oxidized LDL, blood pressure, glucose or insulin versus placebo.",{"st":"no-estimate","mt":"exact","om":"blood lipids, oxLDL, blood pressure, glucose, insulin","n":77,"dur":"8 weeks","c":"Stevens Y et al. Eur J Nutr 2021","p":"33034707","url":"https://pubmed.ncbi.nlm.nih.gov/33034707/","pl":false}],[12,86,"C","Leaf powder: blood pressure and oxidized LDL","In a 6-month RCT of 60 healthy adults, leaf powder lowered oxidized LDL; home systolic pressure fell more than placebo only in those with prehypertension.",{"st":"no-estimate","mt":"exact","om":"morning/nocturnal home systolic BP (prehypertensive subgroup); plasma oxidized LDL","n":60,"dur":"6 months","c":"Hashimoto M et al. Molecules 2020","p":"32365849","url":"https://pubmed.ncbi.nlm.nih.gov/32365849/","pl":false}],[12,168,"C","Triglycerides in hypertriglyceridemia","The consensus panel described a reported 6–9% triglyceride lowering at 2 g/day in hypertriglyceridemic patients and said it warrants further evaluation.",{"st":"no-estimate","mt":"exact","om":"plasma triglycerides","c":"Gylling H et al. (EAS Consensus Panel) Atherosclerosis 2014","p":"24468148","url":"https://pubmed.ncbi.nlm.nih.gov/24468148/","pl":false}],[12,168,"C","Heart attacks, strokes and other cardiovascular events","The consensus panel states there are no randomized controlled trial data with hard end points to establish clinical benefit from plant sterols or stanols.",{"st":"no-estimate","mt":"exact","om":"cardiovascular hard end-points","c":"Gylling H et al. (EAS Consensus Panel) Atherosclerosis 2014","p":"24468148","url":"https://pubmed.ncbi.nlm.nih.gov/24468148/","pl":false}],[12,188,"C","Blood lipids","A 2025 meta-analysis of 37 RCTs (2,695 participants) found HDL cholesterol rose 2.50 mg/dL, with no significant change in total or LDL cholesterol or triglycerides.",{"st":"none","pl":false}],[12,189,"C","Stroke","A meta-analysis of 16 cohort studies associated the highest potassium intakes with a 13% lower stroke risk than the lowest (RR 0.87, 95% CI 0.80 to 0.94, adjusted for blood pressure). This is an observational association, not a supplement trial.",{"st":"pooled","mt":"exact","m":"RR","v":0.87,"lo":0.8,"hi":0.94,"om":"stroke risk","c":"Vinceti M et al. J Am Heart Assoc 2016","p":"27792643","url":"https://pubmed.ncbi.nlm.nih.gov/27792643/","pl":false,"ex":"the estimate compares highest with lowest dietary intake in observational studies; it is an association, not a supplement trial"}],[12,87,"C","Blood lipids","A 12-week RCT in 29 healthy adults (20 mg/day) found no change in triglycerides and a marginally significant fall in LDL cholesterol, significant only in those with high baseline LDL.",{"st":"no-estimate","mt":"exact","om":"serum triglycerides and LDL cholesterol","dur":"12 wk","c":"Nakano M et al. J Nutr Sci Vitaminol 2015","p":"26226960","url":"https://pubmed.ncbi.nlm.nih.gov/26226960/","pl":false}],[12,190,"C","Blood lipids, fruit versus cladode","A 2020 systematic review of 11 studies found prickly pear fruit was associated with significant total-cholesterol reductions in all but one study, while cladode effects on lipids were small.",{"st":"no-estimate","mt":"exact","om":"total cholesterol and LDL-C","k":11,"c":"Gouws C et al. Complement Ther Med 2020","p":"32444049","url":"https://pubmed.ncbi.nlm.nih.gov/32444049/","pl":false}],[12,170,"C","HDL cholesterol, triglycerides and apolipoproteins","A 2024 meta-analysis of 14 double-blind trials (2012–2022) found red yeast rice extract lowered total and LDL cholesterol but did not significantly change HDL cholesterol, triglycerides or apolipoproteins A-I and B.",{"st":"no-estimate","mt":"exact","om":"HDL cholesterol, triglycerides, apolipoproteins A-I and B","dur":"4-24 weeks","c":"Trogkanis E et al. Nutrients 2024","p":"38794691","url":"https://pubmed.ncbi.nlm.nih.gov/38794691/","pl":false}],[12,170,"C","Products low in monacolin K","NCCIH states it is unknown whether products with very little monacolin K lower cholesterol; some products contain less monacolin K than the level known to lower cholesterol in clinical trials.",{"st":"none","pl":false}],[12,6,"C","Cardiovascular risk factors","A meta-analysis found no benefit on cardiovascular risk factors; resveratrol did not lower all-cause mortality in older adults, and higher doses may raise cardiovascular risk biomarkers.",{"st":"pooled","mt":"partial","m":"WMD","v":-0.144,"lo":-0.968,"hi":0.68,"u":"mg/L","om":"plasma C-reactive protein","k":10,"c":"Sahebkar A et al. Int J Cardiol 2015","p":"25885871","url":"https://pubmed.ncbi.nlm.nih.gov/25885871/","pl":true}],[12,125,"C","Blood lipids and oxidative stress in adults at cardiovascular risk","40 adults drank six cups of fermented rooibos daily for 6 weeks, compared with a control period: LDL cholesterol and triglycerides fell and HDL rose; the study had no placebo group.",{"st":"no-estimate","mt":"exact","om":"LDL cholesterol; triglycerides; HDL cholesterol","dur":"6 weeks","c":"Marnewick JL et al. J Ethnopharmacol 2011","p":"20833235","url":"https://pubmed.ncbi.nlm.nih.gov/20833235/","pl":false}],[12,125,"C","Angiotensin-converting enzyme (ACE) activity in healthy volunteers","In a randomized crossover study of 17 volunteers, a single 400 ml dose of rooibos inhibited ACE activity at 30 and 60 minutes; nitric oxide did not change. Blood pressure was not an outcome.",{"st":"no-estimate","mt":"exact","om":"ACE activity","dur":"single dose; 30 and 60 min","c":"Persson IA et al. Public Health Nutr 2010","p":"20144258","url":"https://pubmed.ncbi.nlm.nih.gov/20144258/","pl":false}],[12,125,"C","Heart structure and function in adults at cardiovascular risk","A 12-week randomized, placebo-controlled trial of green and fermented rooibos extract capsules reported mixed echocardiography changes, some also in the placebo group.",{"st":"no-estimate","mt":"exact","om":"echocardiographic measures (left atrium, septum, LV mass)","dur":"12 weeks","c":"Hartnick MD et al. J Med Food 2024","p":"38958559","url":"https://pubmed.ncbi.nlm.nih.gov/38958559/","pl":false}],[12,132,"C","Blood pressure and cholesterol in obese adults","In a 6-week crossover RCT of 31 obese adults, a 40 g/day rose hip powder drink lowered systolic blood pressure by 3.4% and total cholesterol by 4.9% versus a control drink; weight and glucose tolerance did not differ.",{"st":"no-ci","mt":"exact","m":"percent-change","v":-3.4,"u":"%","om":"systolic blood pressure","dur":"6 weeks","c":"Andersson U et al. Eur J Clin Nutr 2012","p":"22166897","url":"https://pubmed.ncbi.nlm.nih.gov/22166897/","pl":false}],[12,18,"C","Blood cholesterol","MSK reports that some limited human studies suggest improved total and LDL cholesterol in people with moderately elevated levels.",{"st":"no-estimate","mt":"partial","om":"serum total and LDL cholesterol","n":15,"dur":"4 wk","c":"Guo H et al. J Nutr Sci Vitaminol (Tokyo) 2007","p":"17934240","url":"https://pubmed.ncbi.nlm.nih.gov/17934240/","pl":false}],[12,26,"C","Blood cholesterol and lipids","NCCIH: a few studies suggest sage may benefit blood cholesterol and other lipids.",{"st":"none","pl":false}],[12,208,"C","Blood pressure","A 2019 meta-analysis of nine RCTs (462 participants) called a systolic reduction versus placebo (mean difference -6.32 mm Hg) significant, though its reported confidence interval (-7.69 to 0.46) includes zero; the diastolic change was not significant, and heterogeneity was significant.",{"st":"pooled","mt":"exact","m":"MD","v":-6.32,"lo":-7.69,"hi":0.46,"u":"mm Hg","om":"systolic blood pressure","k":9,"n":462,"c":"Bundgaard Anker CC et al. Nutrients 2019","p":"31438580","url":"https://pubmed.ncbi.nlm.nih.gov/31438580/","pl":false,"ex":"the printed interval is not labeled a 95% confidence interval, crosses zero although the abstract calls the reduction significant, and is asymmetric about the estimate"}],[12,208,"C","Blood pressure and fasting glucose (earlier pooled trials)","A 2015 meta-analysis (9 studies, 756 participants) found no significant change in systolic pressure but lower diastolic pressure and fasting glucose; effects were small and heterogeneous, and rebaudioside A showed no significant effect.",{"st":"pooled","mt":"exact","m":"MD","v":-2.98,"lo":-6.23,"hi":0.27,"u":"mm Hg","om":"systolic blood pressure","k":9,"n":756,"c":"Onakpoya IJ, Heneghan CJ. Eur J Prev Cardiol 2015","p":"25412840","url":"https://pubmed.ncbi.nlm.nih.gov/25412840/","pl":false,"ex":"the abstract does not state the confidence level of the printed interval, so it cannot be shown as a 95% confidence interval"}],[12,91,"C","Heart failure (left ventricular ejection fraction)","A meta-analysis of two randomized placebo-controlled trials found thiamin improved net change in ejection fraction; the authors did not assess clinical significance.",{"st":"pooled","mt":"exact","m":"MD","v":3.28,"lo":0.64,"hi":5.93,"u":"%","om":"left ventricular ejection fraction","k":2,"n":38,"c":"DiNicolantonio JJ et al. Ochsner J 2013","p":"24357996","url":"https://pubmed.ncbi.nlm.nih.gov/24357996/","pl":true}],[12,124,"C","Heart failure with preserved ejection fraction","A 12-week phase 2 RCT (216 patients; ubiquinol 600 mg/day and/or D-ribose 15 g/day, factorial design) reported that ubiquinol and/or D-ribose improved symptom scores, vigor and ejection fraction; 6-minute walk did not improve.",{"st":"no-estimate","mt":"exact","om":"KCCQ clinical summary score, vigor, ejection fraction","c":"Pierce JD et al. Am J Cardiol 2022","p":"35644694","url":"https://pubmed.ncbi.nlm.nih.gov/35644694/","pl":false}],[12,209,"C","Coronary artery calcification and heart disease","A 3-year RCT in 388 older adults (500 mcg phylloquinone) found no overall difference in calcification progression; cohort studies linked higher menaquinone intake to lower coronary heart disease mortality.",{"st":"no-estimate","mt":"exact","om":"coronary artery calcium progression (Agatston score)","n":388,"dur":"3 y","c":"Shea MK et al. Am J Clin Nutr 2009","p":"19386744","url":"https://pubmed.ncbi.nlm.nih.gov/19386744/","pl":false}],[12,210,"C","Coronary artery calcification in symptomatic coronary artery disease","A 2-year RCT (VitaK-CAC; 180 patients randomized, 360 micrograms/day) found slower progression of coronary artery calcium scores with MK-7 than placebo (P =.02); no significant adverse effects were observed.",{"st":"no-estimate","mt":"exact","om":"coronary artery calcium (CAC) score progression","n":180,"c":"Vossen LM et al. JAMA Cardiol 2026","p":"42268593","url":"https://pubmed.ncbi.nlm.nih.gov/42268593/","pl":false}],[12,210,"C","Arterial calcification in type 2 diabetes with cardiovascular disease","A 6-month RCT (68 patients, 360 micrograms/day) found MK-7 did not reduce femoral arterial calcification; PET-measured activity tended to increase versus placebo (P = 0.06, not significant).",{"st":"single-trial","mt":"exact","m":"other","v":0.25,"lo":-0.02,"hi":0.51,"om":"active arterial calcification (18F-NaF PET TBR)","dur":"6-mo","c":"Zwakenberg SR et al. Am J Clin Nutr 2019","p":"31387121","url":"https://pubmed.ncbi.nlm.nih.gov/31387121/","pl":false}],[12,211,"C","Blood lipids","The 2017 meta-analysis of 13 RCTs found no difference in total cholesterol, triglycerides, LDL or HDL cholesterol.",{"st":"no-estimate","mt":"exact","om":"TC, TG, LDL, HDL","k":13,"c":"Phimarn W et al. Eur J Nutr 2017","p":"26972284","url":"https://pubmed.ncbi.nlm.nih.gov/26972284/","pl":false}],[12,195,"X","Chronic heart failure: ejection fraction","In a 12-week double-blind RCT of 100 patients on standard therapy, 750 mg twice daily of a bark water extract did not change ejection fraction or most secondary outcomes versus placebo.",{"st":"no-estimate","mt":"exact","om":"left ventricular ejection fraction at 12 weeks","n":100,"dur":"12 weeks","c":"Maulik SK et al. Phytomedicine 2016","p":"26988798","url":"https://pubmed.ncbi.nlm.nih.gov/26988798/","pl":false}],[12,31,"X","Cardiovascular disease (other than stroke)","Folic acid lowers homocysteine but trials, including one in 5,442 women using 2,500 mcg, found no reduction in major cardiovascular events.",{"st":"single-trial","mt":"exact","m":"RR","v":1.03,"lo":0.9,"hi":1.19,"om":"composite of MI, stroke, coronary revascularization or CVD mortality","n":5442,"dur":"7.3 years","c":"Albert CM et al. JAMA 2008 (WAFACS)","p":"18460663","url":"https://pubmed.ncbi.nlm.nih.gov/18460663/","pl":true}],[12,147,"X","Blood pressure, glycemic control, body composition and inflammatory markers","A 2023 meta-analysis (14 trials, 1,458 participants) found lower total cholesterol, LDL and triglycerides but no effect on blood pressure, glycemic control, body composition or inflammatory markers.",{"st":"no-estimate","mt":"exact","om":"blood pressure, glycemic control, body composition, inflammatory markers","k":14,"n":1458,"c":"Huang H et al. Diabetes Metab Syndr 2023","p":"38039646","url":"https://pubmed.ncbi.nlm.nih.gov/38039646/","pl":false}],[12,117,"X","Vascular stiffness and heart function after acute myocardial infarction","In the VINTAGE MI trial (153 patients, 6 months), L-arginine added to standard care did not improve vascular stiffness or ejection fraction; 6 patients (8.6%) on L-arginine died versus none on placebo.",{"st":"no-estimate","mt":"exact","om":"vascular stiffness, ejection fraction, mortality","dur":"6 months","c":"Schulman SP et al. JAMA 2006","p":"16391217","url":"https://pubmed.ncbi.nlm.nih.gov/16391217/","pl":false}],[12,85,"X","Blood cholesterol and triglycerides","A 2021 meta-analysis of 7 articles reporting randomized trials found MCT oil did not change total, LDL or HDL cholesterol but slightly raised triglycerides (0.14 mmol/L).",{"st":"pooled","mt":"exact","m":"MD","v":0.14,"lo":0.01,"hi":0.27,"u":"mmol/L","om":"blood triglycerides","k":7,"i2":42.8,"dur":"minimum 2 weeks","c":"McKenzie KM et al. J Nutr 2021","p":"34255085","url":"https://pubmed.ncbi.nlm.nih.gov/34255085/","pl":true}],[12,33,"X","Cardiovascular events","PHS II (14,641 men, median 11.2 years) and COSMOS (median 3.6 years) found no reduction in major cardiovascular events.",{"st":"single-trial","mt":"partial","m":"HR","v":1.01,"lo":0.91,"hi":1.1,"om":"major cardiovascular events","dur":"median 11.2 years","c":"Sesso HD et al. JAMA 2012 (PHS II)","p":"23117775","url":"https://pubmed.ncbi.nlm.nih.gov/23117775/","pl":true}],[12,185,"X","Progression of subclinical atherosclerosis","A double-blind RCT (NAPS; 265 adults without cardiovascular disease, 2,000 FU/day, median 3 years) found no effect on carotid intima-media thickness or arterial stiffness progression, blood pressure or any laboratory measure.",{"st":"no-estimate","mt":"exact","om":"annualized change in carotid intima-media thickness and arterial stiffness","dur":"median 3 years","c":"Hodis HN et al. Clin Hemorheol Microcirc 2021","p":"33843667","url":"https://pubmed.ncbi.nlm.nih.gov/33843667/","pl":false}],[12,167,"X","Cardiovascular events and mortality (nicotinic acid)","A 2017 Cochrane review (23 RCTs, 39,195 participants; median 2 g/day) found no reduction in overall or cardiovascular mortality. HPS2-THRIVE (25,673 adults on statins) and AIM-HIGH (3,414 patients) found no fewer cardiovascular events.",{"st":"pooled","mt":"exact","m":"RR","v":1.05,"lo":0.97,"hi":1.12,"om":"overall mortality","k":12,"n":35543,"i2":0,"dur":"median duration of treatment was 11.5 months","c":"Schandelmaier S et al. Cochrane Database Syst Rev 2017","p":"28616955","url":"https://pubmed.ncbi.nlm.nih.gov/28616955/","pl":true}],[12,105,"X","Blood lipids","A meta-analysis of five RCTs (442 subjects) found no clinically relevant effect of quercetin on LDL, HDL or total cholesterol; triglycerides fell only in a higher-dose, longer-duration subgroup.",{"st":"pooled","mt":"exact","m":"WMD","v":1.43,"lo":-0.92,"hi":3.78,"u":"mg/dL","om":"LDL cholesterol","k":5,"n":442,"c":"Sahebkar A. Crit Rev Food Sci Nutr 2017","p":"25897620","url":"https://pubmed.ncbi.nlm.nih.gov/25897620/","pl":true}],[12,192,"X","Seed oil replacing saturated fat after a coronary event (Sydney Diet Heart Study)","In a randomized trial of 458 men, replacing saturated fats with safflower oil and safflower-oil margarine led to higher death rates from all causes, cardiovascular disease and coronary heart disease than controls.",{"st":"single-trial","mt":"exact","m":"HR","v":1.62,"lo":1.0,"hi":2.64,"om":"all-cause mortality","n":458,"dur":"1966-73 trial","c":"Ramsden CE et al. BMJ 2013","p":"23386268","url":"https://pubmed.ncbi.nlm.nih.gov/23386268/","pl":true}],[12,93,"X","Cardiovascular events","A Cochrane review of SELECT and 11 smaller trials (19,715 participants) found selenium did not reduce fatal or nonfatal cardiovascular events.",{"st":"pooled","mt":"exact","m":"RR","v":1.03,"lo":0.95,"hi":1.11,"om":"all CVD events (fatal and non-fatal)","c":"Rees K et al. Cochrane Database Syst Rev 2013","p":"23440843","url":"https://pubmed.ncbi.nlm.nih.gov/23440843/","pl":true}],[12,20,"X","Total and LDL cholesterol in menopausal women (isoflavone extract alone)","A meta-analysis of randomized placebo-controlled trials (10 and 9 trials) found about 70 mg/day extracted isoflavones alone for 1–3 months did not improve total or LDL cholesterol in normocholesterolemic menopausal women.",{"st":"pooled","mt":"exact","m":"other","v":0.01,"lo":-0.12,"hi":0.14,"u":"mmol/L","om":"total cholesterol","k":10,"dur":"1-3 months","c":"Taku K et al. Ther Clin Risk Manag 2008","p":"19209289","url":"https://pubmed.ncbi.nlm.nih.gov/19209289/","pl":false}],[12,94,"X","Cardiovascular disease","A Cochrane review of 15 studies (71,422 participants) found B12 alone or with other B vitamins did not reduce heart attacks or death rates; B-PROOF follow-up (1,298 participants) found no effect.",{"st":"pooled","mt":"exact","m":"RR","v":1.02,"lo":0.95,"hi":1.1,"om":"myocardial infarction, homocysteine-lowering B-vitamin regimens (B6, folic acid, B12), not B12 alone","k":12,"n":46699,"i2":0,"c":"Martí-Carvajal AJ et al. Cochrane Database Syst Rev 2017","p":"28816346","url":"https://pubmed.ncbi.nlm.nih.gov/28816346/","pl":true}],[12,10,"X","Cardiovascular disease","Trials including HOPE 2 (over 5,500 adults), a 5,442-woman trial (50 mg/day with folic acid and B12), Norwegian trials (6,837 patients) and VISP found no effect on cardiovascular events or stroke.",{"st":"none","pl":false}],[12,212,"X","Cardiovascular disease","The Women's Antioxidant Cardiovascular Study (8,171 women, 500 mg/day, 9.4 years) and Physicians' Health Study II (500 mg/day, 8 years) found no effect on major cardiovascular events.",{"st":"single-trial","mt":"exact","m":"RR","v":1.02,"lo":0.92,"hi":1.13,"om":"combined CVD events (MI, stroke, coronary revascularization, CVD death)","n":8171,"dur":"mean duration of 9.4 years","c":"Cook NR et al. Arch Intern Med 2007 (Women's Antioxidant Cardiovascular Study)","p":"17698683","url":"https://pubmed.ncbi.nlm.nih.gov/17698683/","pl":true}],[12,70,"X","Cardiovascular disease","In VITAL (25,871 adults; 2,000 IU/day; median 5.3 years), vitamin D did not significantly reduce heart attacks, strokes, coronary revascularization or cardiovascular deaths.",{"st":"single-trial","mt":"exact","m":"HR","v":0.97,"lo":0.85,"hi":1.12,"om":"major cardiovascular events (MI, stroke or cardiovascular death)","n":25871,"dur":"median follow-up of 5.3 years","c":"Manson JE et al. N Engl J Med 2019","p":"30415629","url":"https://pubmed.ncbi.nlm.nih.gov/30415629/","pl":true}],[12,92,"X","Cardiovascular disease","HOPE (almost 10,000 high-risk patients, 400 IU/day, 4.5 years), Physicians' Health Study II (almost 15,000 men, 8 years) and the Women's Health Study (almost 40,000 women, 10 years) found no reduction in major cardiovascular events.",{"st":"single-trial","mt":"partial","m":"RR","v":1.05,"lo":0.95,"hi":1.16,"om":"composite of myocardial infarction, stroke and cardiovascular death","c":"HOPE Study Investigators (Yusuf S et al.). N Engl J Med 2000","p":"10639540","url":"https://pubmed.ncbi.nlm.nih.gov/10639540/","pl":true}],[13,164,"A","Blood glucose and insulin after meals","A 2021 meta-analysis of 103 acute crossover trial comparisons (538 participants) found adding oat beta-glucan to carbohydrate meals reduced glucose response (iAUC) by 23% and insulin by 22%; certainty was high and effects depended on dose and molecular weight.",{"st":"pooled","mt":"exact","m":"ratio-of-means","v":0.77,"lo":0.74,"hi":0.81,"om":"postprandial glucose iAUC","n":538,"c":"Zurbau A et al. Eur J Clin Nutr 2021","p":"33608654","url":"https://pubmed.ncbi.nlm.nih.gov/33608654/","pl":true}],[13,107,"A","Blood glucose after a meal (whey taken before the meal)","A 2023 meta-analysis of 16 randomized crossover trials (244 individuals) found whey premeals lowered peak glucose by 1.4 mmol/L versus control (high certainty); long-term effects await future trials.",{"st":"pooled","mt":"exact","m":"MD","v":-1.4,"lo":-1.9,"hi":-0.9,"u":"mmol/L","om":"postprandial peak glucose","k":16,"n":244,"dur":"acute (premeal, single-meal crossover trials)","c":"Smedegaard S et al. Am J Clin Nutr 2023","p":"37536867","url":"https://pubmed.ncbi.nlm.nih.gov/37536867/","pl":false,"ex":"the abstract does not state the confidence level of the printed interval, so it cannot be shown as a 95% confidence interval"}],[13,213,"B","Body weight in adults","A 2018 meta-analysis of 12 placebo-controlled trials found slightly lower body weight (−0.69 kg) and BMI (−0.38 kg/m²) with ALA, but no significant change in waist circumference.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.69,"lo":-1.27,"hi":-0.1,"u":"kg","om":"body weight","k":12,"i2":0,"c":"Namazi N et al. Clin Nutr 2018","p":"28629898","url":"https://pubmed.ncbi.nlm.nih.gov/28629898/","pl":true}],[13,171,"B","Fasting blood glucose in adults","A 2023 meta-analysis of five RCTs (3-12 weeks) found lower fasting blood glucose and improved lipids with amla; authors called for more studies.",{"st":"no-estimate","mt":"exact","om":"fasting blood glucose","k":5,"dur":"3 to 12 weeks","c":"Setayesh L et al. Diabetes Metab Syndr 2023","p":"36934568","url":"https://pubmed.ncbi.nlm.nih.gov/36934568/","pl":false}],[13,172,"B","Blood glucose in type 2 diabetes","NCCIH reports some evidence of a modest blood glucose-lowering effect in people with type 2 diabetes.",{"st":"none","pl":false}],[13,164,"B","Fasting glucose and HbA1c in type 2 diabetes","A 2016 meta-analysis of 4 articles (350 patients; 2.5–3.5 g/day for 3–8 weeks) found oat beta-glucan lowered fasting glucose by 0.52 mmol/L and HbA1c by 0.21%; fasting insulin did not fall significantly.",{"st":"pooled","mt":"exact","m":"MD","v":-0.52,"lo":-0.94,"hi":-0.1,"u":"mmol/L","om":"fasting plasma glucose","k":4,"n":350,"dur":"3 to 8 weeks","c":"Shen XL et al. Nutrients 2016","p":"26771637","url":"https://pubmed.ncbi.nlm.nih.gov/26771637/","pl":true}],[13,173,"B","Blood sugar control in type 2 diabetes (2019 meta-analysis)","A 2019 meta-analysis of 10 studies (1,045 patients, 4–16 weeks) found single-herb preparations lowered fasting glucose (-0.72 mmol/L) and HbA1c (-0.26%) versus placebo; evidence was rated low to very low quality.",{"st":"pooled","mt":"exact","m":"MD","v":-0.72,"lo":-1.33,"hi":-0.12,"u":"mmol/L","om":"fasting plasma glucose (FPG)","k":10,"n":1045,"i2":14,"dur":"4-16 weeks","c":"Peter EL et al. J Ethnopharmacol 2019","p":"30385422","url":"https://pubmed.ncbi.nlm.nih.gov/30385422/","pl":true}],[13,173,"B","Glucose and insulin resistance in prediabetes and type 2 diabetes (2025 meta-analysis)","A 2025 meta-analysis of 25 RCTs (34 sub-studies) reported lower fasting glucose (SMD -0.46), HbA1c (SMD -0.57), insulin and HOMA-IR, with no effect on HOMA-beta.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.46,"lo":-0.73,"hi":-0.18,"om":"fasting blood glucose (FBG)","k":25,"c":"Mkhize SAL et al. Metabol Open 2025","p":"41280283","url":"https://pubmed.ncbi.nlm.nih.gov/41280283/","pl":true}],[13,174,"B","Fasting glucose and HbA1c in adults","A 2024 meta-analysis of 30 randomized trials found lower fasting glucose and HbA1c but no change in insulin or HOMA-IR; heterogeneity was very high (I² over 90%).",{"st":"pooled","mt":"exact","m":"SMD","v":-1.71,"lo":-2.11,"hi":-1.31,"om":"fasting blood sugar","k":30,"i2":92.7,"c":"Shirvani S et al. Prostaglandins Other Lipid Mediat 2024","p":"39181437","url":"https://pubmed.ncbi.nlm.nih.gov/39181437/","pl":true}],[13,77,"B","Blood glucose and lipids","A 2020 meta-analysis of 4 RCTs (184 participants) found lower HbA1c (-0.92%) with carnosine but no significant change in fasting blood sugar, HOMA-IR, cholesterol, triglycerides or HDL-C.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.92,"lo":-1.2,"hi":-0.63,"u":"%","om":"HbA1c","k":4,"n":184,"i2":69,"dur":"at least 2 weeks","c":"Peng W et al. Complement Ther Med 2020","p":"31987255","url":"https://pubmed.ncbi.nlm.nih.gov/31987255/","pl":true}],[13,196,"B","Body weight and body fat","A 2019 meta-analysis (21 trials, 1,316 people, 200–1,000 mcg/day, 9–24 weeks) found about 0.75 kg more weight loss than placebo; ODS says these effects have little clinical significance.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.75,"lo":-1.04,"hi":-0.45,"u":"kg","om":"weight loss (body weight)","k":21,"n":1316,"c":"Tsang C et al. Clin Obes 2019","p":"31115179","url":"https://pubmed.ncbi.nlm.nih.gov/31115179/","pl":true}],[13,198,"B","Body weight and body fat in adults","A 2024 meta-analysis of 70 RCTs (4,159 adults) found CLA lowered body mass by 0.35 kg and fat mass by 0.44 kg versus control; in high-quality trials, fat mass and body fat percentage did not change.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.35,"lo":-0.54,"hi":-0.15,"om":"body mass","k":70,"n":4159,"c":"Asbaghi O et al. Br J Nutr 2024","p":"37671495","url":"https://pubmed.ncbi.nlm.nih.gov/37671495/","pl":true}],[13,198,"B","Long-term weight in overweight and obesity","A 2012 meta-analysis of 7 RCTs lasting at least 6 months found 0.70 kg more weight loss and 1.33 kg more fat loss than placebo; the authors judged clinical relevance uncertain, and four trials had serious reporting flaws.",{"st":"pooled","mt":"exact","m":"MD","v":-0.7,"lo":-1.09,"hi":-0.32,"u":"kg","om":"body weight","k":7,"dur":"at least 6 months","c":"Onakpoya IJ et al. Eur J Nutr 2012","p":"21990002","url":"https://pubmed.ncbi.nlm.nih.gov/21990002/","pl":true}],[13,116,"B","Short-term weight loss (pre-2004 research, usually combined with caffeine)","Supplements with ephedrine alkaloids, usually plus caffeine, had modest short-term effects on weight; no studies assessed long-term effects, and NCCIH states the benefit did not outweigh the serious risks.",{"st":"pooled","mt":"partial","m":"MD","v":1.0,"lo":0.7,"hi":1.3,"u":"kg/mo","om":"weight loss vs placebo (ephedrine + caffeine)","k":12,"c":"Shekelle PG et al. JAMA 2003","p":"12672771","url":"https://pubmed.ncbi.nlm.nih.gov/12672771/","pl":true,"se":"positive = more weight lost per month"}],[13,177,"B","Body weight in adults (2011 meta-analysis)","A 2011 systematic review included 12 RCTs and pooled nine: a small, statistically significant weight loss versus placebo (-0.88 kg, 95% CI -1.75 to -0.00); clinical relevance was uncertain.",{"st":"pooled","mt":"exact","m":"MD","v":-0.88,"lo":-1.75,"hi":-0.0,"u":"kg","om":"body weight","k":9,"c":"Onakpoya I et al. J Obes 2011","p":"21197150","url":"https://pubmed.ncbi.nlm.nih.gov/21197150/","pl":true}],[13,177,"B","Weight, BMI, body fat and waist (2020 meta-analysis)","A 2020 meta-analysis of eight RCTs (530 subjects) found lower weight (-1.34 kg), BMI (-0.99 kg/m2), percentage fat mass (-0.42%) and waist circumference (-4.16 cm) than placebo.",{"st":"pooled","mt":"exact","m":"MD","v":-1.34,"lo":-2.62,"hi":-0.07,"u":"kg","om":"body weight","k":8,"n":530,"c":"Golzarand M et al. Complement Ther Med 2020","p":"32951714","url":"https://pubmed.ncbi.nlm.nih.gov/32951714/","pl":true}],[13,179,"B","Fasting glucose, lipids and inflammation markers","A 2020 meta-analysis of 50 trials reported lower fasting plasma glucose, total and LDL cholesterol, triglycerides and CRP, with no change in HbA1c, HDL cholesterol or body measurements; its abstract does not say all trials tested the extract alone.",{"st":"pooled","mt":"exact","m":"WMD","v":-2.01,"lo":-3.14,"hi":-0.86,"om":"fasting plasma glucose","k":50,"c":"Asbaghi O et al. Phytother Res 2020","p":"31880030","url":"https://pubmed.ncbi.nlm.nih.gov/31880030/","pl":true}],[13,181,"B","Blood sugar in adults (randomized trials)","A 2023 meta-analysis of six randomized trials found lower fasting blood sugar than control; the authors cite notable heterogeneity, low study quality and little diversity among participants.",{"st":"no-estimate","mt":"exact","om":"fasting blood sugar","c":"Zamani M et al. Phytother Res 2023","p":"36580574","url":"https://pubmed.ncbi.nlm.nih.gov/36580574/","pl":false}],[13,182,"B","Fasting glucose and lipids","A 2020 meta-analysis of randomized trials found fasting glucose 3.96 mg/dL and LDL 7.84 mg/dL lower than placebo, with no significant change in total cholesterol, HDL or triglycerides.",{"st":"pooled","mt":"exact","m":"WMD","v":-3.964,"lo":-6.227,"hi":-1.702,"u":"mg/dL","om":"fasting plasma glucose","c":"Bule M et al. Food Res Int 2020","p":"32156406","url":"https://pubmed.ncbi.nlm.nih.gov/32156406/","pl":true}],[13,183,"B","Body weight in adults","The 2024 Talukdar meta-analysis found body weight fell 0.97 kg (36 RCTs, 1,672 participants; low certainty); effects were larger in trials of 6 weeks or more and in pre-obese and obese participants.",{"st":"pooled","mt":"exact","m":"MD","v":-0.97,"lo":-1.28,"hi":-0.66,"u":"kg","om":"body weight","k":36,"n":1672,"c":"Talukdar JR et al. Am J Clin Nutr 2024","p":"38309832","url":"https://pubmed.ncbi.nlm.nih.gov/38309832/","pl":true}],[13,183,"B","BMI, fat mass and waist circumference","A 2024 meta-analysis of 32 studies of chicory inulin-type fructans versus placebo found lower BMI (−0.39 kg/m2), fat mass (−0.37 kg) and waist circumference (−1.03 cm). Two of three authors work for a fructan producer.",{"st":"pooled","mt":"exact","m":"MD","v":-0.39,"lo":-0.57,"hi":-0.2,"u":"kg/m2","om":"BMI","n":985,"c":"Reimer RA et al. Am J Clin Nutr 2024","p":"39313030","url":"https://pubmed.ncbi.nlm.nih.gov/39313030/","pl":true}],[13,214,"B","Body weight and blood lipids in adults with overweight or obesity","2025 meta-analysis of 11 trials: seaweed lowered BMI (SMD −0.40) and percent body fat, mainly with brown seaweed for at least 8 weeks, and lowered total and LDL cholesterol; no effect on glucose metabolism.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.4,"lo":-0.65,"hi":-0.16,"u":"kg/m2","om":"BMI","k":11,"c":"Łagowska K et al. Nutr Rev 2025","p":"38749056","url":"https://pubmed.ncbi.nlm.nih.gov/38749056/","pl":true}],[13,35,"B","Blood glucose control in type 2 diabetes or insulin resistance","A 2023 meta-analysis of 41 trials (about 2,900 participants) found lower fasting glucose, insulin resistance and HbA1c; ODS states larger trials are needed.",{"st":"pooled","mt":"exact","m":"WMD","v":-3.22,"lo":-5.21,"hi":-1.23,"u":"mg/dl","om":"fasting blood glucose","k":41,"n":2900,"i2":88.6,"c":"Zamani M et al. Front Nutr 2023","p":"36704801","url":"https://pubmed.ncbi.nlm.nih.gov/36704801/","pl":true}],[13,35,"B","Body weight","A 2016 meta-analysis of 9 trials (911 participants) found an average 1.33 kg greater weight loss than placebo.",{"st":"pooled","mt":"exact","m":"MD","v":-1.33,"lo":-2.09,"hi":-0.57,"u":"kg","om":"body weight","k":9,"n":911,"c":"Pooyandjoo M et al. Obes Rev 2016","p":"27335245","url":"https://pubmed.ncbi.nlm.nih.gov/27335245/","pl":true}],[13,85,"B","Body weight and body composition in healthy adults","A 2015 meta-analysis of 13 RCTs (749 adults) found MCTs in place of long-chain triglycerides lowered body weight by 0.51 kg and reduced waist circumference and body fat; commercial bias was detected.",{"st":"pooled","mt":"exact","m":"MD","v":-0.51,"lo":-0.8,"hi":-0.23,"u":"kg","om":"body weight","k":13,"n":749,"i2":35,"dur":">3 weeks","c":"Mumme K, Stonehouse W. J Acad Nutr Diet 2015","p":"25636220","url":"https://pubmed.ncbi.nlm.nih.gov/25636220/","pl":true}],[13,85,"B","Weight and glucose-lipid markers in overweight or obesity","A 2024 meta-analysis found greater weight reduction with MCT-enriched than long-chain-fat diets (−1.53%), mainly with pure MCTs, and lower blood triglycerides and HOMA-IR; medium-long-chain triglyceride diets did not significantly reduce weight.",{"st":"pooled","mt":"exact","m":"WMD","v":-1.53,"lo":-2.44,"hi":-0.63,"u":"%","om":"weight reduction","c":"He H et al. Clin Nutr 2024","p":"38936302","url":"https://pubmed.ncbi.nlm.nih.gov/38936302/","pl":true}],[13,188,"B","Blood glucose and insulin","A 2024 meta-analysis of 32 RCTs found small reductions in fasting glucose (-2.22 mg/dL), fasting insulin, HbA1c (-0.22%) and HOMA-IR; authors called for longer trials.",{"st":"pooled","mt":"exact","m":"WMD","v":-2.22,"lo":-3.95,"hi":-0.5,"u":"mg/dL","om":"fasting blood glucose","k":32,"c":"Bahari H et al. Diabetes Metab Syndr 2024","p":"38194826","url":"https://pubmed.ncbi.nlm.nih.gov/38194826/","pl":true}],[13,188,"B","Blood glucose, insulin and HbA1c (2025 pooled analysis)","A 2025 meta-analysis of 34 RCTs (1,500 participants) found lower fasting glucose (-3.04 mg/dL), insulin and HOMA-IR, but no significant change in HbA1c; authors called for longer and larger trials.",{"st":"pooled","mt":"exact","m":"MD","v":2.5,"lo":1.0,"hi":4.0,"u":"mg/dL","om":"HDL cholesterol","c":"Cheng W et al. Prostaglandins Other Lipid Mediat 2025","p":"40216355","url":"https://pubmed.ncbi.nlm.nih.gov/40216355/","pl":true}],[13,148,"B","Blood sugar and lipids in adults with type 2 diabetes","A 2025 meta-analysis of 12 RCTs (731 adults; 9 placebo-controlled) reported lower fasting glucose, HbA1c, HOMA-IR, LDL cholesterol and triglycerides and higher HDL; glucose and HbA1c results were heterogeneous and 6 trials were from Iran.",{"st":"pooled","mt":"exact","m":"MD","v":-1.13,"lo":-2.0,"hi":-0.27,"om":"fasting blood sugar","k":12,"n":731,"c":"Zhang Y et al. Front Nutr 2025","p":"41141253","url":"https://pubmed.ncbi.nlm.nih.gov/41141253/","pl":true}],[13,160,"B","Fasting glucose and insulin resistance","A 2023 meta-analysis of RCTs found purslane lowered fasting blood glucose (weighted mean difference -6.37) but had no significant effect on insulin, HOMA-IR or QUICKI; the authors called for higher-quality trials.",{"st":"pooled","mt":"exact","m":"WMD","v":-6.37,"lo":-9.34,"hi":-3.4,"om":"fasting blood glucose","c":"Abbasi S et al. Phytother Res 2023","p":"37661794","url":"https://pubmed.ncbi.nlm.nih.gov/37661794/","pl":true}],[13,191,"B","Fasting glucose and insulin resistance","A 2021 meta-analysis of 19 RCTs (excluding type 1 resistant starch and mixtures) found resistant starch lowered fasting glucose by 0.09 mmol/L and HOMA-IR by 0.33 versus digestible starch; other insulin measures did not change significantly.",{"st":"pooled","mt":"exact","m":"other","v":-0.09,"lo":-0.13,"hi":-0.04,"u":"mmol/l","om":"fasting plasma glucose","k":19,"c":"Xiong K et al. Br J Nutr 2021","p":"32959735","url":"https://pubmed.ncbi.nlm.nih.gov/32959735/","pl":false}],[13,215,"B","Blood glucose in adults with type 2 diabetes (nettle supplementation)","A 2020 meta-analysis of 8 RCTs (401 participants) found lower fasting blood sugar (-18.01 mg/dl) but no significant change in insulin, HOMA-IR or HbA1c; heterogeneity was high.",{"st":"pooled","mt":"exact","m":"WMD","v":-18.01,"lo":-30.04,"hi":-5.97,"u":"mg/dl","om":"fasting blood sugar","k":8,"n":401,"i2":94.6,"c":"Ziaei R et al. Phytother Res 2020","p":"31802554","url":"https://pubmed.ncbi.nlm.nih.gov/31802554/","pl":true}],[13,90,"B","Blood glucose, lipids and other cardiometabolic risk factors","A 2026 meta-analysis of 34 RCTs found oral taurine lowered fasting glucose (−5.90 mg/dL), HbA1c, triglycerides, total and LDL cholesterol, and systolic pressure (−4.38 mmHg); 1.5–3.0 g/day appeared more effective.",{"st":"pooled","mt":"exact","m":"MD","v":-5.9,"lo":-9.65,"hi":-2.15,"u":"mg/dL","om":"fasting blood glucose","c":"Nie Z et al. Nutr Rev 2026","p":"41275513","url":"https://pubmed.ncbi.nlm.nih.gov/41275513/","pl":true}],[13,151,"B","HbA1c, blood pressure and CRP in type 2 diabetes","A 2023 meta-analysis of 10 RCTs found tocotrienol-rich fraction (250-400 mg) lowered HbA1c (-0.23; n = 754) but did not lower systolic or diastolic blood pressure or hs-CRP.",{"st":"pooled","mt":"exact","m":"other","v":-0.23,"lo":-0.44,"hi":-0.02,"om":"HbA1c","k":10,"n":754,"c":"Phang SCW et al. Adv Nutr 2023","p":"37321474","url":"https://pubmed.ncbi.nlm.nih.gov/37321474/","pl":false}],[13,211,"B","Fasting glucose, HbA1c and insulin in adults","A 2023 meta-analysis of 12 trials (615 participants) found mulberry leaf or leaf extract lowered fasting glucose by 0.47 mmol/L, HbA1c by 2.92 mmol/mol and fasting insulin by 0.58 μIU/mL.",{"st":"no-ci","mt":"exact","m":"WMD","v":-0.47,"u":"mmol L-1","om":"fasting blood glucose","k":12,"n":615,"c":"Cui W et al. Food Funct 2023","p":"36644880","url":"https://pubmed.ncbi.nlm.nih.gov/36644880/","pl":false}],[13,211,"B","Blood glucose after meals","A 2017 meta-analysis of 13 RCTs of Morus alba products found lower post-meal glucose at 30, 60 and 90 minutes, but no difference in fasting glucose, HbA1c or HOMA-IR.",{"st":"pooled","mt":"exact","m":"MD","v":-1.04,"lo":-1.36,"hi":-0.73,"om":"postprandial glucose at 30 min","k":13,"c":"Phimarn W et al. Eur J Nutr 2017","p":"26972284","url":"https://pubmed.ncbi.nlm.nih.gov/26972284/","pl":true}],[13,108,"C","Insulin sensitivity and metabolic markers in overweight or obese insulin-resistant adults","In a 3-month pilot RCT (40 enrolled, 32 completed), pasteurized A. muciniphila (10^10 bacteria/day) improved insulin sensitivity (+28.6%) and lowered insulinemia and total cholesterol versus placebo; body-weight change was not significant.",{"st":"no-ci","mt":"exact","m":"percent-change","v":28.62,"u":"%","om":"insulin sensitivity","n":40,"dur":"three months","c":"Depommier C et al. Nat Med 2019","p":"31263284","url":"https://pubmed.ncbi.nlm.nih.gov/31263284/","pl":false}],[13,108,"C","Weight regain after diet-induced weight loss","In an RCT of 90 adults with overweight or obesity, 24 weeks of pasteurized MucT after an 8-week low-energy diet led to less weight regain than placebo (1.2 vs 3.2 kg).",{"st":"no-estimate","mt":"exact","u":"kg","om":"body weight regain during maintenance","n":90,"dur":"24 weeks (after 8-week low-energy diet)","c":"Mount S et al. Nat Med 2026","p":"42120725","url":"https://pubmed.ncbi.nlm.nih.gov/42120725/","pl":false}],[13,108,"C","Body weight and HbA1c in overweight or obese type 2 diabetes (strain AKK-WST01)","In a 12-week RCT of 58 participants, live AKK-WST01 did not differ from placebo in body weight or HbA1c overall; reductions appeared only in those with low baseline A. muciniphila. It does not apply directly to pasteurized products.",{"st":"no-estimate","mt":"exact","om":"body weight and HbA1c","n":58,"dur":"12 weeks","c":"Zhang Y et al. Cell Metab 2025","p":"39879980","url":"https://pubmed.ncbi.nlm.nih.gov/39879980/","pl":false}],[13,216,"C","Blood sugar in people with diabetes (oral)","Small studies suggest oral aloe may lower fasting blood sugar and HbA1c in people with diabetes.",{"st":"none","pl":false}],[13,216,"C","Body weight in adults with overweight or obesity and diabetes or prediabetes","One small study found a specific oral gel product taken for 8 weeks modestly reduced body weight and fat mass.",{"st":"no-estimate","mt":"exact","om":"body weight and body fat mass","n":136,"dur":"8 wk","c":"Choi HC et al. Nutrition 2013","p":"23735317","url":"https://pubmed.ncbi.nlm.nih.gov/23735317/","pl":false}],[13,138,"C","Fasting blood sugar and body weight","A 2026 meta-analysis of seven studies found no significant change in fasting blood sugar, body weight, BMI or waist circumference.",{"st":"pooled","mt":"exact","m":"WMD","v":0.05,"lo":-0.05,"hi":0.16,"u":"mmol/L","om":"fasting blood sugar","c":"Lohrasbi N et al. Endocrinol Diabetes Metab 2026","p":"41317342","url":"https://pubmed.ncbi.nlm.nih.gov/41317342/","pl":true}],[13,75,"C","Cardiometabolic measures in prediabetes and diabetes","A 2022 review of 20 studies (1,295 participants) reported improved fasting glucose and other factors, but NCCIH calls blood-sugar research overall inconclusive and conflicting.",{"st":"no-estimate","mt":"partial","om":"fasting plasma glucose and other cardiometabolic markers","k":20,"c":"Naseri K et al. Nutrients 2022","p":"35745129","url":"https://pubmed.ncbi.nlm.nih.gov/35745129/","pl":false}],[13,217,"C","Blood glucose in type 2 diabetes (added to metformin)","A 2024 review of 20 studies (953 adults) found larger falls in fasting glucose and HbA1c with astragalus plus metformin than metformin alone; most studies were low quality with bias.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.67,"lo":-1.13,"hi":-0.2,"om":"fasting plasma glucose","k":20,"n":953,"c":"Hong KF et al. J Integr Complement Med 2024","p":"37433206","url":"https://pubmed.ncbi.nlm.nih.gov/37433206/","pl":true}],[13,141,"C","Glucose tolerance in type 2 diabetes (added to metformin)","A randomized placebo-controlled crossover trial (3.52 g/day, 8-week periods) in patients already on metformin reported better glucose tolerance with the root; some participants had raised liver enzymes.",{"st":"no-estimate","mt":"exact","om":"glucose tolerance","dur":"8 wk per crossover period","c":"Shin NR et al. Am J Physiol Endocrinol Metab 2020","p":"31770016","url":"https://pubmed.ncbi.nlm.nih.gov/31770016/","pl":false}],[13,172,"C","Body weight","Evidence comes mainly from preliminary studies with few clinical trials in people; NCCIH finds not enough rigorous evidence to judge effectiveness.",{"st":"none","pl":false}],[13,173,"C","Blood sugar control in type 2 diabetes (Cochrane review)","A 2012 Cochrane review of four RCTs (479 participants, up to 3 months, generally high risk of bias) found no significant difference in glycemic control versus placebo, metformin or glibenclamide and called the evidence insufficient.",{"st":"no-estimate","mt":"exact","om":"glycaemic control","k":4,"n":479,"dur":"up to three months","c":"Ooi CP et al. Cochrane Database Syst Rev 2012","p":"22895968","url":"https://pubmed.ncbi.nlm.nih.gov/22895968/","pl":false}],[13,173,"C","Metabolic syndrome measures (2024 meta-analysis)","A 2024 meta-analysis of nine RCTs (414 patients, 4–16 weeks) found no significant effect versus placebo on fasting glucose, HbA1c, lipids, body weight or blood pressure; statistical power was low.",{"st":"pooled","mt":"partial","m":"MD","v":-0.03,"lo":-0.38,"hi":0.31,"om":"fasting blood glucose","k":9,"n":414,"i2":34,"dur":"4-16 weeks","c":"Laczkó-Zöld E et al. Front Nutr 2023","p":"38274207","url":"https://pubmed.ncbi.nlm.nih.gov/38274207/","pl":true}],[13,173,"C","Body weight and body composition","A 2024 meta-analysis of 10 trials (448 participants) found no significant change in body weight, BMI, waist circumference or percentage body fat.",{"st":"pooled","mt":"exact","m":"WMD","v":0.04,"lo":-0.16,"hi":0.25,"u":"Kg","om":"body weight (BW)","k":10,"n":448,"c":"Zou Y et al. Prostaglandins Other Lipid Mediat 2024","p":"39079610","url":"https://pubmed.ncbi.nlm.nih.gov/39079610/","pl":true}],[13,110,"C","Body weight","Effect is unclear: studies were small with conflicting results, and most tested combination products, so bitter orange's own effect cannot be isolated.",{"st":"none","pl":false}],[13,110,"C","Weight-loss trials reviewed systematically","A 2011 systematic review of four weight-loss trials found the efficacy evidence contradictory and weak; all reviews called for longer, rigorous, larger trials.",{"st":"none","pl":false}],[13,111,"C","Fasting blood glucose","A 2024 meta-analysis pooling animal studies and RCTs found lower fasting glucose in human studies (SMD -0.51, 95% CI -0.98 to -0.05).",{"st":"pooled","mt":"exact","m":"SMD","v":-0.51,"lo":-0.98,"hi":-0.05,"om":"fasting blood glucose (human studies)","c":"Na Takuathung M et al. Nutr Res 2024","p":"38194854","url":"https://pubmed.ncbi.nlm.nih.gov/38194854/","pl":true}],[13,218,"C","Weight loss alongside a reduced-calorie diet (EU traditional use)","EMA's herbal committee found clinical evidence insufficient; a study of a combined preparation in obese postmenopausal women had shortcomings, such as an inadequate statistical method, so firm conclusions could not be drawn.",{"st":"none","pl":false}],[13,218,"C","Body weight and blood glucose in prediabetes (Ascophyllum plus Fucus extract)","A 12-week RCT in 56 overweight or obese prediabetic adults found no effect of 500 mg/day brown-seaweed extract on body weight or blood glucose versus placebo; C-peptide and IL-6 changed slightly.",{"st":"no-estimate","mt":"exact","om":"body weight and blood glucose","n":56,"dur":"12 weeks","c":"Vodouhè M et al. Mar Drugs 2022","p":"35323474","url":"https://pubmed.ncbi.nlm.nih.gov/35323474/","pl":false}],[13,218,"C","Insulin response to a carbohydrate meal (single dose)","In a crossover RCT in 23 adults, 500 mg of an Ascophyllum nodosum and Fucus vesiculosus blend before 50 g of carbohydrate lowered the insulin response by 12.1% but did not change glucose.",{"st":"no-ci","mt":"exact","m":"percent-change","v":12.1,"u":"%","om":"insulin incremental area under the curve after 50 g carbohydrate","n":23,"dur":"single dose","c":"Paradis ME, Couture P, Lamarche B. Appl Physiol Nutr Metab 2011","p":"22087795","url":"https://pubmed.ncbi.nlm.nih.gov/22087795/","pl":false}],[13,219,"C","Weight in obese adults with impaired glucose tolerance or type 2 diabetes (agar)","RCT in 76 patients: adding agar to a conventional diet for 12 weeks gave greater weight loss (−2.8 vs −1.3 kg) and total cholesterol reduction than diet alone.",{"st":"no-estimate","mt":"exact","om":"change in body weight","dur":"12 weeks","c":"Maeda H et al. Diabetes Obes Metab 2005","p":"15642074","url":"https://pubmed.ncbi.nlm.nih.gov/15642074/","pl":false}],[13,196,"C","Blood glucose in type 2 diabetes","A 2019 review of 58 trials found slightly lower fasting glucose and HbA1c of unclear clinical significance; a 24-week trial (137 people, 1,000 mcg/day picolinate) found no significant effect.",{"st":"none","pl":false}],[13,196,"C","Metabolic syndrome","Two trials (63 people, 500 mcg twice daily, 16 weeks; 70 people, 300 mcg/day, 24 weeks) showed no meaningful benefit.",{"st":"no-estimate","mt":"partial","om":"insulin sensitivity index","n":63,"dur":"16 weeks","c":"Iqbal N et al. Metab Syndr Relat Disord 2009","p":"19422140","url":"https://pubmed.ncbi.nlm.nih.gov/19422140/","pl":false}],[13,220,"C","Blood sugar in type 1 or type 2 diabetes","Cochrane 2012: 10 RCTs, 577 participants, mostly cassia at a mean 2 g daily for 4 to 16 weeks; no significant HbA1c difference versus control, fasting glucose inconclusive, evidence insufficient.",{"st":"no-estimate","mt":"exact","om":"HbA1c; fasting blood glucose","k":10,"n":577,"dur":"4 to 16 weeks","c":"Leach MJ, Kumar S. Cochrane Database Syst Rev 2012","p":"22972104","url":"https://pubmed.ncbi.nlm.nih.gov/22972104/","pl":false}],[13,221,"C","Body weight and body fat in overweight adults","In an 8-week placebo-controlled RCT of 67 overweight adults, 300 mg/day of a stem-and-leaf extract lowered body fat and waist and hip size; the investigators' university funded the study.",{"st":"no-estimate","mt":"exact","om":"body fat percentage","n":67,"dur":"8 weeks","c":"Nash R et al. J Altern Complement Med 2019","p":"29912570","url":"https://pubmed.ncbi.nlm.nih.gov/29912570/","pl":false}],[13,221,"C","Body weight and blood lipids in overweight and obese adults","In a placebo-controlled trial of 168 overweight or obese adults (153 completed), 300 mg/day of the same extract reduced weight, body fat, total and LDL cholesterol, triglycerides and fasting glucose.",{"st":"no-estimate","mt":"exact","om":"body weight, body fat, lipids, fasting glucose","n":168,"c":"Oben JE et al. Lipids Health Dis 2007","p":"17274828","url":"https://pubmed.ncbi.nlm.nih.gov/17274828/","pl":false}],[13,42,"C","Blood sugar measures in adults","A 2021 meta-analysis of 8 RCTs (552 adults) found no significant effect of cumin on fasting glucose, insulin or HOMA-IR versus placebo.",{"st":"pooled","mt":"exact","m":"WMD","v":-17.77,"lo":-36.42,"hi":0.87,"u":"mg/dl","om":"fasting blood sugar","n":552,"c":"Karimian J et al. Phytother Res 2021","p":"33720457","url":"https://pubmed.ncbi.nlm.nih.gov/33720457/","pl":true}],[13,42,"C","Blood sugar in chronic disease","A second 2021 meta-analysis of 8 controlled trials in people with chronic diseases reported lower fasting glucose and HbA1c, but no significant change in insulin.",{"st":"pooled","mt":"exact","m":"SMD","v":-1.4,"lo":-2.29,"hi":-0.51,"om":"fasting blood sugar","c":"Tavakoli-Rouzbehani OM et al. J Ethnopharmacol 2021","p":"34371114","url":"https://pubmed.ncbi.nlm.nih.gov/34371114/","pl":true}],[13,115,"C","Post-meal blood glucose in prediabetes (12 weeks)","In an RCT of 80 prediabetic adults, a dieckol-rich extract (1,500 mg/day for 12 weeks) lowered postprandial glucose versus placebo; insulin and C-peptide did not differ significantly from placebo.",{"st":"no-estimate","mt":"exact","om":"postprandial glucose","dur":"12 weeks","c":"Lee SH, Jeon YJ. Food Funct 2015","p":"25608849","url":"https://pubmed.ncbi.nlm.nih.gov/25608849/","pl":false}],[13,115,"C","Post-meal blood glucose in prediabetes (single dose)","In an RCT in 20 prediabetic adults, a single 600 mg dose lowered glucose at 90 and 120 minutes after a 75 g carbohydrate load, but glucose area under the curve and insulin did not differ.",{"st":"no-estimate","mt":"exact","om":"postprandial blood glucose at 90 and 120 min","dur":"single dose","c":"Almutairi MG et al. Food Sci Nutr 2023","p":"36789057","url":"https://pubmed.ncbi.nlm.nih.gov/36789057/","pl":false}],[13,115,"C","Glucose and lipids across marine algal polyphenol trials","A 2018 systematic review of five trials (271 adults) found small-to-medium effects on fasting glucose, total and LDL cholesterol, but inadequate evidence to confirm consistent effects.",{"st":"no-estimate","mt":"exact","om":"fasting glucose, total and LDL cholesterol","n":271,"c":"Murray M et al. Crit Rev Food Sci Nutr 2018","p":"28414549","url":"https://pubmed.ncbi.nlm.nih.gov/28414549/","pl":false}],[13,13,"C","Blood sugar in type 2 diabetes","Some research suggests fenugreek may lower blood sugar, but many studies were not high quality; NCCIH finds not enough high-quality evidence to judge.",{"st":"none","pl":false}],[13,222,"C","Body weight in adults with overweight or obesity","One clinical trial suggests flaxseed mucilage powder mixed with water might support weight loss; flaxseed lignan extract and flaxseed oil supplements do not seem to help.",{"st":"no-estimate","mt":"partial","om":"body weight reduction","n":108,"dur":"12 weeks","c":"Bongartz U et al. Obes Facts 2022","p":"35130547","url":"https://pubmed.ncbi.nlm.nih.gov/35130547/","pl":false}],[13,222,"C","Fasting glucose and insulin resistance in gestational diabetes","Some research suggests ALA-containing flaxseed oil supplements might improve fasting measures and insulin resistance in pregnant people with gestational diabetes.",{"st":"no-estimate","mt":"partial","om":"fasting plasma glucose, insulin, insulin resistance","n":60,"dur":"6 weeks","c":"Jamilian M et al. Br J Nutr 2020","p":"31902378","url":"https://pubmed.ncbi.nlm.nih.gov/31902378/","pl":false}],[13,222,"C","Blood sugar control in type 2 diabetes (lignan extract)","NCCIH states more research is needed on whether flaxseed lignan extract improves glycemic control or fasting blood glucose.",{"st":"none","pl":false}],[13,200,"C","Blood sugar in type 2 diabetes","Crossover RCT in 30 patients: 1,620 mg/day for 12 weeks increased stool frequency; HbA1c fell slightly (6.73% to 6.59%) only in a subgroup of 14 without insulin resistance.",{"st":"no-estimate","mt":"exact","om":"HbA1c","dur":"12 weeks per crossover period","c":"Sakai C et al. Yonago Acta Med 2019","p":"30962740","url":"https://pubmed.ncbi.nlm.nih.gov/30962740/","pl":false}],[13,59,"C","Insulin sensitivity in prediabetes","In a 12-week double-blind RCT in 44 overweight or obese prediabetic adults, 15 g/day GOS did not improve insulin sensitivity measured by hyperinsulinemic-euglycemic clamp, although it increased Bifidobacterium.",{"st":"no-estimate","mt":"exact","om":"peripheral insulin sensitivity (hyperinsulinemic-euglycemic clamp)","n":44,"c":"Canfora EE et al. Gastroenterology 2017","p":"28396144","url":"https://pubmed.ncbi.nlm.nih.gov/28396144/","pl":false}],[13,177,"C","Body weight in adults with obesity (12-week trial)","In a 12-week placebo-controlled trial cited by LiverTox, 135 adults with obesity given HCA 1,500 mg daily lost a similar amount of weight as those on placebo (3.2 vs 4.1 kg).",{"st":"no-estimate","mt":"exact","u":"kg","om":"body weight change","n":135,"dur":"12 weeks","c":"Heymsfield SB et al. JAMA 1998","p":"9820262","url":"https://pubmed.ncbi.nlm.nih.gov/9820262/","pl":false}],[13,177,"C","Weight loss overall (NCCIH assessment)","NCCIH states it is unclear whether Garcinia cambogia products help with weight loss: some evidence suggests a modest effect, while other evidence shows none.",{"st":"none","pl":false}],[13,177,"C","Fasting glucose, insulin and liver enzymes","A 2025 meta-analysis of nine publications (444 participants) found no significant effect on fasting blood sugar, insulin, ALT or AST compared with control groups.",{"st":"pooled","mt":"exact","m":"WMD","v":1.02,"lo":-1.29,"hi":3.33,"u":"mg/dl","om":"fasting blood sugar","k":9,"n":444,"c":"Tavakoli S et al. J Nutr Sci 2025","p":"39943939","url":"https://pubmed.ncbi.nlm.nih.gov/39943939/","pl":true}],[13,178,"C","Blood sugar in people with diabetes","NCCIH states garlic supplements may reduce blood sugar to a small extent.",{"st":"none","pl":false}],[13,165,"C","Body weight in overweight or obese people","Pooling 8 placebo-controlled RCTs showed no statistically significant weight loss (mean difference -0.22 kg); reporting quality varied across trials.",{"st":"pooled","mt":"exact","m":"MD","v":-0.22,"lo":-0.62,"hi":0.19,"u":"kg","om":"body weight","k":8,"i2":65,"c":"Onakpoya I et al. J Am Coll Nutr 2014","p":"24533610","url":"https://pubmed.ncbi.nlm.nih.gov/24533610/","pl":true}],[13,165,"C","Weight loss (NIH ODS summary)","ODS describes effects on weight as inconsistent: a 2015 review of 6 trials (293 participants, 1.24–3.99 g/day for up to 12 weeks) found no significant effect on body weight.",{"st":"no-estimate","mt":"partial","om":"body weight","k":6,"c":"Zalewski BM et al. Nutrition 2015","p":"25701331","url":"https://pubmed.ncbi.nlm.nih.gov/25701331/","pl":false}],[13,153,"C","Insulin sensitivity in obese men with or without type 2 diabetes","A 3-week double-blind RCT in 20 men found whole-body insulin sensitivity increased with 1,000 mg/day glutathione; markers of oxidative stress did not change.",{"st":"no-estimate","mt":"exact","om":"whole-body insulin sensitivity (hyperinsulinemic-euglycemic clamp)","c":"Søndergård SD et al. Appl Physiol Nutr Metab 2021","p":"33740389","url":"https://pubmed.ncbi.nlm.nih.gov/33740389/","pl":false}],[13,201,"C","Blood glucose in type 2 diabetes","MSK describes preliminary data suggesting hypoglycemic effects in type 2 diabetes and states that human studies are limited.",{"st":"none","pl":false}],[13,180,"C","Body weight","NCCIH reports that catechins and caffeine may have a modest effect, and that results may vary with product composition and physical activity.",{"st":"none","pl":false}],[13,181,"C","Glycemic control in type 2 diabetes","A 2021 meta-analysis (10 studies, 419 participants) reported reductions in fasting and post-meal glucose and HbA1c, but compared post-treatment values with baseline rather than with a control group; heterogeneity was high.",{"st":"pooled","mt":"exact","m":"SMD","v":1.57,"lo":2.22,"hi":-0.93,"om":"reduction in fasting blood glucose vs baseline","k":10,"n":419,"i2":90,"c":"Devangan S et al. Phytother Res 2021","p":"34467577","url":"https://pubmed.ncbi.nlm.nih.gov/34467577/","pl":false,"pr":"interval printed with lower > upper"}],[13,181,"C","Overall effectiveness in diabetes","LiverTox states that several human trials showed mild decreases in fasting glucose, but overall effectiveness in diabetes has not been shown.",{"st":"none","pl":false}],[13,130,"C","Blood glucose control","A 2020 meta-analysis of 6 trials (318 participants) found no significant effect on fasting glucose, insulin, HbA1c, HOMA-IR or QUICKI.",{"st":"pooled","mt":"exact","m":"WMD","v":-1.1,"lo":-3.79,"hi":1.57,"u":"mg/dL","om":"fasting blood glucose","k":6,"n":318,"c":"Shams-Rad S et al. Br J Clin Pharmacol 2020","p":"31489695","url":"https://pubmed.ncbi.nlm.nih.gov/31489695/","pl":true}],[13,51,"C","Blood glucose in type 2 diabetes","A single-blind, placebo-controlled crossover trial (1996) reported fasting glucose 21.0 mg/dl and post-meal glucose 15.8 mg/dl lower with holy basil leaves than placebo leaves.",{"st":"single-trial","mt":"exact","m":"MD","v":-21.0,"lo":-31.4,"hi":-11.2,"u":"mg/dl","om":"fasting blood glucose","c":"Agrawal P et al. Int J Clin Pharmacol Ther 1996","p":"8880292","url":"https://pubmed.ncbi.nlm.nih.gov/8880292/","pl":false,"sn":"printed without a minus sign; shown as a reduction"}],[13,203,"C","Blood glucose and lipids in type 2 diabetes","In a 12-week trial in 48 adults with type 2 diabetes, 30 g/day dried jujube lowered fasting glucose, triglycerides, total and LDL cholesterol compared with control.",{"st":"no-estimate","mt":"exact","om":"fasting plasma glucose, TG, TC, LDL-C","n":48,"dur":"12 weeks","c":"Farhadnejad H et al. Clin Nutr ESPEN 2022","p":"35623863","url":"https://pubmed.ncbi.nlm.nih.gov/35623863/","pl":false}],[13,214,"C","Glucose and lipid measures with algae and seaweed extracts","2020 meta-analysis of 27 RCTs (1,221 participants) pooling various algae and extracts: HbA1c −0.18% and triglycerides lower, but HDL also fell and fasting glucose did not change.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.18,"lo":-0.27,"hi":-0.1,"u":"%","om":"HbA1c","k":27,"n":1221,"c":"Ding KX et al. Nutrients 2020","p":"32521609","url":"https://pubmed.ncbi.nlm.nih.gov/32521609/","pl":true}],[13,1,"C","Glycemic control in type 2 diabetes","Small trials conflict: magnesium oxide or chloride improved glucose measures in some, while a 3-month trial (50 insulin-treated patients, 369 mg/day) found no effect. The ADA found not enough evidence to recommend it.",{"st":"no-estimate","mt":"partial","om":"glycaemic control (glucose, HbA1c)","dur":"3 months","c":"de Valk HW et al. Diabet Med 1998","p":"9632126","url":"https://pubmed.ncbi.nlm.nih.gov/9632126/","pl":false}],[13,223,"C","Type 2 diabetes","Observational studies link both higher and lower blood manganese to diabetes, and some find no association; clinical trials in humans are lacking.",{"st":"none","pl":false}],[13,67,"C","Insulin resistance in women with obesity","A 26-week randomized pilot (22 women, 20 completed) comparing behavioral therapy with or without mangosteen extract reported a significant improvement in insulin sensitivity in the mangosteen group.",{"st":"no-estimate","mt":"exact","om":"HOMA-IR","n":22,"dur":"26 weeks","c":"Watanabe M et al. Nutrients 2018","p":"29747432","url":"https://pubmed.ncbi.nlm.nih.gov/29747432/","pl":false}],[13,45,"C","Blood sugar in type 2 diabetes","A small number of studies, mostly from Middle Eastern countries, suggest extracts may help control blood sugar; generalizability is unclear.",{"st":"none","pl":false}],[13,37,"C","Blood sugar, blood lipids and body weight in adults","A 2025 meta-analysis of nine randomized trials (649 participants) found no significant effect on most cardiometabolic outcomes; GRADE certainty was very low for all outcomes.",{"st":"no-estimate","mt":"exact","om":"cardiometabolic outcomes (glycemic, lipid, anthropometric)","k":9,"c":"Crișan D et al. Nutrients 2025","p":"41305552","url":"https://pubmed.ncbi.nlm.nih.gov/41305552/","pl":false}],[13,38,"C","Metabolic and hormonal measures in PCOS","A guideline meta-analysis of 30 trials (2,230 women) found possible benefits for some metabolic measures but likely no effect on other outcomes; evidence was limited and inconclusive.",{"st":"no-estimate","mt":"exact","om":"metabolic, hormonal and reproductive outcomes in PCOS","n":2230,"c":"Fitz V et al. J Clin Endocrinol Metab 2024","p":"38163998","url":"https://pubmed.ncbi.nlm.nih.gov/38163998/","pl":false}],[13,224,"C","Blood sugar in adults with metabolic syndrome","One 12-week RCT (80 adults; 125-500 mg twice daily of a leaf-and-twig extract) reported dose-dependent improvements in fasting glucose, HbA1c and insulin resistance.",{"st":"no-estimate","mt":"exact","om":"fasting blood sugar, HbA1c, insulin resistance","dur":"12 weeks","c":"Pingali U et al. J Med Food 2021","p":"34582720","url":"https://pubmed.ncbi.nlm.nih.gov/34582720/","pl":false}],[13,121,"C","Body weight, glucose and blood lipids in adults","A meta-analysis of 15 randomized trials found no significant effects on body weight, BMI, fasting glucose, HbA1c or lipids; insulin resistance (HOMA-IR) showed a non-significant downward trend.",{"st":"no-estimate","mt":"exact","om":"body weight, BMI, fasting glucose, HbA1c, lipids, HOMA-IR","dur":"14 days to 24 weeks","c":"Yang W et al. Nutrients 2026","p":"42514320","url":"https://pubmed.ncbi.nlm.nih.gov/42514320/","pl":false}],[13,207,"C","Fasting blood glucose and cardiometabolic markers","A meta-analysis of 12 RCTs (703 adults, 2 days to 12 weeks) found that fasting glucose, in studies using low doses, favored the control group; authors called for more consistent trials.",{"st":"no-estimate","mt":"exact","om":"fasting glycemia","k":12,"n":703,"dur":"2 days to 12 weeks","c":"Álvares AA et al. Nutr Rev 2024","p":"38287654","url":"https://pubmed.ncbi.nlm.nih.gov/38287654/","pl":false}],[13,189,"C","Blood glucose","Observational studies link low intake with higher diabetes risk; one small trial (29 adults with prediabetes, 40 mEq/day for 3 months) lowered fasting glucose only.",{"st":"no-estimate","mt":"exact","u":"mg/dL","om":"fasting glucose","c":"Chatterjee R et al. Am J Clin Nutr 2017","p":"29092881","url":"https://pubmed.ncbi.nlm.nih.gov/29092881/","pl":false}],[13,190,"C","Body weight in adults","A 2015 meta-analysis of five RCTs found no significant difference in body weight between Opuntia ficus-indica and controls (mean difference -0.83 kg, 95% CI -2.49 to 0.83); trials varied in design and reporting quality.",{"st":"pooled","mt":"exact","m":"MD","v":-0.83,"lo":-2.49,"hi":0.83,"u":"kg","om":"body weight","k":5,"i2":93,"c":"Onakpoya IJ et al. Nutrition 2015","p":"25837206","url":"https://pubmed.ncbi.nlm.nih.gov/25837206/","pl":true}],[13,190,"C","Blood glucose and insulin, fruit versus cladode","A 2019 systematic review of 20 human studies found cladode and some Opuntia products mostly reduced glucose and insulin, while the fruit mostly had no significant effect; fruit and cladode studies had high risk of bias.",{"st":"no-estimate","mt":"exact","om":"serum glucose and insulin","k":20,"c":"Gouws CA et al. Medicina (Kaunas) 2019","p":"31096667","url":"https://pubmed.ncbi.nlm.nih.gov/31096667/","pl":false}],[13,160,"C","Type 2 diabetes on one oral glucose-lowering drug","A 12-week placebo-controlled RCT (63 adults) of purslane extract found a larger systolic blood pressure drop (-7.5 vs -0.01 mmHg); HbA1c fell more only in a subgroup of responders.",{"st":"no-estimate","mt":"exact","om":"systolic blood pressure change from baseline to week 12","n":63,"dur":"12 weeks (week 12 end-of-follow-up)","c":"Wainstein J et al. J Med Food 2016","p":"26854844","url":"https://pubmed.ncbi.nlm.nih.gov/26854844/","pl":false}],[13,225,"C","Blood sugar, lipids and blood pressure in type 2 diabetes","Cochrane 2015: 5 trials (398 participants). In pooled data from type 2 diabetes trials (1.4–3 g/day, 12–16 weeks), HbA1c, cholesterol, blood pressure and triglycerides did not differ from placebo; risk of bias was unclear in 4 of 5 trials.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.1,"lo":-1.05,"hi":0.85,"u":"%","om":"HbA1c","k":2,"n":130,"dur":"12 to 16 weeks","c":"Klupp NL et al. Cochrane Database Syst Rev 2015","p":"25686270","url":"https://pubmed.ncbi.nlm.nih.gov/25686270/","pl":true}],[13,191,"C","Type 2 diabetes risk","FDA concluded there is limited credible evidence for a relationship between high-amylose maize starch (at least 50% RS2) and reduced type 2 diabetes risk; a few studies with mixed surrogate-endpoint results suggested a reduction.",{"st":"none","pl":false}],[13,6,"C","Blood sugar control in type 2 diabetes","A Cochrane review of 3 trials (50 adults; 10–1,000 mg/day for 4–5 weeks) found neutral effects on HbA1c, fasting glucose and insulin resistance; evidence was insufficient to judge efficacy or safety.",{"st":"pooled","mt":"exact","m":"MD","v":0.1,"lo":-0.02,"hi":0.2,"u":"%","om":"HbA1c","k":2,"n":31,"dur":"four weeks to five weeks","c":"Jeyaraman MM et al. Cochrane Database Syst Rev 2020","p":"31978258","url":"https://pubmed.ncbi.nlm.nih.gov/31978258/","pl":true}],[13,18,"C","Blood sugar markers","A 2019 meta-analysis of 5 placebo-controlled trials found no significant effect on fasting glucose (205 participants) or HbA1c (130 participants); the authors cite methodology issues and confounders such as diet.",{"st":"pooled","mt":"exact","m":"MD","v":-0.95,"lo":-5.83,"hi":3.87,"u":"mg/dl","om":"fasting plasma glucose (FPG)","k":5,"n":205,"i2":0,"c":"Mahboobi S et al. Complement Ther Med 2019","p":"31126561","url":"https://pubmed.ncbi.nlm.nih.gov/31126561/","pl":false,"sn":"printed without a minus sign; shown as a reduction"}],[13,192,"C","Seed oil: blood sugar in obese postmenopausal women with type 2 diabetes","In one double-masked crossover RCT (55 enrolled, 35 completed), 8 g/day safflower oil for 16 weeks lowered HbA1c and raised HDL cholesterol.",{"st":"no-ci","mt":"exact","m":"other","v":-0.64,"u":"%","om":"HbA1c","n":35,"dur":"16 weeks","c":"Asp ML et al. Clin Nutr 2011","p":"21295383","url":"https://pubmed.ncbi.nlm.nih.gov/21295383/","pl":false}],[13,26,"C","Blood sugar","NCCIH: there is not enough evidence to show whether sage affects blood glucose.",{"st":"none","pl":false}],[13,26,"C","Blood sugar and lipids in diabetes","A meta-analysis of 3 trials in people with diabetes reported lower fasting glucose (−31.15 mg/dL) and HbA1c (−0.94%); the authors called for stronger trials because so few exist.",{"st":"pooled","mt":"exact","m":"MD","v":-31.15,"lo":-37.56,"hi":-24.73,"u":"mg/dL","om":"fasting blood sugar","k":3,"c":"Abdollahi A et al. J Complement Integr Med 2023","p":"35106985","url":"https://pubmed.ncbi.nlm.nih.gov/35106985/","pl":true}],[13,27,"C","Blood glucose in adults with mild hyperglycemia (omija and soybean mixture)","A 12-week placebo-controlled trial in 80 adults found lower fasting and post-meal glucose with an omija-soybean extract mixture; schisandra alone was not tested.",{"st":"no-estimate","mt":"exact","om":"fasting plasma glucose","dur":"12 weeks","c":"Kim DS et al. Nutrients 2022","p":"35956334","url":"https://pubmed.ncbi.nlm.nih.gov/35956334/","pl":false}],[13,28,"C","Blood glucose, blood pressure and BMI","The 2022 Geng meta-analysis of 15 RCTs found no effect on blood sugar, blood pressure or body mass index.",{"st":"no-estimate","mt":"exact","om":"blood sugar, blood pressure, BMI","k":15,"c":"Geng Y et al. Phytother Res 2022","p":"36043374","url":"https://pubmed.ncbi.nlm.nih.gov/36043374/","pl":false}],[13,193,"C","Body weight and body fat in adults","A 2025 meta-analysis of 17 RCTs found small reductions in body weight (-1.07 kg), BMI (-0.40) and body fat percentage (-0.84%), but no significant change in waist circumference.",{"st":"none","pl":false}],[13,208,"C","Blood sugar and HbA1c","The 2019 Bundgaard Anker meta-analysis found no significant effect on HbA1c and only a non-significant reduction in fasting blood glucose.",{"st":"no-estimate","mt":"exact","om":"HbA1c and fasting blood glucose","k":9,"n":462,"c":"Bundgaard Anker CC et al. Nutrients 2019","p":"31438580","url":"https://pubmed.ncbi.nlm.nih.gov/31438580/","pl":false}],[13,194,"C","Insulin, glucose and body weight","In the 2025 Huang meta-analysis of 17 trials, insulin (−1.68 µU/mL), HOMA-IR and body weight (−1.03 kg) fell versus control, but fasting blood glucose did not change significantly.",{"st":"pooled","mt":"exact","m":"WMD","v":-1.68,"lo":-3.26,"hi":-0.09,"u":"µU/mL","om":"fasting insulin","k":17,"n":1170,"c":"Huang H et al. BMC Complement Med Ther 2025","p":"41372916","url":"https://pubmed.ncbi.nlm.nih.gov/41372916/","pl":true}],[13,194,"C","Glycemic measures (earlier pooled analysis)","A 2021 meta-analysis of 6 trials (278 participants) found no significant effect of sumac powder on fasting glucose, HbA1c, HOMA-IR or insulin.",{"st":"pooled","mt":"exact","m":"WMD","v":-7.08,"lo":-14.85,"hi":0.7,"u":"mg/dl","om":"fasting blood glucose","k":6,"n":278,"i2":59.8,"c":"Mohit M et al. Complement Ther Med 2021","p":"34365008","url":"https://pubmed.ncbi.nlm.nih.gov/34365008/","pl":true}],[13,56,"C","Blood sugar and lipids","A meta-analysis of 10 randomized trials found a small fall in fasting blood sugar (−0.51 mg/dl) and no effect on total cholesterol, triglycerides or HDL cholesterol.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.51,"lo":-0.98,"hi":-0.06,"u":"mg/dl","om":"fasting blood sugar","k":10,"c":"Moosavian SP et al. Complement Ther Med 2022","p":"36038032","url":"https://pubmed.ncbi.nlm.nih.gov/36038032/","pl":true}],[13,91,"C","Diabetes","Small studies used 150–300 mg/day thiamin and three benfotiamine trials used 120–900 mg/day; ODS states larger, longer, well-designed studies are required.",{"st":"none","pl":false}],[13,124,"C","Glucose control in type 2 diabetes","A 12-week RCT (50 patients, 100 mg/day liquid ubiquinol) reported lower HbA1c than placebo (P = 0.03) and higher catalase and glutathione peroxidase activities.",{"st":"no-estimate","mt":"exact","om":"HbA1c","dur":"12 weeks","c":"Yen CH et al. Br J Nutr 2018","p":"29936921","url":"https://pubmed.ncbi.nlm.nih.gov/29936921/","pl":false}],[13,210,"C","Glycemic control and blood lipids","A 2025 meta-analysis of six RCTs reported lower insulin, HbA1c and HOMA-IR with MK-7, with high heterogeneity (I2 84-87%), and no meaningful effect on other measures; authors called for higher-quality trials.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.56,"lo":-0.76,"hi":-0.35,"om":"HOMA-IR","i2":84.3,"c":"Nikpayam O et al. Prostaglandins Other Lipid Mediat 2025","p":"40054729","url":"https://pubmed.ncbi.nlm.nih.gov/40054729/","pl":true}],[13,211,"C","Overall blood sugar management (2022 review)","A 2022 systematic review of RCTs found Morus alba can reduce post-meal glucose and insulin but judged the evidence insufficient to conclude it is effective for lowering blood glucose.",{"st":"no-estimate","mt":"exact","om":"postprandial glucose and insulin; blood glucose","c":"Jeong HI, Jang S, Kim KH. Evid Based Complement Alternat Med 2022","p":"35656460","url":"https://pubmed.ncbi.nlm.nih.gov/35656460/","pl":false}],[13,211,"C","Obese adults with borderline diabetes","In a 12-week randomized study, leaf powder (12 mg DNJ three times daily) lowered fasting glucose by 3.86 mg/dL and HbA1c by 0.11% from baseline; glucose tolerance did not improve.",{"st":"no-ci","mt":"exact","m":"other","v":3.86,"u":"mg/dL","om":"decrease in fasting plasma glucose from baseline","dur":"12 weeks","c":"Thaipitakwong T et al. Complement Ther Med 2020","p":"32147046","url":"https://pubmed.ncbi.nlm.nih.gov/32147046/","pl":false}],[13,226,"C","Type 2 diabetes and glucose measures","Meta-analyses reported improved glucose and lipid measures, but ODS concludes the evidence to date is insufficient to support any conclusions.",{"st":"none","pl":false}],[13,112,"D","Blood glucose, weight and blood pressure in rats","Aqueous buchu extract normalized glucose in diabetic rats, and in rats on a high-fat diet it reduced weight gain and returned diet-raised blood pressure to control values; the review authors say these results remain questionable in humans without trials.",{"st":"not-human","pl":false}],[13,152,"D","Blood sugar","Terpenoids inhibited the enzyme alpha-glucosidase in laboratory tests, and antidiabetic effects were studied in diabetic mice; not studied in people.",{"st":"not-human","pl":false}],[13,125,"D","Blood glucose in diabetic rodents","A meta-analysis of 12 rodent studies found lower blood glucose with rooibos extracts or their polyphenols, with substantial heterogeneity; no human data were included.",{"st":"not-human","pl":false}],[13,108,"X","Whole-body insulin sensitivity in adults with metabolic syndrome","In a double-blind placebo-controlled trial of 142 adults, 4 months of pasteurized MucT (30 billion cells/day) did not change the primary endpoint (Matsuda index); benefits appeared only in exploratory subgroups.",{"st":"no-estimate","mt":"exact","om":"whole-body insulin sensitivity (Matsuda index)","n":142,"dur":"4 months","c":"Suenaert P et al. Gut Microbes 2026","p":"42343233","url":"https://pubmed.ncbi.nlm.nih.gov/42343233/","pl":false}],[13,100,"X","Body weight and body composition","A 2022 meta-analysis found betaine did not significantly change body mass, BMI, body fat percentage, fat mass or fat-free mass compared with control.",{"st":"pooled","mt":"partial","m":"WMD","v":-0.4,"lo":-1.46,"hi":0.64,"u":"kg","om":"body mass","c":"Ashtary-Larky D et al. Br J Nutr 2022","p":"34743773","url":"https://pubmed.ncbi.nlm.nih.gov/34743773/","pl":true}],[13,34,"X","Body weight and body fat","A meta-analysis of 41 RCTs (4,802 adults) found calcium supplements had no effect on weight or body fat.",{"st":"pooled","mt":"partial","m":"MD","v":-0.17,"lo":-0.7,"hi":0.37,"u":"kg","om":"body weight (calcium supplements)","k":20,"n":2711,"c":"Booth AO et al. Br J Nutr 2015","p":"26234296","url":"https://pubmed.ncbi.nlm.nih.gov/26234296/","pl":true}],[13,120,"X","Insulin sensitivity in obese, insulin-resistant men","A 12-week randomized trial in 40 men (2,000 mg/day) found no improvement in clamp-measured insulin sensitivity, glucose metabolism, energy expenditure or body composition.",{"st":"no-estimate","mt":"exact","om":"insulin sensitivity (hyperinsulinemic euglycemic clamp)","n":40,"dur":"12 wk","c":"Dollerup OL et al. Am J Clin Nutr 2018","p":"29992272","url":"https://pubmed.ncbi.nlm.nih.gov/29992272/","pl":false}],[13,70,"X","Type 2 diabetes in prediabetes","A trial in 2,423 adults with prediabetes and overweight or obesity (4,000 IU/day D3, median 2.5 years) found no significant reduction in diabetes versus placebo.",{"st":"single-trial","mt":"exact","m":"HR","v":0.88,"lo":0.75,"hi":1.04,"om":"new-onset type 2 diabetes","n":2423,"dur":"median follow-up of 2.5 years","c":"Pittas AG et al. N Engl J Med 2019","p":"31173679","url":"https://pubmed.ncbi.nlm.nih.gov/31173679/","pl":true}],[14,227,"A","Antibiotic-associated diarrhea in children and adults","A 2015 meta-analysis of 21 RCTs (4,780 participants) found S. boulardii lowered antibiotic-associated diarrhea risk from 18.7% to 8.5% versus placebo or no treatment (children 20.9% to 8.8%; adults 17.4% to 8.2%).",{"st":"pooled","mt":"exact","m":"RR","v":0.47,"lo":0.38,"hi":0.57,"om":"antibiotic-associated diarrhoea","k":21,"n":4780,"c":"Szajewska H, Kołodziej M. Aliment Pharmacol Ther 2015","p":"26216624","url":"https://pubmed.ncbi.nlm.nih.gov/26216624/","pl":true}],[14,140,"B","Irritable bowel syndrome in adults (strain Unique IS2)","In an RCT of 136 adults with IBS, Unique IS2 (2 billion CFU/day for 8 weeks) improved abdominal pain/discomfort and complete spontaneous bowel movements versus placebo.",{"st":"no-estimate","mt":"exact","om":"abdominal discomfort/pain intensity and complete spontaneous bowel movements","n":136,"dur":"8 weeks","c":"Madempudi RS et al. Sci Rep 2019","p":"31434935","url":"https://pubmed.ncbi.nlm.nih.gov/31434935/","pl":false}],[14,140,"B","Irritable bowel syndrome in children aged 4–12 (strain Unique IS2)","In a double-blind RCT of 141 children, 8 weeks of Unique IS2 chewable tablets reduced pain intensity and improved stool consistency, bloating and other IBS symptoms versus placebo.",{"st":"no-estimate","mt":"exact","om":"reduction in pain intensity (weekly pain intensity scale)","n":141,"dur":"8 weeks","c":"Sudha MR et al. Benef Microbes 2018","p":"29695183","url":"https://pubmed.ncbi.nlm.nih.gov/29695183/","pl":false}],[14,228,"B","Infant colic in breastfed infants (larger trial)","In an RCT of 192 breastfed infants with colic in China, BB-12 (1 x 10^9 CFU/day for 21 days) increased the share with at least 50% less crying and fussing versus placebo.",{"st":"no-estimate","mt":"exact","om":"proportion of infants with >=50% reduction in daily crying/fussing time","dur":"21 days","c":"Chen K et al. Benef Microbes 2021","p":"34550055","url":"https://pubmed.ncbi.nlm.nih.gov/34550055/","pl":false}],[14,228,"B","Infant colic in breastfed infants (smaller trial)","In an RCT of 80 exclusively breastfed infants with colic in Italy, BB-12 (1 x 10^9 CFU/day for 28 days) increased the rate of at least 50% less daily crying versus placebo.",{"st":"no-estimate","mt":"exact","om":"rate of infants with >=50% reduction of mean daily crying duration","n":80,"dur":"28 days","c":"Nocerino R et al. Aliment Pharmacol Ther 2020","p":"31797399","url":"https://pubmed.ncbi.nlm.nih.gov/31797399/","pl":false}],[14,229,"B","Ulcerative colitis: relapse and remission versus mesalazine (pooled trials)","A 2015 meta-analysis of 6 trials (719 patients) found relapse rates similar with EcN and mesalazine (36.8% vs 36.1%); remission induction was similar to controls, and only one study used a placebo comparison.",{"st":"pooled","mt":"exact","m":"OR","v":1.07,"lo":0.7,"hi":1.64,"om":"ulcerative colitis relapse","k":6,"n":719,"c":"Losurdo G et al. J Gastrointestin Liver Dis 2015","p":"26697577","url":"https://pubmed.ncbi.nlm.nih.gov/26697577/","pl":true}],[14,229,"B","Acute diarrhea in infants and toddlers","In a double-blind RCT of 113 children aged 2–47 months, EcN suspension shortened the median time to treatment response (2.5 vs 4.8 days) versus placebo.",{"st":"no-ci","mt":"exact","m":"other","v":2.3,"u":"days","om":"time to treatment response","n":113,"c":"Henker J et al. Eur J Pediatr 2007","p":"17287932","url":"https://pubmed.ncbi.nlm.nih.gov/17287932/","pl":false}],[14,229,"B","Diarrhea lasting more than 4 days in infants and toddlers","In an RCT of 151 children aged 1–47 months, 21 days of EcN raised response rates versus placebo (day 21: 98.7% vs 71.1%).",{"st":"no-ci","mt":"partial","m":"other","v":3.3,"u":"days","om":"time to treatment response","dur":"21 days","c":"Henker J et al. Pediatr Infect Dis J 2008","p":"18469732","url":"https://pubmed.ncbi.nlm.nih.gov/18469732/","pl":false}],[14,59,"B","Lactose intolerance symptoms","In a 30-day double-blind RCT in 377 patients with lactose intolerance, 40% given the purified GOS RP-G28 had a 4-point or greater symptom-score reduction or no symptoms, versus 26% on placebo (P = 0.016).",{"st":"no-estimate","mt":"exact","om":"responders: ≥4-point reduction or zero on lactose-intolerance symptom composite score","n":377,"dur":"30 days","c":"Chey W et al. Nutrients 2020","p":"32290344","url":"https://pubmed.ncbi.nlm.nih.gov/32290344/","pl":false}],[14,14,"B","Nausea and vomiting of pregnancy","NCCIH states research shows ginger may be helpful; most studies tested dietary supplements rather than foods.",{"st":"none","pl":false}],[14,183,"B","Bowel movement frequency","A 2019 meta-analysis of 47 publications found short-chain β-fructans (DP below 10) increased stool frequency by 0.36 bowel movements per day; long-chain β-fructans (DP 10 or more) had no significant effect.",{"st":"no-ci","mt":"exact","m":"other","v":0.36,"u":"defecations per day","om":"bowel movement frequency","k":47,"c":"de Vries J et al. Nutrients 2019","p":"30621208","url":"https://pubmed.ncbi.nlm.nih.gov/30621208/","pl":false}],[14,163,"B","Antibiotic-associated diarrhea","A 2015 meta-analysis of 12 RCTs (1,499 participants) found LGG lowered risk from 22.4% to 12.3% (11 RCTs; low-quality evidence); the reduction was significant in children (5 RCTs) but not in adults overall (6 RCTs).",{"st":"pooled","mt":"exact","m":"RR","v":0.49,"lo":0.29,"hi":0.83,"om":"antibiotic-associated diarrhoea (risk)","k":11,"n":1308,"c":"Szajewska H et al. Aliment Pharmacol Ther 2015","p":"26365389","url":"https://pubmed.ncbi.nlm.nih.gov/26365389/","pl":true}],[14,163,"B","Duration of diarrhea in children with acute gastroenteritis (pooled trials)","A 2019 meta-analysis of 18 RCTs (4,208 children) found LGG shortened diarrhea by 0.85 day and hospital stays, with no effect on stool volume; heterogeneity was high and trials had methodological limitations.",{"st":"pooled","mt":"exact","m":"MD","v":-0.85,"lo":-1.15,"hi":-0.56,"u":"day","om":"duration of diarrhoea","k":15,"n":3820,"c":"Szajewska H et al. Aliment Pharmacol Ther 2019","p":"31025399","url":"https://pubmed.ncbi.nlm.nih.gov/31025399/","pl":true}],[14,163,"B","Abdominal pain-related functional GI disorders in children","A 2011 meta-analysis (3 RCTs, 290 children) found more treatment responders with LGG than placebo (RR 1.31), especially in irritable bowel syndrome; no difference in functional abdominal pain or dyspepsia.",{"st":"pooled","mt":"exact","m":"RR","v":1.31,"lo":1.08,"hi":1.59,"om":"treatment responders (no pain or decreased pain intensity)","n":290,"c":"Horvath A et al. Aliment Pharmacol Ther 2011","p":"21507030","url":"https://pubmed.ncbi.nlm.nih.gov/21507030/","pl":true}],[14,230,"B","Irritable bowel syndrome symptoms in adults (pooled single-strain trials)","A 2026 meta-analysis of 6 placebo-controlled RCTs of 299v alone found lower abdominal pain severity and more patients reporting symptom improvement, but no significant effect on bloating or constipation resolution; heterogeneity varied.",{"st":"no-estimate","mt":"partial","om":"IBS symptoms","c":"Maslennikov R et al. J Clin Med 2026","p":"41682832","url":"https://pubmed.ncbi.nlm.nih.gov/41682832/","pl":false}],[14,230,"B","Irritable bowel syndrome global symptoms (broad meta-analysis)","A 2023 meta-analysis of 82 IBS trials (10,332 patients) rated the certainty of evidence for a benefit of L. plantarum 299V on global symptoms as low.",{"st":"no-estimate","mt":"exact","om":"IBS global symptoms","c":"Goodoory VC et al. Gastroenterology 2023","p":"37541528","url":"https://pubmed.ncbi.nlm.nih.gov/37541528/","pl":false}],[14,230,"B","Irritable bowel syndrome (largest single trial)","In a double-blind RCT of 214 patients meeting Rome III criteria, 4 weeks of 299v lowered abdominal pain severity and frequency and bloating versus placebo.",{"st":"no-estimate","mt":"exact","om":"abdominal pain severity and frequency (VAS)","dur":"4 weeks","c":"Ducrotté P et al. World J Gastroenterol 2012","p":"22912552","url":"https://pubmed.ncbi.nlm.nih.gov/22912552/","pl":false}],[14,231,"B","Crying and fussing in infants with colic (pooled individual data)","A 2018 individual-participant meta-analysis of 4 double-blind RCTs (345 infants) found 25.4 fewer minutes of crying/fussing at day 21 versus placebo; effects were large in breastfed infants but not significant in formula-fed infants.",{"st":"pooled","mt":"exact","m":"MD","v":-25.4,"lo":-47.3,"hi":-3.5,"u":"minutes","om":"daily crying and/or fussing time at day 21","k":4,"n":345,"dur":"21 days","c":"Sung V et al. Pediatrics 2018","p":"29279326","url":"https://pubmed.ncbi.nlm.nih.gov/29279326/","pl":true}],[14,231,"B","Acute gastroenteritis in children","A 2019 meta-analysis of 4 RCTs (347 children) found diarrhea shortened by 0.87 day versus placebo or no treatment; the authors note small effect sizes of limited clinical relevance and trial limitations.",{"st":"pooled","mt":"exact","m":"MD","v":-0.87,"lo":-1.43,"hi":-0.31,"u":"days","om":"duration of diarrhea","k":4,"n":347,"c":"Patro-Gołąb B, Szajewska H. Nutrients 2019","p":"31739457","url":"https://pubmed.ncbi.nlm.nih.gov/31739457/","pl":true}],[14,5,"B","Irritable bowel syndrome (IBS) symptoms","A 2022 review of 10 studies (1,030 participants) found enteric-coated peppermint oil better than placebo for overall IBS symptoms, with more, mostly mild, side effects; a 2021 ACG guideline recommended it.",{"st":"pooled","mt":"exact","m":"RR","v":0.65,"lo":0.43,"hi":0.98,"om":"global IBS symptoms (not improving)","k":10,"n":1030,"c":"Ingrosso MR et al. Aliment Pharmacol Ther 2022","p":"35942669","url":"https://pubmed.ncbi.nlm.nih.gov/35942669/","pl":true}],[14,232,"B","Antibiotic-associated diarrhea","A 2015 meta-analysis of 21 trials (4,780 participants) found S. boulardii lowered antibiotic-associated diarrhea from 18.7% to 8.5% versus placebo or no treatment (RR 0.47, 95% CI 0.38 to 0.57); in adults, from 17.4% to 8.2%.",{"st":"pooled","mt":"exact","m":"RR","v":0.47,"lo":0.38,"hi":0.57,"om":"antibiotic-associated diarrhoea (all ages)","k":21,"n":4780,"c":"Szajewska H, Kołodziej M. Aliment Pharmacol Ther 2015","p":"26216624","url":"https://pubmed.ncbi.nlm.nih.gov/26216624/","pl":true}],[14,232,"B","C. difficile diarrhea during antibiotic use","A 2017 analysis of 31 studies (8,672 patients, mostly hospitalized) concluded with moderate certainty that probiotics can reduce risk; the best types, doses and durations are uncertain.",{"st":"pooled","mt":"exact","m":"RR","v":0.4,"lo":0.3,"hi":0.52,"om":"incidence of C. difficile-associated diarrhoea","k":31,"n":8672,"c":"Goldenberg JZ et al. Cochrane Database Syst Rev 2017","p":"29257353","url":"https://pubmed.ncbi.nlm.nih.gov/29257353/","pl":true}],[14,232,"B","Necrotizing enterocolitis in preterm infants","An AGA 2020 review (63 trials, 15,712 infants) found specific Lactobacillus/Bifidobacterium combinations reduced severe disease and mortality, but a 2023 Cochrane review called evidence for infants under 32 weeks or 1,500 g inconclusive.",{"st":"pooled","mt":"exact","m":"OR","v":0.35,"lo":0.2,"hi":0.59,"om":"severe necrotizing enterocolitis (Bell stage II or more)","k":63,"n":15712,"c":"Morgan RL et al. Gastroenterology 2020","p":"32592699","url":"https://pubmed.ncbi.nlm.nih.gov/32592699/","pl":true}],[14,191,"B","Bowel function in healthy adults","A 2017 meta-analysis of RCTs in healthy adults found resistant starch increased fecal wet weight (35.51 g/day) and butyrate and lowered fecal pH, but did not significantly change defecation frequency.",{"st":"pooled","mt":"exact","m":"WMD","v":35.51,"lo":1.21,"hi":69.82,"u":"g/d","om":"fecal wet weight","c":"Shen D et al. Int J Food Sci Nutr 2017","p":"27593182","url":"https://pubmed.ncbi.nlm.nih.gov/27593182/","pl":true}],[14,227,"B","Acute gastroenteritis in children","A 2020 meta-analysis of 29 RCTs found S. boulardii shortened diarrhea by 1.06 days (23 RCTs, 3,450 children) versus placebo or no treatment, but evidence quality was very low and heterogeneity high.",{"st":"pooled","mt":"exact","m":"MD","v":-1.06,"lo":-1.32,"hi":-0.79,"u":"day","om":"duration of diarrhoea","k":23,"n":3450,"i2":90,"c":"Szajewska H et al. Aliment Pharmacol Ther 2020","p":"32056266","url":"https://pubmed.ncbi.nlm.nih.gov/32056266/","pl":true}],[14,227,"B","Helicobacter pylori eradication therapy (added to standard antibiotics)","A 2015 meta-analysis of 11 RCTs (2,200 participants) found adding S. boulardii raised eradication from 71% to 80% and reduced therapy-related side effects, particularly diarrhea and nausea.",{"st":"pooled","mt":"exact","m":"RR","v":1.11,"lo":1.06,"hi":1.17,"om":"H. pylori eradication rate","k":11,"n":2200,"c":"Szajewska H et al. Aliment Pharmacol Ther 2015","p":"25898944","url":"https://pubmed.ncbi.nlm.nih.gov/25898944/","pl":true}],[14,161,"B","Acute travelers' diarrhea (latex-derived SP-303)","In an RCT of 184 travelers, SP-303 125-500 mg four times daily for 2 days shortened time to the last unformed stool (30.3-32.6 h vs 38.7 h with placebo).",{"st":"no-estimate","mt":"exact","om":"time to last unformed stool (TLUS48)","dur":"2 days","c":"DiCesare D et al. Am J Gastroenterol 2002","p":"12385443","url":"https://pubmed.ncbi.nlm.nih.gov/12385443/","pl":false}],[14,161,"B","Non-infectious diarrhea in adults with HIV (crofelemer, prescription drug)","In the phase 3 ADVENT trial (376 patients), more patients responded to crofelemer 125 mg twice daily than to placebo over 4 weeks (17.6% vs 8.0%).",{"st":"no-estimate","mt":"exact","om":"clinical response (≤2 watery stools/week during ≥2 of 4 weeks)","dur":"4 weeks","c":"Macarthur RD et al. HIV Clin Trials 2013","p":"24334179","url":"https://pubmed.ncbi.nlm.nih.gov/24334179/","pl":false}],[14,10,"B","Nausea and vomiting in pregnancy","Two RCTs found 30–75 mg/day oral pyridoxine significantly decreased nausea, but a Cochrane review could not draw firm conclusions on vitamin B6's value.",{"st":"none","pl":false}],[14,226,"B","Acute diarrhea in children","A 2016 Cochrane review (33 trials, 10,841 children) found diarrhea about half a day shorter in children over 6 months, with no effect in infants under 6 months (low certainty).",{"st":"pooled","mt":"exact","m":"MD","v":-11.46,"lo":-19.72,"hi":-3.19,"u":"hours","om":"duration of acute diarrhoea","k":9,"n":2581,"c":"Lazzerini M et al. Cochrane Database Syst Rev 2016","p":"27996088","url":"https://pubmed.ncbi.nlm.nih.gov/27996088/","pl":true}],[14,135,"C","Ulcerative colitis","In one trial, higher-dose extract produced more clinical responses than placebo; another found it comparable to mesalamine. MSK says additional studies are needed to confirm these effects.",{"st":"no-estimate","mt":"partial","om":"clinical response at week 8","dur":"8 weeks","c":"Sandborn WJ et al. Am J Gastroenterol 2013","p":"23044768","url":"https://pubmed.ncbi.nlm.nih.gov/23044768/","pl":false}],[14,233,"C","Functional dyspepsia (Cochrane assessment)","A 2023 Cochrane review found one placebo-controlled trial (43 participants): asafoetida may improve dyspepsia symptoms (SMD −1.51), with low-certainty evidence.",{"st":"single-trial","mt":"exact","m":"SMD","v":-1.51,"lo":-2.2,"hi":-0.83,"om":"dyspepsia symptoms","k":1,"n":43,"c":"Báez G et al. Cochrane Database Syst Rev 2023","p":"37323050","url":"https://pubmed.ncbi.nlm.nih.gov/37323050/","pl":true}],[14,233,"C","Functional dyspepsia symptoms in adults","A double-blind RCT in 62 participants with functional dyspepsia symptoms (250 mg/day of a hydrogel formulation for 14 days) reported less bloating, early satiety and heartburn than placebo.",{"st":"no-estimate","mt":"exact","om":"early satiety, bloating and heartburn (Leuven Postprandial Distress Scale)","n":62,"dur":"14 days","c":"Das SS et al. Medicine (Baltimore) 2025","p":"41054174","url":"https://pubmed.ncbi.nlm.nih.gov/41054174/","pl":false}],[14,140,"C","Stool frequency in adults with chronic constipation (strain Unique IS2)","A 2022 meta-analysis of constipation RCTs found probiotics overall increased stool frequency, but the Bacillus coagulans Unique IS2 subgroup did not show a significant effect.",{"st":"no-estimate","mt":"exact","om":"stool frequency (Bacillus coagulans Unique IS2 subgroup)","c":"van der Schoot A et al. Clin Nutr 2022","p":"36372047","url":"https://pubmed.ncbi.nlm.nih.gov/36372047/","pl":false}],[14,140,"C","Functional gastrointestinal complaints in healthy adults (strain GBI-30, 6086)","In a double-blind RCT of 111 adults in China, GBI-30, 6086 (1 x 10^9/day for 4 weeks) increased stools per week and improved fecal consistency versus placebo, with fewer participants constipated.",{"st":"no-estimate","mt":"exact","om":"stools per week, fecal consistency, constipation","n":111,"dur":"four weeks","c":"Gang H et al. Benef Microbes 2025","p":"40707016","url":"https://pubmed.ncbi.nlm.nih.gov/40707016/","pl":false}],[14,140,"C","Functional gas and bloating (strain MTCC 5856)","In a double-blind RCT of 70 adults in India, MTCC 5856 (2 billion spores/day for 4 weeks) lowered indigestion (gas and bloating) scores versus placebo.",{"st":"no-estimate","mt":"exact","om":"GSRS indigestion subscale score (gas and bloating)","n":70,"dur":"4 weeks","c":"Majeed M et al. Medicine (Baltimore) 2023","p":"36862903","url":"https://pubmed.ncbi.nlm.nih.gov/36862903/","pl":false}],[14,228,"C","Defecation frequency in adults with low stool frequency and abdominal discomfort","In one RCT of 1,248 adults, 4 weeks of BB-12 (1 or 10 billion CFU/day) raised average defecation frequency versus placebo; the main responder analysis (OR 1.31, P = 0.071) and global relief of abdominal discomfort were not significant.",{"st":"single-trial","mt":"exact","m":"OR","v":1.31,"lo":0.98,"hi":1.75,"om":"responder: defecation frequency above baseline for >=50% of the time","dur":"4 weeks","c":"Eskesen D et al. Br J Nutr 2015","p":"26382580","url":"https://pubmed.ncbi.nlm.nih.gov/26382580/","pl":true}],[14,234,"C","Mild diarrhea (EU traditional use, dried fruit)","The EU monograph accepts dried bilberry fruit tea for mild diarrhea and mouth rinses for minor oral inflammation exclusively on the basis of long-standing use.",{"st":"none","pl":false}],[14,126,"C","Crohn's disease and collagenous colitis","No significant benefit was found for maintaining remission in Crohn's disease; evidence in collagenous colitis is unclear or negative.",{"st":"none","pl":false}],[14,143,"C","Ulcerative colitis (rectal enema)","One randomized placebo-controlled study (53 patients; 80 mg enema daily for 2 weeks), reported only as a meeting abstract, found no clear between-group difference; FDA found a lack of evidence to support effectiveness.",{"st":"single-trial","mt":"exact","m":"MD","v":1.6,"lo":-4.84,"hi":1.62,"u":"points on Disease Activity Index","om":"change in Disease Activity Index (composite of clinical, laboratory, endoscopic and pathohistological findings)","n":53,"dur":"two weeks","c":"Ruenzi et al. 2005 (meeting abstract), as summarized in FDA PCAC Briefing Document for BPC-157, July 2026","url":"https://www.fda.gov/media/193343/download","pl":false,"ex":"the difference is printed without a sign while its interval is centred near the negative value; shown as printed, not drawn"}],[14,219,"C","Relapse of ulcerative colitis with carrageenan","RCT of 12 people with ulcerative colitis in remission on a no-carrageenan diet: 3 given carrageenan capsules relapsed versus none given placebo, within up to one year.",{"st":"no-estimate","mt":"exact","om":"relapse of ulcerative colitis","dur":"up to one year","c":"Bhattacharyya S et al. Nutr Healthy Aging 2017","p":"28447072","url":"https://pubmed.ncbi.nlm.nih.gov/28447072/","pl":false}],[14,219,"C","Inflammation and gut symptoms in ulcerative colitis","Crossover pilot RCT in 7 people with quiescent ulcerative colitis: 7 days of food-grade carrageenan did not change disease activity or inflammatory markers versus placebo.",{"st":"no-estimate","mt":"exact","om":"Simple Clinical Colitis Activity Index and inflammatory biomarkers","n":7,"dur":"7 days","c":"Laatikainen R et al. Food Nutr Res 2023","p":"37920677","url":"https://pubmed.ncbi.nlm.nih.gov/37920677/","pl":false}],[14,50,"C","Infant colic and childhood diarrhea","Combination products containing chamomile may help; chamomile alone has not been shown to help.",{"st":"none","pl":false}],[14,229,"C","Irritable bowel syndrome","A 2026 meta-analysis of 2 placebo-controlled RCTs of EcN alone found no significant difference from placebo in reduction of abdominal pain or urgency.",{"st":"no-estimate","mt":"exact","om":"IBS symptoms (abdominal pain, urgency)","c":"Maslennikov R et al. J Clin Med 2026","p":"41682832","url":"https://pubmed.ncbi.nlm.nih.gov/41682832/","pl":false}],[14,8,"C","Infant colic","One RCT in 125 infants aged 2–12 weeks found fennel seed oil emulsion relieved colic in 65% versus 23.7% with placebo; no side effects were reported.",{"st":"single-trial","mt":"exact","m":"RD","v":41,"lo":25,"hi":57,"u":"%","om":"elimination of colic (Wessel criteria)","c":"Alexandrovich I et al. Altern Ther Health Med 2003","p":"12868253","url":"https://pubmed.ncbi.nlm.nih.gov/12868253/","pl":true}],[14,59,"C","Symptoms of irritable bowel syndrome (IBS)","In a 12-week randomized controlled trial in 44 patients with IBS, 3.5 g/day trans-galactooligosaccharide improved stool consistency, flatulence, bloating and global assessment, and 7 g/day improved global assessment and anxiety scores; placebo had no effect.",{"st":"no-estimate","mt":"exact","om":"IBS symptoms (stool consistency, flatulence, bloating, subjective global assessment, anxiety)","n":44,"dur":"12-week","c":"Silk DB et al. Aliment Pharmacol Ther 2009","p":"19053980","url":"https://pubmed.ncbi.nlm.nih.gov/19053980/","pl":false}],[14,59,"C","Functional constipation","In a 4-week double-blind RCT in 63 patients meeting Rome IV criteria (34 GOS, 29 placebo), GOS improved daily bowel movements and stool shape versus placebo.",{"st":"no-estimate","mt":"exact","om":"bowel movements per day and stool shape","n":63,"dur":"four-week","c":"Lee JH et al. Food Funct 2024","p":"38787732","url":"https://pubmed.ncbi.nlm.nih.gov/38787732/","pl":false}],[14,235,"C","Dyspeptic symptoms in adults","The main gentian-only study was open and uncontrolled: 205 patients took a gentian dry extract for 15 days, with 68% average symptom improvement. EMA said the open design only supports plausibility.",{"st":"none","pl":false}],[14,235,"C","Saliva and gastric secretion (bitter-taste response)","In a Latin-square study in 24 healthy volunteers, 2% gentian tincture increased salivary secretion over 30 minutes, similar to a citric acid control; older small studies reported increased saliva and gastric secretion.",{"st":"none","pl":false}],[14,235,"C","Loss of appetite and mild digestive disorders (EU traditional use)","The EU monograph accepts these uses exclusively on the basis of long-standing use, not proof of efficacy from clinical trials.",{"st":"none","pl":false}],[14,14,"C","Motion sickness","NCCIH states most studies of ginger for motion sickness haven't shown it to be helpful.",{"st":"none","pl":false}],[14,14,"C","Chemotherapy-related and postoperative nausea","Uncertain whether ginger adds benefit to standard treatment for chemotherapy nausea, or helps nausea after surgery.",{"st":"none","pl":false}],[14,165,"C","Functional constipation in children","A meta-analysis of 3 RCTs (122 children) found more frequent bowel movements but no difference in stool consistency or treatment success; the authors urge caution given the small samples.",{"st":"pooled","mt":"exact","m":"MD","v":1.4,"lo":0.36,"hi":2.44,"om":"defecation frequency per week","k":3,"n":122,"c":"Han Y et al. Asia Pac J Clin Nutr 2017","p":"28429913","url":"https://pubmed.ncbi.nlm.nih.gov/28429913/","pl":true}],[14,183,"C","Symptoms of irritable bowel syndrome (IBS)","A 2019 meta-analysis of 11 RCTs (729 adults with IBS or other functional bowel disorders) found prebiotics did not improve symptoms or quality of life; inulin-type fructans worsened flatulence. No included study was at low risk of bias in every category.",{"st":"pooled","mt":"exact","m":"OR","v":0.62,"lo":0.07,"hi":5.69,"om":"global symptom response","k":11,"n":729,"c":"Wilson B et al. Am J Clin Nutr 2019","p":"30949662","url":"https://pubmed.ncbi.nlm.nih.gov/30949662/","pl":true}],[14,236,"C","Digestive complaints (fullness, slow digestion, flatulence)","EMA found insufficient clinical-trial evidence; EU use rests on long-standing traditional use. A 12-person study of curcumin (20-80 mg) showed gallbladder contraction, which EMA judged insufficient for firm conclusions.",{"st":"none","pl":false}],[14,203,"C","Chronic idiopathic constipation","A 12-week placebo-controlled trial in 37 patients with prolonged transit time reported shorter transit time and milder symptoms with a liquid jujube extract; 16 of 19 placebo patients dropped out because of severe constipation.",{"st":"no-estimate","mt":"exact","om":"colonic transit time and symptom severity","n":37,"dur":"12 weeks","c":"Naftali T et al. Digestion 2008","p":"19142004","url":"https://pubmed.ncbi.nlm.nih.gov/19142004/","pl":false}],[14,203,"C","Functional constipation in children","A double-blind trial in children aged 2-10 (62 completed 3 months) found better response scores, fewer soiling episodes and less pain with jujube syrup than with polyethylene glycol.",{"st":"no-estimate","mt":"exact","om":"therapeutic response score, encopresis, pain","dur":"three months","c":"Keihanian F et al. Sci Rep 2025","p":"39799261","url":"https://pubmed.ncbi.nlm.nih.gov/39799261/","pl":false}],[14,54,"C","Stool frequency and consistency in adults with functional constipation","In a 2014 meta-analysis, L. casei Shirota did not significantly change stool frequency (-0.2 bowel movements/week) or stool consistency, unlike B. lactis; attrition and reporting bias were high across trials.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.2,"lo":-0.8,"hi":0.9,"u":"bowel movements/wk","om":"stool frequency (L. casei Shirota subgroup)","c":"Dimidi E et al. Am J Clin Nutr 2014","p":"25099542","url":"https://pubmed.ncbi.nlm.nih.gov/25099542/","pl":true}],[14,54,"C","Irritable bowel syndrome","A 2026 meta-analysis of 2 placebo-controlled RCTs found no significant effect of L. casei Shirota on abdominal pain, bloating, flatulence or overall IBS symptoms.",{"st":"no-estimate","mt":"exact","om":"IBS symptoms","c":"Maslennikov R et al. J Clin Med 2026","p":"41682832","url":"https://pubmed.ncbi.nlm.nih.gov/41682832/","pl":false}],[14,54,"C","Antibiotic-associated diarrhea in hospitalized patients with spinal cord injury","In an RCT of 164 patients (control: no probiotic), daily LcS during antibiotics and for 7 days after was associated with less antibiotic-associated diarrhea (17.1% vs 54.9%); authors called for a placebo-controlled trial.",{"st":"single-trial","mt":"exact","m":"OR","v":8.46,"lo":3.22,"hi":22.2,"om":"antibiotic-associated diarrhea incidence","n":164,"dur":"antibiotic course plus 7 days","c":"Wong S et al. Br J Nutr 2014","p":"24044687","url":"https://pubmed.ncbi.nlm.nih.gov/24044687/","pl":false,"ex":"the printed odds ratio is for having no probiotic (control versus supplement), the reverse of this comparison"}],[14,237,"C","Digestive symptoms","NCCIH describes the evidence for digestive symptoms as unclear.",{"st":"none","pl":false}],[14,231,"C","Preterm infants: necrotizing enterocolitis, late-onset sepsis and feeding","A 2023 meta-analysis of 12 RCTs (2,284 preterm infants) found less necrotizing enterocolitis (RR 0.57; 8 RCTs), less late-onset sepsis and faster full feeds, but no mortality difference; certainty was very low.",{"st":"pooled","mt":"exact","m":"RR","v":0.57,"lo":0.37,"hi":0.87,"om":"necrotizing enterocolitis stage ≥II","k":8,"c":"Ang JL et al. JPEN J Parenter Enteral Nutr 2023","p":"37742098","url":"https://pubmed.ncbi.nlm.nih.gov/37742098/","pl":true}],[14,231,"C","Antibiotic-associated diarrhea in children","A 2026 systematic review of 3 RCTs (998 children analyzed) found lower risk with use for up to 21 days (2 RCTs; RR 0.50) but no effect with use of 14 days or less or with follow-up to 56 days.",{"st":"pooled","mt":"exact","m":"RR","v":0.5,"lo":0.33,"hi":0.75,"om":"antibiotic-associated diarrhoea, regimens up to 21 days (the analysis to 56 days found no effect)","k":2,"n":751,"dur":"up to 21 days","c":"Szajewska H et al. J Pediatr Gastroenterol Nutr 2026","p":"41486369","url":"https://pubmed.ncbi.nlm.nih.gov/41486369/","pl":true}],[14,238,"C","Functional dyspepsia in adults","A double-blind RCT in 148 patients (350 mg three times daily for 3 weeks) found lower dyspepsia symptom scores than placebo; marked improvement occurred in 77% versus 40%.",{"st":"no-estimate","mt":"exact","om":"Hong Kong index of dyspepsia symptom score; marked symptom improvement","dur":"3 weeks","c":"Dabos KJ et al. J Ethnopharmacol 2010","p":"19961914","url":"https://pubmed.ncbi.nlm.nih.gov/19961914/","pl":false}],[14,238,"C","Functional dyspepsia (Cochrane assessment)","A 2023 Cochrane review rated this single trial (148 participants; SMD −0.33 versus placebo) as low-certainty evidence that mastic may improve dyspepsia symptoms.",{"st":"single-trial","mt":"exact","m":"SMD","v":-0.33,"lo":-0.66,"hi":-0.01,"om":"dyspepsia symptoms","k":1,"n":148,"c":"Báez G et al. Cochrane Database Syst Rev 2023","p":"37323050","url":"https://pubmed.ncbi.nlm.nih.gov/37323050/","pl":true}],[14,238,"C","Functional dyspepsia (crossover trial)","A randomized three-way crossover trial (4-week phases) reported fewer symptoms with mastiha capsules (1.4 g/day) or mastiha-water than in a no-intervention period; there was no placebo.",{"st":"no-estimate","mt":"exact","om":"functional dyspepsia symptoms (Leuven Postprandial Distress Scale)","dur":"three phases of four weeks each, 14-day washouts","c":"Kleftaki SA et al. Pharmacol Res 2025","p":"41197785","url":"https://pubmed.ncbi.nlm.nih.gov/41197785/","pl":false}],[14,238,"C","Helicobacter pylori infection","In a pilot RCT of 52 infected patients, mastic gum alone for 14 days cleared infection in 4/13 and 5/13; standard triple therapy cleared 10/13.",{"st":"no-estimate","mt":"exact","om":"H. pylori eradication (13C urea breath test)","dur":"14 days (mastic arms); 10 days (triple therapy)","c":"Dabos KJ et al. Phytomedicine 2010","p":"19879118","url":"https://pubmed.ncbi.nlm.nih.gov/19879118/","pl":false}],[14,238,"C","Inflammatory bowel disease","A 2023 systematic review found eight human and animal studies (seven from Greece; clinical doses 2.2–2.8 g/day) and concluded that more high-quality clinical trials are needed for reliable conclusions.",{"st":"no-estimate","mt":"exact","om":"IBD outcomes (qualitative synthesis)","k":8,"dur":"4 weeks to 6 months (human studies)","c":"Mavroudi A et al. J Med Food 2023","p":"37001176","url":"https://pubmed.ncbi.nlm.nih.gov/37001176/","pl":false}],[14,224,"C","Stomach acid secretion","A small study found neem bark extract reduced stomach acid secretion; MSK states more human studies are needed.",{"st":"no-ci","mt":"partial","m":"percent-change","v":77,"u":"%","om":"gastric acid secretion","dur":"10 days","c":"Bandyopadhyay U et al. Life Sci 2004","p":"15454339","url":"https://pubmed.ncbi.nlm.nih.gov/15454339/","pl":false}],[14,206,"C","Early postoperative nausea","MSK cites a small clinical study suggesting noni may reduce early postoperative nausea; further research is needed to confirm the effect.",{"st":"no-estimate","mt":"partial","om":"early postoperative nausea (0-6 h)","dur":"single dose 1 hour before surgery","c":"Prapaitrakool S et al. J Med Assoc Thai 2010","p":"21294416","url":"https://pubmed.ncbi.nlm.nih.gov/21294416/","pl":false}],[14,5,"C","Indigestion","Peppermint oil combined with caraway oil may relieve indigestion; peppermint oil alone has no such evidence and may worsen indigestion in some people.",{"st":"none","pl":false}],[14,5,"C","Chemotherapy-related nausea and vomiting","NCCIH reports that inhaled peppermint oil or oral peppermint may reduce chemotherapy-related nausea and vomiting.",{"st":"none","pl":false}],[14,86,"C","Leaf extract: gastrointestinal discomfort","In a 4-week pilot RCT of 50 adults, symptoms improved within the perilla group; versus placebo, only a combined bloating and discomfort score in women differed significantly.",{"st":"no-estimate","mt":"exact","om":"bloating + abdominal discomfort subscore (women subgroup), 5-point daily GI symptom scale","n":50,"dur":"4 weeks","c":"Buchwald-Werner S et al. BMC Complement Altern Med 2014","p":"24885816","url":"https://pubmed.ncbi.nlm.nih.gov/24885816/","pl":false}],[14,190,"C","Irritable bowel syndrome symptoms (nopal fiber)","A one-week RCT in 60 people with IBS found more reported adequate relief with 20 g/day (87%) and 30 g/day (80%) nopal fiber than placebo (33%); 30 g/day caused more loose stools.",{"st":"no-estimate","mt":"exact","om":"adequate relief of IBS symptoms (Global Symptom Question)","n":60,"dur":"one week","c":"Remes-Troche JM et al. Neurogastroenterol Motil 2021","p":"32935904","url":"https://pubmed.ncbi.nlm.nih.gov/32935904/","pl":false}],[14,232,"C","Irritable bowel syndrome symptoms","A 2018 review of 53 studies (5,545 participants) found possible benefits on global symptoms and pain, but no definite conclusions or identification of which strains help.",{"st":"no-estimate","mt":"exact","om":"global IBS symptoms and abdominal pain","k":53,"n":5545,"c":"Ford AC et al. Aliment Pharmacol Ther 2018","p":"30294792","url":"https://pubmed.ncbi.nlm.nih.gov/30294792/","pl":false}],[14,160,"C","Functional constipation","An 8-week double-blind RCT in 60 patients found an ethanol extract of the aerial parts improved complete spontaneous bowel movements, symptoms and quality of life versus placebo.",{"st":"no-estimate","mt":"exact","om":"complete spontaneous bowel movements (CSBM); PAC-QOL and PAC-SYM","dur":"8 weeks","c":"Bang KB et al. Saudi J Gastroenterol 2022","p":"35848700","url":"https://pubmed.ncbi.nlm.nih.gov/35848700/","pl":false}],[14,227,"C","Clostridium difficile-associated diarrhea","In the 2015 meta-analysis of 21 RCTs, the reduction was significant in children (2 RCTs, 579 participants) but not in adults (9 RCTs, 1,441 participants; RR 0.8, 95% CI 0.47–1.34).",{"st":"pooled","mt":"exact","m":"RR","v":0.8,"lo":0.47,"hi":1.34,"om":"Clostridium difficile-associated diarrhoea, adults","k":9,"n":1441,"c":"Szajewska H, Kołodziej M. Aliment Pharmacol Ther 2015","p":"26216624","url":"https://pubmed.ncbi.nlm.nih.gov/26216624/","pl":true}],[14,239,"C","Chronic idiopathic constipation in adults","In one 28-day double-blind trial (90 patients across senna, magnesium oxide and placebo arms), overall improvement was 69.2% with senna 1.0 g versus 11.7% with placebo; bowel movements and quality of life improved. No severe adverse events.",{"st":"no-estimate","mt":"exact","u":"%","om":"overall symptom improvement (responder rate)","c":"Morishita D et al. Am J Gastroenterol 2021","p":"32969946","url":"https://pubmed.ncbi.nlm.nih.gov/32969946/","pl":false}],[14,239,"C","Chronic constipation in adults (pooled trials)","A 2023 meta-analysis pooling two senna trials found 61% responded versus 28% on control, a difference that was not statistically significant (RR 2.78, 95% CI 0.93–8.27).",{"st":"pooled","mt":"exact","m":"RR","v":2.78,"lo":0.93,"hi":8.27,"om":"response (symptom improvement)","k":2,"c":"van der Schoot A et al. Neurogastroenterol Motil 2023","p":"37243443","url":"https://pubmed.ncbi.nlm.nih.gov/37243443/","pl":true}],[14,239,"C","Constipation in palliative care","A Cochrane review of five small trials comparing laxatives, including senna, found similar effectiveness, with evidence too limited to rank them.",{"st":"no-estimate","mt":"exact","om":"laxative effectiveness","c":"Candy B et al. Cochrane Database Syst Rev 2015","p":"25967924","url":"https://pubmed.ncbi.nlm.nih.gov/25967924/","pl":false}],[14,88,"C","Heartburn and lower esophageal sphincter pressure","In a randomized crossover study in healthy volunteers, spearmint (0.5 or 500 mg) did not change sphincter pressure or reflux; the high dose increased symptom scores.",{"st":"no-estimate","mt":"exact","om":"lower oesophageal sphincter pressure, reflux episodes, symptom score","dur":"30 min after single dose","c":"Bulat R et al. Aliment Pharmacol Ther 1999","p":"10383511","url":"https://pubmed.ncbi.nlm.nih.gov/10383511/","pl":false}],[14,143,"D","Gastrointestinal and liver injury models (animal studies)","In rats, BPC-157-related substances reduced colonic fistulas, liver lesions and gastrointestinal lesions induced by various challenges; FDA notes dose-response, molecular targets and mechanism of action remain unestablished.",{"st":"not-human","pl":false}],[14,229,"X","Active ulcerative colitis, EcN added to conventional therapy","In a double-blind RCT of 100 patients, EcN add-on without prior ciprofloxacin gave fewer remissions than placebo (54% vs 89%, per protocol) and the most withdrawals.",{"st":"no-estimate","mt":"exact","om":"clinical remission","n":100,"dur":"7 weeks EcN after 1 week ciprofloxacin/placebo","c":"Petersen AM et al. J Crohns Colitis 2014","p":"24972748","url":"https://pubmed.ncbi.nlm.nih.gov/24972748/","pl":false}],[14,163,"X","Acute gastroenteritis in US preschool children (large RCT)","In a double-blind trial of 971 children aged 3 months to 4 years in 10 US emergency departments, a 5-day LGG course (1 x 10^10 CFU twice daily) did not improve outcomes versus placebo.",{"st":"single-trial","mt":"exact","m":"RR","v":0.96,"lo":0.68,"hi":1.35,"om":"moderate-to-severe gastroenteritis (modified Vesikari score 9 or higher within 14 days)","n":971,"c":"Schnadower D et al. N Engl J Med 2018","p":"30462938","url":"https://pubmed.ncbi.nlm.nih.gov/30462938/","pl":true}],[14,231,"X","Infant colic in a community sample of breastfed and formula-fed infants","In a double-blind RCT of 167 infants in Melbourne, DSM 17938 (1 x 10^8 CFU/day for one month) did not reduce crying; the probiotic group cried or fussed 49 minutes more at 1 month.",{"st":"single-trial","mt":"exact","m":"MD","v":49,"lo":8,"hi":90,"u":"minutes","om":"daily cry or fuss time at 1 month","n":167,"dur":"1 month","c":"Sung V et al. BMJ 2014","p":"24690625","url":"https://pubmed.ncbi.nlm.nih.gov/24690625/","pl":true}],[14,231,"X","Functional abdominal pain and functional constipation in children","A 2026 meta-analysis of single-strain RCTs found no significant benefit on responder rates in functional abdominal pain (5 RCTs, 302 children) or on stool frequency in functional constipation (5 RCTs, 276 children).",{"st":"pooled","mt":"exact","m":"RR","v":1.11,"lo":0.83,"hi":1.47,"om":"responder rate in functional abdominal pain","k":5,"n":302,"c":"Quatrale G et al. J Pediatr Gastroenterol Nutr 2026","p":"42811720","url":"https://pubmed.ncbi.nlm.nih.gov/42811720/","pl":true}],[14,232,"X","Acute infectious diarrhea in children","A 2020 Cochrane review (82 RCTs) reported shorter illness, but low-bias studies showed no difference, and two large emergency-department trials, one of LGG and one of an L. rhamnosus R0011 plus L. helveticus R0052 combination, found the probiotics no better than placebo.",{"st":"pooled","mt":"exact","m":"RR","v":1.0,"lo":0.91,"hi":1.09,"om":"diarrhoea lasting 48 hours or longer","k":2,"n":1770,"c":"Collinson S et al. Cochrane Database Syst Rev 2020","p":"33295643","url":"https://pubmed.ncbi.nlm.nih.gov/33295643/","pl":true}],[15,240,"A","Measles in children","A 2022 Cochrane review found vitamin A supplementation reduced new cases of measles in children (RR 0.45, 95% CI 0.30 to 0.69; 2 studies, 1,982 children) but showed no evidence of a difference in deaths from measles (RR 0.88, 0.69 to 1.11).",{"st":"pooled","mt":"exact","m":"RR","v":0.45,"lo":0.3,"hi":0.69,"om":"measles incidence","k":2,"n":1982,"c":"Imdad A et al. Cochrane Database Syst Rev 2022","p":"35294044","url":"https://pubmed.ncbi.nlm.nih.gov/35294044/","pl":true}],[15,212,"A","Common cold duration","In the 2013 Cochrane review, regular use modestly shortened colds by 8% in adults and 14% in children; taking vitamin C after symptoms began had no consistent effect on duration or severity.",{"st":"no-ci","mt":"exact","m":"percent-change","v":8,"u":"%","om":"duration of common colds (regular supplementation)","c":"Hemilä H, Chalker E. Cochrane Database Syst Rev 2013","p":"23440782","url":"https://pubmed.ncbi.nlm.nih.gov/23440782/","pl":false}],[15,135,"B","Symptoms of acute respiratory tract infections (colds, sore throat, cough)","A 2017 meta-analysis of 33 RCTs (7,175 patients) found improved cough and sore throat versus placebo and shorter symptom duration versus usual care; overall trial quality was poor.",{"st":"pooled","mt":"exact","m":"SMD","v":-0.39,"lo":-0.67,"hi":-0.1,"om":"cough","n":596,"c":"Hu XY et al. PLoS One 2017","p":"28783743","url":"https://pubmed.ncbi.nlm.nih.gov/28783743/","pl":true}],[15,241,"B","Upper respiratory symptoms (colds, flu)","A 2019 meta-analysis of randomized trials with 180 participants in total reported reduced upper respiratory symptoms; NCCIH describes the research as preliminary and few in number.",{"st":"no-estimate","mt":"exact","om":"upper respiratory symptoms","n":180,"c":"Hawkins J et al. Complement Ther Med 2019","p":"30670267","url":"https://pubmed.ncbi.nlm.nih.gov/30670267/","pl":false}],[15,163,"B","Respiratory infections","A 2025 meta-analysis of 69 LGG trials found lower respiratory infection risk (RR 0.87; 18 trials) but limited effects on respiratory symptoms; certainty was mostly low beyond diarrhea outcomes and adult evidence was limited.",{"st":"pooled","mt":"exact","m":"RR","v":0.87,"lo":0.79,"hi":0.97,"om":"respiratory infection risk","k":18,"c":"Hidayat K et al. Food Funct 2025","p":"40702885","url":"https://pubmed.ncbi.nlm.nih.gov/40702885/","pl":true}],[15,36,"B","Late-onset sepsis and necrotizing enterocolitis in preterm infants","A 2020 Cochrane review (12 RCTs, 5,425 preterm infants) found lactoferrin added to enteral feeds reduced late-onset sepsis (RR 0.82; low certainty) but not NEC stage II–III or all-cause mortality.",{"st":"pooled","mt":"exact","m":"RR","v":0.82,"lo":0.74,"hi":0.91,"om":"late-onset sepsis","k":12,"n":5425,"c":"Pammi M, Suresh G. Cochrane Database Syst Rev 2020","p":"32232984","url":"https://pubmed.ncbi.nlm.nih.gov/32232984/","pl":true}],[15,36,"B","Respiratory tract infections and inflammation markers","A 2022 meta-analysis (25 studies) found fewer respiratory infections in infants and children (OR 0.78) but not in adults (OR 1.00); in adults lactoferrin lowered IL-6 but not C-reactive protein.",{"st":"pooled","mt":"exact","m":"OR","v":0.78,"lo":0.61,"hi":0.98,"om":"respiratory tract infection incidence, infants and children (subgroup; adults OR 1.00)","c":"Berthon BS et al. Adv Nutr 2022","p":"35481594","url":"https://pubmed.ncbi.nlm.nih.gov/35481594/","pl":true}],[15,242,"B","Acute bronchitis in adults and children","A Cochrane review found three trials in adults (746 patients) and three in children (819) showing benefit for most outcomes with the liquid preparation but not tablets; evidence quality was low.",{"st":"no-estimate","mt":"exact","om":"symptom resolution in acute bronchitis","c":"Timmer A et al. Cochrane Database Syst Rev 2013","p":"24146345","url":"https://pubmed.ncbi.nlm.nih.gov/24146345/","pl":false}],[15,242,"B","Recovery and paracetamol use in children with bronchitis or tonsillopharyngitis","An individual-data meta-analysis of six placebo-controlled trials (523 children aged 6–10) found less paracetamol use and fewer children off school at treatment end; two authors were employees of Dr. Willmar Schwabe GmbH.",{"st":"pooled","mt":"exact","m":"RR","v":0.43,"lo":0.29,"hi":0.65,"om":"still unable to attend school at treatment end","k":6,"n":523,"c":"Seifert G et al. BMC Pediatr 2019","p":"31014293","url":"https://pubmed.ncbi.nlm.nih.gov/31014293/","pl":true}],[15,226,"B","Duration of the common cold","A 2024 Cochrane review (34 trials, 8,526 participants) found zinc may shorten symptoms by about 2 days, with little to no difference in catching colds; certainty was low to very low.",{"st":"pooled","mt":"exact","m":"MD","v":-2.37,"lo":-4.21,"hi":-0.53,"u":"days","om":"mean duration of cold (zinc used for treatment)","k":8,"n":972,"i2":97,"c":"Nault D et al. Cochrane Database Syst Rev 2024","p":"38719213","url":"https://pubmed.ncbi.nlm.nih.gov/38719213/","pl":true}],[15,97,"C","Common colds in healthy adults (taken preventively)","A 2011 review of five trials (747 participants, all of North American ginseng) found insufficient evidence on cold incidence or severity; two pooled trials showed colds or respiratory infections 6.2 days shorter.",{"st":"pooled","mt":"exact","m":"RR","v":0.7,"lo":0.48,"hi":1.02,"om":"at least one common cold or ARI","n":747,"dur":"8-16 weeks","c":"Seida JK, Durec T, Kuhle S. Evid Based Complement Alternat Med 2011","p":"19592479","url":"https://pubmed.ncbi.nlm.nih.gov/19592479/","pl":true}],[15,135,"C","Mild-to-moderate COVID-19","A 2025 meta-analysis of six RCTs (660 adults) found no significant improvement in fever or cough resolution, CRP or IL-6 versus antivirals or supportive care.",{"st":"pooled","mt":"exact","m":"RR","v":1.12,"lo":0.9,"hi":1.38,"om":"fever resolution","n":660,"i2":0.0,"c":"Prabhakornritta P et al. Front Pharmacol 2025","p":"40822451","url":"https://pubmed.ncbi.nlm.nih.gov/40822451/","pl":true}],[15,217,"C","Immune response and inflammatory markers","A 2023 review of 19 studies (1,094 participants) reported enhanced immune responses and lower proinflammatory cytokines; the studies were small and differed widely in methods.",{"st":"pooled","mt":"exact","m":"SMD","v":-2.8765,"lo":-3.2385,"hi":-2.5145,"om":"proinflammatory cytokines (pooled)","k":19,"n":1094,"c":"Zhang X, Qu X, Zou Y. Complement Med Res 2023","p":"37952511","url":"https://pubmed.ncbi.nlm.nih.gov/37952511/","pl":true}],[15,228,"C","Respiratory infections in healthy infants","In an RCT of 109 one-month-old infants given BB-12 tablets to 8 months, fewer respiratory infections were reported (65% vs 94%); gastrointestinal symptoms, otitis media and antibiotic use did not differ.",{"st":"single-trial","mt":"exact","m":"RR","v":0.69,"lo":0.53,"hi":0.89,"om":"respiratory infections reported","dur":"from age 1-2 months to 8 months","c":"Taipale T et al. Br J Nutr 2011","p":"20863419","url":"https://pubmed.ncbi.nlm.nih.gov/20863419/","pl":true}],[15,127,"C","Sinusitis","NCCIH: a small number of studies have been done; there is not enough high-quality research to say whether oral bromelain should be recommended for sinusitis.",{"st":"none","pl":false}],[15,113,"C","Immune measures in healthy men (C. militaris)","RCT in 79 healthy Korean men: 1.5 g/day ethanol-treated C. militaris for 4 weeks increased NK cell activity and lymphocyte proliferation more than placebo.",{"st":"no-estimate","mt":"exact","om":"NK cell activity, lymphocyte proliferation index","dur":"4 weeks","c":"Kang HJ et al. J Med Food 2015","p":"26284906","url":"https://pubmed.ncbi.nlm.nih.gov/26284906/","pl":false}],[15,243,"C","Catching a cold (prevention trials)","Cochrane (2014): none of 12 prevention comparisons was statistically significant; post hoc pooling suggested a 10% to 20% relative risk reduction of questionable clinical relevance.",{"st":"no-estimate","mt":"exact","om":"people with at least one cold (prevention)","c":"Karsch-Völk M et al. Cochrane Database Syst Rev 2014","p":"24554461","url":"https://pubmed.ncbi.nlm.nih.gov/24554461/","pl":false}],[15,243,"C","Duration of colds (treatment trials)","Of seven treatment trials reporting cold duration, only one showed a significant effect; Cochrane authors said benefits were not shown but a weak benefit from some products is possible (24 trials, 4,631 participants).",{"st":"no-estimate","mt":"exact","om":"duration of colds (treatment)","n":4631,"c":"Karsch-Völk M et al. Cochrane Database Syst Rev 2014","p":"24554461","url":"https://pubmed.ncbi.nlm.nih.gov/24554461/","pl":false}],[15,243,"C","Respiratory infections in children","One recent study suggested fewer infections, but NCCIH states overall evidence is insufficient to support a clear connection.",{"st":"none","pl":false}],[15,241,"C","COVID-19","NCCIH states there is insufficient evidence that elderberry helps COVID-19 symptoms.",{"st":"none","pl":false}],[15,200,"C","Inflammation and immune measures","2026 systematic review of 5 clinical studies: some trials reported lower inflammatory cytokines or NK-cell changes, but findings were not consistently replicated; evidence is limited and heterogeneous.",{"st":"no-estimate","mt":"exact","om":"inflammatory and immune markers","c":"Anari ES et al. Food Funct 2026","p":"42806726","url":"https://pubmed.ncbi.nlm.nih.gov/42806726/","pl":false}],[15,178,"C","Common cold","Cochrane (2014) found one trial: 146 people, 12 weeks; 24 colds with garlic versus 65 with placebo, self-reported; authors call the evidence insufficient.",{"st":"no-estimate","mt":"exact","om":"occurrences of common cold (self-reported)","n":146,"dur":"12 weeks","c":"Lissiman E, Bhasale AL, Cohen M. Cochrane Database Syst Rev 2014","p":"25386977","url":"https://pubmed.ncbi.nlm.nih.gov/25386977/","pl":false}],[15,54,"C","Upper respiratory infections in middle-aged office workers","In an RCT of 96 male office workers, 12 weeks of LcS fermented milk was associated with fewer upper respiratory tract infections than control milk (22.4% vs 53.2%).",{"st":"no-estimate","mt":"exact","om":"incidence of upper respiratory tract infections","n":96,"dur":"12 weeks","c":"Shida K et al. Eur J Nutr 2017","p":"26419583","url":"https://pubmed.ncbi.nlm.nih.gov/26419583/","pl":false}],[15,237,"C","COVID-19","NCCIH states there is no good evidence for licorice in COVID-19.",{"st":"none","pl":false}],[15,84,"C","Immune measures in breast cancer survivors","Phase I/II trial in 34 postmenopausal women free of disease: a liquid extract (0.1–5 mg/kg twice daily, 3 weeks) both raised and lowered different immune measures, with non-monotonic dose responses.",{"st":"no-estimate","mt":"exact","om":"peripheral-blood immunologic parameters (ex vivo)","n":34,"dur":"3 weeks","c":"Deng G et al. J Cancer Res Clin Oncol 2009","p":"19253021","url":"https://pubmed.ncbi.nlm.nih.gov/19253021/","pl":false}],[15,84,"C","Immune cell function in myelodysplastic syndromes","Phase II study (21 enrolled, 18 evaluable): 3 mg/kg twice daily for 12 weeks increased neutrophil and monocyte function in laboratory tests; there was no placebo group.",{"st":"no-estimate","mt":"exact","om":"neutrophil and monocyte function (in vitro ROS production)","n":21,"dur":"12 weeks","c":"Wesa KM et al. Cancer Immunol Immunother 2015","p":"25351719","url":"https://pubmed.ncbi.nlm.nih.gov/25351719/","pl":false}],[15,242,"C","Acute sinusitis and the common cold in adults","Single trials: one in 103 adults with sinusitis showed benefit at day 21; one in the common cold showed benefit at 10 days but not 5. Cochrane rated this evidence very low quality.",{"st":"single-trial","mt":"exact","m":"RR","v":0.43,"lo":0.3,"hi":0.62,"om":"complete resolution at day 21 (acute sinusitis)","n":103,"c":"Timmer A et al. Cochrane Database Syst Rev 2013","p":"24146345","url":"https://pubmed.ncbi.nlm.nih.gov/24146345/","pl":false,"ex":"the abstract does not make clear whether the risk ratio refers to resolution or non-resolution, so its direction cannot be shown"}],[15,28,"C","Common colds and digestive infections in healthy adults","In an RCT of 254 healthy adults, sea buckthorn berries did not change the number or duration of colds or digestive tract infections; serum CRP decreased slightly versus placebo.",{"st":"single-trial","mt":"exact","m":"RR","v":1.15,"lo":0.9,"hi":1.48,"om":"number of common colds","n":254,"c":"Larmo P et al. Eur J Clin Nutr 2008","p":"17593932","url":"https://pubmed.ncbi.nlm.nih.gov/17593932/","pl":true}],[15,244,"C","Immune measures in healthy young adults","52 adults aged 21–41 ate 5 or 10 g of dried shiitake daily for 4 weeks: gamma-delta T and NK-T cell proliferation and salivary IgA increased, and CRP fell. There was no placebo group.",{"st":"no-ci","mt":"exact","m":"percent-change","v":60,"u":"%","om":"gamma-delta T cell proliferation (ex vivo)","dur":"4 weeks","c":"Dai X et al. J Am Coll Nutr 2015","p":"25866155","url":"https://pubmed.ncbi.nlm.nih.gov/25866155/","pl":false}],[15,89,"C","Vaccine responses in adults over 65","A randomized pilot trial in 40 adults (6 mg/day for 13 weeks after a third SARS-CoV-2 vaccine dose) reported stronger antibody and memory B-cell responses, specifically in vaccine non-responders.",{"st":"no-estimate","mt":"exact","om":"spike-specific IgG, memory B cell recall, neutralising antibody activity","n":40,"dur":"13 weeks","c":"Alsaleh G et al. Aging Cell 2026","p":"42169618","url":"https://pubmed.ncbi.nlm.nih.gov/42169618/","pl":false}],[15,245,"C","Sore throat (pharyngotonsillitis) in children and adults","A 2019 systematic review found 4 RCTs (1,846 participants), all poor quality: two child trials versus no treatment reported benefit (pharyngitis, adenoiditis), a 1,314-child placebo trial found none, and an adult trial alongside penicillin showed none.",{"st":"no-estimate","mt":"exact","om":"incidence of pharyngotonsillitis/streptococcal pharyngitis","n":1846,"c":"Wilcox CR et al. Clin Microbiol Infect 2019","p":"30616011","url":"https://pubmed.ncbi.nlm.nih.gov/30616011/","pl":false}],[15,245,"C","Upper respiratory infections in physically active young adults","In a double-blind RCT of 112 adults aged 19–25, symptom severity did not differ from placebo over four months; participants with over 90% adherence reported more symptom-free days.",{"st":"no-estimate","mt":"exact","om":"URTI symptom severity and symptom-free days","n":112,"dur":"four months","c":"Bertuccioli A et al. Microorganisms 2024","p":"39597553","url":"https://pubmed.ncbi.nlm.nih.gov/39597553/","pl":false}],[15,246,"C","HIV viral load and CD4 count in adults with HIV","In a 24-week randomized, placebo-controlled trial (107 analyzed), 1,200 mg twice daily did not change viral load or CD4 count, and days of infection-related events were higher with sutherlandia.",{"st":"no-estimate","mt":"exact","u":"days","om":"HIV viral load, CD4 count, burden of infection","dur":"24 weeks","c":"Wilson D et al. PLoS One 2015","p":"26186450","url":"https://pubmed.ncbi.nlm.nih.gov/26186450/","pl":false}],[15,150,"C","Malaria (whole-plant tea or powder instead of medicines)","WHO does not support use of Artemisia plant material in any form for malaria: content varies, is often insufficient to kill all parasites, and widespread use could hasten artemisinin resistance.",{"st":"none","pl":false}],[15,150,"C","Malaria parasite clearance in randomized trials of A. annua tea","A 2026 systematic review found rapid early parasite clearance, but day-28 parasitological outcomes with tea alone fell consistently below the 95.5-98.6% benchmark for artemisinin-based combination therapy.",{"st":"no-estimate","mt":"exact","om":"day-28 parasitological cure","c":"Nkola JMW et al. Infect Dis Poverty 2026","p":"42596018","url":"https://pubmed.ncbi.nlm.nih.gov/42596018/","pl":false}],[15,247,"C","Acute bronchitis with productive cough (thyme–ivy combination)","A double-blind RCT in 361 adults found a thyme–ivy syrup (5.4 ml three times daily, 11 days) cut daytime coughing fits by 68.7% versus 47.6% with placebo; thyme was not tested alone.",{"st":"no-estimate","mt":"exact","om":"reduction in daytime coughing fits, days 7 to 9 vs baseline","n":361,"dur":"11 days","c":"Kemmerich B et al. Arzneimittelforschung 2006","p":"17063641","url":"https://pubmed.ncbi.nlm.nih.gov/17063641/","pl":false}],[15,226,"C","Pneumonia in young children","A 2016 Cochrane review (6 trials, 5,193 children) found 10–20 mg/day lowered pneumonia incidence; a 2020 meta-analysis found adjunctive zinc did not change mortality or recovery time.",{"st":"pooled","mt":"exact","m":"RR","v":0.87,"lo":0.81,"hi":0.94,"om":"incidence of pneumonia","n":5193,"c":"Lassi ZS et al. Cochrane Database Syst Rev 2016","p":"27915460","url":"https://pubmed.ncbi.nlm.nih.gov/27915460/","pl":true}],[15,226,"C","HIV outcomes","Single trials reported fewer immunological failures or infections, but a Cochrane review (6 trials, 826 adults) found little or no effect on CD4 counts or viral load.",{"st":"no-estimate","mt":"partial","om":"CD4 cell count and viral load (single or dual micronutrients)","c":"Visser ME et al. Cochrane Database Syst Rev 2017","p":"28518221","url":"https://pubmed.ncbi.nlm.nih.gov/28518221/","pl":false}],[15,54,"X","Respiratory symptoms in nursing-home residents aged 65 or older","In a double-blind RCT of 737 residents in 53 nursing homes, 176 days of LcS fermented milk had no significant effect on respiratory symptoms or on antibody response to influenza vaccination.",{"st":"single-trial","mt":"exact","m":"OR","v":0.8715,"lo":0.6168,"hi":1.2887,"om":"probability of respiratory symptoms","n":737,"dur":"176 d","c":"Van Puyenbroeck K et al. Am J Clin Nutr 2012","p":"22440853","url":"https://pubmed.ncbi.nlm.nih.gov/22440853/","pl":true}],[15,230,"X","Outcomes of adults in intensive care","In a multicenter RCT of 218 adult ICU patients, 60 days of 299v did not change days alive and out of hospital (median 49.5 vs 49.0) or nosocomial infection (7.3% vs 4.6%).",{"st":"single-trial","mt":"exact","m":"other","v":0.0,"lo":-6.1,"hi":7.1,"u":"days","om":"days alive and out of hospital to day 60","dur":"60 days","c":"Litton E et al. Intensive Care Med 2021","p":"33566129","url":"https://pubmed.ncbi.nlm.nih.gov/33566129/","pl":false}],[15,245,"X","Acute otitis media in children attending day care","In a double-blind RCT of 827 children aged 1–6 years, 6 months of K12 (1 x 10^9 CFU/day) did not reduce otitis media needing antimicrobial therapy (8.2% vs 5.8% with placebo).",{"st":"single-trial","mt":"exact","m":"RR","v":1.42,"lo":0.86,"hi":2.34,"om":"at least 1 episode of acute otitis media requiring antimicrobial therapy","n":827,"dur":"6 months","c":"Sarlin S et al. JAMA Netw Open 2023","p":"37917062","url":"https://pubmed.ncbi.nlm.nih.gov/37917062/","pl":true}],[15,212,"X","Common cold incidence","A 2013 Cochrane review of placebo-controlled trials using at least 200 mg/day found regular use did not reduce colds in the general community (RR 0.97; 10,708 participants); in 5 trials of 598 marathon runners, skiers and soldiers, it roughly halved cold risk (RR 0.48).",{"st":"pooled","mt":"exact","m":"RR","v":0.97,"lo":0.94,"hi":1.0,"om":"incidence of common cold, general-community subgroup","n":10708,"c":"Hemilä H, Chalker E. Cochrane Database Syst Rev 2013","p":"23440782","url":"https://pubmed.ncbi.nlm.nih.gov/23440782/","pl":true}],[16,101,"B","Hepatic encephalopathy in people with cirrhosis","A 2026 Cochrane review (18 RCTs, 934 adults; oral or intravenous) found BCAAs reduced hepatic encephalopathy (RR 0.79; low certainty); the effect on all-cause mortality was very uncertain.",{"st":"pooled","mt":"exact","m":"RR","v":0.79,"lo":0.64,"hi":0.96,"om":"hepatic encephalopathy (no improvement)","k":18,"n":934,"dur":"follow-up four days to two years","c":"Aamann L et al. Cochrane Database Syst Rev 2026","p":"41542879","url":"https://pubmed.ncbi.nlm.nih.gov/41542879/","pl":true}],[16,189,"B","Kidney stones (potassium citrate)","A 2015 Cochrane review (seven studies, 477 participants) found fewer new stones with potassium citrate; AHRQ judged supplement evidence insufficient. The proposed mechanism is citrate, not potassium itself.",{"st":"pooled","mt":"exact","m":"RR","v":0.26,"lo":0.1,"hi":0.68,"om":"new stone formation, all citrate salts pooled","k":7,"n":324,"c":"Phillips R et al. Cochrane Database Syst Rev 2015","p":"26439475","url":"https://pubmed.ncbi.nlm.nih.gov/26439475/","pl":true}],[16,217,"C","Kidney measures in membranous nephropathy (added to usual therapy)","A 2023 review of 50 studies (3,423 participants) found greater improvement in some kidney indicators; authors cited low quality, small size and limited geographic location of the studies.",{"st":"pooled","mt":"exact","m":"MD","v":-1.05,"lo":-1.21,"hi":-0.89,"om":"24-hour urinary total protein","k":50,"n":3423,"c":"Wang D et al. Medicine (Baltimore) 2023","p":"36862887","url":"https://pubmed.ncbi.nlm.nih.gov/36862887/","pl":true}],[16,76,"C","Kidney damage markers in type 2 diabetic nephropathy","A 12-week RCT (82 patients, 900 mg/day, added to ACE inhibitors or ARBs) improved thiamine status but did not reduce urinary albumin or KIM-1 excretion.",{"st":"no-estimate","mt":"exact","om":"24-h urinary albumin excretion and KIM-1 excretion","dur":"12 weeks","c":"Alkhalaf A et al. Diabetes Care 2010","p":"20413516","url":"https://pubmed.ncbi.nlm.nih.gov/20413516/","pl":false}],[16,41,"C","Nonalcoholic fatty liver disease","Observational and small studies link low choline intake to liver dysfunction or fibrosis; ODS states further research is needed.",{"st":"none","pl":false}],[16,113,"C","Kidney function in chronic kidney disease (C. sinensis preparations)","Cochrane 2014: 22 studies (1,746 participants). With conventional treatment, cordyceps lowered serum creatinine (MD −60.76 µmol/L) and proteinuria in people not on dialysis; evidence was low quality.",{"st":"pooled","mt":"exact","m":"MD","v":-60.76,"lo":-85.82,"hi":-35.71,"u":"μmol/L","om":"serum creatinine","k":14,"n":987,"c":"Zhang HW et al. Cochrane Database Syst Rev 2014","p":"25519252","url":"https://pubmed.ncbi.nlm.nih.gov/25519252/","pl":true}],[16,113,"C","Kidney transplant recipients (C. sinensis preparations)","Cochrane 2015: 5 studies (447 participants). Versus azathioprine, no difference in graft or patient survival, with possibly fewer acute rejections; all studies had unclear risk of bias.",{"st":"no-estimate","mt":"exact","om":"graft and patient survival; acute rejection (vs azathioprine)","k":4,"n":265,"dur":"three months to one year","c":"Hong T et al. Cochrane Database Syst Rev 2015","p":"26457607","url":"https://pubmed.ncbi.nlm.nih.gov/26457607/","pl":false}],[16,204,"C","Acute viral hepatitis (liver tests)","In a small RCT (33 patients, HBsAg-negative acute viral hepatitis), root powder 375 mg three times daily for 2 weeks lowered bilirubin and liver enzymes faster than placebo (27.44 vs 75.9 days to bilirubin 2.5 mg%).",{"st":"no-estimate","mt":"exact","om":"time for total serum bilirubin to fall to 2.5 mg%","dur":"2 weeks","c":"Vaidya AB et al. J Postgrad Med 1996","p":"9715310","url":"https://pubmed.ncbi.nlm.nih.gov/9715310/","pl":false}],[16,45,"C","Alcohol-related and hepatitis B or C liver disease","Cochrane (2007): 18 trials, 1,088 patients, mostly low quality; no significant effect on mortality, complications or histology; a liver-mortality signal vanished in high-quality trials.",{"st":"pooled","mt":"exact","m":"RR","v":0.78,"lo":0.53,"hi":1.15,"om":"mortality","k":18,"n":1088,"c":"Rambaldi A, Jacobs BP, Gluud C. Cochrane Database Syst Rev 2007","p":"17943794","url":"https://pubmed.ncbi.nlm.nih.gov/17943794/","pl":true}],[16,69,"C","Fatty liver: liver enzymes, lipids and glucose","An 8-week double-blind RCT in 110 adults on a weight-loss diet found 4 g/day of rosemary leaf powder no better than placebo for liver enzymes, lipids or glucose.",{"st":"no-estimate","mt":"exact","om":"liver enzymes, lipids, glycemic indices","n":110,"dur":"8 weeks","c":"Akbari S et al. Phytother Res 2022","p":"35318738","url":"https://pubmed.ncbi.nlm.nih.gov/35318738/","pl":false}],[16,18,"C","Liver enzymes and glycemic indices in adults","A 2023 meta-analysis of 10 RCTs found no significant overall effect on plasma liver enzymes or glycemic indices; fasting glucose fell in trials lasting 8 weeks or more and in non-healthy populations.",{"st":"pooled","mt":"exact","m":"WMD","v":-4.28,"lo":-7.41,"hi":-1.14,"u":"mg/dl","om":"fasting plasma glucose, subgroup of trials lasting 8 weeks or more","k":10,"dur":"≥ 8 weeks (subgroup)","c":"Bahari H et al. Complement Ther Med 2023","p":"37619715","url":"https://pubmed.ncbi.nlm.nih.gov/37619715/","pl":true}],[16,64,"C","Liver disease","NCCIH states benefit in people is not established; for intrahepatic cholestasis of pregnancy, studies conflicted and data are insufficient, and research on other liver conditions is inconclusive.",{"st":"none","pl":false}],[16,27,"C","Liver function measures","Small uncontrolled studies in liver transplant patients and chronic hepatitis suggested improved liver tests; MSK calls them inconclusive and notes schisandra can lower ALT and AST readings.",{"st":"none","pl":false}],[16,150,"C","Liver enzymes in adults with mild-to-moderate non-alcoholic liver dysfunction","One placebo-controlled trial of a powdered water extract (SPB-201) reported larger AST and ALT decreases than placebo at 4 and 8 weeks, with no significant adverse events.",{"st":"no-ci","mt":"exact","m":"other","v":216,"u":"%","om":"alanine aminotransferase (ALT)","dur":"8 weeks","c":"Han B et al. Clin Nutr Res 2020","p":"33204666","url":"https://pubmed.ncbi.nlm.nih.gov/33204666/","pl":false}],[16,151,"C","Liver markers in nonalcoholic fatty liver disease","A 24-week RCT (71 patients; delta-tocotrienol 300 mg twice daily) reduced fatty liver index, HOMA-IR, hs-CRP, ALT, AST and ultrasound steatosis grade versus placebo.",{"st":"single-trial","mt":"exact","m":"MD","v":-8.52,"lo":-10.7,"hi":-6.3,"om":"fatty liver index","n":71,"dur":"24 weeks","c":"Pervez MA et al. Complement Ther Med 2020","p":"32951743","url":"https://pubmed.ncbi.nlm.nih.gov/32951743/","pl":true}],[16,133,"C","Nonalcoholic fatty liver disease measures","Initial research suggests oral turmeric or curcumin might improve some measures, but it is unclear which measures are consistently improved.",{"st":"none","pl":false}],[16,204,"D","Liver protection in animals","In rats with galactosamine-induced liver injury, 200 mg/kg orally reduced liver lipid content and liver enzymes; this is an animal model, not a human outcome.",{"st":"not-human","pl":false}],[16,45,"X","Hepatitis C and nonalcoholic steatohepatitis (NCCIH-funded trials)","Two NCCIH-funded studies of the extract silymarin, one in hepatitis C and one in nonalcoholic steatohepatitis, did not show benefits.",{"st":"no-estimate","mt":"partial","om":"serum ALT normalization or ≥50% decline (primary outcome)","n":154,"dur":"24 weeks","c":"Fried MW et al. JAMA 2012","p":"22797645","url":"https://pubmed.ncbi.nlm.nih.gov/22797645/","pl":false}],[17,20,"B","Bone mineral density in postmenopausal women","A 2024 meta-analysis of 63 RCTs (4,754 isoflavone and 4,272 placebo participants) found BMD gains at lumbar spine, femoral neck and distal radius, mainly with 12 months or more and at least 50 mg/day genistein.",{"st":"pooled","mt":"exact","m":"MD","v":0.0175,"lo":0.0088,"hi":0.0263,"u":"g/cm2","om":"lumbar spine bone mineral density","k":63,"c":"Inpan R et al. Osteoporos Int 2024","p":"37875614","url":"https://pubmed.ncbi.nlm.nih.gov/37875614/","pl":true}],[17,142,"C","Bone health","A 10-month placebo-controlled trial (28 female athletes and sedentary women, 3 mg/day) did not directly affect bone mineral density; an observational study (134 Korean women) found no correlation with bone density.",{"st":"none","pl":false}],[17,34,"C","Bone density and fractures in older adults","Meta-analyses were mixed: calcium with vitamin D raised bone density, but a review of 14 RCTs found calcium alone did not lower hip fracture; USPSTF found no fracture benefit from under 1,000 mg calcium with under 400 IU vitamin D daily in postmenopausal women.",{"st":"pooled","mt":"partial","m":"RR","v":1.53,"lo":0.97,"hi":2.42,"om":"hip fracture (calcium alone)","c":"Zhao JG et al. JAMA 2017","p":"29279934","url":"https://pubmed.ncbi.nlm.nih.gov/29279934/","pl":true}],[17,221,"C","Bone biomarkers in fractures, dental bone procedures and osteopenia","A 2025 meta-analysis of 7 RCTs (354 participants) found higher serum parathyroid hormone but no change in calcium, phosphorus or alkaline phosphatase; certainty of evidence was very low.",{"st":"pooled","mt":"exact","m":"SMD","v":1.23,"lo":0.79,"hi":1.67,"om":"serum parathyroid hormone","k":7,"n":354,"c":"Na Takuathung M et al. BMC Complement Med Ther 2025","p":"40707943","url":"https://pubmed.ncbi.nlm.nih.gov/40707943/","pl":true}],[17,221,"C","Bone pain and fracture healing","A 2017 meta-analysis of nine studies (1,108 patients, all uses) found significant effects on bone pain; it rated evidence for bone fractures as low quality.",{"st":"no-estimate","mt":"exact","om":"bone pain","k":9,"n":1108,"c":"Sawangjit R et al. Phytother Res 2017","p":"28165166","url":"https://pubmed.ncbi.nlm.nih.gov/28165166/","pl":false}],[17,221,"C","Bone mineral density in postmenopausal women with osteopenia","In one 24-week RCT of 134 women, 1.2 or 1.6 g/day did not change bone mineral density versus placebo, though a bone-formation marker (P1NP) fell.",{"st":"no-estimate","mt":"exact","om":"bone mineral density (%change, lumbar spine, femoral neck, total hip)","n":134,"dur":"24 weeks","c":"Benjawan S et al. Phytomedicine 2022","p":"35523116","url":"https://pubmed.ncbi.nlm.nih.gov/35523116/","pl":false}],[17,1,"C","Bone health and osteoporosis","Observational studies link higher intake to greater bone density; one 30-day trial (20 postmenopausal women, 290 mg/day as citrate) suppressed bone turnover. ODS states more research is needed.",{"st":"no-estimate","mt":"partial","om":"bone turnover markers (iPTH, osteocalcin, urinary deoxypyridinoline)","dur":"30 days","c":"Aydin H et al. Biol Trace Elem Res 2010","p":"19488681","url":"https://pubmed.ncbi.nlm.nih.gov/19488681/","pl":false}],[17,223,"C","Bone health","Human evidence on manganese and osteoporosis is very limited and inconsistent; one small trial combined calcium and trace minerals, so manganese's own effect could not be determined.",{"st":"none","pl":false}],[17,86,"C","Seed oil: bone measures in middle-aged adults","In a 12-month RCT of 52 adults, 7.0 ml/day perilla seed oil raised a heel-ultrasound bone score and lowered a bone-resorption marker versus olive oil.",{"st":"no-estimate","mt":"exact","om":"calcaneal ultrasound %YAM; serum TRACP-5b","n":52,"dur":"12-month","c":"Matsuzaki K et al. Phytother Res 2023","p":"36637040","url":"https://pubmed.ncbi.nlm.nih.gov/36637040/","pl":false}],[17,189,"C","Bone health","Trials of potassium citrate are mixed: one 2-year trial (201 adults 65+) improved spine bone density, while another (276 postmenopausal women, 2 years) found no significant gain.",{"st":"single-trial","mt":"partial","m":"percent-change","v":1.7,"lo":1.0,"hi":2.3,"u":"%","om":"lumbar spine areal bone mineral density","dur":"24 months","c":"Jehle S et al. J Clin Endocrinol Metab 2013","p":"23162100","url":"https://pubmed.ncbi.nlm.nih.gov/23162100/","pl":true}],[17,19,"C","Bone density in postmenopausal women","NCCIH: only a small number of studies have been done on bone density in postmenopausal women, and the results have been inconsistent.",{"st":"none","pl":false}],[17,18,"C","Bone mineral density in postmenopausal women","MSK cites a randomized controlled study suggesting royal jelly may help preserve bone mineral density in postmenopausal women.",{"st":"no-estimate","mt":"exact","om":"bone mineral density and hip structural analysis of the femur","dur":"6 months","c":"Matsushita H et al. Climacteric 2021","p":"32880201","url":"https://pubmed.ncbi.nlm.nih.gov/32880201/","pl":false}],[17,209,"C","Bone density and fractures in postmenopausal women","A 2019 meta-analysis of 36 RCTs, which excluded trials whose integrity was questioned, found no evidence that vitamin K affects bone density or vertebral fractures in postmenopausal or osteoporotic patients; fewer clinical fractures were possible but unconfirmed.",{"st":"pooled","mt":"exact","m":"OR","v":0.96,"lo":0.83,"hi":1.11,"om":"vertebral fractures","k":36,"c":"Mott A et al. Osteoporos Int 2019","p":"31076817","url":"https://pubmed.ncbi.nlm.nih.gov/31076817/","pl":true}],[17,210,"C","Bone loss in healthy postmenopausal women","A 3-year RCT in 244 women (180 micrograms/day MK-7) reduced age-related decline in bone mineral density at the lumbar spine and femoral neck, but not the total hip, and favorably affected bone strength.",{"st":"no-estimate","mt":"exact","om":"bone mineral density (lumbar spine, femoral neck, total hip)","n":244,"dur":"3 years","c":"Knapen MH et al. Osteoporos Int 2013","p":"23525894","url":"https://pubmed.ncbi.nlm.nih.gov/23525894/","pl":false}],[17,210,"C","Osteoporosis risk (all vitamin K forms)","ODS states it is unclear whether supplementation with any form of vitamin K reduces the risk of osteoporosis; findings from clinical trials have been mixed.",{"st":"none","pl":false}],[17,70,"X","Fractures and falls in older adults","A VITAL ancillary study (25,871 participants) found no lower risk of total, hip or nonvertebral fractures; the USPSTF concluded with moderate certainty supplementation does not reduce falls in adults 65+.",{"st":"single-trial","mt":"partial","m":"HR","v":0.98,"lo":0.89,"hi":1.08,"om":"total fractures","n":25871,"dur":"median follow-up of 5.3 years","c":"LeBoff MS et al. N Engl J Med 2022","p":"35939577","url":"https://pubmed.ncbi.nlm.nih.gov/35939577/","pl":true}],[18,248,"B","Quality of life during chemotherapy","The 2008 Cochrane review of 21 RCTs found some evidence of better quality-of-life measures during chemotherapy for breast cancer, from 2 higher-quality trials; the authors said these results need replication.",{"st":"no-estimate","mt":"exact","om":"quality of life during chemotherapy","c":"Horneber MA et al. Cochrane Database Syst Rev 2008","p":"18425885","url":"https://pubmed.ncbi.nlm.nih.gov/18425885/","pl":false}],[18,244,"B","Survival in advanced gastric cancer (lentinan with chemotherapy)","Individual-patient meta-analysis of 5 randomized trials (650 patients, unresectable or recurrent gastric cancer): adding lentinan to chemotherapy was linked to longer overall survival (HR 0.80, 95% CI 0.68–0.95).",{"st":"pooled","mt":"exact","m":"HR","v":0.8,"lo":0.68,"hi":0.95,"om":"overall survival (hazard of death)","k":5,"n":650,"c":"Oba K et al. Anticancer Res 2009","p":"19596954","url":"https://pubmed.ncbi.nlm.nih.gov/19596954/","pl":true}],[18,249,"B","Survival after surgery for gastric cancer (PSK with chemotherapy)","2007 meta-analysis of 8 RCTs (8,009 patients): adding PSK to chemotherapy after curative surgery was linked to longer overall survival (HR 0.88, 95% CI 0.79–0.98).",{"st":"pooled","mt":"exact","m":"HR","v":0.88,"lo":0.79,"hi":0.98,"om":"overall survival (hazard ratio for death)","k":8,"n":8009,"c":"Oba K et al. Cancer Immunol Immunother 2007","p":"17106715","url":"https://pubmed.ncbi.nlm.nih.gov/17106715/","pl":true}],[18,70,"B","Cancer mortality","Three meta-analyses of clinical trials found supplementation reduced total cancer mortality by 12% to 13%; the most recent (10 trials) found the benefit greatest with daily dosing.",{"st":"pooled","mt":"partial","m":"RR","v":0.87,"lo":0.79,"hi":0.96,"om":"total cancer mortality","k":5,"i2":0,"dur":"3-10 years of follow-up","c":"Keum N et al. Ann Oncol 2019","p":"30796437","url":"https://pubmed.ncbi.nlm.nih.gov/30796437/","pl":true}],[18,142,"C","Cancer","Observational studies associate higher boron intake with lower risk of some cancers; ODS states no clinical trials have evaluated boron for cancer.",{"st":"none","pl":false}],[18,126,"C","Brain swelling in people with malignant glioma","In a small study, oral boswellia may have reduced brain edema (swelling) but not the tumor; larger studies are needed.",{"st":"no-estimate","mt":"partial","om":"cerebral edema volume (MRI T2)","n":44,"c":"Kirste S et al. Cancer 2011","p":"21287538","url":"https://pubmed.ncbi.nlm.nih.gov/21287538/","pl":false}],[18,197,"C","Cancer","NCCIH states CoQ10 has not been shown to be of value in cancer treatment, though it may reduce heart damage from one type of chemotherapy drug.",{"st":"none","pl":false}],[18,248,"C","Survival in people with cancer (extracts alone or added to chemotherapy or radiotherapy)","A 2008 Cochrane review of 21 RCTs (3,484 patients) found the evidence on survival weak: 6 of 13 survival trials showed some benefit, but none was of high methodological quality.",{"st":"no-estimate","mt":"exact","om":"overall survival","k":21,"n":3484,"c":"Horneber MA et al. Cochrane Database Syst Rev 2008","p":"18425885","url":"https://pubmed.ncbi.nlm.nih.gov/18425885/","pl":false}],[18,200,"C","Quality of life during rectal cancer chemoradiotherapy","RCT in 87 patients: low-molecular-weight fucoidan improved physical well-being and reduced rash, itching and fatigue, but the overall colorectal quality-of-life score did not differ significantly.",{"st":"no-estimate","mt":"exact","om":"FACT-C quality of life; physical well-being","dur":"3 months posttreatment follow-up","c":"Tsai HL et al. Integr Cancer Ther 2023","p":"37822243","url":"https://pubmed.ncbi.nlm.nih.gov/37822243/","pl":false}],[18,200,"C","Tumor control with chemoembolization in liver cancer","RCT in 82 patients with unresectable hepatocellular carcinoma: low-molecular-weight fucoidan with TACE for 6 months raised disease control (95.24% vs 80.00%); objective response did not differ significantly.",{"st":"no-estimate","mt":"exact","om":"disease control rate (mRECIST)","dur":"6 months","c":"Zou Y et al. Liver Int 2025","p":"40960276","url":"https://pubmed.ncbi.nlm.nih.gov/40960276/","pl":false}],[18,178,"C","Stomach and colorectal cancer risk","NCCIH states consuming garlic does not seem to lower stomach cancer risk; its influence on colorectal cancer risk is uncertain.",{"st":"none","pl":false}],[18,180,"C","Cancer risk","Many studies, summarized in a Cochrane systematic review, have examined green tea and cancer risk; results are inconsistent.",{"st":"pooled","mt":"exact","m":"RR","v":0.83,"lo":0.65,"hi":1.07,"om":"overall cancer incidence","k":3,"n":52479,"c":"Filippini T et al. Cochrane Database Syst Rev 2020","p":"32118296","url":"https://pubmed.ncbi.nlm.nih.gov/32118296/","pl":false,"ex":"the estimate compares highest with lowest intake in observational studies; it is an association, not a randomized comparison"}],[18,205,"C","PSA levels in men with non-metastatic prostate cancer","A 2021 meta-analysis of six RCTs found no significant overall effect of lycopene supplementation on PSA (WMD −0.60 µg/L); a reduction appeared only in studies of men with baseline PSA of 6.5 µg/L or higher.",{"st":"pooled","mt":"exact","m":"WMD","v":-0.6,"lo":-2.01,"hi":0.81,"u":"µg/L","om":"serum PSA","k":6,"c":"Sadeghian M et al. Nutr Cancer 2021","p":"33355018","url":"https://pubmed.ncbi.nlm.nih.gov/33355018/","pl":true}],[18,205,"C","Prostate cancer incidence","A Cochrane review found three RCTs (154 participants), two at high risk of bias, and concluded the evidence was insufficient to support or refute lycopene; only one trial reported prostate cancer incidence.",{"st":"no-estimate","mt":"exact","om":"prostate cancer incidence","c":"Ilic D et al. Cochrane Database Syst Rev 2011","p":"22071840","url":"https://pubmed.ncbi.nlm.nih.gov/22071840/","pl":false}],[18,84,"C","Side effects of chemoradiotherapy in head and neck cancer","A randomized placebo-controlled trial in 141 patients reported that maitake D-fraction capsules taken during chemoradiotherapy reduced severe treatment-related adverse events and improved quality-of-life scores in advanced laryngeal and pharyngeal cancers.",{"st":"no-estimate","mt":"exact","om":"severe chemoradiotherapy-associated adverse events; global QOL","n":141,"c":"Hu CH et al. Acta Biochim Pol 2022","p":"36070433","url":"https://pubmed.ncbi.nlm.nih.gov/36070433/","pl":false}],[18,33,"C","Cancer incidence","PHS II found an 8% lower total cancer risk in men after a median 11.2 years; COSMOS (8,776 men and 12,666 women, median 3.6 years) found no reduction in total invasive cancers.",{"st":"single-trial","mt":"partial","m":"HR","v":0.92,"lo":0.86,"hi":0.998,"om":"total cancer incidence","dur":"median 11.2 years","c":"Gaziano JM et al. JAMA 2012 (PHS II)","p":"23162860","url":"https://pubmed.ncbi.nlm.nih.gov/23162860/","pl":true}],[18,16,"C","Isolated lapachol in chronic myelocytic leukemia","MSK reports that lapachol, a compound in pau d'arco, did not show clinical improvement in patients with chronic myelocytic leukemia.",{"st":"none","pl":false}],[18,188,"C","PSA rise in men with prostate cancer","Data conflict on whether pomegranate juice slows PSA rise in men with high PSA; in advanced prostate cancer, adjunctive juice did not reduce PSA versus placebo."],[18,148,"C","Colorectal adenoma (cancer risk) biomarker trial","MSK reports that supplemental propolis was not useful in a pilot placebo-controlled trial in people with frequent colorectal adenomas, and had negative effects on muscle tissues including myocardial cells.",{"st":"no-estimate","mt":"exact","om":"colon mucosa biomarkers (8-OHdG, PCNA, cyclin D1, Bax) and blood CPK","dur":"3 months","c":"Ishikawa H et al. J Am Coll Nutr 2012","p":"23529990","url":"https://pubmed.ncbi.nlm.nih.gov/23529990/","pl":false}],[18,225,"C","Tumor response, immune measures and quality of life in people with cancer","Cochrane 2016: 5 RCTs of generally poor quality. Reishi added to chemo- or radiotherapy was associated with more tumor responses (RR 1.50, 95% CI 0.90 to 2.51, though the review reports P = 0.02) and small immune-marker changes; no trial measured long-term survival.",{"st":"pooled","mt":"exact","m":"RR","v":1.5,"lo":0.9,"hi":2.51,"om":"tumour response (WHO criteria), G. lucidum plus chemo/radiotherapy","c":"Jin X et al. Cochrane Database Syst Rev 2016","p":"27045603","url":"https://pubmed.ncbi.nlm.nih.gov/27045603/","pl":false,"ex":"the printed interval includes no effect while the abstract reports P = 0.02, so the printed numbers are internally inconsistent"}],[18,225,"C","Colorectal adenomas (precancerous polyps)","Japanese study: 123 people took a mycelial culture extract (MAK) 1.5 g/day for 12 months; adenoma number and size decreased versus 102 untreated controls selected from the same department.",{"st":"no-estimate","mt":"exact","om":"change in number and total size of colorectal adenomas","dur":"12 months","c":"Oka S et al. Hiroshima J Med Sci 2010","p":"20518254","url":"https://pubmed.ncbi.nlm.nih.gov/20518254/","pl":false}],[18,2,"C","Cancer risk","Cohort studies are mixed: some found inverse associations (lung cancer in current smokers; colorectal cancer in postmenopausal women), others none. ODS states clinical trials are needed.",{"st":"none","pl":false}],[18,244,"C","Shiitake extracts added to standard cancer treatment","2026 meta-analysis of 22 trials (1,723 patients): in 13 RCTs, tumor response was better (OR 1.45) but overall survival (HR 0.66, 95% CI 0.34–1.28) and quality of life did not differ.",{"st":"pooled","mt":"exact","m":"HR","v":0.66,"lo":0.34,"hi":1.28,"om":"overall survival","c":"Sohn BS et al. Integr Cancer Ther 2026","p":"42648714","url":"https://pubmed.ncbi.nlm.nih.gov/42648714/","pl":true}],[18,244,"C","PSA levels in prostate cancer","Open-label study of 62 men with prostate cancer and rising PSA: an oral shiitake mycelium extract for 6 months produced no PSA responses, and 23 of 61 progressed; authors judged it ineffective alone.",{"st":"no-estimate","mt":"exact","om":"PSA response / progression","n":61,"dur":"6 months","c":"deVere White RW et al. Urology 2002","p":"12385925","url":"https://pubmed.ncbi.nlm.nih.gov/12385925/","pl":false}],[18,20,"C","Breast cancer risk","NCCIH: observational studies link higher soy intake in Asian and Asian-American women to lower breast cancer risk, but soy products in supplement form have not been shown to reduce breast cancer risk.",{"st":"none","pl":false}],[18,250,"C","Cancer trials (prostate, breast, pancreatic, melanoma)","A 2023 systematic review of 8 RCTs found changes in some genes and tissue biomarkers; PSA results in prostate cancer were inconsistent, and a survival difference in pancreatic cancer was not statistically significant.",{"st":"no-estimate","mt":"exact","om":"overall survival (pancreatic cancer) and PSA (prostate cancer)","c":"ElKhalifa D et al. Front Oncol 2023","p":"38074675","url":"https://pubmed.ncbi.nlm.nih.gov/38074675/","pl":false}],[18,249,"C","Side effects of treatment and survival in colorectal cancer","Cochrane 2022: 7 RCTs (1,569 participants), 6 in Japan. Low-certainty evidence of a small 5-year survival benefit (RR 1.08); very low certainty on side effects. Chemotherapy regimens do not reflect current practice.",{"st":"pooled","mt":"exact","m":"RR","v":1.08,"lo":1.01,"hi":1.15,"om":"survival at five years","k":3,"n":1094,"c":"Pilkington K et al. Cochrane Database Syst Rev 2022","p":"36445793","url":"https://pubmed.ncbi.nlm.nih.gov/36445793/","pl":true}],[18,249,"C","Lung cancer (PSK with standard treatment)","A systematic review found 6 RCTs using PSK 3 g/day with chemotherapy; each reported benefit on at least one endpoint (immune measures, weight, performance status, symptoms or survival).",{"st":"no-estimate","mt":"exact","om":"immune, hematological, performance status, body weight, symptoms, survival","c":"Fritz H et al. Integr Cancer Ther 2015","p":"25784670","url":"https://pubmed.ncbi.nlm.nih.gov/25784670/","pl":false}],[18,249,"C","Immune measures in breast cancer","Studies in breast cancer have measured changes in blood immune cells, not clinical outcomes such as survival, symptoms or quality of life.",{"st":"none","pl":false}],[18,152,"D","Cancer cells and tumors in the laboratory","Extracts and constituents such as inotodiol inhibited colon, lung, liver and cervical cancer cells in vitro and melanoma in mice; no human studies have tested this.",{"st":"not-human","pl":false}],[18,34,"X","Overall cancer risk","A meta-analysis of 10 RCTs (10,496 people, at least 500 mg/day, mean 3.9 years) found no change in total cancer risk; a 4-year RCT (2,303 women, 1,500 mg plus vitamin D) also found none.",{"st":"pooled","mt":"exact","m":"RR","v":0.95,"lo":0.76,"hi":1.18,"om":"total cancer","k":10,"n":10496,"dur":"mean duration 3·9 years","c":"Bristow SM et al. Br J Nutr 2013","p":"23601861","url":"https://pubmed.ncbi.nlm.nih.gov/23601861/","pl":true}],[18,248,"X","Survival and quality of life in advanced pancreatic cancer (MISTRAL trial)","In a double-blind RCT in advanced pancreatic cancer (143 extract, 147 placebo, added to standard care), extract injected subcutaneously three times weekly for nine months did not improve overall survival (median 7.8 vs 8.3 months) or global quality of life.",{"st":"single-trial","mt":"exact","m":"HR","v":1.13,"lo":0.89,"hi":1.44,"om":"overall survival","dur":"nine months of injections","c":"Wode K et al. Dtsch Arztebl Int 2024","p":"38915151","url":"https://pubmed.ncbi.nlm.nih.gov/38915151/","pl":false,"ex":"the abstract does not state the confidence level of the printed interval, so it cannot be shown as a 95% confidence interval"}],[18,31,"X","Cancer","Trials do not show reduced cancer risk; a Norwegian trial (800 mcg with B12) found 21% higher incidence. A 2015 NTP panel concluded folic acid does not reduce cancer risk in people with adequate status.",{"st":"single-trial","mt":"partial","m":"HR","v":1.21,"lo":1.03,"hi":1.41,"om":"cancer incidence","n":6837,"dur":"median 39 months of treatment plus 38 months posttrial follow-up","c":"Ebbing M et al. JAMA 2009","p":"19920236","url":"https://pubmed.ncbi.nlm.nih.gov/19920236/","pl":true}],[18,68,"X","Second head and neck or lung tumors","MSK reports that a large trial found NAC did not inhibit formation of secondary head and neck or lung tumors.",{"st":"no-estimate","mt":"exact","om":"second primary tumors; event-free and overall survival","n":2592,"dur":"2 years","c":"van Zandwijk N et al. J Natl Cancer Inst 2000","p":"10861309","url":"https://pubmed.ncbi.nlm.nih.gov/10861309/","pl":false}],[18,93,"X","Cancer incidence and mortality","SELECT (over 35,000 men, 200 mcg/day selenomethionine) found no reduction in prostate cancer; a 2018 Cochrane review (10 trials, 27,232 people) found little to no effect on cancer incidence or mortality.",{"st":"pooled","mt":"exact","m":"RR","v":1.01,"lo":0.93,"hi":1.1,"om":"any cancer incidence (RCTs at low risk of bias)","k":3,"n":19475,"c":"Vinceti M et al. Cochrane Database Syst Rev 2018","p":"29376219","url":"https://pubmed.ncbi.nlm.nih.gov/29376219/","pl":true}],[18,240,"X","Lung cancer in smokers (beta-carotene, with or without retinyl palmitate)","In CARET (18,314 current and former smokers, including some asbestos-exposed men) lung cancer risk rose 28%; in ATBC (29,133 male smokers, 20 mg/day beta-carotene) it rose 18%. Overall mortality was also higher.",{"st":"single-trial","mt":"partial","m":"RR","v":1.28,"lo":1.04,"hi":1.57,"om":"lung cancer incidence","n":18314,"dur":"mean 4.0 years","c":"Omenn GS et al. N Engl J Med 1996 (CARET)","p":"8602180","url":"https://pubmed.ncbi.nlm.nih.gov/8602180/","pl":true}],[18,94,"X","Cancer","A meta-analysis of 18 RCTs (74,498 individuals; 20–2,000 mcg/day for 2–7.3 years) found little or no effect on cancer incidence.",{"st":"pooled","mt":"exact","m":"RR","v":1.04,"lo":0.98,"hi":1.1,"om":"cancer incidence","n":74498,"c":"Zhang SL et al. Medicine (Baltimore) 2016","p":"27495015","url":"https://pubmed.ncbi.nlm.nih.gov/27495015/","pl":false,"ex":"the estimate is for B-vitamin supplementation in general, not vitamin B12 alone"}],[18,10,"X","Cancer","Two Norwegian trials found no association between B6 supplementation and cancer incidence, cancer mortality or all-cause mortality; observational data link higher intake with 20% lower colorectal cancer risk.",{"st":"no-estimate","mt":"exact","om":"cancer incidence, cancer mortality and all-cause mortality","n":6837,"c":"Ebbing M et al. JAMA 2009","p":"19920236","url":"https://pubmed.ncbi.nlm.nih.gov/19920236/","pl":false}],[18,212,"X","Cancer","Physicians' Health Study II (500 mg/day, mean 8 years) and the Women's Antioxidant Cardiovascular Study (500 mg/day, mean 9.4 years) found no effect on total cancer; most randomized trials show no effect on cancer risk.",{"st":"single-trial","mt":"partial","m":"HR","v":1.01,"lo":0.92,"hi":1.1,"om":"total cancer","n":14641,"dur":"mean follow-up of 8.0 years","c":"Gaziano JM et al. JAMA 2009 (Physicians' Health Study II)","p":"19066368","url":"https://pubmed.ncbi.nlm.nih.gov/19066368/","pl":true}],[18,70,"X","Cancer incidence","VITAL (25,871 adults; 2,000 IU/day D3; median 5.3 years) found no significant difference in breast, prostate or colorectal cancer; ODS states studies do not show supplementation reduces cancer incidence.",{"st":"single-trial","mt":"exact","m":"HR","v":0.96,"lo":0.88,"hi":1.06,"om":"invasive cancer of any type (primary end point)","n":25871,"dur":"median follow-up of 5.3 years","c":"Manson JE et al. N Engl J Med 2019","p":"30415629","url":"https://pubmed.ncbi.nlm.nih.gov/30415629/","pl":true}],[18,92,"X","Prostate and other cancers","SELECT (35,533 men, 400 IU/day synthetic, about 5.5 years) found no reduction in prostate cancer and, after 1.5 more years, 17% higher risk; HOPE-TOO and the Women's Health Study found no effect on cancer.",{"st":"single-trial","mt":"exact","m":"HR","v":1.17,"lo":1.004,"hi":1.36,"om":"prostate cancer incidence","c":"Klein EA et al. JAMA 2011","p":"21990298","url":"https://pubmed.ncbi.nlm.nih.gov/21990298/","pl":false,"pr":"interval is not a 95% confidence interval","ex":"the abstract gives a 99% confidence interval, not a 95% interval"}],[19,251,"A","UTI after a medical intervention","Cochrane 2023: 6 trials, 1,434 people susceptible to UTI after an intervention; RR 0.47 (95% CI 0.37 to 0.61; I² = 0%).",{"st":"pooled","mt":"exact","m":"RR","v":0.47,"lo":0.37,"hi":0.61,"om":"symptomatic, culture-verified UTI","k":6,"n":1434,"i2":0,"c":"Williams G et al. Cochrane Database Syst Rev 2023","p":"37947276","url":"https://pubmed.ncbi.nlm.nih.gov/37947276/","pl":true}],[19,251,"B","Recurrent urinary tract infections in women","Cochrane 2023: 8 trials, 1,555 participants; symptomatic, culture-verified UTI RR 0.74 (95% CI 0.55 to 0.99), with moderate heterogeneity (I² = 54%). NCCIH describes findings as inconsistent.",{"st":"pooled","mt":"exact","m":"RR","v":0.74,"lo":0.55,"hi":0.99,"om":"symptomatic, culture-verified UTI","k":8,"n":1555,"i2":54,"c":"Williams G et al. Cochrane Database Syst Rev 2023","p":"37947276","url":"https://pubmed.ncbi.nlm.nih.gov/37947276/","pl":true}],[19,251,"B","Urinary tract infections in children","Cochrane 2023: 5 trials, 504 participants; RR 0.46 (95% CI 0.32 to 0.68).",{"st":"pooled","mt":"exact","m":"RR","v":0.46,"lo":0.32,"hi":0.68,"om":"symptomatic, culture-verified UTI","k":5,"n":504,"i2":21,"c":"Williams G et al. Cochrane Database Syst Rev 2023","p":"37947276","url":"https://pubmed.ncbi.nlm.nih.gov/37947276/","pl":true}],[19,215,"B","Root extract trials in men with benign prostatic hyperplasia","LiverTox summarizes a 52-week trial (226 men, 429 mg root extract) with slightly larger symptom-score gains than placebo (-5.7 vs -4.8) and a 558-man crossover trial reporting 81% vs 16% improvement.",{"st":"no-estimate","mt":"partial","om":"improvement in lower urinary tract symptoms; IPSS","n":558,"dur":"6 months (follow-up to 18 months)","c":"Safarinejad MR. J Herb Pharmacother 2005","p":"16635963","url":"https://pubmed.ncbi.nlm.nih.gov/16635963/","pl":false}],[19,143,"C","Interstitial cystitis (injection into the bladder wall)","A single-arm pilot study in 12 women (10 mg injected during cystoscopy) reported complete symptom resolution in 10 and 80% improvement in 2; there was no comparison group.",{"st":"no-estimate","mt":"exact","om":"Global Response Assessment / symptom resolution","n":12,"dur":"single procedure","c":"Lee E et al. Altern Ther Health Med 2024","p":"39325560","url":"https://pubmed.ncbi.nlm.nih.gov/39325560/","pl":false}],[19,251,"C","Neuromuscular bladder dysfunction","Cochrane 2023: 3 trials, 464 adults with incomplete bladder emptying; RR 0.97 (95% CI 0.78 to 1.19), low-certainty evidence.",{"st":"pooled","mt":"exact","m":"RR","v":0.97,"lo":0.78,"hi":1.19,"om":"symptomatic, culture-verified UTI","k":3,"n":464,"i2":0,"c":"Williams G et al. Cochrane Database Syst Rev 2023","p":"37947276","url":"https://pubmed.ncbi.nlm.nih.gov/37947276/","pl":true}],[19,200,"C","Urinary symptoms in benign prostatic hyperplasia","RCT in 95 men aged 45–80 with moderate BPH: Undaria pinnatifida fucoidan for 90 days reduced symptom scores (IPSS −3.40 vs −0.93 with placebo); urine flow, residual volume and PSA did not differ.",{"st":"no-estimate","mt":"exact","om":"total IPSS (International Prostate Symptom Score)","dur":"90 days","c":"Wimmer BC et al. Res Rep Urol 2026","p":"42488927","url":"https://pubmed.ncbi.nlm.nih.gov/42488927/","pl":false}],[19,159,"C","Urinary symptoms from benign prostatic enlargement","In a 12-month, partially blinded RCT of 1,431 men aged 50–80, response with pumpkin seed (5 g twice daily) was 58.5% versus 47.3% with placebo (descriptively significant); seed-extract capsules did not differ from placebo.",{"st":"no-estimate","mt":"exact","u":"%","om":"IPSS responder rate (decrease >=5 points at 12 months)","c":"Vahlensieck W et al. Urol Int 2015","p":"25196580","url":"https://pubmed.ncbi.nlm.nih.gov/25196580/","pl":false}],[19,159,"C","Prostate symptoms: seed oil versus tamsulosin","In a 3-month single-blind trial of 73 men, symptom scores improved with pumpkin seed oil (360 mg twice daily) and with tamsulosin, but fell more with tamsulosin by months 1 and 3.",{"st":"no-estimate","mt":"exact","om":"IPSS decrease","dur":"3 months","c":"Zerafatjou N et al. BMC Urol 2021","p":"34666728","url":"https://pubmed.ncbi.nlm.nih.gov/34666728/","pl":false}],[19,159,"C","Overactive bladder in women (combination product)","An uncontrolled, industry-funded 12-week observational study of a pumpkin seed oil, Rhus aromatica and hop combination in 117 women reported fewer daytime and nighttime urinations.",{"st":"no-estimate","mt":"exact","om":"day- and nighttime urination frequency","n":117,"c":"Gauruder-Burmester A et al. Planta Med 2019","p":"31261419","url":"https://pubmed.ncbi.nlm.nih.gov/31261419/","pl":false}],[19,225,"C","Lower urinary tract symptoms in men","One dose-ranging RCT in 50 men aged 50 and older: an extract (0.6, 6 or 60 mg once daily) improved symptom scores (IPSS) versus placebo; urine flow, prostate volume and PSA did not change.",{"st":"no-estimate","mt":"exact","om":"International Prostate Symptom Score (IPSS)","c":"Noguchi M et al. Asian J Androl 2008","p":"18097503","url":"https://pubmed.ncbi.nlm.nih.gov/18097503/","pl":false}],[19,132,"C","Urinary tract infection after cesarean delivery","In one RCT of 400 women, 500 mg Rosa canina fruit capsules twice daily for 20 days were followed by fewer positive urine cultures than placebo; cystitis incidence did not differ.",{"st":"single-trial","mt":"exact","m":"OR","v":0.22,"lo":0.07,"hi":0.67,"om":"urinary tract infection (positive urine culture) on days 7-10 after cesarean","dur":"20 days","c":"Seifi M et al. Phytother Res 2018","p":"29024081","url":"https://pubmed.ncbi.nlm.nih.gov/29024081/","pl":true}],[19,162,"C","Chronic prostatitis/chronic pelvic pain syndrome","A 2022 review of five studies did not find a significant benefit.",{"st":"none","pl":false}],[19,215,"C","Root: lower urinary tract symptoms of benign prostatic hyperplasia (regulatory assessment)","EMA's herbal committee (2025) found eight randomized, double-blind, placebo-controlled root trials but judged them inadequate to prove efficacy: short, small, poorly defined preparations. It accepted traditional use only.",{"st":"none","pl":false}],[19,251,"X","Elderly people in long-term care","Cochrane 2023: 3 trials, 1,489 participants; RR 0.93 (95% CI 0.67 to 1.30), moderate-certainty evidence of no clear benefit.",{"st":"pooled","mt":"exact","m":"RR","v":0.93,"lo":0.67,"hi":1.3,"om":"symptomatic, culture-verified UTI","k":3,"n":1489,"i2":9,"c":"Williams G et al. Cochrane Database Syst Rev 2023","p":"37947276","url":"https://pubmed.ncbi.nlm.nih.gov/37947276/","pl":true}],[19,251,"X","Pregnant women","Cochrane 2023: 3 trials, 765 participants; RR 1.06 (95% CI 0.75 to 1.50), moderate-certainty evidence of no clear benefit.",{"st":"pooled","mt":"exact","m":"RR","v":1.06,"lo":0.75,"hi":1.5,"om":"symptomatic, culture-verified UTI","k":3,"n":765,"i2":3,"c":"Williams G et al. Cochrane Database Syst Rev 2023","p":"37947276","url":"https://pubmed.ncbi.nlm.nih.gov/37947276/","pl":true}],[19,162,"X","Urinary symptoms of benign prostatic enlargement (BPH)","Cochrane (2023): 27 studies, 4,656 participants; saw palmetto alone made little to no difference in symptoms or quality of life at 3 to 6 and 12 to 17 months (high-certainty evidence).",{"st":"pooled","mt":"exact","m":"MD","v":-0.9,"lo":-1.74,"hi":-0.07,"u":"points on IPSS (0 to 35)","om":"urologic symptoms (IPSS), short term","k":9,"n":1681,"i2":68,"dur":"3 to 6 months","c":"Franco JV et al. Cochrane Database Syst Rev 2023","p":"37345871","url":"https://pubmed.ncbi.nlm.nih.gov/37345871/","pl":true}],[19,162,"X","Hexane-extracted versus other products for BPH","Reviewers analyzed hexane-extracted products separately and found no difference in effect on BPH symptoms.",{"st":"none","pl":false}],[20,83,"B","Macular pigment optical density and visual acuity in people with or at risk of AMD","A meta-analysis of five RCTs (445 participants) found lutein raised macular pigment optical density and gave a milder improvement in visual acuity versus placebo; the authors said the number of studies was not adequate for conclusive evidence.",{"st":"pooled","mt":"exact","m":"MD","v":0.09,"lo":0.06,"hi":0.12,"om":"macular pigment optical density","n":445,"c":"Wang X et al. Ophthalmic Res 2014","p":"25358528","url":"https://pubmed.ncbi.nlm.nih.gov/25358528/","pl":true}],[20,158,"B","Dry eye (honey applied to the eye)","A meta-analysis of 5 RCTs (288 adults) reported improved symptom scores, tear evaporation and ocular surface staining versus control; the authors state study limitations affect reliability and call for high-quality trials.",{"st":"no-estimate","mt":"exact","om":"Ocular Surface Disease Index and other dry eye measures","k":5,"n":288,"c":"Hu J et al. Clin Exp Optom 2023","p":"35950413","url":"https://pubmed.ncbi.nlm.nih.gov/35950413/","pl":false}],[20,33,"B","Progression of age-related macular degeneration (AREDS formula)","AREDS (4,757 participants enrolled, mean 6.3 years; high-dose vitamins C and E, beta-carotene, zinc, copper) lowered the odds of advanced AMD by about 28% (about 25% lower estimated 5-year risk) in people at high risk; it did not affect AMD onset.",{"st":"no-ci","mt":"partial","m":"OR","v":0.72,"om":"development of advanced AMD","n":3640,"dur":"average 6.3 years","c":"Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001 (AREDS report no. 8)","p":"11594942","url":"https://pubmed.ncbi.nlm.nih.gov/11594942/","pl":false}],[20,226,"B","Advanced age-related macular degeneration","AREDS (4,757 adults aged 55–80; about 5 years): in those at high risk of advanced AMD, 80 mg zinc (as zinc oxide) plus antioxidants and 2 mg copper gave about 25% lower risk than placebo; AREDS2 results with 25 mg were called preliminary.",{"st":"no-ci","mt":"partial","m":"OR","v":0.72,"om":"development of advanced AMD (antioxidants plus zinc vs placebo)","n":3640,"dur":"average follow-up 6.3 years","c":"Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001 (AREDS report no. 8)","p":"11594942","url":"https://pubmed.ncbi.nlm.nih.gov/11594942/","pl":false}],[20,234,"C","Eye fatigue from screen work","RCT in office workers (88 enrolled, 80 completed): 480 mg/day extract for 8 weeks lessened the screen-induced drop in flicker fusion and some fatigue symptoms versus placebo; near-point accommodation did not change.",{"st":"no-estimate","mt":"exact","m":"other","lo":0.1,"hi":1.6,"om":"VDT-load-induced reduction in critical flicker fusion (CFF)","n":88,"dur":"8 weeks","c":"Ozawa Y et al. J Nutr Health Aging 2015","p":"25923485","url":"https://pubmed.ncbi.nlm.nih.gov/25923485/","pl":false}],[20,252,"C","Diabetic retinopathy","One 3-month randomized study (60 patients) compared Ruscus extract with troxerutin and buckwheat herb; changes in retinal electrical activity were not statistically significant versus baseline.",{"st":"none","pl":false}],[20,156,"C","Retinal function in retinitis pigmentosa","In a crossover RCT (29 analyzed), 300 mg/day D. bardawil powder (about 20 mg beta-carotene) for 90 days raised dark-adapted ERG b-wave amplitude versus placebo; visual field and acuity did not change.",{"st":"no-estimate","mt":"exact","u":"μV","om":"dark-adapted maximal ERG b-wave amplitude","dur":"90 days per period (crossover)","c":"Rotenstreich Y et al. JAMA Ophthalmol 2013","p":"23700011","url":"https://pubmed.ncbi.nlm.nih.gov/23700011/","pl":false}],[20,201,"C","Macular pigment in healthy middle-aged adults","In an unmasked 90-day trial in 27 adults aged 45-65, 28 g goji berries five times weekly increased macular pigment optical density; a lutein/zeaxanthin supplement group showed no change.",{"st":"no-estimate","mt":"exact","om":"macular pigment optical density","n":27,"dur":"90 days","c":"Li X et al. Nutrients 2021","p":"34959963","url":"https://pubmed.ncbi.nlm.nih.gov/34959963/","pl":false}],[20,201,"C","Retinitis pigmentosa","A 12-month double-masked placebo-controlled trial (42 completers) found visual acuity better preserved with a Lycium barbarum supplement; visual field and electroretinogram measures did not differ.",{"st":"no-estimate","mt":"exact","om":"best corrected visual acuity","dur":"12 months","c":"Chan HH et al. J Ethnopharmacol 2019","p":"30877066","url":"https://pubmed.ncbi.nlm.nih.gov/30877066/","pl":false}],[20,83,"C","Lutein/zeaxanthin in place of beta-carotene in the AREDS formulation","In 10-year AREDS2 follow-up (3,882 participants), an epidemiologic study, lutein/zeaxanthin versus beta carotene had HR 0.85 for late AMD; beta carotene had been replaced by lutein/zeaxanthin in the revised supplement.",{"st":"single-trial","mt":"exact","m":"HR","v":0.85,"lo":0.73,"hi":0.98,"om":"progression to late AMD","n":3882,"dur":"10 years","c":"Chew EY et al. JAMA Ophthalmol 2022","p":"35653117","url":"https://pubmed.ncbi.nlm.nih.gov/35653117/","pl":true}],[20,83,"C","Retinopathy of prematurity in preterm infants","Three RCTs (406 preterm infants) of oral lutein/zeaxanthin versus placebo failed to show any reduction in retinopathy of prematurity, bronchopulmonary dysplasia, sepsis, NEC or mortality.",{"st":"no-estimate","mt":"exact","om":"retinopathy of prematurity incidence","n":406,"c":"Cota F et al. J Matern Fetal Neonatal Med 2022","p":"32041442","url":"https://pubmed.ncbi.nlm.nih.gov/32041442/","pl":false}],[20,131,"C","Intraocular pressure in glaucoma or ocular hypertension","A systematic review included 6 studies (199 patients) and pooled 3; PEA reduced intraocular pressure.",{"st":"no-estimate","mt":"exact","om":"intraocular pressure","k":6,"n":199,"c":"Crupi L et al. Nat Prod Res 2025","p":"38269580","url":"https://pubmed.ncbi.nlm.nih.gov/38269580/","pl":false}],[20,28,"C","Dry eye symptoms","In an RCT (100 adults, 86 completed), 2 g/day sea buckthorn oil for 3 months limited the cold-season rise in tear osmolarity versus placebo and lowered some symptom intensities.",{"st":"no-estimate","mt":"exact","om":"tear film osmolarity increase","n":100,"dur":"3 mo","c":"Larmo PS et al. J Nutr 2010","p":"20554904","url":"https://pubmed.ncbi.nlm.nih.gov/20554904/","pl":false}],[20,253,"C","Demodex eyelid mites (eyelid inflammation)","Several studies have looked at this use, but effectiveness is uncertain.",{"st":"none","pl":false}],[20,240,"C","Advanced age-related macular degeneration (AMD)","AREDS (formula with 15 mg beta-carotene, vitamins C and E, zinc, copper; 5 years) reported 25% lower risk of advanced AMD; AREDS2 (4,203 people) found beta-carotene was not a required ingredient.",{"st":"no-ci","mt":"partial","m":"OR","v":0.72,"om":"development of advanced AMD","n":3640,"dur":"average 6.3 years","c":"Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001 (AREDS report no. 8)","p":"11594942","url":"https://pubmed.ncbi.nlm.nih.gov/11594942/","pl":false}],[20,212,"C","Age-related macular degeneration (AMD)","In AREDS (3,597 people, 500 mg with other antioxidants, 6.3 years) high-risk participants had 28% lower risk of advanced AMD, but evidence does not show vitamin C alone affects AMD risk.",{"st":"no-ci","mt":"partial","m":"OR","v":0.72,"om":"progression to advanced AMD","n":3640,"dur":"6.3 years","c":"Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001 (AREDS report no. 8)","p":"11594942","url":"https://pubmed.ncbi.nlm.nih.gov/11594942/","pl":false}],[20,92,"C","Age-related macular degeneration (AMD)","AREDS (formula with 400 IU vitamin E plus other nutrients) reported 25% lower risk of advanced AMD at 5 years in high-risk people; two trials of vitamin E alone or with beta-carotene found no protection.",{"st":"single-trial","mt":"partial","m":"OR","v":0.66,"lo":0.47,"hi":0.91,"om":"progression to advanced AMD","c":"Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001 (AREDS report no. 8)","p":"11594942","url":"https://pubmed.ncbi.nlm.nih.gov/11594942/","pl":false,"pr":"interval is not a 95% confidence interval","ex":"the abstract gives a 99% confidence interval, not a 95% interval"}],[20,234,"X","Night vision in healthy people","A systematic review of 12 placebo-controlled trials found the 4 most recent RCTs negative; negative results came from more rigorous trials. Improvement of normal night vision is not supported by rigorous studies.",{"st":"no-estimate","mt":"exact","om":"night vision","k":12,"c":"Canter PH, Ernst E. Surv Ophthalmol 2004","p":"14711439","url":"https://pubmed.ncbi.nlm.nih.gov/14711439/","pl":false}],[20,83,"X","Progression to advanced age-related macular degeneration (AMD), added to the AREDS formulation","AREDS2 (4,203 people aged 50–85 at risk of advanced AMD; median 5 years): adding lutein 10 mg + zeaxanthin 2 mg to the AREDS formulation did not further reduce risk of progression to advanced AMD in primary analyses (HR 0.90).",{"st":"no-ci","mt":"exact","m":"HR","v":0.9,"om":"progression to advanced AMD (by eye)","n":4203,"dur":"median follow-up 5 years","c":"Age-Related Eye Disease Study 2 Research Group. JAMA 2013","p":"23644932","url":"https://pubmed.ncbi.nlm.nih.gov/23644932/","pl":false}],[20,83,"X","Cataract surgery and vision loss","In AREDS2 (3,159 participants with a natural lens, median 4.7 years), lutein/zeaxanthin had no statistically significant overall effect on cataract surgery (HR 0.96) or vision loss.",{"st":"single-trial","mt":"exact","m":"HR","v":0.96,"lo":0.84,"hi":1.1,"om":"progression to cataract surgery","n":3159,"dur":"median follow-up 4.7 years","c":"AREDS2 Research Group (Chew EY et al.). JAMA Ophthalmol 2013","p":"23645227","url":"https://pubmed.ncbi.nlm.nih.gov/23645227/","pl":true}],[20,39,"X","Progression of age-related macular degeneration","AREDS2, with more than 4,000 participants, found that adding EPA and DHA to the AREDS supplement formula provided no additional benefit.",{"st":"no-ci","mt":"exact","m":"HR","v":0.97,"om":"progression to advanced age-related macular degeneration","n":4203,"dur":"median follow-up 5 years","c":"AREDS2 Research Group. JAMA 2013","p":"23644932","url":"https://pubmed.ncbi.nlm.nih.gov/23644932/","pl":false}],[20,212,"X","Cataracts","AREDS participants did not have a significantly lower risk of developing cataracts or cataract progression; a Swedish cohort linked about 1,000 mg/day supplements to 25% higher cataract extraction risk.",{"st":"no-ci","mt":"exact","m":"OR","v":0.97,"om":"development or progression of age-related lens opacities","n":4629,"dur":"average of 6.3 years","c":"Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001 (AREDS report no. 9)","p":"11594943","url":"https://pubmed.ncbi.nlm.nih.gov/11594943/","pl":false}],[20,92,"X","Cataracts","AREDS found no apparent effect on cataract development or progression over about 6.3 years, and AREDS2 confirmed this.",{"st":"no-ci","mt":"partial","m":"OR","v":0.97,"om":"development or progression of age-related lens opacities","n":4629,"dur":"average of 6.3 years","c":"Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001 (AREDS report no. 9)","p":"11594943","url":"https://pubmed.ncbi.nlm.nih.gov/11594943/","pl":false}]]}